Genomic_Variant	Chr	Position	Ref	Alt	Gene	NCBI_Gene_ID	Gene_ID_Link	Gene_Location	Variant_Type	Variant_Annotation	Protein	Protein_Length	NCBI_Protein_ID	Protein_ID_Link	Amino_Acid_Change	VoCs_and_VoIs	VoCs_and_VoIs_link	VoCs_and_VoIs_Description	SIFT_Score	SIFT_Prediction	GERP	PhyloP	PhastCons	Uniprot_Domains	UNIPROT_Disulphite_Bond	UNIPROT_glyphos	UNIPROT_Transmembrane	IEDB_B-Cell_Epitopes	IEDB_CD4_Epitopes	IEDB_cd4Epitope_Score	IEDB_CD8_Epitopes	IEDB_cd8Epitope_Score	MPDI_Potential_Immunogenic_Regions	MPDI_Potential_Immunodominant_Epitopes	ARTIC_Primers	RT-PCR_Primers/Probes	Sequencing_Error_Sites	Homoplasic_Positions	Hypermutable_Sites	Variant_Category	Co_Mutations	Global_Allele_Frequency	Method_of_Study	Experiment	Functional_Consequence	Reference	Reference_Link	Article 	Authors	Allele_Frequency_by_Geography	Location_link	IndiCoV_Link
25314G>T	1	25314	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	 G1251V	None	-	None	0.02	Deleterious	0.698	2.44436	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Sequence and mutation analysis followed by secondary structure predictions.	The triple site mutation 28881-28883 that brings change in two amino acid 203-204:RG>KR, is known to play a critical role in virion assembly and structure. The mutated 203/204 region of N protein affects the SR (serine-arginine)-rich motif of the protein (a crucial region for controlling viral transcription and replication) by introducing lysin in between them that might hamper the phosphorylation at serine residue required for normal functioning of N protein. Significant reduction in pathogenicity has been observed with the deletion of SR domain, therefore it is important to target 203-204:RG>KR positions of the N protein to design the drugs for controlling the disease.  	Rehman, S., Mahmood, T., Aziz, E., & Batool, R. (2020). Identification of novel mutations in SARS-COV-2 isolates from Turkey. Archives of Virology, 165(12), 2937–2944. https://doi.org/10.1007/s00705-020-04830-0	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538173/	Identication of novel mutations in SARS-COV-2 isolates from Turkey	Shazia Rehman, Tariq Mahmood, Ejaz Aziz, Riffat Batool		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87456&&LOCATION=1:25314:G:T
24000G>T	1	24000	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	 S813I	None	-	None	0.01	Deleterious	0.746	0.969701	0.338583	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000				Soliman, M. S., AbdelFattah, M., Aman, S., Ibrahim, L. M., & Aziz, R. K. (2020). A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions. Omics : a journal of integrative biology, 10.1089/omi.2020.0194. Advance online publication. https://doi.org/10.1089/omi.2020.0194	https://pubmed.ncbi.nlm.nih.gov/33253058/	A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions	May S Soliman , May AbdelFattah, Soad M N Aman, Lamyaa M Ibrahim, Ramy K Aziz 		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Deletion	Deletion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	∆H69/∆V70																												Computational and statistical analyses	In-silico analysis on phylogeny, transmissibility and Competitive advantage and increased growth rate	Deletion ∆H69/∆V70 in spike has arisen in multiple independent lineages of SARS-CoV-2, is linked to immune escape in immunocompromised patients, and enhances viral infectivity in vitro. This deletion is also responsible for certain commercial testing kits failing to detect the spike glycoprotein gene, and genomic data confirm that these S gene target failures in England are now overwhelmingly attributable to the new variant	Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., Wenseleers, T., Gimma, A., Waites, W., Wong, K. L. M., van Zandvoort, K., Silverman, J. D., Diaz-Ordaz, K., Keogh, R., Eggo, R. M., . . . Edmunds, W. J. (2021). Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science, 372(6538), eabg3055. https://doi.org/10.1126/science.abg3055	https://pubmed.ncbi.nlm.nih.gov/33658326/	Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England	Nicholas G Davies 1, Sam Abbott # 2, Rosanna C Barnard # 2, Christopher I Jarvis # 2, Adam J Kucharski # 2, James D Munday # 2, Carl A B Pearson # 2, Timothy W Russell # 2, Damien C Tully # 2, Alex D Washburne # 3, Tom Wenseleers # 4, Amy Gimma 2, William Waites 2, Kerry L M Wong 2, Kevin van Zandvoort 2, Justin D Silverman 5, CMMID COVID-19 Working Group; COVID-19 Genomics UK (COG-UK) Consortium; Karla Diaz-Ordaz 6, Ruth Keogh 6, Rosalind M Eggo 2, Sebastian Funk 2, Mark Jit 2, Katherine E Atkins 2 7, W John Edmunds 2		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22592G>T	1	22592	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A344S	None	-	None	0.88	Tolerated	0.715	2.63294	1	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_VFNATRFASVYAWNR	9.3	Surface glycoprotein_GEVFNATRF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0008250	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in decreased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Africa(0.000535);Asia(0.000110);Europe(0.000124);Oceania(0.000056);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85550&&LOCATION=1:22592:G:T
22604G>A	1	22604	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A348T	None	-	None	0.02	Deleterious	0.753	1.75899	0.80315	disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_VFNATRFASVYAWNR	9.3	Surface glycoprotein_NATRFASVY	0.1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0025260	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Africa(0.002472);Asia(0.000037);Europe(0.000017);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85572&&LOCATION=1:22604:G:A
22605C>T	1	22605	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A348V	None	-	None	0.02	Deleterious	1.65	3.2572	0.80315	disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_VFNATRFASVYAWNR	9.3	Surface glycoprotein_NATRFASVY	0.1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000670	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Europe(0.000011);Oceania(0.000056);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22530C>T	1	22530	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A419S	None	-	None	0.37	Tolerated	-1.36	0.510488	0	NA	NA	NA	NA	NA	Surface glycoprotein_SNFRVQPTESIVRFP	16	Surface glycoprotein_QPTESIVRF	0.02	NA	NA	nCoV-2019_75_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0001430	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Asia(0.000085);Europe(0.000058);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef854a0&&LOCATION=1:22530:C:T
22865G>T	1	22865	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A435S	None	-	None	0.5	Tolerated	1.65	4.256	0.913386	disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_IAWNSNNLDSK	NA	NA	NA	NA	NA	NA	NA	S Reverse	NA	NA	NA	No co - mutations reported	NA	0.0000900	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Asia(0.000061);Europe(0.000029);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85847&&LOCATION=1:22865:G:T
22986C>T	1	22986	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A475V	None	-	None	0.37	Tolerated	1.56	0.135937	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_STEIYQAGSTPCNGV	Surface glycoprotein_LKPFERDISTEIYQA	14	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0006770	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an decreased infectivity compared to the reference strain via cell line studies 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.000134);Asia(0.000122);Europe(0.000254);Oceania(0.000167);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef859a4&&LOCATION=1:22986:C:T
23120G>T	1	23120	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A520S	None	-	None	0.53	Tolerated	1.65	4.256	1	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_QPYRVVVLSFELLHA	14	NA	NA	NA	NA	NA	SARS-CoV-2_IBS_S1_F	NA	NA	NA	No co - mutations reported	NA	0.0048250	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in decreased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Africa(0.001069);Asia(0.002119);Europe(0.000858);Oceania(0.000779);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85b4b&&LOCATION=1:23120:G:T
23125G>T	1	23125	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A522S	None	-	None	0.3	Tolerated	-3.3	-1.48712	0.889764	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_77_LEFT	SARS-CoV-2_IBS_S1_F	NA	NA	NA	No co - mutations reported	NA	0.0047680	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in decreased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Africa(0.001002);Asia(0.000840);Europe(0.002147);Oceania(0.000779);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8824e&&LOCATION=1:23125:G:T
23271C>A	1	23271	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A570D	B.1.1.7	https://outbreak.info/situation-reports?pango=B.1.1.7	Characteristic mutation of B.1.1.7 lineage																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23521C>T	1	23521	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A653V	None	-	None	1	Tolerated	-0.869	0.385638	0.992126	NA	NA	NA	NA	Surface glycoprotein_GAEHVNNSYE	NA	NA	Surface glycoprotein_AEHVNNSY	0.11	NA	NA	nCoV-2019_77_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0075130	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Africa(0.004945);Asia(0.000536);Europe(0.001921);Oceania(0.000111);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8824e&&LOCATION=1:23521:C:T
21762C>T	1	21762	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A67V	B.1.525	https://outbreak.info/situation-reports?pango=B.1.525	Characteristic mutation of B.1.525 lineage																												Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo			
23614A>G	1	23614	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A684A	None	-	None	0.6	Tolerated	-1	0.421984	0.110236	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8613e&&LOCATION=1:23614:A:G
23614A>C	1	23614	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A684A	None	-	None	0.6	Tolerated	-1	0.421984	0.110236	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8613d&&LOCATION=1:23614:A:C
23613C>G	1	23613	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A684G	None	-	None	0.34	Tolerated	0.347	0.312441	0.102362	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8613b&&LOCATION=1:23613:C:G
23612G>T	1	23612	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A684S	None	-	None	0.47	Tolerated	NA	-0.016189	0.0944882	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001520	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Asia(0.000073);Europe(0.000079);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86139&&LOCATION=1:23612:G:T
23612G>A	1	23612	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A684T	None	-	None	0.41	Tolerated	NA	-0.016189	0.0944882	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0011910	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.000200);Asia(0.000877);Europe(0.000114);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86136&&LOCATION=1:23612:G:A
23613C>T	1	23613	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A684V	None	-	None	0.54	Tolerated	0.347	0.312441	0.102362	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0020830	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.000668);Asia(0.000609);Europe(0.000583);Oceania(0.000223);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8613c&&LOCATION=1:23613:C:T
23624G>T	1	23624	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A688S	None	-	None	0.59	Tolerated	-0.234	0.0933543	0	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0026540	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.000802);Asia(0.001523);Europe(0.000162);Oceania(0.000167);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8615e&&LOCATION=1:23624:G:T
23625C>T	1	23625	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A688V	None	-	None	0.37	Tolerated	-0.276	1.62696	0	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0113100	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.006615);Asia(0.001413);Europe(0.002781);Oceania(0.000501);	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86161&&LOCATION=1:23625:C:T
23664C>T	1	23664	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A701V	B.1.351	https://outbreak.info/situation-reports?pango=B.1.351	Characteristic mutation of B.1.351 lineage																																	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23678G>T	1	23678	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A706S	None	-	None	0.94	Tolerated	1.65	4.256	0.929134	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_LGAENSVAY	0.07	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0002800	Computational Analysis	Sequence alignments followed by Secondary structure predictions and  protein dynamics study	Effect of the mutations on the structural dynamics of Spike glycoprotein were measured using the differences of free energy (ΔΔG) between wild-type and mutant. The ΔΔG, as a consequence of mutation, correlates with the structural changes in three-dimensional structure of protein, and, thus, measures the effect of mutation on protein stability. A706S was predicted to stabilize the protein structure with the ΔΔG value of 0.167 kcal/mol.	Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891	https://pubmed.ncbi.nlm.nih.gov/33015411/	Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics	Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad	Africa(0.000067);Asia(0.000134);Europe(0.000079)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86207&&LOCATION=1:23678:G:T
23874C>T	1	23874	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A771V	None	-	None	0.15	Tolerated	1.65	3.27011	0.850394	NA	NA	NA	NA	Surface glycoprotein_AVEQDKNTQE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000920	Computational Analysis	Sequence and mutation analysis followed by secondary structure predictions.	The triple site mutation 28881-28883 that brings change in two amino acid 203-204:RG>KR, is known to play a critical role in virion assembly and structure. The mutated 203/204 region of N protein affects the SR (serine-arginine)-rich motif of the protein (a crucial region for controlling viral transcription and replication) by introducing lysin in between them that might hamper the phosphorylation at serine residue required for normal functioning of N protein. Significant reduction in pathogenicity has been observed with the deletion of SR domain, therefore it is important to target 203-204:RG>KR positions of the N protein to design the drugs for controlling the disease.  	Rehman, S., Mahmood, T., Aziz, E., & Batool, R. (2020). Identification of novel mutations in SARS-COV-2 isolates from Turkey. Archives of Virology, 165(12), 2937–2944. https://doi.org/10.1007/s00705-020-04830-0	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538173/	Identication of novel mutations in SARS-COV-2 isolates from Turkey	Shazia Rehman, Tariq Mahmood, Ejaz Aziz, Riffat Batool	Asia(0.000049);Europe(0.000043)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86438&&LOCATION=1:23874:C:T
24054C>T	1	24054	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A831V	None	-	None	1	Tolerated	1.65	3.27011	1	NA	NA	NA	NA	NA	NA	19	Surface glycoprotein_TLADAGFIK	-1	Spike glycoprotein	FIEDLLFNKVTLADAGF	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	Co-occurrinng with 23403A>G (D614G)	0.0012160	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an decreased infectivity compared to the reference strain via cell line studies 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800##Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Foley, B., Giorgi, E. E., Bhattacharya, T., Parker, M. D., Partridge, D. G., Evans, C. M., Freeman, T. M., de Silva, T. I., LaBranche, C. C., Montefiori, D. C., & on behalf of the Sheffield COVID-19 Genomics Group. (n.d.). Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. https://doi.org/10.1101/2020.04.29.069054	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/##https://www.sciencedirect.com/science/article/pii/S0092867420308205?via%3Dihub	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity##Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##B Korber,  WM Fischer,  S Gnanakaran, H Yoon,  J Theiler, W Abfalterer,  B Foley, EE Giorgi,  T Bhattacharya, MD Parker, DG Partridge, CM Evans, TM Freeman,  TI de Silva, on behalf of the Sheffield COVID-19 Genomics Group,  CC LaBranche,  DC Montefiori	Africa(0.000134);Asia(0.000183);Europe(0.000676);Oceania(0.000223)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86634&&LOCATION=1:24054:C:T
24197G>T	1	24197	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A879S	None	-	None	0.66	Tolerated	0.52	1.07924	0.590551	NA	NA	NA	NA	Surface glycoprotein_DEMIAQYTSALLAG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	Co-occuring with 23403A>G (D614G)	0.0064430	Computational Analysis and Experimental	Sequence alignments followed by Secondary structure predictions and  protein dynamics study.##pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Effect of the mutations on the structural dynamics of Spike glycoprotein were measured using the differences of free energy (ΔΔG) between wild-type and mutant. The ΔΔG, as a consequence of mutation, correlates with the structural changes in three-dimensional structure of protein, and, thus, measures the effect of mutation on protein stability. A879S was predicted to destabilize the protein structure with the ΔΔG value of −0.384 kcal/mol.##Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera. These co-occurring mutations were found to have an decreased sensitivity to convalescent sera	Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891##Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	https://pubmed.ncbi.nlm.nih.gov/33015411/##http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics##The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad##Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.004143);Asia(0.001194);Europe(0.000001);Europe(0.001049);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef867e5&&LOCATION=1:24197:G:T
24237C>T	1	24237	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A892V	None	-	None	0.06	Tolerated	1.65	3.27011	0.992126	NA	NA	NA	NA	NA	NA	NA	NA	NA	Spike glycoprotein	GAALQIPFAMQMAYRFN, PFAMQMAYRFNGIGVTQ, MAYRFNGIGVTQNVLYE	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0011890	Computational Analysis	Sequence alignments followed by Secondary structure predictions and  protein dynamics study	Effect of the mutations on the structural dynamics of Spike glycoprotein were measured using the differences of free energy (ΔΔG) between wild-type and mutant. The ΔΔG, as a consequence of mutation, correlates with the structural changes in three-dimensional structure of protein, and, thus, measures the effect of mutation on protein stability. A892V was predicted to destabilize the protein structure with the ΔΔG value of −0.05 kcal/mol.	Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891	https://pubmed.ncbi.nlm.nih.gov/33015411/	Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics	Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad	Africa(0.000334);Asia(0.000219);Europe(0.000580);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86855&&LOCATION=1:24237:C:T
24351C>T	1	24351	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	A930V	None	-	None	0	Deleterious	1.65	3.27011	0.976378	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0079140	Computational Analysis	Protein Sequence Alignmnet . MutPred server was used to analyze the mutation. JMol and ConSurf tools were used to predict the structure of the proteins. PyMoL standalone software was used to visualize the structure and understand the pattern of bonding.	Mutation A930V falls in the S2 subunit of S protein. In substitution of A (alanine) to V (valine) at position 930 (A930V) both the amino acids are hydrophobic in nature, any change that might occur due to this mutation might get masked upon tertiary structure formation and thus not impose a functional change in the protein, i.e. a conservative mutation.##Comparisons of MD simulations in the WT and mutants revealed a significant de-stabilization effect of the mutations on RBD and HR1 domains	Saha, P., Banerjee, A. K., Tripathi, P. P., Srivastava, A. K., & Ray, U. (2020). A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity. Bioscience Reports, 40(5), 1. https://doi.org/10.1042/bsr20201312##Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891##Ahamad, S., Kanipakam, H., & Gupta, D. (2020). Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1811774	https://pubmed.ncbi.nlm.nih.gov/32378705/##https://pubmed.ncbi.nlm.nih.gov/32851910/	A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity##Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics##Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding	Priyanka Saha , Arup Kumar Banerjee , Prem Prakash Tripathi , Amit Kumar Srivastava , Upasana Ray##Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad##Shahzaib Ahamad 1, Hema Kanipakam 1, Dinesh Gupta 1	Africa(0.000067);Asia(0.000037);Europe(0.000022);Oceania(0.007788)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86995&&LOCATION=1:24351:C:T
25311G>T	1	25311	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	C1250F	None	-	None	0.01	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0010890	Computational Analysis	Multiple Sequence Alignment (MSA) and Mutation analysis followed by RNA Secondary Structure prediction and Base Pair Probability Analysis. Potential miRNA Binding Sites and Splice sites were also analysed	G25311U in a patient sample isolated in Indiaremoved the miR-4661-3p binding site within the S gene	Hosseini Rad SM, A., & McLellan, A. D. (2020). Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting. International Journal of Molecular Sciences, 21(13), 4807. https://doi.org/10.3390/ijms21134807	https://pubmed.ncbi.nlm.nih.gov/32645951/	Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting	Ali Hosseini Rad Sm , Alexander D McLellan	Africa(0.000200);Asia(0.000317);Europe(0.000405);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8744d&&LOCATION=1:25311:G:T
27790G>C	1	27790	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	C12S	None	-	None	0	Deleterious	0.695	2.49356	1	NA	NA	NA	Transmembrane	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_92_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	A list of computational methods were performed which includes, Sequence retrieval and data mining of SNPs followed by functional annotation, Predicting evolutionary conserved residues using ConSurf webserver, mCSM webserver to predict the protein stability analysis, Predicting disease related mutations using MutPred, I-TASSER to generate complete 3D structure of both proteins for their wild-type and mutated sequences and Molecular docking analysis.	The mutations W461R, G405E and F588S in ACE2 receptor protein and population specific mutations P391S, C12S and G1223A in the spike glycoprotein were predicted as highly destabilizing to the structure of the bound complex. C12S mutant observed majorly in Indian isolates was found to affect the mCSM protein stability score thereby possessing a potential to destabilize the structure of the protein.	Khalid, Z., & Naveed, H. (2020). Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1823885	https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1823885	Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms	Zoya Khalid, Hammad Naveed		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef891f7&&LOCATION=1:27790:G:C
22858C>A	1	22858	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Stop Gain	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	C432*	None	-	None	NA	NA	-2.18	-0.238614	0.976378	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	S Reverse	NA	NA	NA	No co - mutations reported	NA	0.0001430	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.000067);Asia(0.000073);Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85831&&LOCATION=1:22858:C:A
24914G>C	1	24914	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D1118H	B.1.1.7##B.1.620	https://outbreak.info/situation-reports?pango=B.1.1.7##https://outbreak.info/situation-reports?pango=B.1.620	Characteristic mutation of B.1.1.7 and B.1.620 lineages																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
21893G>A	1	21893	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D111N	None	-	None	0.45	Tolerated	-0.219	0.168063	0	Disulf_bond	BetaCoV_S1-NTD	NA	NA	Surface glycoprotein_TLDSKTQSLLIVNNATNV	NA	NA	Surface glycoprotein_TLDSKTQSL	0.14	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0008060	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Africa(0.000134);Asia(0.000329);Europe(0.000343)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef84cb5&&LOCATION=1:21893:G:A
21974G>T	1	21974	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D138Y	P.1	https://outbreak.info/situation-reports?pango=P.1	Characteristic mutation of P.1 lineage																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22206A>G	1	22206	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D215G	B.1.351##B.1.616	https://outbreak.info/situation-reports?pango=B.1.351##https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.351 and B.1.616 lineages																																	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22444C>T	1	22444	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D294D	None	-	None	1	Tolerated	-3.3	-1.23717	0.0314961	disulf_bond	BetaCoV_S1-NTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	SARS-CoV-2_IBS_S2_R	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8535b&&LOCATION=1:22444:C:T
22443A>T 	1	22443	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D294E	None	-	None	0.02	Deleterious	1.65	2.21203	0.0314961	Disulf_bond	BetaCoV_S1-NTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	SARS-CoV-2_IBS_S2_R	NA	NA	NA	No co - mutations reported	NA	0.0000020	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Europe(0.000002)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22444C>A	1	22444	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D294E	None	-	None	0.02	Deleterious	1.65	2.21203	0.0314961	Disulf_bond	BetaCoV_S1-NTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	SARS-CoV-2_IBS_S2_R	NA	NA	NA	No co - mutations reported	NA	0.0000020	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Europe(0.000002)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85359&&LOCATION=1:22444:C:A
22652G>T	1	22652	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D364Y	None	-	None	0	Deleterious	1.65	4.256	0.551181	NA	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_KRISNCVADYSVLYNSASFST	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000240	Computational Analysis and Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR.####In-silico analysis on mutant affinity was also checked.	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain.##D364Y displayed higher binding affinity to human ACE2, likely due to the enhanced structural stabilization of the RBD beta-sheet scaffold.	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800##Ou, J., Zhou, Z., Dai, R., Zhao, S., Wu, X., Zhang, J., Lan, W., Cui, L., Wu, J., Seto, D., Chodosh, J., Zhang, G., & Zhang, Q. (n.d.). Emergence of SARS-CoV-2 spike RBD mutants that enhance viral infectivity through increased human ACE2 receptor binding affinity. https://doi.org/10.1101/2020.03.15.991844	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/##https://www.biorxiv.org/content/10.1101/2020.03.15.991844v5.full	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity##Emergence of SARS-CoV-2 spike RBD mutants that enhance viral infectivity through increased human ACE2 receptor binding affinity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##Junxian Ou, Zhonghua Zhou, Ruixue Dai, Shan Zhao, Xiaowei Wu, Jing Zhang, Wendong Lan, Lilian Cui, Jianguo Wu, Donald Seto, James Chodosh, Gong Zhang,  Qiwei Zhang	Asia(0.000024)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef855f9&&LOCATION=1:22652:G:T
22962A>T	1	22962	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D467V	None	-	None	0.23	Tolerated	1.65	2.25839	0.488189	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_LKPFERDISTEIYQA	14	Surface glycoprotein_KPFERDISTEI	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000560	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85958&&LOCATION=1:22962:A:T
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D480G	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Experimental	Pseudotyped Virus Infectivity analysis. 	A single SARS-CoV-1 amino acid change, Spike D480A/G in the receptor binding domain (RBD), arose in infected humans and civets and became the dominant variant among 2003/2004 viruses. D480A/G escapes neutralizing antibody 80R, and immune pressure from 80R in vitro could recapitulate emergence of the D480 mutation. Although there is no evidence yet of antigenic drift for SARS-CoV-2, with extended human-to-human transmission, SARS-CoV-2 could also acquire mutations with fitness advantages and immunological resistance. Attending to this risk now by identifying evolutionary transitions that may be relevant to the fitness or antigenic profile of the virus is important to ensure effectiveness of the vaccines and immunotherapeutic interventions as they advance to the clinic.	Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., Hastie, K. M., Parker, M. D., Partridge, D. G., Evans, C. M., Freeman, T. M., de Silva, T. I., Sheffield COVID-19 Genomics Group, McDanal, C., Perez, L. G., … Montefiori, D. C. (2020). Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell, 182(4), 812–827.e19.	https://linkinghub.elsevier.com/retrieve/pii/S0092867420308205	Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus	Bette Korber, Will M. Fischer, Sandrasegaram Gnanakaran, Celia C. LaBranche, Erica O. Saphire, David C. Montefiori		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23403A>G	1	23403	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D614G	B.1.1.7## B.1.351## P.1## B.1.525## B.1.427/B.1.429## P.3## B.1.616## B.1.617.1## B.1.617.2## B.1.617.3## B.1.620## B.1.621	https://outbreak.info/situation-reports?pango=B.1.1.7##https://outbreak.info/situation-reports?pango=B.1.351##https://outbreak.info/situation-reports?pango=P.1##https://outbreak.info/situation-reports?pango=B.1.525##https://outbreak.info/situation-reports?pango=B.1.427##https://outbreak.info/situation-reports?pango=P.3##https://outbreak.info/situation-reports?pango=B.1.616##https://outbreak.info/situation-reports?pango=B.1.617.1##https://docs.google.com/spreadsheets/d/1HiZZ5_9c6eqpjiWd0y4m12XaHRN_0jlQIQ6IZPVFScI/edit#gid=0##https://outbreak.info/situation-reports?pango=B.1.617.3##https://outbreak.info/situation-reports?pango=B.1.620##https://outbreak.info/situation-reports?pango=B.1.621	Characteristic mutation of B.1.1.7, B.1.351,  P.1,  B.1.525,  B.1.427/B.1.429,  P.3,  B.1.616,  B.1.617.1, B.1.617.2, B.1.617.3, B.1.620 and B.1.621 lineages.	0.3	Tolerated	1.65	2.25839	1	NA	NA	NA	NA	Surface glycoprotein_FGGVSVITPGTNTSNQVAVLYQDVNCTEV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Multiple co-occurring mutations reported	L5F, Q321L, V341I, K458R, I472V, Q675H, A831V, A879S, D936Y, S939F, S943T, M1237I	3.8132660	Computational Analysis and Experimental	Computational structural analysis using cryo electron microscopy structures of Spike protein followed by calculation of free energy changes due to mutations.##Maloney murine leukemia virus (MLV)-based pseudoviruses (PVs), expressing green fluorescent protein (GFP) and pseudotyped with the S protein of SARS-CoV-2 (SARS2) carrying the D614 or G614 genotype (SD614 and SG614, respectively) were produced from transfected HEK293T cells were used to determine the alteration properties of D614G mutation.	Increased case fatality rate correlated strongly with the proportion of viruses bearing G614 on a country by country basis. The amino acid at position 614 occurs at an internal protein interface of the viral spike, and the presence of G at this position was calculated to destabilize a specific conformation of the viral spike, within which the key host receptor binding site is more accessible.##614G is associated with higher viral load and younger age of patients	Zhang, L., Jackson, C. B., Mou, H., Ojha, A., Rangarajan, E. S., Izard, T., Farzan, M., & Choe, H. (2020). The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv : the preprint server for biology, 2020.06.12.148726.https://doi.org/10.1101/2020.06.12.148726##Becerra-Flores, M., & Cardozo, T. (2020). SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate. International journal of clinical practice, 74(8), e13525. https://doi.org/10.1111/ijcp.13525##Raghav, S., Ghosh, A., Turuk, J., Kumar, S., Jha, A., Madhulika, S., Priyadarshini, M., Biswas, V. K., Sushree Shyamli, P., Singh, B., Singh, N., Singh, D., Datey, A., Kiran, A., Smita, S., Sabat, J., Bhattacharya, D., Dash, R., Senapati, S., … ILS COVID-19 team. (n.d.). SARS-CoV2 genome analysis of Indian isolates and molecular modelling of D614G mutated spike protein with TMPRSS2 depicted its enhanced interaction and virus infectivity. https://doi.org/10.1101/2020.07.23.217430##Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., Hastie, K. M., Parker, M. D., Partridge, D. G., Evans, C. M., Freeman, T. M., de Silva, T. I., Sheffield COVID-19 Genomics Group, McDanal, C., Perez, L. G., … Montefiori, D. C. (2020). Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell, 182(4), 812–827.e19.##Eaaswarkhanth, M., Al Madhoun, A., & Al-Mulla, F. (2020). Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 96, 459–460. https://doi.org/10.1016/j.ijid.2020.05.071##Maitra, A., Sarkar, M. C., Raheja, H., Biswas, N. K., Chakraborti, S., Singh, A. K., Ghosh, S., Sarkar, S., Patra, S., Mondal, R. K., Ghosh, T., Chatterjee, A., Banu, H., Majumdar, A., Chinnaswamy, S., Srinivasan, N., Dutta, S., & Das, S. (2020). Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility. Journal of Biosciences, 45(1), 1. https://doi.org/10.1007/s12038-020-00046-1##Volz, E., Hill, V., McCrone, J. T., Price, A., Jorgensen, D., O'Toole, Á., Southgate, J., Johnson, R., Jackson, B., Nascimento, F. F., Rey, S. M., Nicholls, S. M., Colquhoun, R. M., da Silva Filipe, A., Shepherd, J., Pascall, D. J., Shah, R., Jesudason, N., Li, K., Jarrett, R., … Connor, T. R. (2021). Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity. Cell, 184(1), 64–75.e11. https://doi.org/10.1016/j.cell.2020.11.020##Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428##Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010##Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411##Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://www.nature.com/articles/s41467-020-19808-4##https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/##https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/##https://pubmed.ncbi.nlm.nih.gov/33961693/##https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity##SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate##SARS-CoV2 genome analysis of Indian isolates and molecular modelling of D614G mutated spike protein with TMPRSS2 depicted its enhanced interaction and virus infectivity##Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus##Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?##Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility##Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity##SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant##Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil##Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees##Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Lizhou Zhang, Cody B Jackson, Huihui Mou, Amrita Ojha, Erumbi S Rangarajan, Tina Izard, Michael Farzan, Hyeryun Choe##Manuel Becerra-Flores ,Timothy Cardozo##Sunil Raghav, Arup Ghosh, Jyotirmayee Turuk, Sugandh Kumar, Atimukta Jha, Swati Madhulika, Manasi Priyadarshini, Viplov K. Biswas, P. Sushree Shyamli, Bharati Singh, Neha Singh, Deepika Singh, Ankita Datey, Avula Kiran, Shuchi Smita, Jyotsnamayee Sabat, Debdutta Bhattacharya, Rupesh Dash, Shantibhushan Senapati, Tushar K. Beuria, Rajeeb Swain, Soma Chattopadhyay, Gulam Hussain Syed, Anshuman Dixit, Punit Prasad, Odisha COVID-19 study group, ILS COVID-19 team, Sanghamitra Pati, Ajay Parida##Bette Korber, Will M. Fischer, Sandrasegaram Gnanakaran, Celia C. LaBranche, Erica O. Saphire, David C. Montefiori##Muthukrishnan Eaaswarkhanth, Ashraf Al Madhoun, Fahd Al-Mulla##Arindam Maitra, Mamta Chawla Sarkar, Harsha Raheja,Nidhan K Biswas,Sohini Chakraborti,Animesh Kumar Singh,Shekhar Ghosh, Sumanta Sarkar,Subrata Patra,Rajiv Kumar Mondal, Trinath Ghosh,Ananya Chatterjee,Hasina Banu,Agniva Majumdar,Sreedhar Chinnaswamy,Narayanaswamy Srinivasan,Shanta Dutta, and  Saumitra Das##Erik Volz 1, Verity Hill 2, John T McCrone 2, Anna Price 3, David Jorgensen 4, Áine O'Toole 2, Joel Southgate 5, Robert Johnson 4, Ben Jackson 2, Fabricia F Nascimento 4, Sara M Rey 6, Samuel M Nicholls 7, Rachel M Colquhoun 2, Ana da Silva Filipe 8, James Shepherd 8, David J Pascall 9, Rajiv Shah 8, Natasha Jesudason 8, Kathy Li 8, Ruth Jarrett 8, Nicole Pacchiarini 6, Matthew Bull 6, Lily Geidelberg 4, Igor Siveroni 4, COG-UK Consortium; Ian Goodfellow 10, Nicholas J Loman 7, Oliver G Pybus 11, David L Robertson 8, Emma C Thomson 8, Andrew Rambaut 12, Thomas R Connor 13##Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group##Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6#Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2##Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo	Africa(0.921088);Asia(0.913533);Europe(0.000123);Europe(0.976964);Oceania(1.001558)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85e7d&&LOCATION=1:23403:A:G
21801A>C	1	21801	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D80A	B.1.351	https://outbreak.info/situation-reports?pango=B.1.351	Characteristic mutation of B.1.351 lineage																																	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
24079T>A	1	24079	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D839E	None	-	None	0.48	Tolerated	-3.3	-1.00208	0.96063	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_80_LEFT	NA	NA	NA	NA	Fusion peptide mutation	NA	0.0000260	Computational Analysis	Sequence alignments followed by Secondary structure predictions and  protein dynamics study	Mutation found to occur in the region of fusion peptide. This mutation could potentially impact conformational rearrangements as the S2 unit transitions from pre-fusion to post-fusion by enhancing the association of the HR1 trimer and maintaining amphipathicity when the a single HR1 helix is extended	Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Foley, B., Giorgi, E. E., Bhattacharya, T., Parker, M. D., Partridge, D. G., Evans, C. M., Freeman, T. M., de Silva, T. I., LaBranche, C. C., Montefiori, D. C., & on behalf of the Sheffield COVID-19 Genomics Group. (n.d.). Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. https://doi.org/10.1101/2020.04.29.069054	https://www.sciencedirect.com/science/article/pii/S0092867420308205?via%3Dihub	Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2	B Korber,  WM Fischer,  S Gnanakaran, H Yoon,  J Theiler, W Abfalterer,  B Foley, EE Giorgi,  T Bhattacharya, MD Parker, DG Partridge, CM Evans, TM Freeman,  TI de Silva, on behalf of the Sheffield COVID-19 Genomics Group,  CC LaBranche,  DC Montefiori	Asia(0.000012);Europe(0.000014)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8667c&&LOCATION=1:24079:T:A
24079T>G	1	24079	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D839E	None	-	None	0.48	Tolerated	-3.3	-1.00208	0.96063	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_80_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Sequence alignments followed by Secondary structure predictions and  protein dynamics study	Mutation found to occur in the region of fusion peptide. This mutation could potentially impact conformational rearrangements as the S2 unit transitions from pre-fusion to post-fusion by enhancing the association of the HR1 trimer and maintaining amphipathicity when the a single HR1 helix is extended	Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Foley, B., Giorgi, E. E., Bhattacharya, T., Parker, M. D., Partridge, D. G., Evans, C. M., Freeman, T. M., de Silva, T. I., LaBranche, C. C., Montefiori, D. C., & on behalf of the Sheffield COVID-19 Genomics Group. (n.d.). Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. https://doi.org/10.1101/2020.04.29.069054	https://www.sciencedirect.com/science/article/pii/S0092867420308205?via%3Dihub	Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2	B Korber,  WM Fischer,  S Gnanakaran, H Yoon,  J Theiler, W Abfalterer,  B Foley, EE Giorgi,  T Bhattacharya, MD Parker, DG Partridge, CM Evans, TM Freeman,  TI de Silva, on behalf of the Sheffield COVID-19 Genomics Group,  CC LaBranche,  DC Montefiori		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8667e&&LOCATION=1:24079:T:G
24077G>A	1	24077	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D839N	None	-	None	1	Tolerated	1.65	4.256	0.992126	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Fusion peptide mutation	NA	0.0003190	Computational Analysis	Sequence alignments followed by Secondary structure predictions and  protein dynamics study	Mutation found to occur in the region of fusion peptide. This mutation could potentially impact conformational rearrangements as the S2 unit transitions from pre-fusion to post-fusion by enhancing the association of the HR1 trimer and maintaining amphipathicity when the a single HR1 helix is extended	Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Foley, B., Giorgi, E. E., Bhattacharya, T., Parker, M. D., Partridge, D. G., Evans, C. M., Freeman, T. M., de Silva, T. I., LaBranche, C. C., Montefiori, D. C., & on behalf of the Sheffield COVID-19 Genomics Group. (n.d.). Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. https://doi.org/10.1101/2020.04.29.069054	https://www.sciencedirect.com/science/article/pii/S0092867420308205?via%3Dihub	Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2	B Korber,  WM Fischer,  S Gnanakaran, H Yoon,  J Theiler, W Abfalterer,  B Foley, EE Giorgi,  T Bhattacharya, MD Parker, DG Partridge, CM Evans, TM Freeman,  TI de Silva, on behalf of the Sheffield COVID-19 Genomics Group,  CC LaBranche,  DC Montefiori	Africa(0.000200);Europe(0.000008);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86677&&LOCATION=1:24077:G:A
24077G>T	1	24077	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D839Y	None	-	None	0.02	Deleterious	1.65	4.256	0.992126	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0026400	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800##Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Foley, B., Giorgi, E. E., Bhattacharya, T., Parker, M. D., Partridge, D. G., Evans, C. M., Freeman, T. M., de Silva, T. I., LaBranche, C. C., Montefiori, D. C., & on behalf of the Sheffield COVID-19 Genomics Group. (n.d.). Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. https://doi.org/10.1101/2020.04.29.069054	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/##http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/##https://www.sciencedirect.com/science/article/pii/S0092867420308205?via%3Dihub	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity##Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##B Korber,  WM Fischer,  S Gnanakaran, H Yoon,  J Theiler, W Abfalterer,  B Foley, EE Giorgi,  T Bhattacharya, MD Parker, DG Partridge, CM Evans, TM Freeman,  TI de Silva, on behalf of the Sheffield COVID-19 Genomics Group,  CC LaBranche,  DC Montefiori	Africa(0.000067);Asia(0.000219);Europe(0.000630);Oceania(0.001724)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86678&&LOCATION=1:24077:G:T
24369A>C	1	24369	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D936A	None	-	None	0.09	Tolerated	1.65	2.28422	1	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000030	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869c9&&LOCATION=1:24369:A:C
24370C>A	1	24370	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D936E	None	-	None	1	Tolerated	-3.3	-0.125732	0.992126	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000460	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Asia(0.000024);Europe(0.000022)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869cb&&LOCATION=1:24370:C:A
24370C>G	1	24370	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D936E	None	-	None	1	Tolerated	-3.3	-0.125732	0.992126	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869cc&&LOCATION=1:24370:C:G
24368G>C	1	24368	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D936H	None	-	None	0.02	Deleterious	1.65	4.256	1	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0023420	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Africa(0.000267);Asia(0.001730);Europe(0.000234);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869c5&&LOCATION=1:24368:G:C
24368G>A	1	24368	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D936N	None	-	None	0.19	Tolerated	1.65	4.256	1	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0020200	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Africa(0.001270);Asia(0.000183);Europe(0.000511);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869c4&&LOCATION=1:24368:G:A
24369A>T	1	24369	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D936V	None	-	None	0.03	Deleterious	1.65	2.28422	1	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000960	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Europe(0.000096)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869cb&&LOCATION=1:24370:C:A
24368G>T	1	24368	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D936Y	None	-	None	0.01	Deleterious	1.65	4.256	1	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	Co-occuring with 23403A>G (D614G)	0.0063050	Computational Analysis and Experimentally	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.##pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.##Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly increased infectivity in comparison to the reference strain##Comparisons of MD simulations in the WT and mutants revealed a significant de-stabilization effect of the mutations on RBD and HR1 domains	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152##Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800##Ahamad, S., Kanipakam, H., & Gupta, D. (2020). Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1811774	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full##http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly##The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity##Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding	Luigi Cavallo, Romina Oliva##Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##Shahzaib Ahamad 1, Hema Kanipakam 1, Dinesh Gupta 1	Africa(0.002071);Asia(0.001047);Europe(0.002909);Oceania(0.000278)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869c8&&LOCATION=1:24368:G:T
24410G>A	1	24410	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	D950N	B.1.617.2	https://outbreak.info/situation-reports?pango=B.1.617.2	Characteristic mutation of B.1.617.2 lineage																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
24836G>A	1	24836	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	E1092K	P.3	https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of P.3 lineage 																																		
23014A>T	1	23014	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	E484D	None	-	None	0.62	Tolerated	-1.88	-1.23742	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000650	Computational Analysis	Multiple sequence alignment followed by topology-based feature generation and convolutional neural network-assisted models for analysing the protein structure	Prediction of free adversarial free energy change due to mutations identified Y423F as a hotspot residue, significantly increasing the infectivity of the virus	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/	Mutations Strengthened SARS-CoV-2 Infectivity	Jiahui Chen, Rui Wang, Menglun Wang and Guo-Wei Wei	Asia(0.000049);Europe(0.000016)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef859fb&&LOCATION=1:23014:A:T
23012G>A	1	23012	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	E484K	B.1.1.7## B.1.351## P.1## B.1.525## P.3## B.1.620	https://outbreak.info/situation-reports?pango=B.1.1.7##https://outbreak.info/situation-reports?pango=B.1.351##https://outbreak.info/situation-reports?pango=P.1##https://outbreak.info/situation-reports?pango=B.1.525##https://outbreak.info/situation-reports?pango=P.3##https://outbreak.info/situation-reports?pango=B.1.620	Characteristic mutation of B.1.1.7, B.1.351, P.1,  B.1.525, P.3 and B.1.620 lineages.	0.92	Tolerated	-1.76	-2.61077	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.3632070	Experimental	Study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.####Neutralization assays with monoclonal antibodies were also performed.	Viruses passaged in the presence of monoclonal antibodies C121, C144  had mutations at positions E484 and Q493. In contrast, virus populations passaged in the presence of monoclonal antibody C135 lacked mutations at E484 or Q493. he E484K and Q493R mutants that emerged during replication in the presence of C121 or C144, both caused apparently complete, or near complete, resistance to both antibodies. However, both of these mutants retained full sensitivity to C135. Eight anti-spike antibodies were tested against sixteen SARS-CoV-2 spike protein RBD variants. Variants were encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. IC50(M) values are shown for each variant. There was no observed neutralization with hIgG1 isotype control 	Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312##Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831##Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428##Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010##Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33112236/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/##https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/##https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/##https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants##Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies##SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant##Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil##Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz##Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous##Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group##Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6##Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo	Africa(0.279367);Asia(0.056577);Europe(0.020477);Oceania(0.006786)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef859f3&&LOCATION=1:23012:G:A
23311G>T	1	23311	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	E583D	None	-	None	0.33	Tolerated	-3.3	-3.60957	0	Disulf_bond	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0097500	Computational Analysis	Protein-specific analysis (Topology based Machine Learning structure prediction)	With the hypothesize that single mutations on S protein RBD with positive binding affinity changes will enhance the viral transmission since natural selection favors them, E583D is found to be an infectivity enhancing S protein mutation along with Q675R co mutation. Also, E583D mutation was predicted to decrease the stability of the protein with ΔΔG value of −0.143 kcal/mol	Wang, R., Chen, J., Gao, K., Hozumi, Y., Yin, C., & Wei, G. (2020). Characterizing SARS-CoV-2 mutations in the United States. Research Square. https://doi.org/10.21203/rs.3.rs-49671/v1##Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430589/##https://pubmed.ncbi.nlm.nih.gov/33015411/	Characterizing SARS-CoV-2 mutations in the United States##Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics	Rui Wang, Jiahui Chen, Kaifu Gao, Yuta Hozumi , Changchuan Yin, and Guo-Wei Wei##Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad	Africa(0.001069);Asia(0.002387);Europe(0.004792);Oceania(0.001502)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85d71&&LOCATION=1:23311:G:T
23311G>C	1	23311	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	E583D	None	-	None	0.33	Tolerated	-3.3	-3.60957	0	disulf_bond	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Sequence alignments followed by Secondary structure predictions and  protein dynamics study	Effect of the mutations on the structural dynamics of Spike glycoprotein were measured using the differences of free energy (ΔΔG) between wild-type and mutant. The ΔΔG, as a consequence of mutation, correlates with the structural changes in three-dimensional structure of protein, and, thus, measures the effect of mutation on protein stability. E583D was predicted to destabilize the protein structure with the ΔΔG value of −0.143kcal/mol.	Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891	https://pubmed.ncbi.nlm.nih.gov/33015411/	Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics	Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85d6f&&LOCATION=1:23311:G:C
23311G>T	1	23311	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	E583D	None	-	None	0.33	Tolerated	-3.3	-3.60957	0	disulf_bond	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Sequence alignments followed by Secondary structure predictions and  protein dynamics study	Effect of the mutations on the structural dynamics of Spike glycoprotein were measured using the differences of free energy (ΔΔG) between wild-type and mutant. The ΔΔG, as a consequence of mutation, correlates with the structural changes in three-dimensional structure of protein, and, thus, measures the effect of mutation on protein stability. E583D was predicted to destabilize the protein structure with the ΔΔG value of −0.143kcal/mol.	Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891	https://pubmed.ncbi.nlm.nih.gov/33015411/	Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics	Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85d71&&LOCATION=1:23311:G:T
22033C>A	1	22033	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F157L	None	-	None	0.76	Tolerated	-0.866	0.551307	0.00787402	Disulf_bond	BetaCoV_S1-NTD	NA	NA	Surface glycoprotein_HKNNKSWMESEFRVYSSANNCTF	Surface glycoprotein_EFRVYSSANNCTFEY	18	NA	NA	NA	NA	nCoV-2019_72_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0231220	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Africa(0.021515);Asia(0.000609);Europe(0.000831);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef84e44&&LOCATION=1:22033:C:A
22574T>C	1	22574	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F338L	None	-	None	0.11	Tolerated	1.65	2.13354	0.968504	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_RFPNITNLCPF	0.07	Spike glycoprotein	VRFPNITNLCPFGEVFN	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0003090	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was accessed. Increased sensitivity to convalescent sera. This mutation was found to possess over 4-fold sensitivity to one or two of the ten tested sera.	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.000134);Asia(0.000012);Europe(0.000107);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85517&&LOCATION=1:22574:T:C
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F456	None	-	None																						No co - mutations reported	NA	0.0000000	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	Deep mutational scanning library yeast surface-display induction and labeling followed by Cell sorting, Sequencing and Phenotype analysis	Mutants at this amino acid residue were found to abolish the binding affinity to hACE2 in comparison to wildtype	Yi, C., Sun, X., Ye, J. et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol 17, 621–630 (2020). https://doi.org/10.1038/s41423-020-0458-z	https://www.nature.com/articles/s41423-020-0458-z	Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies	Chunyan Yi, Xiaoyu Sun, Jing Ye, Longfei Ding, Meiqin Liu, Zhuo Yang, Xiao Lu, Yaguang Zhang, Liyang Ma, Wangpeng Gu, Aidong Qu, Jianqing Xu, Zhengli Shi, Zhiyang Ling & Bing Sun 		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23018T>C	1	23018	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F486L	None	-	None	0.69	Tolerated	-1.88	-0.238614	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000460	Computational Analysis	Secondary Structure and Solvent Accessibility Prediction##Computational Analysis and Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	Likely to make changes in both protein secondary structure and relative solvent accessibility in the RBD region.#This mutation if found to enhances RBD expression but abolishes Binding affinity. ACE2-contact residues exhibit binding-stability tradeoffs, as has been seen in the active sites and binding interfaces of other proteins. Mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505, consistent with the destabilizing effect of surface-exposed hydrophobic patches. These hydrophobic residues form ACE2-packing contacts and are required for binding.	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009	https://www.nature.com/articles/s41598-021-83105-3##https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)#Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom	Europe(0.000046)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a02&&LOCATION=1:23018:T:C
23020T>A	1	23020	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F486L	None	-	None	0.69	Tolerated	-3.3	-3.11017	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	This mutation if found to enhances RBD expression but abolishes Binding affinity. ACE2-contact residues exhibit binding-stability tradeoffs, as has been seen in the active sites and binding interfaces of other proteins. Mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505, consistent with the destabilizing effect of surface-exposed hydrophobic patches. These hydrophobic residues form ACE2-packing contacts and are required for binding.##Comparisons of MD simulations in the WT and mutants revealed a significant de-stabilization effect of the mutations on RBD and HR1 domains	Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012##Ahamad, S., Kanipakam, H., & Gupta, D. (2020). Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1811774	https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all##https://pubmed.ncbi.nlm.nih.gov/32851910/	Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding##Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding	Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom##Shahzaib Ahamad 1, Hema Kanipakam 1, Dinesh Gupta 1		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a07&&LOCATION=1:23020:T:A
23018T>G	1	23018	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F486V	None	-	None	0.54	Tolerated	-1.88	-0.238614	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	This mutation if found to enhances RBD expression but abolishes Binding affinity. ACE2-contact residues exhibit binding-stability tradeoffs, as has been seen in the active sites and binding interfaces of other proteins. Mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505, consistent with the destabilizing effect of surface-exposed hydrophobic patches. These hydrophobic residues form ACE2-packing contacts and are required for binding.	Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012	https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding	Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a03&&LOCATION=1:23018:T:G
23019T>A	1	23019	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F486Y	None	-	None	1	Tolerated	-1.94	0.0110866	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	This mutation if found to enhances RBD expression but abolishes Binding affinity. ACE2-contact residues exhibit binding-stability tradeoffs, as has been seen in the active sites and binding interfaces of other proteins. Mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505, consistent with the destabilizing effect of surface-exposed hydrophobic patches. These hydrophobic residues form ACE2-packing contacts and are required for binding.	Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012	https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding	Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a05&&LOCATION=1:23019:T:A
23030T>C	1	23030	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F490L	None	-	None	0.65	Tolerated	-3.3	-0.987717	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0006720	Experimental	This study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Mutations in proximity to ACE binding site and neutralizing epitopes were tested for their ability to confer resistance to the monoclonal antibodies, using an HIV-1-based pseudotyped virus-based assay. Naturally occurring mutations at positions E484, F490, Q493, and S494 conferred complete or partial resistance to C121 and C144	Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312	https://pubmed.ncbi.nlm.nih.gov/33112236/	Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants	Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz	Africa(0.000067);Asia(0.000231);Europe(0.000207);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a26&&LOCATION=1:23030:T:C
23032T>A	1	23032	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F490L	None	-	None	0.65	Tolerated	-3.3	-1.73682	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an decreased infectivity compared to the reference strain via cell line studies 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a2d&&LOCATION=1:23032:T:A
23032T>G	1	23032	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F490L	None	-	None	0.65	Tolerated	-3.3	-1.73682	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an decreased infectivity compared to the reference strain via cell line studies 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a2f&&LOCATION=1:23032:T:G
21726T>A	1	21726	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F55I	None	-	None	0.85	Tolerated	1.65	2.21203	0.0314961	Disulf_bond	BetaCoV_S1-NTD	NA	NA	NA	Surface glycoprotein_TQDLFLPFFSNVTWF	19	NA	NA	NA	NA	nCoV-2019_71_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000120	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Asia(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef84ab0&&LOCATION=1:21726:T:A
23952T>G	1	23952	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F797C	None	-	None	0.04	Deleterious	1.65	2.17468	1	NA	NA	NA	NA	NA	NA	NA	Surface glycoprotein_IYKTPPIKDF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000990	Computational Analysis	Sequence analysis followed by Molecular dynamics simulations of the protein and their complexes	Spike proteins are the key Surface glycoproteins and are well reported for their prominent role in interaction with host cell receptors.  ΔΔG value ( -1.501262) show that the mutantion possess a negative stabilization effect on spike protein. 	Khan, M. I., Khan, Z. A., Baig, M. H., Ahmad, I., Farouk, A.-E. A., Song, Y. G., & Dong, J.-J. (2020). Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLOS ONE, 15(9), e0238344. https://doi.org/10.1371/journal.pone.0238344	https://pubmed.ncbi.nlm.nih.gov/32881907/	Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight	Mohd Imran Khan, Zainul A Khan, Mohammad Hassan Baig, Irfan Ahmad, Abd-ElAziem Farouk, Young Goo Song, Jae-Jun Dong	Asia(0.000097);Europe(0.000002)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8650c&&LOCATION=1:23952:T:G
24224T>C	1	24224	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	F888L	B.1.525	https://outbreak.info/situation-reports?pango=B.1.525	Characteristic mutation of B.1.525 lineage																												Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo			
24933G>T	1	24933	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G1124V	None	-	None	0.17	Tolerated	1.65	4.256	0.96063	disulf_bond	NA	NA	NA	Surface glycoprotein_TDNTFVSGNCD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0068010	Computational Analysis	Sequence analysis followed by identification of Structural and function impact of mutations	The Gly at this position is solvent exposed and is present at the tip of the C-terminal end of a β-strand. This position is proximal to the region where the S protein attaches itself to the viral membrane (figure 5). It is to be noted that the Gly at this position is conserved among the closely related coronaviruses (Bat coronavirus RaTG13 and HKU3, SARS-CoV) hinting toward its possible role in maintenance of structure and function of the S protein (figure 7). In general, as explained above, Gly backbone has higher conformational freedom than any other amino acid residues (Ramakrishnan and Ramachandran 1965). Therefore, substitution of Gly with Val would impart rigidity to the local region. The possible implication of such rigidity on the association of S protein with viral membrane could be understood from a structure of S protein in association with the viral membrane.	Maitra, A., Sarkar, M. C., Raheja, H., Biswas, N. K., Chakraborti, S., Singh, A. K., Ghosh, S., Sarkar, S., Patra, S., Mondal, R. K., Ghosh, T., Chatterjee, A., Banu, H., Majumdar, A., Chinnaswamy, S., Srinivasan, N., Dutta, S., & Das, S. (2020). Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility. Journal of Biosciences, 45(1), 1. https://doi.org/10.1007/s12038-020-00046-1	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269891/	Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility	Arindam Maitra, Mamta Chawla Sarkar, Harsha Raheja,Nidhan K Biswas,Sohini Chakraborti,Animesh Kumar Singh,Shekhar Ghosh, Sumanta Sarkar,Subrata Patra,Rajiv Kumar Mondal, Trinath Ghosh,Ananya Chatterjee,Hasina Banu,Agniva Majumdar,Sreedhar Chinnaswamy,Narayanaswamy Srinivasan,Shanta Dutta, and  Saumitra Das	Africa(0.000668);Asia(0.000524);Europe(0.000324);Oceania(0.005285)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8700c&&LOCATION=1:24933:G:T
21987G>T	1	21987	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G142V																																					
22899G>C	1	22899	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G446A	None	-	None	0.79	Tolerated	NA	0.385638	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_75_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000150	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G446 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020a). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000012);Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858a2&&LOCATION=1:22899:G:C
22898G>T	1	22898	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G446C	None	-	None	0.07	Tolerated	NA	0.385638	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_75_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G446 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020a). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858a0&&LOCATION=1:22898:G:T
22899G>A	1	22899	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G446D	None	-	None	0.65	Tolerated	NA	0.385638	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_75_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000100	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G446 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020a). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Europe(0.000010)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858a1&&LOCATION=1:22899:G:A
22898G>C	1	22898	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G446R	None	-	None	0.57	Tolerated	NA	0.385638	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_75_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000040	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G446 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020a). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Europe(0.000004)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8589f&&LOCATION=1:22898:G:C
22898G>A	1	22898	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G446S	None	-	None	0.82	Tolerated	NA	0.385638	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_75_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0003010	Computational Analysis and Experimental	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking####Generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G446 residue might potentially alter viral binding properties.#Mutations in proximity to ACE binding site and neutralizing epitopes were tested for their ability to confer resistance to the monoclonal antibodies, using an HIV-1-based pseudotyped virus-based assay. Naturally occurring mutations that conferred complete or partial resistance to C135 were at positions R346, N439, N440, K444, V445 and G446. 	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020a). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355# Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312	https://pubmed.ncbi.nlm.nih.gov/32635180/#https://pubmed.ncbi.nlm.nih.gov/33112236/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design#Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz	Africa(0.000134);Europe(0.000056);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8589e&&LOCATION=1:22898:G:A
22899G>T	1	22899	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G446V	None	-	None	0.33	Tolerated	NA	0.385638	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_75_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0010850	Computational Analysis and Experimental	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking##pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR.##Generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain#Mutations in proximity to ACE binding site and neutralizing epitopes were tested for their ability to confer resistance to the monoclonal antibodies, using an HIV-1-based pseudotyped virus-based assay. Naturally occurring mutations that conferred complete or partial resistance to C135 were at positions R346, N439, N440, K444, V445 and G446. 	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020a). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355# Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1.  https://doi.org/10.2139/ssrn.3635800# Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312	https://pubmed.ncbi.nlm.nih.gov/32635180/#http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/#https://pubmed.ncbi.nlm.nih.gov/33112236/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design#The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity#Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang ; Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz	Africa(0.000200);Asia(0.000341);Europe(0.000266);Oceania(0.000278)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858a5&&LOCATION=1:22899:G:T
22988G>A	1	22988	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G476S	None	-	None	0.73	Tolerated	1.56	0.260787	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_STEIYQAGSTPCNGV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0004030	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction.####Neutralization assays with monoclonal antibodies were also performed.	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in decreased antigenicity of the Spike protein epitopes.##Eight anti-spike antibodies were tested against sixteen SARS-CoV-2 spike protein RBD variants. Variants were encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. IC50(M) values are shown for each variant. There was no observed neutralization with hIgG1 isotype control 	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790##Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development##Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh##Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Africa(0.000134);Asia(0.000073);Europe(0.000196)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef859a9&&LOCATION=1:22988:G:A
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G485D	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23049G>C	1	23049	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G496A	None	-	None	0.17	Tolerated	-3.17	-0.738016	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G496 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a65&&LOCATION=1:23049:G:C
23048G>T	1	23048	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G496C	None	-	None	0.01	Deleterious	1.65	4.13115	0.889764	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000700	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G496 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Africa(0.000067);Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a64&&LOCATION=1:23048:G:T
23048G>C	1	23048	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G496R	None	-	None	0.03	Deleterious	1.65	4.13115	0.889764	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000050	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G496 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Europe(0.000005)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a63&&LOCATION=1:23048:G:C
23048G>A	1	23048	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G496S	None	-	None	0.56	Tolerated	1.65	4.13115	0.889764	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0002240	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G496 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Europe(0.000168);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a62&&LOCATION=1:23048:G:A
23049G>T	1	23049	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G496V	None	-	None	0.02	Deleterious	-3.17	-0.738016	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000820	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G496 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000012);Europe(0.000014);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a66&&LOCATION=1:23049:G:T
23067G>C	1	23067	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G502A	None	-	None	0.29	Tolerated	-2.71	-0.488315	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking##This study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G502 residue might potentially alter viral binding properties.#Several mutations to G502 enhance RBD expression but abolishes binding due to steric clashes with ACE2. These point mutations were introduced via site-directed mutagenesis into the vector and binding/stability assays were performed.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355.## Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012https://doi.org/10.3390/vaccines8030355#	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design#Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85aa0&&LOCATION=1:23067:G:C
23066G>T	1	23066	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G502C	None	-	None	0.08	Tolerated	-2.71	-0.488315	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000010	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking##This study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G502 residue might potentially alter viral binding properties.#Several mutations to G502 enhance RBD expression but abolishes binding due to steric clashes with ACE2. These point mutations were introduced via site-directed mutagenesis into the vector and binding/stability assays were performed.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355.## Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012https://doi.org/10.3390/vaccines8030355#	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design##Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom	Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a9e&&LOCATION=1:23066:G:T
23067G>A	1	23067	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G502D	None	-	None	0.31	Tolerated	-2.71	-0.488315	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000010	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking##This study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G502 residue might potentially alter viral binding properties.#Several mutations to G502 enhance RBD expression but abolishes binding due to steric clashes with ACE2. These point mutations were introduced via site-directed mutagenesis into the vector and binding/stability assays were performed.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355.## Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012https://doi.org/10.3390/vaccines8030355#	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design##Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom	Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a9f&&LOCATION=1:23067:G:A
23066G>C	1	23066	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G502R	None	-	None	0.19	Tolerated	-2.71	-0.488315	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000130	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking##This study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G502 residue might potentially alter viral binding properties.#Several mutations to G502 enhance RBD expression but abolishes binding due to steric clashes with ACE2. These point mutations were introduced via site-directed mutagenesis into the vector and binding/stability assays were performed.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355.## Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012https://doi.org/10.3390/vaccines8030355#	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design##Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom	Asia(0.000012);Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a9d&&LOCATION=1:23066:G:C
23066G>A	1	23066	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G502S	None	-	None	0.26	Tolerated	-2.71	-0.488315	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000010	Computational Analysis , Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking and Computational Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein ; This study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G502 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355.## Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012https://doi.org/10.3390/vaccines8030355#	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design##Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom	Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a9c&&LOCATION=1:23066:G:A
23108G>S	1	23108	G	S	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Stop Gain	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G516*	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85b23&&LOCATION=1:23108:G:S
23567G>A	1	23567	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G669S																																					
24057G>A	1	24057	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	G832D	None	-	None	0.01	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	NA	19	Surface glycoprotein_TLADAGFIK	-1	Spike glycoprotein	FIEDLLFNKVTLADAGF	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000790	Computational Analysis	Multiple Sequence Alignment (MSA) and Mutation analysis followed by RNA Secondary Structure prediction and Base Pair Probability Analysis. Potential miRNA Binding Sites and Splice sites were also analysed	Reported to be a recurrent conserved mutation. Sequences carrying recurrent mutations C24034U and G24057A were predicted to have lost the miR-338-3p binding sites, although these mutations did not decrease the binding energy of miR-338-3p to S.	Hosseini Rad SM, A., & McLellan, A. D. (2020). Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting. International Journal of Molecular Sciences, 21(13), 4807. https://doi.org/10.3390/ijms21134807	https://pubmed.ncbi.nlm.nih.gov/32645951/	Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting	Ali Hosseini Rad Sm , Alexander D McLellan	Africa(0.000067);Asia(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8663d&&LOCATION=1:24057:G:A
24863C>T	1	24863	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	H1101Y	P.3	https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of P.3 lineage 																																		
21707C>T	1	21707	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	H49Y	None	-	None	1	Tolerated	-3.3	-0.853921	0	Disulf_bond	BetaCoV_S1-NTD	NA	NA	NA	NA	NA	Surface glycoprotein_KVFRSSVLH	0.14	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0100410	Computational Analysis	Multiple sequence alignment followed by Mutation analysis, Protein structure prediction and functional implications of the mutations	H49Y mutation showed a reduction in total free energy in all three conformations thereby suggesting the potential role of this naturally occurring mutation in Spike protein evolution and Stability. showed stabilizing structure, suggesting its prevalent role in spike protein evolution.	Laha, S., Chakraborty, J., Das, S., Manna, S. K., Biswas, S., & Chatterjee, R. (2020). Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission. Infection, Genetics and Evolution, 85, 104445. https://doi.org/10.1016/j.meegid.2020.104445##Durmaz, B., Abdulmajed, O., & Durmaz, R. ı. (2020). Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor. Medeniyet Medical Journal, 1. https://doi.org/10.5222/mmj.2020.98048	https://pubmed.ncbi.nlm.nih.gov/32615316/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584268/	Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission##Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor	Sayantan Laha, Joyeeta Chakraborty, Shantanab Das, Soumen Kanti Manna, Sampa Biswas, RaghunathChatterjee##Bengül Durmaz, Olkar Abdulmajed, and  Rıza Durmaz	Africa(0.002071);Asia(0.005164);Europe(0.001749);Oceania(0.001057)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef84a78&&LOCATION=1:21707:C:T
23118A>C	1	23118	A	C 	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	H519P	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000270	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR.####Neutralization assays with monoclonal antibodies were also performed.	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an decreased infectivity compared to the reference strain via cell line studies 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800##Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831##Eight anti-spike antibodies were tested against sixteen SARS-CoV-2 spike protein RBD variants. Variants were encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. IC50(M) values are shown for each variant. There was no observed neutralization with hIgG1 isotype control 	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity##Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Asia(0.000024);Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85b41&&LOCATION=1:23118:A:C
23119T>A	1	23119	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	H519Q	None	-	None	0.3	Tolerated	-3.3	-0.238614	0.889764	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_QPYRVVVLSFELLHA	14	NA	NA	NA	NA	NA	SARS-CoV-2_IBS_S1_F	NA	NA	NA	No co - mutations reported	NA	0.0002070	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in decreased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Africa(0.000067);Asia(0.000024);Europe(0.000005);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85b45&&LOCATION=1:23119:T:A
23525C>T	1	23525	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	H655Y	P.1##B.1.616	https://outbreak.info/situation-reports?pango=P.1##https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of P.1 and B.1.616 lineages																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
21758C>G	1	21758	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	H66D																																					
22863T>A	1	22863	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	I434K	None	-	None	0.05	Deleterious	1.65	2.13354	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_IAWNSNNLDSK	NA	NA	NA	NA	NA	NA	NA	S Reverse	NA	NA	NA	No co - mutations reported	NA	0.0000120	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Asia(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8583f&&LOCATION=1:22863:T:A
22964A>T	1	22964	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	I468F	None	-	None	0.35	Tolerated	-3.3	0.0110866	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_LKPFERDISTEIYQA	14	Surface glycoprotein_KPFERDISTEI	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000700	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Changes in RBD region demonstrates altered sensitivity to neutralizing mAbs. I468F was observed to be more susceptible to neutralization mediated by mAbs. Also, this variation is found to possess increased sensitivity to the convalescent sera compared with reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Asia(0.000012);Europe(0.000002);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8595f&&LOCATION=1:22964:A:T
22965T>C	1	22965	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	I468T	None	-	None	0.2	Tolerated	1.65	2.13354	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_LKPFERDISTEIYQA	14	Surface glycoprotein_KPFERDISTEI	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0002710	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Changes in RBD region demonstrates altered sensitivity to neutralizing mAbs. I468T was observed to be more susceptible to neutralization mediated by mAbs. Also, this variation is found to possess increased sensitivity to the convalescent sera compared with reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.000200);Europe(0.000015);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85961&&LOCATION=1:22965:T:C
22976A>G	1	22976	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	I472V	None	-	None	1	Tolerated	-1.71	2.63294	0.00787402	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_STEIYQAGSTPCNGV	Surface glycoprotein_LKPFERDISTEIYQA	14	Surface glycoprotein_KPFERDISTEI	-1	NA	NA	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	Co-occuring with 23403A>G (D614G)	0.0001740	Computational Analysis and Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR.####Neutralization assays with monoclonal antibodies were also performed.	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an decreased infectivity compared to the reference strain via cell line studies.##Eight anti-spike antibodies were tested against sixteen SARS-CoV-2 spike protein RBD variants. Variants were encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. IC50(M) values are shown for each variant. There was no observed neutralization with hIgG1 isotype control 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800##Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity##Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Africa(0.000134);Asia(0.000012);Europe(0.000028)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85987&&LOCATION=1:22976:A:G
23942A>T	1	23942	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	I794F	None	-	None	0.14	Tolerated	-2.29	-1.5498	0	NA	NA	NA	NA	NA	NA	NA	Surface glycoprotein_KQIYKTPPIK	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0003710	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S2-2 region of Fusion Peptide (FP) were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in I794 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Africa(0.000334);Asia(0.000037)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef864f2&&LOCATION=1:23942:A:T
23942A>C	1	23942	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	I794L	None	-	None	1	Tolerated	-2.29	-1.5498	0	NA	NA	NA	NA	NA	NA	NA	Surface glycoprotein_KQIYKTPPIK	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0002340	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S2-2 region of Fusion Peptide (FP) were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in I794 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000037);Europe(0.000197)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef864f0&&LOCATION=1:23942:A:C
23943T>A	1	23943	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	I794N	None	-	None	0.04	Deleterious	1.65	2.17468	0	NA	NA	NA	NA	NA	NA	NA	Surface glycoprotein_KQIYKTPPIK	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000120	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S2-2 region of Fusion Peptide (FP) were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in I794 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef864f3&&LOCATION=1:23943:T:A
23943T>C	1	23943	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	I794T	None	-	None	0.07	Tolerated	1.65	2.17468	0	NA	NA	NA	NA	NA	NA	NA	Surface glycoprotein_KQIYKTPPIK	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001530	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S2-2 region of Fusion Peptide (FP) were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in I794 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000024);Europe(0.000073);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef864f4&&LOCATION=1:23943:T:C
23942A>G	1	23942	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	I794V	None	-	None	0.28	Tolerated	-2.29	-1.5498	0	NA	NA	NA	NA	NA	NA	NA	Surface glycoprotein_KQIYKTPPIK	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000210	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S2-2 region of Fusion Peptide (FP) were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in I794 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000012);Europe(0.000009)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef864f1&&LOCATION=1:23942:A:G
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Insertion	Insertion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	ins15ATLRI																												Computational Prediction	Raw reads were downloaded from SRA database.The reads were mapped to the SARS-CoV-2 reference genome (NC_045512.2) with bowtie2 version 2.2.142, either in pair mode of single read mode, depending on the type of data deposited to the SRA. The variants in each genome were called with LoFreq version 2.1.543 as described in Galaxy. All insertions identified with LoFreq were visualized with the IGV software and manually inspected. An insertion was considered a real biological event if it had an allele frequency in reads of at least 60%, was located in the middle of the amplification fragment, and was covered by at least 100 reads.	Predicted to lead to escape from neutralizing antibodies whereas other inserts might result in escape from T-cell immunity. Located in an epitope that is recognized by antibodies obtained from convalescent plasma of recent COVID-19 patients	Garushyants, S. K., Rogozin, I. B., & Koonin, E. V. (2021). Insertions in SARS-CoV-2 genome caused by template switch and duplications give rise to new variants of potential concern. bioRxiv : the preprint server for biology, 2021.04.23.441209. https://doi.org/10.1101/2021.04.23.441209	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077628/	Insertions in SARS-CoV-2 genome caused by template switch and duplications give rise to new variants of potential concern	Sofya K. Garushyants, Igor B. Rogozin, and Eugene V. Koonin		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Insertion	Insertion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	ins246DSWG																												Computational Prediction	Raw reads were downloaded from SRA database.The reads were mapped to the SARS-CoV-2 reference genome (NC_045512.2) with bowtie2 version 2.2.142, either in pair mode of single read mode, depending on the type of data deposited to the SRA. The variants in each genome were called with LoFreq version 2.1.543 as described in Galaxy. All insertions identified with LoFreq were visualized with the IGV software and manually inspected. An insertion was considered a real biological event if it had an allele frequency in reads of at least 60%, was located in the middle of the amplification fragment, and was covered by at least 100 reads.	Predicted to lead to escape from neutralizing antibodies whereas other inserts might result in escape from T-cell immunity. Located in an epitope that is recognized by antibodies obtained from convalescent plasma of recent COVID-19 patients. ins246DSWG is located in the loop that is responsible for the interaction with the 4A8 antibody and potentially other antibodies	Garushyants, S. K., Rogozin, I. B., & Koonin, E. V. (2021). Insertions in SARS-CoV-2 genome caused by template switch and duplications give rise to new variants of potential concern. bioRxiv : the preprint server for biology, 2021.04.23.441209. https://doi.org/10.1101/2021.04.23.441209	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077628/	Insertions in SARS-CoV-2 genome caused by template switch and duplications give rise to new variants of potential concern	Sofya K. Garushyants, Igor B. Rogozin, and Eugene V. Koonin		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Insertion	Insertion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	ins98KAE																												Computational Prediction	Raw reads were downloaded from SRA database.The reads were mapped to the SARS-CoV-2 reference genome (NC_045512.2) with bowtie2 version 2.2.142, either in pair mode of single read mode, depending on the type of data deposited to the SRA. The variants in each genome were called with LoFreq version 2.1.543 as described in Galaxy. All insertions identified with LoFreq were visualized with the IGV software and manually inspected. An insertion was considered a real biological event if it had an allele frequency in reads of at least 60%, was located in the middle of the amplification fragment, and was covered by at least 100 reads.	Located in the neighboring loops, and given that the central region of the NTD has been shown to be essential for the virus interaction with CD4+ cells38, could be associated with the escape from the T-cell immunity.	Garushyants, S. K., Rogozin, I. B., & Koonin, E. V. (2021). Insertions in SARS-CoV-2 genome caused by template switch and duplications give rise to new variants of potential concern. bioRxiv : the preprint server for biology, 2021.04.23.441209. https://doi.org/10.1101/2021.04.23.441209	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077628/	Insertions in SARS-CoV-2 genome caused by template switch and duplications give rise to new variants of potential concern	Sofya K. Garushyants, Igor B. Rogozin, and Eugene V. Koonin		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22695A>G	1	22695	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	K378R	None	-	None	0.13	Tolerated	1.65	2.25839	0.0472441	NA	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_NSASFSTFK	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000960	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Africa(0.000067);Asia(0.000024);Europe(0.000005)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8566e&&LOCATION=1:22695:A:G
22720A>G	1	22720	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	K386K	None	-	None	1	Tolerated	-1.39	0.510488	0.937008	disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	S Forward	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef856b8&&LOCATION=1:22720:A:G
22811A>G	1	22811	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	K417E	None	-	None	0.26	Tolerated	0.737	2.63294	1	disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_RQIAPGQTGK	0.03	NA	NA	nCoV-2019_76_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000030	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef857ad&&LOCATION=1:22811:A:G
22813G>T	1	22813	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	K417N	B.1.351	https://outbreak.info/situation-reports?pango=B.1.351	Characteristic mutation of B.1.351 lineage																																	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22812A>C	1	22812	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	K417T	P.1	https://outbreak.info/situation-reports?pango=P.1	Characteristic mutation of P.1 lineage																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22894G>T	1	22894	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	K444N	None	-	None	0.54	Tolerated	0.498	-7.72964	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_IAWNSNNLDSK	NA	NA	NA	NA	NA	NA	nCoV-2019_75_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0002030	Experimental	This study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Mutations in proximity to ACE binding site and neutralizing epitopes were tested for their ability to confer resistance to the monoclonal antibodies, using an HIV-1-based pseudotyped virus-based assay.The K444N and V445E mutants retained near Wild Type (WT) levels of binding to all three antibodies, despite exhibiting partial resistance to C135	Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312	https://pubmed.ncbi.nlm.nih.gov/33112236/	Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants	Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz	Asia(0.000085);Europe(0.000062);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85893&&LOCATION=1:22894:G:T
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	K444Q	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22936G>C	1	22936	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	K458N	None	-	None	0.43	Tolerated	-3.3	-6.85569	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_YLYRLFRKSNLKPFE	9.2	Surface glycoprotein_RLFRKSNLK	0.01	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0002060	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an decreased infectivity compared to the reference strain via cell line studies 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Asia(0.000097);Europe(0.000109)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8590e&&LOCATION=1:22936:G:C
22936G>T	1	22936	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	K458N	None	-	None	0.43	Tolerated	-3.3	-6.85569	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_YLYRLFRKSNLKPFE	9.2	Surface glycoprotein_RLFRKSNLK	0.01	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an decreased infectivity compared to the reference strain via cell line studies 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8590f&&LOCATION=1:22936:G:T
22935A>G	1	22935	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	K458R	None	-	None	0.51	Tolerated	-3.3	-2.11137	0	disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_YLYRLFRKSNLKPFE	9.2	Surface glycoprotein_RLFRKSNLK	0.01	NA	NA	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	Co-occuring with 23403A>G (D614G)	0.0000040	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.##pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).##Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly increased infectivity in comparison to the reference strain	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831##Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/##http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies##The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous##Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Europe(0.000004)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8590b&&LOCATION=1:22935:A:G
23147A>G	1	23147	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	K529E	None	-	None	1	Tolerated	-3.3	-3.98413	0	NA	NA	NA	NA	Surface glycoprotein_GPKKSTNLVKNKCVNFNFNGLTGTGVLTESN	NA	NA	Surface glycoprotein_GPKKSTNLV	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000500	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in decreased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Asia(0.000012);Europe(0.000038)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85b9e&&LOCATION=1:23147:A:G
21614C>T	1	21614	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L18F	P.1	https://outbreak.info/situation-reports?pango=P.1	Characteristic mutation of P.1 lineage																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22441C>A	1	22441	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L293M	None	-	None	0.65	Tolerated	-3.3	-2.25915	0	Disulf_bond	BetaCoV_S1-NTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	SARS-CoV-2_IBS_S2_R	NA	NA	NA	No co - mutations reported	NA	0.0000120	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Asia(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22439C>A 	1	22439	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L293V	None	-	None	0.38	Tolerated	1.65	3.23402	0.0472441	Disulf_bond	BetaCoV_S1-NTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	SARS-CoV-2_IBS_S2_R	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85347&&LOCATION=1:22439:C:A
22917T>G	1	22917	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L452R	B.1.427/B.1.429## B.1.617.1## B.1.617.2## B.1.617.3	https://outbreak.info/situation-reports?pango=B.1.427##https://outbreak.info/situation-reports?pango=B.1.617.1##https://outbreak.info/situation-reports?pango=B.1.617.2##https://outbreak.info/situation-reports?pango=B.1.617.3	Characteristic mutation of B.1.427/B.1.429, B.1.617.1, B.1.617.2 and B.1.617.3 lineages.	0.35	Tolerated	-3.3	-1.23742	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_YLYRLFRKSNLKPFE	9.2	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0766430	Computational Analysis	Multiple sequence alignment followed by topology-based feature generation and convolutional neural network-assisted models for analysing the protein structure	Prediction of free adversarial free energy change due to mutations identified Y423F as a hotspot residue, significantly increasing the infectivity of the virus	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009##Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/##https://pubmed.ncbi.nlm.nih.gov/33961693/	Mutations Strengthened SARS-CoV-2 Infectivity##Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Jiahui Chen, Rui Wang, Menglun Wang and Guo-Wei Wei##Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2	Africa(0.026260);Asia(0.037490);Europe(0.005161);Oceania(0.007732)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858d6&&LOCATION=1:22917:T:G
22927G>C	1	22927	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L455F	None	-	None	0.84	Tolerated	-3.3	-8.22904	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_YLYRLFRKSNLKPFE	9.2	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0017760	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	Deep mutational scanning library yeast surface-display induction and labeling followed by Cell sorting, Sequencing and Phenotype analysis	Several ACE2-contact residues exhibit binding-stability tradeoffs, as has been seen in the active sites and binding interfaces of other proteins. Mutations to polar residues at positions L455 would enhance expression but reduce binding, consistent with specific geometric constraints imposed by the close packing of these residues at the ACE2 surface##Mutants at L455 residue were found to abolish the inding affinity to hACE2 in comparison to wildtype	Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012##Yi, C., Sun, X., Ye, J. et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol 17, 621–630 (2020). https://doi.org/10.1038/s41423-020-0458-z	https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all##https://www.nature.com/articles/s41423-020-0458-z	Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding##Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies	Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom##Francesco Ortuso, Daniele Mercatelli,Pietro Hiram Guzzi, Federico Manuel Giorgi##Chunyan Yi, Xiaoyu Sun, Jing Ye, Longfei Ding, Meiqin Liu, Zhuo Yang, Xiao Lu, Yaguang Zhang, Liyang Ma, Wangpeng Gu, Aidong Qu, Jianqing Xu, Zhengli Shi, Zhiyang Ling & Bing Sun 	Africa(0.000200);Asia(0.000085);Europe(0.000378);Oceania(0.001113)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858ef&&LOCATION=1:22927:G:C
22927G>T	1	22927	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L455F	None	-	None	0.84	Tolerated	-3.3	-8.22904	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_YLYRLFRKSNLKPFE	9.2	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	Deep mutational scanning library yeast surface-display induction and labeling followed by Cell sorting, Sequencing and Phenotype analysis	Several ACE2-contact residues exhibit binding-stability tradeoffs, as has been seen in the active sites and binding interfaces of other proteins. Mutations to polar residues at positions L455 would enhance expression but reduce binding, consistent with specific geometric constraints imposed by the close packing of these residues at the ACE2 surface##Mutants at L455 residue were found to abolish the inding affinity to hACE2 in comparison to wildtype	Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012##Yi, C., Sun, X., Ye, J. et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol 17, 621–630 (2020). https://doi.org/10.1038/s41423-020-0458-z	https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all##https://www.nature.com/articles/s41423-020-0458-z	Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding##Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies	Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom##Francesco Ortuso, Daniele Mercatelli,Pietro Hiram Guzzi, Federico Manuel Giorgi##Chunyan Yi, Xiaoyu Sun, Jing Ye, Longfei Ding, Meiqin Liu, Zhuo Yang, Xiao Lu, Yaguang Zhang, Liyang Ma, Wangpeng Gu, Aidong Qu, Jianqing Xu, Zhengli Shi, Zhiyang Ling & Bing Sun 		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858f0&&LOCATION=1:22927:G:T
22925T>A	1	22925	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L455M	None	-	None	0.2	Tolerated	-2.14	0.0110866	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_YLYRLFRKSNLKPFE	9.2	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000010	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	Deep mutational scanning library yeast surface-display induction and labeling followed by Cell sorting, Sequencing and Phenotype analysis	Several ACE2-contact residues exhibit binding-stability tradeoffs, as has been seen in the active sites and binding interfaces of other proteins. Mutations to polar residues at positions L455 would enhance expression but reduce binding, consistent with specific geometric constraints imposed by the close packing of these residues at the ACE2 surface##Mutants at L455 residue were found to abolish the inding affinity to hACE2 in comparison to wildtype	Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012##Yi, C., Sun, X., Ye, J. et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol 17, 621–630 (2020). https://doi.org/10.1038/s41423-020-0458-z	https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all##https://www.nature.com/articles/s41423-020-0458-z	Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding##Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies	Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom##Francesco Ortuso, Daniele Mercatelli,Pietro Hiram Guzzi, Federico Manuel Giorgi##Chunyan Yi, Xiaoyu Sun, Jing Ye, Longfei Ding, Meiqin Liu, Zhuo Yang, Xiao Lu, Yaguang Zhang, Liyang Ma, Wangpeng Gu, Aidong Qu, Jianqing Xu, Zhengli Shi, Zhiyang Ling & Bing Sun 	Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858e9&&LOCATION=1:22925:T:A
22925T>G	1	22925	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L455V	None	-	None	0.56	Tolerated	-2.14	0.0110866	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_YLYRLFRKSNLKPFE	9.2	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000020	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	Deep mutational scanning library yeast surface-display induction and labeling followed by Cell sorting, Sequencing and Phenotype analysis	Several ACE2-contact residues exhibit binding-stability tradeoffs, as has been seen in the active sites and binding interfaces of other proteins. Mutations to polar residues at positions L455 would enhance expression but reduce binding, consistent with specific geometric constraints imposed by the close packing of these residues at the ACE2 surface##Mutants at L455 residue were found to abolish the inding affinity to hACE2 in comparison to wildtype	Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012##Yi, C., Sun, X., Ye, J. et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol 17, 621–630 (2020). https://doi.org/10.1038/s41423-020-0458-z	https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all##https://www.nature.com/articles/s41423-020-0458-z	Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding##Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies	Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom##Francesco Ortuso, Daniele Mercatelli,Pietro Hiram Guzzi, Federico Manuel Giorgi##Chunyan Yi, Xiaoyu Sun, Jing Ye, Longfei Ding, Meiqin Liu, Zhuo Yang, Xiao Lu, Yaguang Zhang, Liyang Ma, Wangpeng Gu, Aidong Qu, Jianqing Xu, Zhengli Shi, Zhiyang Ling & Bing Sun 	Europe(0.000002)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858eb&&LOCATION=1:22925:T:G
22926T>A	1	22926	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Stop Gain	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L455X	None	-	None	NA	NA	-3.3	-0.113764	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_YLYRLFRKSNLKPFE	9.2	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	Deep mutational scanning library yeast surface-display induction and labeling followed by Cell sorting, Sequencing and Phenotype analysis	Several ACE2-contact residues exhibit binding-stability tradeoffs, as has been seen in the active sites and binding interfaces of other proteins. Mutations to polar residues at positions L455 would enhance expression but reduce binding, consistent with specific geometric constraints imposed by the close packing of these residues at the ACE2 surface##Mutants at L455 residue were found to abolish the inding affinity to hACE2 in comparison to wildtype	Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012##Yi, C., Sun, X., Ye, J. et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol 17, 621–630 (2020). https://doi.org/10.1038/s41423-020-0458-z	https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all##https://www.nature.com/articles/s41423-020-0458-z	Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding##Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies	Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom##Francesco Ortuso, Daniele Mercatelli,Pietro Hiram Guzzi, Federico Manuel Giorgi##Chunyan Yi, Xiaoyu Sun, Jing Ye, Longfei Ding, Meiqin Liu, Zhuo Yang, Xiao Lu, Yaguang Zhang, Liyang Ma, Wangpeng Gu, Aidong Qu, Jianqing Xu, Zhengli Shi, Zhiyang Ling & Bing Sun 		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858ed&&LOCATION=1:22926:T:A
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L455Y																												Computational Prediction	Molecular dynamics simulation based prediction of mutation effects on protein structure	Comparisons of MD simulations in the WT and mutants revealed a significant de-stabilization effect of the mutations on RBD and HR1 domains	Ahamad, S., Kanipakam, H., & Gupta, D. (2020). Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1811774	https://pubmed.ncbi.nlm.nih.gov/32851910/	Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding	Shahzaib Ahamad, Hema Kanipakam, Dinesh Gupta		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
21723G>C	1	21723	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L54F	None	-	None	0.11	Tolerated	-3.3	-2.1314	0	Disulf_bond	BetaCoV_S1-NTD	NA	NA	NA	Surface glycoprotein_TQDLFLPFFSNVTWF	19	NA	NA	NA	NA	nCoV-2019_71_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0155000	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes. This mutation was also found to increase the protein stabilty with very high positive ΔΔG value of 0.558 kcal/mol	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790##Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/##https://pubmed.ncbi.nlm.nih.gov/33015411/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development##Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh##Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad	Africa(0.001270);Asia(0.011437);Europe(0.002237);Oceania(0.000556)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=606412809d714f1000207cc8&&LOCATION=1:21724:G:C
21723T>G	1	21723	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L54W	None	-	None	0.1	Tolerated	-3.3	-2.1314	0	Disulf_bond	BetaCoV_S1-NTD	NA	NA	NA	Surface glycoprotein_TQDLFLPFFSNVTWF	19	NA	NA	NA	NA	nCoV-2019_71_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000040	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Europe(0.000004)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
21575C>T	1	21575	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L5F	None	-	None	0.05	Deleterious	-3.25	-7.36907	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	homoplasic position	NA	Signal peptide mutation. Functional consequences induced by co - occurring mutations	Co-occuring with 23403A>G (D614G)	0.0838660	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly increased infectivity in comparison to the reference strain	Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Foley, B., Giorgi, E. E., Bhattacharya, T., Parker, M. D., Partridge, D. G., Evans, C. M., Freeman, T. M., de Silva, T. I., LaBranche, C. C., Montefiori, D. C., & on behalf of the Sheffield COVID-19 Genomics Group. (n.d.). Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. https://doi.org/10.1101/2020.04.29.069054##Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	https://www.sciencedirect.com/science/article/pii/S0092867420308205?via%3Dihub##http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2##The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	B Korber,  WM Fischer,  S Gnanakaran, H Yoon,  J Theiler, W Abfalterer,  B Foley, EE Giorgi,  T Bhattacharya, MD Parker, DG Partridge, CM Evans, TM Freeman,  TI de Silva, on behalf of the Sheffield COVID-19 Genomics Group,  CC LaBranche,  DC Montefiori##Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.010691);Asia(0.050560);Europe(0.017887);Oceania(0.004728)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef848d8&&LOCATION=1:21575:C:T
21584T>G	1	21584	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L8V	None	-	None	0.83	Tolerated	-3.25	-0.0874331	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	signal peptide mutation	NA	0.0006840			Signal peptide mutation	Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Foley, B., Giorgi, E. E., Bhattacharya, T., Parker, M. D., Partridge, D. G., Evans, C. M., Freeman, T. M., de Silva, T. I., LaBranche, C. C., Montefiori, D. C., & on behalf of the Sheffield COVID-19 Genomics Group. (n.d.). Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. https://doi.org/10.1101/2020.04.29.069054	https://www.sciencedirect.com/science/article/pii/S0092867420308205?via%3Dihub	Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2	B Korber,  WM Fischer,  S Gnanakaran, H Yoon,  J Theiler, W Abfalterer,  B Foley, EE Giorgi,  T Bhattacharya, MD Parker, DG Partridge, CM Evans, TM Freeman,  TI de Silva, on behalf of the Sheffield COVID-19 Genomics Group,  CC LaBranche,  DC Montefiori	Asia(0.000682);Europe(0.000002)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef848f3&&LOCATION=1:21584:T:G
21585T>G	1	21585	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	L8W	None	-	None	0.01	Deleterious	-3.25	0.806803	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000070	Computational Analysis	Genome wide mutation prediction and analysis	Potential role in the virus escaping host immune response and thus developing resistance to drugs.	Durmaz, B., Abdulmajed, O., & Durmaz, R. ı. (2020). Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor. Medeniyet Medical Journal, 1. https://doi.org/10.5222/mmj.2020.98048	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584268/	Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor	Bengül Durmaz, Olkar Abdulmajed, and  Rıza Durmaz	Europe(0.000007)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef848f7&&LOCATION=1:21585:T:G
25273G>C	1	25273	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	M1237I	None	-	None	0.05	Deleterious	-0.274	1.80496	1	NA	NA	NA	NA	Surface glycoprotein_MVTIMLCCMTS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	23403A>G  ;  25273G>C/T	0.0067300	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an decreased infectivity compared to the reference strain via cell line studies 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.004143);Asia(0.000950);Europe(0.000002);Europe(0.001301);Oceania(0.000334)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef873de&&LOCATION=1:25273:G:C
25273G>T	1	25273	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	M1237I	None	-	None	0.05	Deleterious	-0.274	1.80496	1	NA	NA	NA	NA	Surface glycoprotein_MVTIMLCCMTS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	23403A>G  ;  25273G>C/T	0.0000000	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an decreased infectivity compared to the reference strain via cell line studies 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef873de&&LOCATION=1:25273:G:C
24854A>G					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N1098D																												Computational Prediction	Genome sequence analysis followed by protein structure modelling	N1098D is located in the root of S2 subunit close to viral envelope. presumed to remove a potential N-glycosylation site.	Afrin, S. Z., Paul, S. K., Begum, J. A., Nasreen, S. A., Ahmed, S., Ahmad, F. U., Aziz, M. A., Parvin, R., Aung, M. S., & Kobayashi, N. (2021). Extensive genetic diversity with novel mutations in spike glycoprotein of SARS-CoV-2, Bangladesh in late 2020. New Microbes and New Infections, 100889. https://doi.org/10.1016/j.nmni.2021.100889	https://pubmed.ncbi.nlm.nih.gov/33936746/	Extensive genetic diversity with novel mutations in spike glycoprotein of SARS-CoV-2, Bangladesh in late 2020	Sultana Zahura Afrin , Shyamal Kumar Paul , Jahan Ara Begum , Syeda Anjuman Nasreen , Salma Ahmed , Fahim Uddin Ahmad , Md Abdul Aziz , Rokshana Parvin , Meiji Soe Aung , Nobumichi Kobayashi		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86f2b&&LOCATION=1:24854:A:G
25121A>G	1	25121	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N1187D																																					
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N1223R	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	A list of computational methods were performed which includes, Sequence retrieval and data mining of SNPs followed by functional annotation, Predicting evolutionary conserved residues using ConSurf webserver, mCSM webserver to predict the protein stability analysis, Predicting disease related mutations using MutPred, I-TASSER to generate complete 3D structure of both proteins for their wild-type and mutated sequences and Molecular docking analysis.	N1223R mutant observed majorly in English population was found to affect the mCSM protein stability score thereby possessing a potential to destabilize the structure of the protein.	Khalid, Z., & Naveed, H. (2020). Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1823885	https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1823885	Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms	Zoya Khalid, Hammad Naveed		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N122W	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Molecular docking and computational mutation analysis	Asn122Trp have been predicted as the most likely SPMs in the GBD of SARS-CoV-2 S involved in very specific recognition with 9-O-Ac-Sia through electrostatic interactions.	Mitrasinovic, P. M. (n.d.). Prediction of Single Point Mutations in Ganglioside-Binding Domain of SARS-CoV-2 S and Their Effects on Binding of 9-O-Acetylated Sialic Acid and Hidroxychloroquine. https://doi.org/10.26434/chemrxiv.12765953.v1	https://europepmc.org/article/ppr/ppr197275	Prediction of Single Point Mutations in Ganglioside-Binding Domain of SARS-CoV-2 S and Their Effects on Binding of 9-O-Acetylated Sialic Acid and Hidroxychloroquine	Petar M. Mitrasinovic		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22007A>C	1	22007	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N149H	None	-	None	0.24	Tolerated	-3.3	0.040315	0	Disulf_bond	BetaCoV_S1-NTD	glyco	NA	Surface glycoprotein_HKNNKSWMESEFRVYSSANNCTF	NA	NA	Surface glycoprotein_GVYYHKNNK	0.03	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000150	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was accessed. Increased sensitivity to convalescent sera. This mutation was found to possess over 4-fold sensitivity to one or two of the ten tested sera.	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Asia(0.000012);Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef84df9&&LOCATION=1:22007:A:C
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N165A	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0				Casalino, L., Gaieb, Z., Goldsmith, J. A., Hjorth, C. K., Dommer, A. C., Harbison, A. M., Fogarty, C. A., Barros, E. P., Taylor, B. C., McLellan, J. S., Fadda, E., & Amaro, R. E. (2020). Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein. ACS central science, 6(10), 1722–1734. https://doi.org/10.1021/acscentsci.0c01056	https://pubmed.ncbi.nlm.nih.gov/33140034/	Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein	Lorenzo Casalino, Zied Gaieb, Jory A Goldsmith, Christy K Hjorth, Abigail C Dommer, Aoife M Harbison, Carl A Fogarty, Emilia P Barros , Bryn C Taylor, Jason S McLellan, Elisa Fadda, Rommie E Amaro		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N234A	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0				Casalino, L., Gaieb, Z., Goldsmith, J. A., Hjorth, C. K., Dommer, A. C., Harbison, A. M., Fogarty, C. A., Barros, E. P., Taylor, B. C., McLellan, J. S., Fadda, E., & Amaro, R. E. (2020). Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein. ACS central science, 6(10), 1722–1734. https://doi.org/10.1021/acscentsci.0c01056	https://pubmed.ncbi.nlm.nih.gov/33140034/	Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein	Lorenzo Casalino, Zied Gaieb, Jory A Goldsmith, Christy K Hjorth, Abigail C Dommer, Aoife M Harbison, Carl A Fogarty, Emilia P Barros , Bryn C Taylor, Jason S McLellan, Elisa Fadda, Rommie E Amaro		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22406A>G					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N282D																												Computational Prediction	Genome sequence analysis followed by protein structure modelling	presumed to remove a potential N-glycosylation site.	Afrin, S. Z., Paul, S. K., Begum, J. A., Nasreen, S. A., Ahmed, S., Ahmad, F. U., Aziz, M. A., Parvin, R., Aung, M. S., & Kobayashi, N. (2021). Extensive genetic diversity with novel mutations in spike glycoprotein of SARS-CoV-2, Bangladesh in late 2020. New Microbes and New Infections, 100889. https://doi.org/10.1016/j.nmni.2021.100889	https://pubmed.ncbi.nlm.nih.gov/33936746/	Extensive genetic diversity with novel mutations in spike glycoprotein of SARS-CoV-2, Bangladesh in late 2020	Sultana Zahura Afrin , Shyamal Kumar Paul , Jahan Ara Begum , Syeda Anjuman Nasreen , Salma Ahmed , Fahim Uddin Ahmad , Md Abdul Aziz , Rokshana Parvin , Meiji Soe Aung , Nobumichi Kobayashi		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef852d0&&LOCATION=1:22406:A:G
22622A>G	1	22622	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N354D	None	-	None	0.04	Deleterious	0.737	2.63294	0.992126	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_VFNATRFASVYAWNR	9.3	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0002330	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR. Eight anti-spike antibodies were tested against sixteen SARS-CoV-2 spike protein RBD variants. Variants were encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells.	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was accessed. Increased sensitivity to convalescent sera. This mutation was found to possess over 4-fold sensitivity to one or two of the ten tested sera.##This mutation resulted in no observed neutralization with hIgG1 isotype control.	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800##Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity##Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Asia(0.000024);Europe(0.000209)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef855a7&&LOCATION=1:22622:A:G
22879C>A	1	22879	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N439K	None	-	None	0.93	Tolerated	-3.06	-1.61197	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_IAWNSNNLDSK	NA	NA	NA	NA	NA	NA	nCoV-2019_75_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0543540	Computational Analysis and Experimental	Binding free energy calculation , Cell line studies and site directed mutagenesis##pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene. This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR##The study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain##Mutations in proximity to ACE binding site and neutralizing epitopes were tested for their ability to confer resistance to the monoclonal antibodies, using an HIV-1-based pseudotyped virus-based assay. Naturally occurring mutations that conferred complete or partial resistance to C135 were at positions R346, N439, N440, K444, V445 and G446.##Also, N439K is found to  minimally modify the Spike-ACE2 recognition. N439K variant stood out from other circulating RBD variants as having a plausible mechanism for maintainence of viral fitness. N439K variant exhibits a 2 fold enhanced binding affinity to human ACE2 receptor	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009## Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800##Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312##Ortuso, F., Mercatelli, D., Guzzi, P. H., & Giorgi, F. M. (n.d.). Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex. https://doi.org/10.1101/2020.09.09.289074##Thomson, E. C., Rosen, L. E., Shepherd, J. G., Spreafico, R., da Silva Filipe, A., Wojcechowskyj, J. A., Davis, C., Piccoli, L., Pascall, D. J., Dillen, J., Lytras, S., Czudnochowski, N., Shah, R., Meury, M., Jesudason, N., De Marco, A., Li, K., Bassi, J., O’Toole, A., … COVID-19 Genomics UK (COG-UK) consortium. (n.d.). The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity. https://doi.org/10.1101/2020.11.04.355842 	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/##http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/##https://pubmed.ncbi.nlm.nih.gov/33112236/##https://www.tandfonline.com/doi/full/10.1080/07391102.2021.1886175##https://www.sciencedirect.com/science/article/pii/S0092867421000805?via%3Dihub	Mutations Strengthened SARS-CoV-2 Infectivity##The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity##Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants##Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex##The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity	Jiahui Chen, Rui Wang, Menglun Wang and Guo-Wei Wei##Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz##Francesco Ortuso, Daniele Mercatelli,Pietro Hiram Guzzi, Federico Manuel Giorgi##Emma C Thomson, Laura E Rosen, James G Shepherd, Roberto Spreafico, Ana da Silva Filipe, Jason A Wojcechowskyj, Chris Davis, Luca Piccoli, David J Pascall, Josh Dillen, Spyros Lytras, Nadine Czudnochowski, Rajiv Shah, Marcel Meury, Natasha Jesudason, Anna De Marco, Kathy Li, Jessica Bassi, Aine O'Toole, Dora Pinto, Rachel M Colquhoun, Katja Culap, Ben Jackson, Fabrizia Zatta, Andrew Rambaut, Stefano Jaconi, Vattipally B Sreenu, Jay Nix, Ruth F Jarrett, Martina Beltramello, Kyriaki Nomikou, Matteo Pizzuto, Lily Tong, Elisabetta Cameroni, Natasha Johnson, Arthur Wickenhagen, Alessandro Ceschi, Daniel Mair, Paolo Ferrari, Katherine Smollett, Federica Sallusto, Stephen Carmichael, Christian Garzoni, Jenna Nichols, Massimo Galli, Joseph Hughes, Agostino Riva, Antonia Ho, Malcolm G Semple, Peter JM Openshaw, Kenneth Baillie, The ISARIC4C Investigators, COVID-19 Genomics UK (COG-UK) consortium, Suzannah J Rihn, Samantha J Lycett, Herbert W Virgin, Amalio Telenti, Davide Corti, David L Robertson, Gyorgy Snell	Africa(0.001002);Asia(0.007211);Europe(0.029453);Oceania(0.016688)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85869&&LOCATION=1:22879:C:A
22879C>G	1	22879	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N439K	None	-	None	0.93	Tolerated	-3.06	-1.61197	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_IAWNSNNLDSK	NA	NA	NA	NA	NA	NA	nCoV-2019_75_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis and Experimental	Binding free energy calculation , Cell line studies and site directed mutagenesis##pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene. This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR##The study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain##Mutations in proximity to ACE binding site and neutralizing epitopes were tested for their ability to confer resistance to the monoclonal antibodies, using an HIV-1-based pseudotyped virus-based assay. Naturally occurring mutations that conferred complete or partial resistance to C135 were at positions R346, N439, N440, K444, V445 and G446.##Also, N439K is found to  minimally modify the Spike-ACE2 recognition. N439K variant stood out from other circulating RBD variants as having a plausible mechanism for maintainence of viral fitness. N439K variant exhibits a 2 fold enhanced binding affinity to human ACE2 receptor	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009## Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800##Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312##Ortuso, F., Mercatelli, D., Guzzi, P. H., & Giorgi, F. M. (n.d.). Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex. https://doi.org/10.1101/2020.09.09.289074##Thomson, E. C., Rosen, L. E., Shepherd, J. G., Spreafico, R., da Silva Filipe, A., Wojcechowskyj, J. A., Davis, C., Piccoli, L., Pascall, D. J., Dillen, J., Lytras, S., Czudnochowski, N., Shah, R., Meury, M., Jesudason, N., De Marco, A., Li, K., Bassi, J., O’Toole, A., … COVID-19 Genomics UK (COG-UK) consortium. (n.d.). The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity. https://doi.org/10.1101/2020.11.04.355842 	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/##http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/##https://pubmed.ncbi.nlm.nih.gov/33112236/##https://www.tandfonline.com/doi/full/10.1080/07391102.2021.1886175##https://www.sciencedirect.com/science/article/pii/S0092867421000805?via%3Dihub	Mutations Strengthened SARS-CoV-2 Infectivity##The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity##Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants##Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex##The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity	Jiahui Chen, Rui Wang, Menglun Wang and Guo-Wei Wei##Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz##Francesco Ortuso, Daniele Mercatelli,Pietro Hiram Guzzi, Federico Manuel Giorgi##Emma C Thomson, Laura E Rosen, James G Shepherd, Roberto Spreafico, Ana da Silva Filipe, Jason A Wojcechowskyj, Chris Davis, Luca Piccoli, David J Pascall, Josh Dillen, Spyros Lytras, Nadine Czudnochowski, Rajiv Shah, Marcel Meury, Natasha Jesudason, Anna De Marco, Kathy Li, Jessica Bassi, Aine O'Toole, Dora Pinto, Rachel M Colquhoun, Katja Culap, Ben Jackson, Fabrizia Zatta, Andrew Rambaut, Stefano Jaconi, Vattipally B Sreenu, Jay Nix, Ruth F Jarrett, Martina Beltramello, Kyriaki Nomikou, Matteo Pizzuto, Lily Tong, Elisabetta Cameroni, Natasha Johnson, Arthur Wickenhagen, Alessandro Ceschi, Daniel Mair, Paolo Ferrari, Katherine Smollett, Federica Sallusto, Stephen Carmichael, Christian Garzoni, Jenna Nichols, Massimo Galli, Joseph Hughes, Agostino Riva, Antonia Ho, Malcolm G Semple, Peter JM Openshaw, Kenneth Baillie, The ISARIC4C Investigators, COVID-19 Genomics UK (COG-UK) consortium, Suzannah J Rihn, Samantha J Lycett, Herbert W Virgin, Amalio Telenti, Davide Corti, David L Robertson, Gyorgy Snell		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8586a&&LOCATION=1:22879:C:G
22882T>G	1	22882	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N440K	None	-	None	0.73	Tolerated	-3.3	0.135937	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_IAWNSNNLDSK	NA	NA	NA	NA	NA	NA	nCoV-2019_75_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0188890	Experimental	This study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Sensitivity of isolated RBD mutants to neutralization by the three monoclonal antibodies was determined. N440 mutants that emerged during replication in the presence of C135 were resistant to C135, but retained full sensitivity to both C121 and C144 antibodies.	Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312	https://pubmed.ncbi.nlm.nih.gov/33112236/	Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants	Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz	Africa(0.009555);Asia(0.007698);Europe(0.001024);Oceania(0.000612)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85873&&LOCATION=1:22882:T:G
22910A>G	1	22910	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N450D	None	-	None	0.29	Tolerated	-3.3	-0.613165	0	disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0003430	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Africa(0.000334);Europe(0.000009)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858c2&&LOCATION=1:22910:A:G
23063A>T	1	23063	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N501D	None	-	None	0.04	Deleterious	-3.3	-0.613165	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in N501 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a93&&LOCATION=1:23063:A:T
23063A>C	1	23063	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N501H	None	-	None	0.12	Tolerated	-3.3	-0.613165	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000270	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in N501 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000012);Europe(0.000015)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a91&&LOCATION=1:23063:A:C
23065T>A	1	23065	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N501K	None	-	None	0.94	Tolerated	-3.3	-8.97814	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000120	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in N501 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a98&&LOCATION=1:23065:T:A
23065T>G	1	23065	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N501K	None	-	None	0.94	Tolerated	-3.3	-8.97814	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in N501 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a9a&&LOCATION=1:23065:T:G
23064A>G	1	23064	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N501S	None	-	None	0.74	Tolerated	-3.3	-2.61077	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001380	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in N501 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000073);Europe(0.000009);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a96&&LOCATION=1:23064:A:G
23064A>C	1	23064	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N501T	None	-	None	0.58	Tolerated	-3.3	-2.61077	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0146140	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking##Molecular dynamics simulation based prediction of mutation effects on protein structure	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in N501 residue might potentially alter viral binding properties.##Comparisons of MD simulations in the WT and mutants revealed a significant de-stabilization effect of the mutations on RBD and HR1 domains.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355##Ahamad, S., Kanipakam, H., & Gupta, D. (2020). Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1811774	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://pubmed.ncbi.nlm.nih.gov/32851910/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design##Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Shahzaib Ahamad 1, Hema Kanipakam 1, Dinesh Gupta 1	Africa(0.003942);Asia(0.000682);Europe(0.000478);Oceania(0.009512)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a95&&LOCATION=1:23064:A:C
	1				S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N501V	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis and Experimental	Rosetta Flex ddG calculation is an Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity upon Mutation. Mutations potentially impacting the binding energies were further validated using SPR assay. The affinity between SARS-CoV-2 Spike Protein (RBD His Tag) and hACE2 was measured using a Reichert4SPR system (Reichert Technologies, Depew, NY, USA) in single-cycle mode. 	N501V mutations is found to decrease the stability with a ddG value of -1.02	Xue, T., Wu, W., Guo, N., Wu, C., Huang, J., Lai, L., Liu, H., Li, Y., Wang, T., & Wang, Y. (n.d.). Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay. https://doi.org/10.1101/2020.12.24.424245	https://www.biorxiv.org/content/10.1101/2020.12.24.424245v1.full.pdf	Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay	Ting Xue, Weikun Wu, Ning Guo, Chengyong Wu, Jian Huang, Lipeng Lai, Hong Liu, Yalun Li, Tianyuan Wang and Yuxi Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23063A>G	1	23063	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N501Y	B.1.1.7## B.1.351## P.1##P.3	https://outbreak.info/situation-reports?pango=B.1.1.7##https://outbreak.info/situation-reports?pango=B.1.351##https://outbreak.info/situation-reports?pango=P.1##https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of B.1.1.7,  B.1.351,  P.1 and P.3 lineages.	0.62	Tolerated	-3.3	-0.613165	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	1.0008260	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking##In-silico analysis on phylogeny, transmissibility and Competitive advantage and increased growth rate	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in N501 residue might potentially alter viral binding properties. N501Y, targets an AA predicted to have a strong role in the interaction.##Mutation N501Y is a key contact residue in the receptor binding domain and enhances virus binding affinity to human angiotensin-converting enzyme 2	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355##Ortuso, F., Mercatelli, D., Guzzi, P. H., & Giorgi, F. M. (n.d.). Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex. https://doi.org/10.1101/2020.09.09.289074##Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., Wenseleers, T., Gimma, A., Waites, W., Wong, K. L. M., van Zandvoort, K., Silverman, J. D., Diaz-Ordaz, K., Keogh, R., Eggo, R. M., . . . Edmunds, W. J. (2021). Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science, 372(6538), eabg3055. https://doi.org/10.1126/science.abg3055##Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428##Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://www.tandfonline.com/doi/full/10.1080/07391102.2021.1886175##https://pubmed.ncbi.nlm.nih.gov/33658326/##https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/##https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design##Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex##Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England##SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant##Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Francesco Ortuso, Daniele Mercatelli,Pietro Hiram Guzzi, Federico Manuel Giorgi##Nicholas G Davies 1, Sam Abbott # 2, Rosanna C Barnard # 2, Christopher I Jarvis # 2, Adam J Kucharski # 2, James D Munday # 2, Carl A B Pearson # 2, Timothy W Russell # 2, Damien C Tully # 2, Alex D Washburne # 3, Tom Wenseleers # 4, Amy Gimma 2, William Waites 2, Kerry L M Wong 2, Kevin van Zandvoort 2, Justin D Silverman 5, CMMID COVID-19 Working Group; COVID-19 Genomics UK (COG-UK) Consortium; Karla Diaz-Ordaz 6, Ruth Keogh 6, Rosalind M Eggo 2, Sebastian Funk 2, Mark Jit 2, Katherine E Atkins 2 7, W John Edmunds 2##Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group##Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6	Africa(0.301550);Asia(0.112520);Europe(0.553992);Oceania(0.032764)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a92&&LOCATION=1:23063:A:G
24034C>T	1	24034	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	N824N	None	-	None	0.7	Tolerated	-3.3	-1.76888	0.0314961	NA	NA	NA	NA	NA	NA	19	Surface glycoprotein_LLFNKVTLA	-1	Spike glycoprotein	FIEDLLFNKVTLADAGF	NA	NA	NA	NA	Hypermutable low-fitness site	No co - mutations reported	NA	0.0000000	Computational Analysis	Multiple Sequence Alignment (MSA) and Mutation analysis followed by RNA Secondary Structure prediction and Base Pair Probability Analysis. Potential miRNA Binding Sites and Splice sites were also analysed	Reported to be a recurrent conserved mutation. Sequences carrying recurrent mutations C24034U and G24057A were predicted to have lost the miR-338-3p binding sites, although these mutations did not decrease the binding energy of miR-338-3p to S.	Hosseini Rad SM, A., & McLellan, A. D. (2020). Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting. International Journal of Molecular Sciences, 21(13), 4807. https://doi.org/10.3390/ijms21134807	https://pubmed.ncbi.nlm.nih.gov/32645951/	Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting	Ali Hosseini Rad Sm , Alexander D McLellan		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef865f7&&LOCATION=1:24034:C:T
25350C>T	1	25350	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P1263L	None	-	None	1	Tolerated	1.65	3.2969	0.992126	NA	NA	NA	NA	NA	NA	NA	Surface glycoprotein_SEPVLKGVKL	-1	Spike glycoprotein	CKFDEDDSEPVLKGVKLHYT	nCoV-2019_83_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0058640	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This mutation was found to have significantly decreased infectivity in comparison to the reference strain.	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.001136);Asia(0.001047);Europe(0.001678);Oceania(0.002003)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef874c3&&LOCATION=1:25350:C:T
21638C>T	1	21638	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P26S	P.1##B.1.620	https://outbreak.info/situation-reports?pango=P.1##https://outbreak.info/situation-reports?pango=B.1.620	Characteristic mutation of P.1 and B.1.620 lineages																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
9159C>T	1	9159	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P2965L	None	-	None	0	Deleterious	1.65	3.2943	1	NA	Lumenal	NA	NA	NA	orf1ab polyprotein_DTRYVLMDGSIIQFP	6.2	orf1ab_SIIQFPNTY	0.1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	A list of computational methods were performed which includes, Sequence retrieval and data mining of SNPs followed by functional annotation, Predicting evolutionary conserved residues using ConSurf webserver, mCSM webserver to predict the protein stability analysis, Predicting disease related mutations using MutPred, I-TASSER to generate complete 3D structure of both proteins for their wild-type and mutated sequences and Molecular docking analysis.	P2965L mutant observed majorly in Pakistani isolates was found to affect the mCSM protein stability score thereby possessing a potential to destabilize the structure of the protein.	Khalid, Z., & Naveed, H. (2020). Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1823885	https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1823885	Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms	Zoya Khalid, Hammad Naveed		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7bc2e&&LOCATION=1:9159:C:T
22374A>G	1	22374	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P391S	None	-	None	0.64	Tolerated	1.65	2.21203	0.015748	NA	BetaCoV_S1-NTD	NA	NA	NA	NA	NA	Surface glycoprotein_YYVGYLQPRTF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	A list of computational methods were performed which includes, Sequence retrieval and data mining of SNPs followed by functional annotation, Predicting evolutionary conserved residues using ConSurf webserver, mCSM webserver to predict the protein stability analysis, Predicting disease related mutations using MutPred, I-TASSER to generate complete 3D structure of both proteins for their wild-type and mutated sequences and Molecular docking analysis.	The mutations W461R, G405E and F588S in ACE2 receptor protein and population specific mutations P391S, C12S and G1223A in the spike glycoprotein were predicted as highly destabilizing to the structure of the bound complex. P391S, mutant observed majorly in Pakistani isolates was found to affect the mCSM protein stability score thereby possessing a potential to destabilize the structure of the protein.	Khalid, Z., & Naveed, H. (2020). Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1823885	https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1823885	Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms	Zoya Khalid, Hammad Naveed		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8525c&&LOCATION=1:22374:A:G
23034C>G	1	23034	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P491R	None	-	None	0.11	Tolerated	1.65	2.00869	0.0314961	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000560	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a35&&LOCATION=1:23034:C:G
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P499	None	-	None																						No co - mutations reported	NA	0.0005050	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	Deep mutational scanning library yeast surface-display induction and labeling followed by Cell sorting, Sequencing and Phenotype analysis	Mutants at this amino acid residue were found to abolish the binding affinity to hACE2 in comparison to wildtype	Yi, C., Sun, X., Ye, J. et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol 17, 621–630 (2020). https://doi.org/10.1038/s41423-020-0458-z	https://www.nature.com/articles/s41423-020-0458-z	Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies	Chunyan Yi, Xiaoyu Sun, Jing Ye, Longfei Ding, Meiqin Liu, Zhuo Yang, Xiao Lu, Yaguang Zhang, Liyang Ma, Wangpeng Gu, Aidong Qu, Jianqing Xu, Zhengli Shi, Zhiyang Ling & Bing Sun 	Africa(0.000401);Asia(0.000049);Europe(0.000055)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23123C>T	1	23123	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P521S	None	-	None	1	Tolerated	1.65	3.2572	1	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_77_LEFT	SARS-CoV-2_IBS_S1_F	NA	NA	NA	No co - mutations reported	NA	0.0003790	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.000134);Asia(0.000061);Europe(0.000073);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85b58&&LOCATION=1:23123:C:T
23604C>A	1	23604	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P681H	B.1.1.7## P.3## B.1.620	https://outbreak.info/situation-reports?pango=B.1.1.7##https://outbreak.info/situation-reports?pango=P.3##https://outbreak.info/situation-reports?pango=B.1.620	Characteristic mutation of B.1.1.7, P.3 and B.1.620 lineages. 	0.37	Tolerated	NA	-0.016189	0.0314961	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.7566400	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations##In-silico analysis on phylogeny, transmissibility and Competitive advantage and increased growth rate	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.##Mutation P681H is immediately adjacent to the furin cleavage site in spike, a known region of importance for infection and transmission	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783##Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., Wenseleers, T., Gimma, A., Waites, W., Wong, K. L. M., van Zandvoort, K., Silverman, J. D., Diaz-Ordaz, K., Keogh, R., Eggo, R. M., . . . Edmunds, W. J. (2021). Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science, 372(6538), eabg3055. https://doi.org/10.1126/science.abg3055##Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/##https://pubmed.ncbi.nlm.nih.gov/33658326/##https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein##Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England##SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong##Nicholas G Davies 1, Sam Abbott # 2, Rosanna C Barnard # 2, Christopher I Jarvis # 2, Adam J Kucharski # 2, James D Munday # 2, Carl A B Pearson # 2, Timothy W Russell # 2, Damien C Tully # 2, Alex D Washburne # 3, Tom Wenseleers # 4, Amy Gimma 2, William Waites 2, Kerry L M Wong 2, Kevin van Zandvoort 2, Justin D Silverman 5, CMMID COVID-19 Working Group; COVID-19 Genomics UK (COG-UK) Consortium; Karla Diaz-Ordaz 6, Ruth Keogh 6, Rosalind M Eggo 2, Sebastian Funk 2, Mark Jit 2, Katherine E Atkins 2 7, W John Edmunds 2##Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group	Africa(0.068622);Asia(0.109962);Europe(0.546794);Oceania(0.031262)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8611e&&LOCATION=1:23604:C:A
23604C>T	1	23604	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P681L	None	-	None	0.58	Tolerated	NA	-0.016189	0.0314961	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0028710	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.000200);Asia(0.002399);Europe(0.000105);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8611f&&LOCATION=1:23604:C:T
23605T>A	1	23605	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P681P	None	-	None	0.38	Tolerated	NA	-0.016189	0.0393701	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0002320	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.000067);Asia(0.000049);Europe(0.000060);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86120&&LOCATION=1:23605:T:A
23605T>C	1	23605	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P681P	None	-	None	0.38	Tolerated	NA	-0.016189	0.0393701	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86121&&LOCATION=1:23605:T:C
23605T>G	1	23605	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P681P	None	-	None	0.38	Tolerated	NA	-0.016189	0.0393701	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86122&&LOCATION=1:23605:T:G
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Insertion	Insertion					P681RRA684																												Computational Prediction and association analysis	Protein structure modelling 	Existence of this four-residue insertion, PRRA, preceding the furin cleavage site (R685-S686 peptide bond) between the subunits S1 and S2 of each protomer. The insertion PRRA together with the sequentially preceding seven amino acids and succeeding Arg (fully conserved among β-coronaviruses) have been pointed out to form a motif, Y674QTQTNSPRRAR685, homologous to that of neurotoxins from Ophiophagus (cobra) and Bungarus genera, as well as neurotoxin-like regions from three RABV strains. This close sequence similarity to both bacterial and viral SAgs, in support of the potential superantigenic character of the amino acid stretch Y674-R685 of SARS-CoV-2.	Cheng, M. H., Zhang, S., Porritt, R. A., Arditi, M., & Bahar, I. (2020). An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations. bioRxiv : the preprint server for biology, 2020.05.21.109272. https://doi.org/10.1101/2020.05.21.109272	https://pubmed.ncbi.nlm.nih.gov/32511374/	An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations	Mary Hongying Cheng 1, She Zhang 1, Rebecca A Porritt 2 3, Moshe Arditi 2 3, Ivet Bahar 1		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23603C>T	1	23603	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P681S	None	-	None	0.96	Tolerated	NA	-0.016189	0.023622	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8611d&&LOCATION=1:23603:C:T
23939C>G	1	23939	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P793A	None	-	None	0.79	Tolerated	-3.3	-1.22117	0	NA	NA	NA	NA	NA	NA	NA	Surface glycoprotein_KQIYKTPPIK	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S2-2 region of Fusion Peptide (FP) were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in P793 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef864e9&&LOCATION=1:23939:C:G
23940C>T	1	23940	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P793L	None	-	None	0.4	Tolerated	0.737	1.7365	0	NA	NA	NA	NA	NA	NA	NA	Surface glycoprotein_KQIYKTPPIK	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0003880	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S2-2 region of Fusion Peptide (FP) were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in P793 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Africa(0.000200);Asia(0.000085);Europe(0.000047);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef864ec&&LOCATION=1:23940:C:T
23940C>A	1	23940	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P793Q	None	-	None	0.56	Tolerated	0.737	1.7365	0	NA	NA	NA	NA	NA	NA	NA	Surface glycoprotein_KQIYKTPPIK	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000310	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S2-2 region of Fusion Peptide (FP) were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in P793 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000024);Europe(0.000007)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef864ea&&LOCATION=1:23940:C:A
23940C>G	1	23940	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P793R	None	-	None	0.53	Tolerated	0.737	1.7365	0	NA	NA	NA	NA	NA	NA	NA	Surface glycoprotein_KQIYKTPPIK	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S2-2 region of Fusion Peptide (FP) were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in P793 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef864eb&&LOCATION=1:23940:C:G
23939C>A	1	23939	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	P793T	None	-	None	0.58	Tolerated	-3.3	-1.22117	0	NA	NA	NA	NA	NA	NA	NA	Surface glycoprotein_KQIYKTPPIK	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000290	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S2-2 region of Fusion Peptide (FP) were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in P793 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000012);Europe(0.000017)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef864e8&&LOCATION=1:23939:C:A
24775A>C/T	1	24775	A	C/T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q1071H	B.1.617.1	https://outbreak.info/situation-reports?pango=B.1.617.1	Characteristic mutation of B.1.617.1 lineage 																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
22277C>A	1	22277	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q239K	None	-	None	0.34	Tolerated	-3.3	0.040315	0	NA	BetaCoV_S1-NTD	NA	NA	NA	Surface glycoprotein_IGINITRFQTLLALH	18	Surface glycoprotein_INITRFQTL	0.06	NA	NA	nCoV-2019_74_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000230	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800##Durmaz, B., Abdulmajed, O., & Durmaz, R. ı. (2020). Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor. Medeniyet Medical Journal, 1. https://doi.org/10.5222/mmj.2020.98048	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584268/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity##Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##Bengül Durmaz, Olkar Abdulmajed, and  Rıza Durmaz	Europe(0.000023)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8510c&&LOCATION=1:22277:C:A
22524A>T	1	22524	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q321	None	-	None	0.08	Tolerated	-2.46	-0.215181	0	NA	NA	NA	NA	NA	Surface glycoprotein_SNFRVQPTESIVRFP	16	Surface glycoprotein_QPTESIVRF	0.02	NA	NA	nCoV-2019_75_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0017300	Computational Analysis and Experimental	Sequence alignments followed by Secondary structure predictions and  protein dynamics study##pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Effect of the mutations on the structural dynamics of Spike glycoprotein were measured using the differences of free energy (ΔΔG) between wild-type and mutant. The ΔΔG, as a consequence of mutation, correlates with the structural changes in three-dimensional structure of protein, and, thus, measures the effect of mutation on protein stability. Q271R was predicted to stabilize the protein structure with the ΔΔG value of 0.379 kcal/mol.##Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an increased infectivity compared to the reference strain via cell line studies 	Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891##Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	https://pubmed.ncbi.nlm.nih.gov/33015411/##http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics##The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad##Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.000869);Asia(0.000122);Europe(0.000183);Oceania(0.000556)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8548e&&LOCATION=1:22524:A:T
22787C>G	1	22787	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q321L	None	-	None	0.25	Tolerated	1.65	3.2572	0.88189	disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_RQIAPGQTGK	0.03	NA	NA	NA	NA	NA	NA	NA	Co - mutations reported	Co-occuring with 23403A>G (D614G)	0.0007300	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Africa(0.000668);Asia(0.000049);Europe(0.000013)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85773&&LOCATION=1:22787:C:G
25504C>G	1	25504	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q38E	None	-	None	0	Deleterious	1.65	3.2969	1	NA	NA	NA	Transmembrane	NA	ORF3a protein_SDFVRATATIPIQAS	14	ORF3a protein_IPIQASLPF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	A protein sequence of ORF3a is composed of twenty different amino acids with various frequencies. The probability of occurrence of each amino acid Ai is determined by the formula   f (Ai)/l, where f (Ai) denotes the frequency of occurrence of the amino acid Ai in the primary sequence ORF3a and l stands as the length of ORF3a protein. This was followed by determining the conservation of amino acids using Shannon Entropy (SE) calculation.	In SARS-CoV, it was reported that tetramerization of the ORF3a protein is an important step for the ion channel formation which further increased the infectivity of the virus. From this study mutations W131C, T151I, R134L and D155Y may facilitate the tetramerization process in SARS-COV2 and thereby assisting the ion channel formation and favouring the virus with its infectivity. Similar to that of SARS-COV, it is also responsible for apoptosis mediated by TRAF-3 (Domain III). Mutations in this region Q38E and Q38P may enhance the effect of apoptosis but further studies are required.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef876aa&&LOCATION=1:25504:C:G
25505A>C	1	25505	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q38P	None	-	None	0	Deleterious	1.65	2.23123	1	NA	NA	NA	Transmembrane	NA	ORF3a protein_SDFVRATATIPIQAS	14	ORF3a protein_IPIQASLPF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	A protein sequence of ORF3a is composed of twenty different amino acids with various frequencies. The probability of occurrence of each amino acid Ai is determined by the formula   f (Ai)/l, where f (Ai) denotes the frequency of occurrence of the amino acid Ai in the primary sequence ORF3a and l stands as the length of ORF3a protein. This was followed by determining the conservation of amino acids using Shannon Entropy (SE) calculation.	In SARS-CoV, it was reported that tetramerization of the ORF3a protein is an important step for the ion channel formation which further increased the infectivity of the virus. From this study mutations W131C, T151I, R134L and D155Y may facilitate the tetramerization process in SARS-COV2 and thereby assisting the ion channel formation and favouring the virus with its infectivity. Similar to that of SARS-COV, it is also responsible for apoptosis mediated by TRAF-3 (Domain III). Mutations in this region Q38E and Q38P may enhance the effect of apoptosis but further studies are required.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef876ac&&LOCATION=1:25505:A:C
29498C>G	1	29498	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q409E	None	-	None	0.16	Tolerated	-2.21	-0.0880472	0.992126	NA	NA	NA	NA	Nucleocapsid phosphoprotein_KQLQQSMSSADS	NA	NA	NA	NA	NA	NA	nCoV-2019_98_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000120	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Asia(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a66e&&LOCATION=1:29498:C:G
22802C>T	1	22802	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Stop Gain	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q414*	None	-	None	NA	NA	-3.3	-1.48712	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_RQIAPGQTGK	0.03	NA	NA	nCoV-2019_76_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0046740	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.002940);Asia(0.000512);Europe(0.001166);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85799&&LOCATION=1:22802:C:T
22802C>G	1	22802	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q414E	None	-	None	0.95	Tolerated	-3.3	-1.48712	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_RQIAPGQTGK	0.03	NA	NA	nCoV-2019_76_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85797&&LOCATION=1:22802:C:G
22803A>C	1	22803	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q414P	None	-	None	0.22	Tolerated	1.65	2.25839	0.00787402	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_RQIAPGQTGK	0.03	NA	NA	nCoV-2019_76_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000250	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Asia(0.000024);Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8579a&&LOCATION=1:22803:A:C
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q474	None	-	None																						No co - mutations reported	NA	0.0001880	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	Deep mutational scanning library yeast surface-display induction and labeling followed by Cell sorting, Sequencing and Phenotype analysis	Mutants at this amino acid residue were found to abolish the binding affinity to hACE2 in comparison to wildtype	Yi, C., Sun, X., Ye, J. et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol 17, 621–630 (2020). https://doi.org/10.1038/s41423-020-0458-z	https://www.nature.com/articles/s41423-020-0458-z	Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies	Chunyan Yi, Xiaoyu Sun, Jing Ye, Longfei Ding, Meiqin Liu, Zhuo Yang, Xiao Lu, Yaguang Zhang, Liyang Ma, Wangpeng Gu, Aidong Qu, Jianqing Xu, Zhengli Shi, Zhiyang Ling & Bing Sun 	Africa(0.000067);Asia(0.000049);Europe(0.000016);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23039C>G	1	23039	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q493E	None	-	None	0.66	Tolerated	-3.3	-2.11137	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000130	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in Q493 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000012);Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a46&&LOCATION=1:23039:C:G
23041A>C	1	23041	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q493H	None	-	None	0.19	Tolerated	-3.3	-1.61197	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000350	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in Q493 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Europe(0.000035)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a4b&&LOCATION=1:23041:A:C
23041A>T	1	23041	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q493H	None	-	None	0.19	Tolerated	-3.3	-1.61197	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in Q493 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a4c&&LOCATION=1:23041:A:T
23039C>A	1	23039	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q493K	None	-	None	0.47	Tolerated	-3.3	-2.11137	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000730	Computational Analysis and Experimental	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking##This study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis. ####Neutralization assays with monoclonal antibodies were also performed.	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in Q493 residue might potentially alter viral binding properties.#Viruses passaged in the presence of monoclonal antibodies C121, C144  had mutations at positions E484 and Q493. In contrast, virus populations passaged in the presence of monoclonal antibody C135 lacked mutations at E484 or Q493. he E484K and Q493R mutants that emerged during replication in the presence of C121 or C144, both caused apparently complete, or near complete, resistance to both antibodies. However, both of these mutants retained full sensitivity to C135. Eight anti-spike antibodies were tested against sixteen SARS-CoV-2 spike protein RBD variants. Variants were encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. IC50(M) values are shown for each variant. There was no observed neutralization with hIgG1 isotype control 	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020a). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355## Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312##Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://pubmed.ncbi.nlm.nih.gov/33112236/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design#Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants##Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz##Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Asia(0.000024);Europe(0.000049)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a45&&LOCATION=1:23039:C:A
23039C>A	1	23039	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q493K	None	-	None	0.47	Tolerated	-3.3	-2.11137	0	disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a45&&LOCATION=1:23039:C:A
23040A>T	1	23040	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q493L	None	-	None	0.15	Tolerated	-3.3	-2.11137	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000470	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in Q493 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000024);Europe(0.000023)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a4a&&LOCATION=1:23040:A:T
	1				S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q493M	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis and Experimental	Rosetta Flex ddG calculation is an Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity upon Mutation. Mutations potentially impacting the binding energies were further validated using SPR assay. The affinity between SARS-CoV-2 Spike Protein (RBD His Tag) and hACE2 was measured using a Reichert4SPR system (Reichert Technologies, Depew, NY, USA) in single-cycle mode. 	Q493M mutations is found to increase the stability with a ddG value of -0.82	Xue, T., Wu, W., Guo, N., Wu, C., Huang, J., Lai, L., Liu, H., Li, Y., Wang, T., & Wang, Y. (n.d.). Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay. https://doi.org/10.1101/2020.12.24.424245	https://www.biorxiv.org/content/10.1101/2020.12.24.424245v1.full.pdf	Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay	Ting Xue, Weikun Wu, Ning Guo, Chengyong Wu, Jian Huang, Lipeng Lai, Hong Liu, Yalun Li, Tianyuan Wang and Yuxi Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q493N																												Computational Prediction	Molecular dynamics simulation based prediction of mutation effects on protein structure	Comparisons of MD simulations in the WT and mutants revealed a significant de-stabilization effect of the mutations on RBD and HR1 domains	Ahamad, S., Kanipakam, H., & Gupta, D. (2020). Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1811774	https://pubmed.ncbi.nlm.nih.gov/32851910/	Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding	Shahzaib Ahamad, Hema Kanipakam, Dinesh Gupta		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23040A>C	1	23040	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q493P	None	-	None	0.22	Tolerated	-3.3	-2.11137	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000010	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in Q493 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a48&&LOCATION=1:23040:A:C
23040A>G	1	23040	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q493R	None	-	None	0.32	Tolerated	-3.3	-2.11137	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000640	Computational Analysis and Experimental	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking##This study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in Q493 residue might potentially alter viral binding properties.#Viruses passaged in the presence of monoclonal antibodies C121, C144  had mutations at positions E484 and Q493. In contrast, virus populations passaged in the presence of monoclonal antibody C135 lacked mutations at E484 or Q493. he E484K and Q493R mutants that emerged during replication in the presence of C121 or C144, both caused apparently complete, or near complete, resistance to both antibodies. However, both of these mutants retained full sensitivity to C135.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020a). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355# Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://pubmed.ncbi.nlm.nih.gov/33112236/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design##Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz	Europe(0.000064)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a49&&LOCATION=1:23040:A:G
23054C>G	1	23054	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q498E	None	-	None	1	Tolerated	-3.3	-6.10658	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G498 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a78&&LOCATION=1:23054:C:G
23056A>C	1	23056	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q498H	None	-	None	0.29	Tolerated	-3.3	-4.73323	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000320	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G498 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000024);Europe(0.000008)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a7f&&LOCATION=1:23056:A:C
23056A>T	1	23056	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q498H	None	-	None	0.29	Tolerated	-3.3	-4.73323	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G498 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a81&&LOCATION=1:23056:A:T
23054C>A	1	23054	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q498K	None	-	None	0.94	Tolerated	-3.3	-6.10658	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000030	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G498 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a77&&LOCATION=1:23054:C:A
23055A>T	1	23055	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q498L	None	-	None	0.49	Tolerated	-3.3	-0.862866	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000010	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G498 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a7e&&LOCATION=1:23055:A:T
23055A>C	1	23055	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q498P	None	-	None	0.31	Tolerated	-3.3	-0.862866	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000120	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G498 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a7b&&LOCATION=1:23055:A:C
23055A>G	1	23055	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q498R	None	-	None	0.59	Tolerated	-3.3	-0.862866	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G498 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a7c&&LOCATION=1:23055:A:G
	1				S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q498W	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis and Experimental	Rosetta Flex ddG calculation is an Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity upon Mutation. Mutations potentially impacting the binding energies were further validated using SPR assay. The affinity between SARS-CoV-2 Spike Protein (RBD His Tag) and hACE2 was measured using a Reichert4SPR system (Reichert Technologies, Depew, NY, USA) in single-cycle mode. 	Q498W mutation is found to increase the stabilty with a ddG value of -3.66.	Xue, T., Wu, W., Guo, N., Wu, C., Huang, J., Lai, L., Liu, H., Li, Y., Wang, T., & Wang, Y. (n.d.). Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay. https://doi.org/10.1101/2020.12.24.424245	https://www.biorxiv.org/content/10.1101/2020.12.24.424245v1.full.pdf	Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay	Ting Xue, Weikun Wu, Ning Guo, Chengyong Wu, Jian Huang, Lipeng Lai, Hong Liu, Yalun Li, Tianyuan Wang and Yuxi Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23054C>T	1	23054	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Stop Gain	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q498X	None	-	None	NA	NA	-3.3	-6.10658	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in G498 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a79&&LOCATION=1:23054:C:T
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q498Y																												Computational Prediction	Molecular dynamics simulation based prediction of mutation effects on protein structure	Comparisons of MD simulations in the WT and mutants revealed a significant de-stabilization effect of the mutations on RBD and HR1 domains	Ahamad, S., Kanipakam, H., & Gupta, D. (2020). Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1811774	https://pubmed.ncbi.nlm.nih.gov/32851910/	Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding	Shahzaib Ahamad, Hema Kanipakam, Dinesh Gupta		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
21717A>G	1	21717	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q52R	B.1.525	https://outbreak.info/situation-reports?pango=B.1.525	Characteristic mutation of B.1.525 lineage																												Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo			
23587G>C	1	23587	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q675H	None	-	None	0.31	Tolerated	-3.09	-0.454362	0.944882	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	NA	NA	Spike glycoprotein	DIPIGAGICASYHTVSLL	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	23403A>G ; 23587G>C/T	0.0542460	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.009154);Asia(0.039244);Europe(0.004235);Oceania(0.001613)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef860e5&&LOCATION=1:23587:G:C
23587G>T	1	23587	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q675H	None	-	None	0.31	Tolerated	-3.09	-0.454362	0.944882	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	NA	NA	Spike glycoprotein	DIPIGAGICASYHTVSLL	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	23403A>G ; 23587G>C/T	0.0000000	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef860e8&&LOCATION=1:23587:G:T
23586A>G	1	23586	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q675R	None	-	None	0.59	Tolerated	0.424	0.969701	0.968504	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	NA	NA	Spike glycoprotein	DIPIGAGICASYHTVSLL	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0040380	Computational Analysis	Protein-specific analysis (Topology based Machine Learning structure prediction)	With the hypothesize that single mutations on S protein RBD with positive binding affinity changes will enhance the viral transmission since natural selection favors them,  Q675R is found to be an infectivity enhancing S protein mutation along with E583D co mutation. 	Wang, R., Chen, J., Gao, K., Hozumi, Y., Yin, C., & Wei, G. (2020). Characterizing SARS-CoV-2 mutations in the United States. Research Square. https://doi.org/10.21203/rs.3.rs-49671/v1	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430589/	Characterizing SARS-CoV-2 mutations in the United States	Rui Wang, Jiahui Chen, Kaifu Gao, Yuta Hozumi , Changchuan Yin, and Guo-Wei Wei	Africa(0.000401);Asia(0.000658);Europe(0.002089);Oceania(0.000890)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef860e1&&LOCATION=1:23586:A:G
23593G>C	1	23593	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q677H	B.1.525	https://outbreak.info/situation-reports?pango=B.1.525	Characteristic mutation of B.1.525 lineage.	0.11	Tolerated	-3.09	-1.33071	0	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	NA	Spike glycoprotein_DIPIGAGICASYHTVSLL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0685290				Soliman, M. S., AbdelFattah, M., Aman, S., Ibrahim, L. M., & Aziz, R. K. (2020). A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions. Omics : a journal of integrative biology, 10.1089/omi.2020.0194. Advance online publication. https://doi.org/10.1089/omi.2020.0194##Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33253058/##https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/ 	A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions##Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	May S Soliman , May AbdelFattah, Soad M N Aman, Lamyaa M Ibrahim, Ramy K Aziz ##Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo	Africa(0.038755);Asia(0.018477);Europe(0.000002);Europe(0.008681);Oceania(0.002614)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23593G>T	1	23593	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q677H	B.1.525	https://outbreak.info/situation-reports?pango=B.1.525	Characteristic mutation of B.1.525 lineage.	0.11	Tolerated	-3.09	-1.33071	0	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	NA	Spike glycoprotein_DIPIGAGICASYHTVSLL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000				Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo			
24408A>G	1	24408	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Q949R																																					
22132G>T	1	22132	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R190S	P.1	https://outbreak.info/situation-reports?pango=P.1	Characteristic mutation of P.1 lineage																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
884C>T	1	884	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R207C	None	-	None	0	Deleterious	0.737	1.79555	0.992126	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	A list of computational methods were performed which includes, Sequence retrieval and data mining of SNPs followed by functional annotation, Predicting evolutionary conserved residues using ConSurf webserver, mCSM webserver to predict the protein stability analysis, Predicting disease related mutations using MutPred, I-TASSER to generate complete 3D structure of both proteins for their wild-type and mutated sequences and Molecular docking analysis.	 R207C mutant observed majorly in Pakistani isolates was found to affect the mCSM protein stability score thereby possessing a potential to destabilize the structure of the protein.	Khalid, Z., & Naveed, H. (2020). Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1823885	https://www.tandfonline.com/doi/full/10.1080/07391102.2020.1823885	Identification of destabilizing SNPs in SARS-CoV2-ACE2 protein and spike glycoprotein: implications for virus entry mechanisms	Zoya Khalid, Hammad Naveed		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef75c01&&LOCATION=1:884:C:T
22599G>A	1	22599	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R346K	None	-	None	0.75	Tolerated	-3.3	-0.738016	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_VFNATRFASVYAWNR	9.3	Surface glycoprotein_GEVFNATRF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0008470	Experimental	This study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Sensitivity of isolated RBD mutants to neutralization by the three monoclonal antibodies was determined. R346 mutants that emerged during replication in the presence of C135 were resistant to C135, but retained full sensitivity to both C121 and C144 antibodies.	Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312	https://pubmed.ncbi.nlm.nih.gov/33112236/	Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants	Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz	Africa(0.000401);Asia(0.000134);Europe(0.000256);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85562&&LOCATION=1:22599:G:A
22599G>N/A	1	22599	G	NA	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R346L	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Experimental	This study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Sensitivity of isolated RBD mutants to neutralization by the three monoclonal antibodies was determined. R346 mutants that emerged during replication in the presence of C135 were resistant to C135, but retained full sensitivity to both C121 and C144 antibodies.	Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312	https://pubmed.ncbi.nlm.nih.gov/33112236/	Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants	Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22600A>C	1	22600	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R346S	None	-	None	1	Tolerated	-3.3	-5.23263	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_VFNATRFASVYAWNR	9.3	Surface glycoprotein_GEVFNATRF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0018750	Experimental	This study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Sensitivity of isolated RBD mutants to neutralization by the three monoclonal antibodies was determined. R346S mutants that emerged during replication in the presence of C135 were resistant to C135, but retained full sensitivity to both C121 and C144 antibodies.	Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312	https://pubmed.ncbi.nlm.nih.gov/33112236/	Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants	Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz	Africa(0.001270);Asia(0.000097);Europe(0.000285);Oceania(0.000223)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22600A>T	1	22600	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R346S	None	-	None	1	Tolerated	-3.3	-5.23263	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_VFNATRFASVYAWNR	9.3	Surface glycoprotein_GEVFNATRF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Experimental	This study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Sensitivity of isolated RBD mutants to neutralization by the three monoclonal antibodies was determined. R346S mutants that emerged during replication in the presence of C135 were resistant to C135, but retained full sensitivity to both C121 and C144 antibodies.	Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312	https://pubmed.ncbi.nlm.nih.gov/33112236/	Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants	Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22784A>T	1	22784	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Stop Gain	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R408*	None	-	None	NA	NA	-2.26	0.0110866	0.181102	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_RQIAPGQTGK	0.03	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8576b&&LOCATION=1:22784:A:T
22782G>T	1	22782	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R408I	None	-	None	0.14	Tolerated	1.65	2.13354	0.370079	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0004210	Computational Analysis and Experimental	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction. Neutralization assays with monoclonal antibodies were also performed.	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in decreased antigenicity of the Spike protein epitopes.##Eight anti-spike antibodies were tested against sixteen SARS-CoV-2 spike protein RBD variants. Variants were encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. IC50(M) values are shown for each variant. There was no observed neutralization with hIgG1 isotype control 	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790##Khan, M. I., Khan, Z. A., Baig, M. H., Ahmad, I., Farouk, A.-E. A., Song, Y. G., & Dong, J.-J. (2020). Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLOS ONE, 15(9), e0238344. https://doi.org/10.1371/journal.pone.0238344##Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/##https://pubmed.ncbi.nlm.nih.gov/32881907/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development##Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight##Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh##Mohd Imran Khan, Zainul A Khan, Mohammad Hassan Baig, Irfan Ahmad, Abd-ElAziem Farouk, Young Goo Song, Jae-Jun Dong##Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Africa(0.000267);Asia(0.000073);Europe(0.000081)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=606412809d714f1000207dfa&&LOCATION=1:22785:G:T
22785G>T	1	22785	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R408I	None	-	None	0.3	Tolerated	1.65	4.256	0.692913	disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_RQIAPGQTGK	0.03	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Sequence analysis followed by Molecular dynamics simulations of the protein and their complexes	Spike proteins are the key Surface glycoproteins and are well reported for their prominent role in interaction with host cell receptors.  The value of ΔΔG show that the mutant R408I (0.49732107 kcal/mol) mutation was having stabilization effect on spike protein. It was found that the mutation on the receptor binding domain (RBD) of spike protein decreases the stability.##Comparisons of MD simulations in the WT and mutants revealed a significant de-stabilization effect of the mutations on RBD and HR1 domains	Khan, M. I., Khan, Z. A., Baig, M. H., Ahmad, I., Farouk, A.-E. A., Song, Y. G., & Dong, J.-J. (2020). Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLOS ONE, 15(9), e0238344. https://doi.org/10.1371/journal.pone.0238344##Ahamad, S., Kanipakam, H., & Gupta, D. (2020). Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1811774	https://pubmed.ncbi.nlm.nih.gov/32881907/##https://pubmed.ncbi.nlm.nih.gov/32851910/	Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight##Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding	Mohd Imran Khan, Zainul A Khan, Mohammad Hassan Baig, Irfan Ahmad, Abd-ElAziem Farouk, Young Goo Song, Jae-Jun Dong##Shahzaib Ahamad 1, Hema Kanipakam 1, Dinesh Gupta		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8576f&&LOCATION=1:22785:G:T
23088G>A	1	23088	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R509K	None	-	None	0.46	Tolerated	1.65	4.256	0.448819	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_QPYRVVVLSFELLHA	14	Surface glycoprotein_QPYRVVVL	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001160	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.000067);Asia(0.000049)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85ae1&&LOCATION=1:23088:G:A
23607G>A	1	23607	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R682Q	None	-	None	0.07	Tolerated	NA	-0.016189	0.0629921	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001170	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.000067);Asia(0.000037);Europe(0.000013)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86127&&LOCATION=1:23607:G:A
23608G>T	1	23608	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R682R	None	-	None	1	Tolerated	NA	-0.016189	0.0708661	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8612c&&LOCATION=1:23608:G:T
23606C>T	1	23606	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R682W	None	-	None	0.01	Deleterious	NA	-0.016189	0.0472441	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001180	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.000067);Asia(0.000037);Europe(0.000014)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86125&&LOCATION=1:23606:C:T
23610G>C	1	23610	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R683P	None	-	None	0.19	Tolerated	NA	-0.016189	0.0787402	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000020	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Europe(0.000002)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86131&&LOCATION=1:23610:G:C
23610G>A	1	23610	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R683Q	None	-	None	0.48	Tolerated	NA	-0.016189	0.0787402	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001820	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.000067);Asia(0.000024);Europe(0.000035);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86130&&LOCATION=1:23610:G:A
23609C>A	1	23609	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	R683R	None	-	None	1	Tolerated	NA	-0.016189	0.0708661	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8612d&&LOCATION=1:23609:C:A
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Deletion	Deletion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	RBDΔ84																												Computational Prediction	Genomic sequence analysis followed by protein modelling	The RBDΔ84 mutant lacks the residues Q474 and F486, forming key interactions in the RBD-ACE2 complex [16]. Furthermore, a recent full single-point mutational scan of the RBD revealed that the Δ84 region contains a number of positions (L461, D467, Y473, C480, N487 and C488) whose mutations significantly deteriorate ACE2 binding. 	Kemenesi, G., Tóth, G. E., Bajusz, D., Keserű, G. M., Terhes, G., Burián, K., Zeghbib, S., Somogyi, B. A., & Jakab, F. (2021). Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis. Genes, 12(2), 194. https://doi.org/10.3390/genes12020194	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911659/	Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis	Gábor Kemenesi Gábor Endre Tóth, Dávid Bajusz, György M. Keserű Gabriella Terhes, Katalin Burián, Safia Zeghbib, Balázs A. Somogyi and Ferenc Jakab		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
21600G>T	1	21600	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S13I	B.1.427/B.1.429	https://outbreak.info/situation-reports?pango=B.1.427	Characteristic mutation of B.1.427/B.1.429 lineage																																		
22301A>C	1	22301	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S221W	None	-	None	0.06	Tolerated	-3.16	-0.342929	0.00787402	NA	BetaCoV_S1-NTD	NA	NA	NA	Surface glycoprotein_TRFQTLLALHRSYLT	9.2	Surface glycoprotein_LLALHRSYL	0.14	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000150	Computational Analysis	Sequence analysis followed by Molecular dynamics simulations of the protein and their complexes	Spike proteins are the key Surface glycoproteins and are well reported for their prominent role in interaction with host cell receptors.  ΔΔG value ( - 0.45085799) show that the mutantion possess a negative stabilization effect on spike protein. 	Khan, M. I., Khan, Z. A., Baig, M. H., Ahmad, I., Farouk, A.-E. A., Song, Y. G., & Dong, J.-J. (2020). Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLOS ONE, 15(9), e0238344. https://doi.org/10.1371/journal.pone.0238344	https://pubmed.ncbi.nlm.nih.gov/32881907/	Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight	Mohd Imran Khan, Zainul A Khan, Mohammad Hassan Baig, Irfan Ahmad, Abd-ElAziem Farouk, Young Goo Song, Jae-Jun Dong	Asia(0.000012);Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85158&&LOCATION=1:22301:A:C
22303T>A	1	22303	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S247R	None	-	None	0.06	Tolerated	-3.16	-0.215181	0.00787402	NA	BetaCoV_S1-NTD	NA	NA	NA	Surface glycoprotein_TRFQTLLALHRSYLT	9.2	Surface glycoprotein_LLALHRSYL	0.14	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0003480	Computational Analysis	Sequence analysis followed by Molecular dynamics simulations of the protein and their complexes	Spike proteins are the key Surface glycoproteins and are well reported for their prominent role in interaction with host cell receptors.  ΔΔG value ( -1.3464875) show that the mutantion possess a negative stabilization effect on spike protein. 	Khan, M. I., Khan, Z. A., Baig, M. H., Ahmad, I., Farouk, A.-E. A., Song, Y. G., & Dong, J.-J. (2020). Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLOS ONE, 15(9), e0238344. https://doi.org/10.1371/journal.pone.0238344	https://pubmed.ncbi.nlm.nih.gov/32881907/	Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight	Mohd Imran Khan, Zainul A Khan, Mohammad Hassan Baig, Irfan Ahmad, Abd-ElAziem Farouk, Young Goo Song, Jae-Jun Dong	Asia(0.000049);Europe(0.000021);Oceania(0.000278)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8515e&&LOCATION=1:22303:T:A
22303T>G	1	22303	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S359N	None	-	None	0.06	Tolerated	-3.16	-0.215181	0.00787402	NA	BetaCoV_S1-NTD	NA	NA	NA	Surface glycoprotein_TRFQTLLALHRSYLT	9.2	Surface glycoprotein_LLALHRSYL	0.14	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001730	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Africa(0.000067);Asia(0.000061);Europe(0.000045)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85160&&LOCATION=1:22303:T:G
22875C>T	1	22875	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S438F	None	-	None	0.06	Tolerated	1.65	3.2572	0.614173	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_IAWNSNNLDSK	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000020	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Europe(0.000002)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85861&&LOCATION=1:22875:C:T
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S459	None	-	None																						No co - mutations reported	NA	0.0041650	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	Deep mutational scanning library yeast surface-display induction and labeling followed by Cell sorting, Sequencing and Phenotype analysis	Mutants at this amino acid residue were found to abolish the binding affinity to hACE2 in comparison to wildtype	Yi, C., Sun, X., Ye, J. et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol 17, 621–630 (2020). https://doi.org/10.1038/s41423-020-0458-z	https://www.nature.com/articles/s41423-020-0458-z	Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies	Chunyan Yi, Xiaoyu Sun, Jing Ye, Longfei Ding, Meiqin Liu, Zhuo Yang, Xiao Lu, Yaguang Zhang, Liyang Ma, Wangpeng Gu, Aidong Qu, Jianqing Xu, Zhengli Shi, Zhiyang Ling & Bing Sun 	Africa(0.000267);Asia(0.003678);Europe(0.000109);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
	1				S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S477H	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis and Experimental	Rosetta Flex ddG calculation is an Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity upon Mutation. Mutations potentially impacting the binding energies were further validated using SPR assay. The affinity between SARS-CoV-2 Spike Protein (RBD His Tag) and hACE2 was measured using a Reichert4SPR system (Reichert Technologies, Depew, NY, USA) in single-cycle mode. 	S477H mutations is found to increase the stability with a ddG value of -1.39	Xue, T., Wu, W., Guo, N., Wu, C., Huang, J., Lai, L., Liu, H., Li, Y., Wang, T., & Wang, Y. (n.d.). Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay. https://doi.org/10.1101/2020.12.24.424245	https://www.biorxiv.org/content/10.1101/2020.12.24.424245v1.full.pdf	Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay	Ting Xue, Weikun Wu, Ning Guo, Chengyong Wu, Jian Huang, Lipeng Lai, Hong Liu, Yalun Li, Tianyuan Wang and Yuxi Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22638G>A	1	22638	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S477I	None	-	None	0.06	Tolerated	-0.306	1.00989	0.622047	disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_KRISNCVADYSVLYNSASFST	NA	NA	NA	NA	NA	NA	nCoV-2019_74_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0008150	Computational Analysis	Mutational analysis of SARS-CoV-2 Spike protein followed by Structural analysis of Spike/ACE2 interaction. Structural models of the SARS-CoV-2 Spike interacting with the human ACE2 from three recent X-ray structures, deposited on the Protein Data Bank: 6LZG, 6M0J  and 6VW1 were obtained. In the present study, Grid Based Pharmacophore Model (GBPM) has been applied to all selected complex models considering Spike and ACE2 either as host or guest. DRY, N1 and O GRID probes were considered for describing hydrophobic, hydrogen bond donor and hydrogen bond acceptor interaction. For each probe a cut-off, required for highlighting the most relevant MIFs points, was fixed above the 30% from the corresponding global minimum interaction energy value.	Mutation at position 477 could minimally modify the Spike-ACE2 recognition. GBPM Q2 classification suggested Serine (S) 477 as a weak contributor to the complex interaction. In all PDB entries selected, Serine 477 is located into a solvent exposed random coil loop. No interaction with ACE2 or Spike residues can be observed. Mutations at position 477  namely S477I, S477R and S477G are predicted to have changes in interactions.	Ortuso, F., Mercatelli, D., Guzzi, P. H., & Giorgi, F. M. (n.d.). Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex. https://doi.org/10.1101/2020.09.09.289074	https://www.tandfonline.com/doi/full/10.1080/07391102.2021.1886175	Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex	Francesco Ortuso, Daniele Mercatelli,Pietro Hiram Guzzi, Federico Manuel Giorgi	Africa(0.000200);Asia(0.000134);Europe(0.000425);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef855cf&&LOCATION=1:22638:G:A
22992G>A	1	22992	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S477N	B.1.620	https://outbreak.info/situation-reports?pango=B.1.620	Characteristic mutation of B.1.620 lineage	0.35	Tolerated	-2.16	0.260787	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_STEIYQAGSTPCNGV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.6500450	Computational Analysis	Multiple sequence alignment followed by topology-based feature generation and convolutional neural network-assisted models for analysing the protein structure	Prediction of free adversarial free energy change due to mutations identified Y423F as a hotspot residue, significantly increasing the infectivity of the virus. Also, S477N mutation can potentially alter ACE 2 receptor interaction.	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009##Ortuso, F., Mercatelli, D., Guzzi, P. H., & Giorgi, F. M. (n.d.). Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex. https://doi.org/10.1101/2020.09.09.289074	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/##https://www.tandfonline.com/doi/full/10.1080/07391102.2021.1886175	Mutations Strengthened SARS-CoV-2 Infectivity##Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex	Jiahui Chen, Rui Wang, Menglun Wang and Guo-Wei Wei##Francesco Ortuso, Daniele Mercatelli,Pietro Hiram Guzzi, Federico Manuel Giorgi	Africa(0.033476);Asia(0.002351);Europe(0.033532);Oceania(0.580686)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef859b7&&LOCATION=1:22992:G:A
23042T>C	1	23042	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S494P	None	-	None	0.23	Tolerated	-3.3	-2.61077	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0035540	Experimental	This study includes generation of various Plasmid constructs, HEK-293T cells and derivatives were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37oC and 5% CO2, Replication competent VSV/SARS-CoV-2/GFP chimeric virus and HIV-1/CCNanoLuc2AEGFP-SARS-CoV-2 pseudotype particles. Selection of viruses in the presence of antibodies was followed by sequence anlysis.	Mutations in proximity to ACE binding site and neutralizing epitopes were tested for their ability to confer resistance to the monoclonal antibodies, using an HIV-1-based pseudotyped virus-based assay. Naturally occurring mutations at positions E484, F490, Q493, and S494 conferred complete or partial resistance to C121 and C144	Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., Gaebler, C., Agudelo, M., Cho, A., Wang, Z., Gazumyan, A., Cipolla, M., Luchsinger, L., Hillyer, C. D., Caskey, M., … Bieniasz, P. D. (2020). Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. ELife, 9, 1. https://doi.org/10.7554/elife.61312	https://pubmed.ncbi.nlm.nih.gov/33112236/	Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants	Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio C C Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz	Africa(0.000735);Asia(0.000682);Europe(0.001970);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a4f&&LOCATION=1:23042:T:C
21711C>T	1	21711	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S50L	None	-	None	0.23	Tolerated	1.65	0.295811	0	Disulf_bond	BetaCoV_S1-NTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0011420	Computational Analysis	Multiple sequence alignment followed by Mutation analysis, Protein structure prediction and functional implications of the mutations	S50L mutation showed a reduction in total free energy in all three conformations thereby suggesting the potential role of this naturally occurring mutation in Spike protein evolution and Stability. showed stabilizing structure, suggesting its prevalent role in spike protein evolution.	Laha, S., Chakraborty, J., Das, S., Manna, S. K., Biswas, S., & Chatterjee, R. (2020). Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission. Infection, Genetics and Evolution, 85, 104445. https://doi.org/10.1016/j.meegid.2020.104445	https://pubmed.ncbi.nlm.nih.gov/32615316/	Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission	Sayantan Laha, Joyeeta Chakraborty, Shantanab Das, Soumen Kanti Manna, Sampa Biswas, RaghunathChatterjee	Africa(0.000200);Asia(0.000195);Europe(0.000079);Oceania(0.000668)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef84a83&&LOCATION=1:21711:C:T
23601C>T	1	23601	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S680F	None	-	None	0.04	Deleterious	NA	-0.016189	0.00787402	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0005630	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.000067);Asia(0.000110);Europe(0.000330);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86116&&LOCATION=1:23601:C:T
23600T>C	1	23600	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S680P	None	-	None	0.18	Tolerated	-3.3	-3.63112	0	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	Spike glycoprotein	DIPIGAGICASYHTVSLL	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000120	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Europe(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86111&&LOCATION=1:23600:T:C
23618A>G	1	23618	A	G 	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S686G	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000050	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Europe(0.000005)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8614b&&LOCATION=1:23618:A:G
23628G>T	1	23628	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S689I	None	-	None	0.12	Tolerated	-0.79	0.860157	0.023622	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_VASQSIIAY	0.02	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0090660	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.008553);Asia(0.000231);Europe(0.000226);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8616d&&LOCATION=1:23628:G:T
21774C>T	1	21774	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S71F	None	-	None	0.03	Deleterious	-3.3	0.168063	0	Disulf_bond	BetaCoV_S1-NTD	NA	NA	Surface glycoprotein_FHAIHVSGTNG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0006710	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in increased antigenicity of the Spike protein epitopes.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh	Africa(0.000067);Asia(0.000183);Europe(0.000087);Oceania(0.000334)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef84b41&&LOCATION=1:21774:C:T
22992G>T	1	22992	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S929C	None	-	None	0.39	Tolerated	-2.16	0.260787	0	disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_STEIYQAGSTPCNGV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was  identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is  located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. 	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef859bb&&LOCATION=1:22992:G:T
24347A>T	1	24347	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S929G	None	-	None	0.01	Deleterious	1.65	2.28422	0.866142	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000010	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86988&&LOCATION=1:24347:A:T
24347A>G	1	24347	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S929I	None	-	None	0.13	Tolerated	1.65	2.28422	0.866142	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0010660	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Africa(0.000535);Asia(0.000219);Europe(0.000145);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86987&&LOCATION=1:24347:A:G
24348G>T	1	24348	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S929N	None	-	None	0.02	Deleterious	-0.685	0.641071	0.897638	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000080	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex	Luigi Cavallo, Romina Oliva	Europe(0.000008)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8698c&&LOCATION=1:24348:G:T
24347A>C	1	24347	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S929R	None	-	None	0.16	Tolerated	1.65	2.28422	0.866142	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000100	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Europe(0.000010)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86986&&LOCATION=1:24347:A:C
24348G>A	1	24348	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S929R	None	-	None	1	Tolerated	-0.685	0.641071	0.897638	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86989&&LOCATION=1:24348:G:A
24349T>A	1	24349	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S929R	None	-	None	0.16	Tolerated	-3.3	0.202898	0.913386	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8698d&&LOCATION=1:24349:T:A
24348G>C	1	24348	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S929T	None	-	None	0.08	Tolerated	-0.685	0.641071	0.897638	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0011660	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent. S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Africa(0.000334);Asia(0.000049);Europe(0.000672);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8698a&&LOCATION=1:24348:G:C
24377T>G	1	24377	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S939A	None	-	None	0.2	Tolerated	-0.804	0.312441	0.0472441	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000950	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Africa(0.000067);Asia(0.000024);Europe(0.000004)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869e2&&LOCATION=1:24377:T:G
24378C>T	1	24378	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S939F	None	-	None	0.02	Deleterious	0.74	1.7365	0.0551181	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	hypermutable low-fitness site	Co - mutations reported	Co-occuring with 23403A>G (D614G)	0.0098120	Computational Analysis and Experimental	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.##pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent.##Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly increased infectivity in comparison to the reference strain	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152##Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full##http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly##The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Luigi Cavallo, Romina Oliva##Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.004276);Asia(0.001559);Europe(0.003198);Oceania(0.000779)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869e6&&LOCATION=1:24378:C:T
24377T>C	1	24377	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S939P	None	-	None	0.11	Tolerated	-0.804	0.312441	0.0472441	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000130	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Asia(0.000012);Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869e1&&LOCATION=1:24377:T:C
24378C>A	1	24378	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S939Y	None	-	None	0.03	Deleterious	0.74	1.7365	0.0551181	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	hypermutable low-fitness site	No co - mutations reported	NA	0.0001540	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Africa(0.000134);Asia(0.000012);Europe(0.000008)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869e4&&LOCATION=1:24378:C:A
24380T>G	1	24380	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S940A	None	-	None	1	Tolerated	-0.862	0.202898	0.23622	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000340	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Asia(0.000024);Europe(0.000010)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869ed&&LOCATION=1:24380:T:G
24381C>G	1	24381	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S940C	None	-	None	0.02	Deleterious	1.65	3.27011	0.551181	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000020	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Europe(0.000002)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869f1&&LOCATION=1:24381:C:G
24381C>T	1	24381	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S940F	None	-	None	0.01	Deleterious	1.65	3.27011	0.551181	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0027230	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Africa(0.001136);Asia(0.000305);Europe(0.000837);Oceania(0.000445)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869f2&&LOCATION=1:24381:C:T
24380T>C	1	24380	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S940P	None	-	None	0.05	Deleterious	-0.862	0.202898	0.23622	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000140	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Asia(0.000012);Europe(0.000002)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869ec&&LOCATION=1:24380:T:C
24380T>A	1	24380	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S940T	None	-	None	0.95	Tolerated	-0.862	0.202898	0.23622	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000400	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Asia(0.000037);Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869eb&&LOCATION=1:24380:T:A
24381C>A	1	24381	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S940Y	None	-	None	0.01	Deleterious	1.65	3.27011	0.551181	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000120	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	This mutation was identified in the fusion core of the heptad repeat (HR1). In the pre-fusion conformation, the mutated position is located on the second of four non-coaxial helical segments composing the HR1. This mutation is not expected to cause relevant changes in the prefusion structure, although could have a destabilizing effect as a consequence of posing large aromatic residues in direct contact with the solvent.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Europe(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef869f0&&LOCATION=1:24381:C:A
24389A>T	1	24389	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S943C	None	-	None	0.07	Tolerated	0.492	0.969701	0.685039	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	S943 is located on a turn immediately downstream the helical segment.  S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86a10&&LOCATION=1:24389:A:T
24389A>G	1	24389	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S943G	None	-	None	0.27	Tolerated	0.492	0.969701	0.685039	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000590	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	S943 is located on a turn immediately downstream the helical segment.  S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Europe(0.000003);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86a0e&&LOCATION=1:24389:A:G
24390G>T	1	24390	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S943I	None	-	None	0.24	Tolerated	-0.241	1.07924	0.787402	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0002410	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	S943 is located on a turn immediately downstream the helical segment.  S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Africa(0.000067);Asia(0.000037);Europe(0.000137)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86a15&&LOCATION=1:24390:G:T
24390G>A	1	24390	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S943N	None	-	None	0.39	Tolerated	-0.241	1.07924	0.787402	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0002550	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	S943 is located on a turn immediately downstream the helical segment.  S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Africa(0.000067);Europe(0.000021);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86a11&&LOCATION=1:24390:G:A
24389A>C	1	24389	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S943P	None	-	None	0.41	Tolerated	0.492	0.969701	0.685039	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	Surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0015680	Computational Analysis	Genome wide mutation prediction and analysis	Potential role in the virus escaping host immune response and thus developing resistance to drugs.	Durmaz, B., Abdulmajed, O., & Durmaz, R. ı. (2020). Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor. Medeniyet Medical Journal, 1. https://doi.org/10.5222/mmj.2020.98048	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584268/	Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor	Bengül Durmaz, Olkar Abdulmajed, and  Rıza Durmaz	Africa(0.000535);Asia(0.000719);Europe(0.000314)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86a0d&&LOCATION=1:24389:A:C
24391T>A	1	24391	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S943R	None	-	None	0.41	Tolerated	-3.3	-0.344819	0.795276	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	surface glycoprotein_SSTASALGK	0.09	NA	NA	nCoV-2019_81_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000220	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	S943 is located on a turn immediately downstream the helical segment.  S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva	Europe(0.000022)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86a16&&LOCATION=1:24391:T:A
24390G>C	1	24390	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S943T	None	-	None	0.57	Tolerated 	0.475	1.00989	0	disulf_bond	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	23403A>G ;  24390G>C	0.0004860	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly increased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.000067);Asia(0.000414);Europe(0.000005)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86a12&&LOCATION=1:24390:G:C
23277C>T	1	23277	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S943T	None	-	None	0.57	Tolerated	0.475	1.00989	0	disulf_bond	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Co - mutations reported	Co-occuring with 23403A>G (D614G)	0.0000000	Computational Analysis	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.	After the proteolytic processing, in the post-fusion conformation, the S protein HR1 and HR2 motifs interact with each other to form a six-helix bundle (6-HB), which promotes initiation of the viral and cellular membranes fusion. 	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly	Luigi Cavallo, Romina Oliva		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85d11&&LOCATION=1:23277:C:T
24390G>C	1	24390	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S943T	None	-	None	0.89	Tolerated	-0.241	1.07924	0.787402	NA	NA	NA	NA	Surface glycoprotein_VLYENQKLIANQFNSAIGKIQDSLSSTASALG	NA	NA	surface glycoprotein_SSTASALGK	0.09	NA	NA	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	23403A>G ;  24390G>C	0.0000000	Computational Analysis and Experimental	Mutants modelling and analysis using the mutate_model module of the Modeller 9v11 program . Molecular models were analysed and visually inspected with Pymol. The COCOMAPS web server was used to analyse the inter-chain contacts and H-bonds as well as the residues accessibility to the solvent.##pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	S943 is located on a turn immediately downstream the helical segment.  S929, D936 and S943 are H-bonded to S1196, R1185 and E1182, respectively. These are all strong H-bonds, especially the one between S943 and E1182, involving a negatively charged residue, and the one between D936 and R1185, being actually a salt bridge estimated to contribute an additional 3-5 kcal/mol to the free energy of protein stability as compare to a neutral H-bond. All these three H-bonds are lost upon mutation, which points to a weakening of the post-fusion assembly.##Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly increased infectivity in comparison to the reference strain	Cavallo, L., & Oliva, R. (n.d.). D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly. https://doi.org/10.1101/2020.06.08.140152##Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	https://www.biorxiv.org/content/10.1101/2020.06.08.140152v1.full##http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	D936Y and Other Mutations in the Fusion Core of the SARS-Cov-2 Spike Protein Heptad Repeat 1 Undermine the Post-Fusion Assembly##The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Luigi Cavallo, Romina Oliva##Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86a12&&LOCATION=1:24390:G:C
24506T>G	1	24506	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	S982A	B.1.1.7	https://outbreak.info/situation-reports?pango=B.1.1.7	Characteristic mutation of B.1.1.7 lineage																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Deletion	Deletion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	SΔCT13 - cytoplasmic tail deletion of 13 amino acids																												Experimental	Sequences of full-length spike (S) or 13 amino acids in cytoplasmic tail deleted S (SΔCT) of SARS-CoV-1 and SARS-CoV-2  were codon optimized and commercially synthesized. Synthetic genes were cloned into the mammalian expression plasmid pcDNA3.1+.  SARS-CoV-2 S D614G and V367F variants were generated by site-directed mutagenesis based on SARS-CoV-2 SΔCT. Human ACE2 genes were commercially synthesized and further cloned into pQCXIP retroviral vector.	SΔCT13, conferred enhanced spike incorporation into pseudovirions and increased viral entry into cells compared to that with full-length spike (S)	Yu, J., Li, Z., He, X., Gebre, M. S., Bondzie, E. A., Wan, H., Jacob-Dolan, C., Martinez, D. R., Nkolola, J. P., Baric, R. S., & Barouch, D. H. (2021). Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays. Journal of virology, JVI.00044-21. Advance online publication. https://doi.org/10.1128/JVI.00044-21	https://pubmed.ncbi.nlm.nih.gov/33727331/	Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays	Jingyou Yu, Zhenfeng Li, Xuan He, Makda S Gebre, Esther A Bondzie, Huahua Wan, Catherine Jacob-Dolan, David R Martinez, Joseph P Nkolola, Ralph S Baric, Dan H Barouch		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
24642C>T	1	24642	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T1027I	P.1##B.1.620	https://outbreak.info/situation-reports?pango=P.1##https://outbreak.info/situation-reports?pango=B.1.620	Characteristic mutation of P.1 and B.1.620 lineages																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
25275C>T	1	25275	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T1238I	None	-	None	0	Deleterious	1.65	3.2969	0.992126	NA	NA	NA	NA	Surface glycoprotein_MVTIMLCCMTS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0003840	Computational Analysis	Sequence and mutation analysis followed by secondary structure predictions.	The triple site mutation 28881-28883 that brings change in two amino acid 203-204:RG>KR, is known to play a critical role in virion assembly and structure. The mutated 203/204 region of N protein affects the SR (serine-arginine)-rich motif of the protein (a crucial region for controlling viral transcription and replication) by introducing lysin in between them that might hamper the phosphorylation at serine residue required for normal functioning of N protein. Significant reduction in pathogenicity has been observed with the deletion of SR domain, therefore it is important to target 203-204:RG>KR positions of the N protein to design the drugs for controlling the disease.  	Rehman, S., Mahmood, T., Aziz, E., & Batool, R. (2020). Identification of novel mutations in SARS-COV-2 isolates from Turkey. Archives of Virology, 165(12), 2937–2944. https://doi.org/10.1007/s00705-020-04830-0	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538173/	Identication of novel mutations in SARS-COV-2 isolates from Turkey	Shazia Rehman, Tariq Mahmood, Ejaz Aziz, Riffat Batool	Africa(0.000067);Asia(0.000037);Europe(0.000224);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef873e8&&LOCATION=1:25275:C:T
21618C>G	1	21618	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T19R	B.1.617.2##B.1.617.3	https://outbreak.info/situation-reports?pango=B.1.617.2##https://outbreak.info/situation-reports?pango=B.1.617.3	Characteristic mutation of B.1.617.2 and B.1.617.3 lineages																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
21621C>A	1	21621	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T20N	P.1	https://outbreak.info/situation-reports?pango=P.1	Characteristic mutation of P.1 lineage																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22995C>T	1	22995	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T478I	None	-	None	0.17	Tolerated	-2.14	-1.73682	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_STEIYQAGSTPCNGV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0019260	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera. This mutations were found to have an decreased infectivity compared to the reference strain via cell line studies 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Africa(0.000334);Asia(0.001194);Europe(0.000398)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef859c5&&LOCATION=1:22995:C:T
22995C>A	1	22995	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T478K	B.1.617.2	https://outbreak.info/situation-reports?pango=B.1.617.2	Characteristic mutation of B.1.617.2 lineage																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
23060A>G	1	23060	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T500A	None	-	None	0.91	Tolerated	-3.3	-0.613165	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000750	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in T500 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Africa(0.000067);Europe(0.000008)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a8a&&LOCATION=1:23060:A:G
23061C>T	1	23061	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T500I	None	-	None	0.47	Tolerated	-3.3	-3.35987	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000270	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in T500 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000024);Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8824e&&LOCATION=1:23061:C:T
23061C>A	1	23061	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T500N	None	-	None	0.58	Tolerated	-3.3	-3.35987	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in T500 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a8c&&LOCATION=1:23061:C:A
23060A>C	1	23060	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T500P	None	-	None	0.34	Tolerated	-3.3	-0.613165	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000120	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in T500 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a89&&LOCATION=1:23060:A:C
	1				S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T500R	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis and Experimental	Rosetta Flex ddG calculation is an Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity upon Mutation. Mutations potentially impacting the binding energies were further validated using SPR assay. The affinity between SARS-CoV-2 Spike Protein (RBD His Tag) and hACE2 was measured using a Reichert4SPR system (Reichert Technologies, Depew, NY, USA) in single-cycle mode. 	T500R mutations is found to increase the stability with a ddG value of -1.23	Xue, T., Wu, W., Guo, N., Wu, C., Huang, J., Lai, L., Liu, H., Li, Y., Wang, T., & Wang, Y. (n.d.). Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay. https://doi.org/10.1101/2020.12.24.424245	https://www.biorxiv.org/content/10.1101/2020.12.24.424245v1.full.pdf	Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay	Ting Xue, Weikun Wu, Ning Guo, Chengyong Wu, Jian Huang, Lipeng Lai, Hong Liu, Yalun Li, Tianyuan Wang and Yuxi Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23060A>T	1	23060	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T500S	None	-	None	0.8	Tolerated	-3.3	-0.613165	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000070	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in T500 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Europe(0.000007)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a8b&&LOCATION=1:23060:A:T
	1				S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T500W	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis and Experimental	Rosetta Flex ddG calculation is an Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity upon Mutation. Mutations potentially impacting the binding energies were further validated using SPR assay. The affinity between SARS-CoV-2 Spike Protein (RBD His Tag) and hACE2 was measured using a Reichert4SPR system (Reichert Technologies, Depew, NY, USA) in single-cycle mode. 	T500W mutations is found to decrease the stability with a ddG value of -1.90	Xue, T., Wu, W., Guo, N., Wu, C., Huang, J., Lai, L., Liu, H., Li, Y., Wang, T., & Wang, Y. (n.d.). Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay. https://doi.org/10.1101/2020.12.24.424245	https://www.biorxiv.org/content/10.1101/2020.12.24.424245v1.full.pdf	Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay	Ting Xue, Weikun Wu, Ning Guo, Chengyong Wu, Jian Huang, Lipeng Lai, Hong Liu, Yalun Li, Tianyuan Wang and Yuxi Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
24042C>T	1	24042	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T572I	None	-	None	0.05	Deleterious	1.65	3.27011	0.984252	NA	NA	NA	NA	NA	Surface glycoprotein_LLFNKVTLADAGFIK	19	Surface glycoprotein_LLFNKVTLA	-1	Spike glycoprotein	FIEDLLFNKVTLADAGF	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0050160	Computational Analysis	Sequence alignments followed by Secondary structure predictions and  protein dynamics study	Effect of the mutations on the structural dynamics of Spike glycoprotein were measured using the differences of free energy (ΔΔG) between wild-type and mutant. The ΔΔG, as a consequence of mutation, correlates with the structural changes in three-dimensional structure of protein, and, thus, measures the effect of mutation on protein stability. T572I was predicted to stabilize the protein structure with the ΔΔG value of 0.296 kcal/mol.	Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891	https://pubmed.ncbi.nlm.nih.gov/33015411/	Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics	Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad	Africa(0.001203);Asia(0.000950);Europe(0.002585);Oceania(0.000278)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86612&&LOCATION=1:24042:C:T
23709C>T	1	23709	C	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T716I	B.1.1.7	https://outbreak.info/situation-reports?pango=B.1.1.7	Characteristic mutation of B.1.1.7 lineage																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23717A>G	1	23717	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T719A	None	-	None	0.01	Deleterious	-1.04	0.860157	1	NA	NA	NA	NA	Surface glycoprotein_TISVTTEILPVSMTKTSVDCT	NA	NA	Surface glycoprotein_IPTNFTISV	0.11	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000120	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Asia(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8626d&&LOCATION=1:23717:A:G
3575G>C	1	3575	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	T827I	None	-	None	1	Tolerated	-0.977	0.0325905	0.992126	NA	Macro	NA	NA	NA	NA	NA	orf1ab_VLSGHNLAK	0.02	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0003540	Computational Analysis	Sequence alignments followed by Secondary structure predictions and  protein dynamics study	Effect of the mutations on the structural dynamics of Spike glycoprotein were measured using the differences of free energy (ΔΔG) between wild-type and mutant. The ΔΔG, as a consequence of mutation, correlates with the structural changes in three-dimensional structure of protein, and, thus, measures the effect of mutation on protein stability. T827I was predicted to stabilize the protein structure with the ΔΔG value of 0.044 kcal/mol.	Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891	https://pubmed.ncbi.nlm.nih.gov/33015411/	Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics	Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad	Asia(0.000024);Europe(0.000330)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef77c2f&&LOCATION=1:3575:G:C
16777G>C	1	16777	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V1104L	None	-	None	0	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	orf1ab_KPRPPLNRNYVF	0.05	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0034020	Computational Analysis	Sequence alignments followed by Secondary structure predictions and  protein dynamics study	Effect of the mutations on the structural dynamics of Spike glycoprotein were measured using the differences of free energy (ΔΔG) between wild-type and mutant. The ΔΔG, as a consequence of mutation, correlates with the structural changes in three-dimensional structure of protein, and, thus, measures the effect of mutation on protein stability. V1104L was predicted to stabilize the protein structure with the ΔΔG value of 0.687 kcal/mol.	Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891	https://pubmed.ncbi.nlm.nih.gov/33015411/	Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics	Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad	Africa(0.001470);Asia(0.000743);Europe(0.001133);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef811e6&&LOCATION=1:16777:G:C
25088G>T	1	25088	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V1176F	P.1##P.3	https://outbreak.info/situation-reports?pango=P.1##https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of P.1 and P.3 lineages																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
24872G>T	1	24872	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V120Y	None	-	None	0.3	Tolerated	0.509	0.526157	0.165354	disulf_bond	NA	NA	NA	NA	NA	NA	surface glycoprotein_GTHWFVTQR	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Molecular docking and computational mutation analysis	Val120Tyr have been predicted as the most likely SPMs in the GBD of SARS-CoV-2 S involved in very specific recognition with 9-O-Ac-Sia through electrostatic interactions. This mutation has been found to be critical in the Ganglioside Binding Domain (GBD) of SARS-CoV-2 S involved in very hydrophobic recognition with Hydroxychloroquine. 	Mitrasinovic, P. M. (n.d.). Prediction of Single Point Mutations in Ganglioside-Binding Domain of SARS-CoV-2 S and Their Effects on Binding of 9-O-Acetylated Sialic Acid and Hidroxychloroquine. https://doi.org/10.26434/chemrxiv.12765953.v1	https://europepmc.org/article/ppr/ppr197275	Prediction of Single Point Mutations in Ganglioside-Binding Domain of SARS-CoV-2 S and Their Effects on Binding of 9-O-Acetylated Sialic Acid and Hidroxychloroquine	Petar M. Mitrasinovic		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86f5e&&LOCATION=1:24872:G:T
21939T>C	1	21939	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V126A	B.1.620	https://outbreak.info/situation-reports?pango=B.1.620	Characteristic mutation of B.1.620 lineage																																		
22583G>A	1	22583	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V341I	None	-	None	0.39	Tolerated	0.738	1.88384	0.929134	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_VFNATRFASVYAWNR	9.3	Surface glycoprotein_GEVFNATRF	-1	Spike glycoprotein	VRFPNITNLCPFGEVFN	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	Co-occurrinng with 23403A>G (D614G)	0.0002650	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR. Also, neutralization assays were performed across SARS-CoV-2 spike RBD variants. Eight anti-spike antibodies were tested against sixteen SARS-CoV-2 spike protein RBD variants. Variants were encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells.	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly increased infectivity in comparison to the reference strain.## This mutation resulted in no observed neutralization with hIgG1 isotype control.	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800##Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity##Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang##Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Asia(0.000037);Europe(0.000061);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85531&&LOCATION=1:22583:G:A
22661G>T	1	22661	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V367F	None	-	None	0.06	Tolerated	0.752	2.7578	0.0472441	NA	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_KRISNCVADYSVLYNSASFST	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0245980	Computational Analysis	Genome sequence alignment followed by topology based Bindinf Free Energy (BFE) analysis####Binding free energy calculation ; pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR.####In-silico analysis on mutant affinity was also checked.	Most significant positive free energy change is caused by mutation V367F. Frequencies of S477N, N439K, V483A, and V367F are higher than those of other mutations, indicating these mutations have a stronger transmission capacity. Changes in RBD region demonstrates altered sensitivity to neutralizing mAbs. V367F was observed to be more susceptible to neutralization mediated by mAbs.##V367Fdisplayed higher binding affinity to human ACE2, likely due to the enhanced structural stabilization of the RBD beta-sheet scaffold.	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226.  https://doi.org/10.1016/j.jmb.2020.07.009##Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800## Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790####Ou, J., Zhou, Z., Dai, R., Zhao, S., Wu, X., Zhang, J., Lan, W., Cui, L., Wu, J., Seto, D., Chodosh, J., Zhang, G., & Zhang, Q. (n.d.). Emergence of SARS-CoV-2 spike RBD mutants that enhance viral infectivity through increased human ACE2 receptor binding affinity. https://doi.org/10.1101/2020.03.15.991844	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/##http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/##https://www.biorxiv.org/content/10.1101/2020.03.15.991844v5.full	Mutations Strengthened SARS-CoV-2 Infectivity##The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity##Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development##Emergence of SARS-CoV-2 spike RBD mutants that enhance viral infectivity through increased human ACE2 receptor binding affinity	Jiahui Chen, Rui Wang, Menglun Wang, Guo-Wei Wei ##Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin , Meng Wang, Qiong Lu, Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li , Weijin Huang, Youchun Wang##Praveen Kumar Singh , Umay Kulsum, Syed Beenish Rufai, S Rashmi Mudliar, Sarman Singh##Junxian Ou, Zhonghua Zhou, Ruixue Dai, Shan Zhao, Xiaowei Wu, Jing Zhang, Wendong Lan, Lilian Cui, Jianguo Wu, Donald Seto, James Chodosh, Gong Zhang,  Qiwei Zhang	Africa(0.022518);Asia(0.000914);Europe(0.000777);Oceania(0.000389)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85613&&LOCATION=1:22661:G:T
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V417L	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0				Shah, M., Ahmad, B., Choi, S., & Woo, H. G. (2020). Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization. Computational and structural biotechnology journal, 18, 3402–3414. https://doi.org/10.1016/j.csbj.2020.11.002	https://pubmed.ncbi.nlm.nih.gov/33200028/	Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization	Masaud Shah, Bilal Ahmad, Sangdun Choi, Hyun Goo Woo 		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
22896T>C	1	22896	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V445A	None	-	None	0.5	Tolerated	.	-0.238614	0	disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_75_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0003920	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Asia(0.000292);Europe(0.000044);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85897&&LOCATION=1:22896:T:C
23004T>C	1	23004	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V483A	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage	0.66	Tolerated	NA	0.135937	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_STEIYQAGSTPCNGV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001260	Computational Analysis	Computational Mutation calling followed by Phylogenetic analysis and Antigenic Epitope prediction	Effect of antigenecity of Spike protein due to a range of variations checked using EMBOSS Antigenic Software reveled that this mutation was one among the range of variations that resulted in decreased antigenicity of the Spike protein epitopes. Also, V483A mutation can potentially alter ACE 2 receptor interaction.	Singh, P. K., Kulsum, U., Rufai, S. B., Mudliar, S. R., & Singh, S. (2020). Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development. Journal of Laboratory Physicians, 12(02), 154–160. https://doi.org/10.1055/s-0040-1715790##Ortuso, F., Mercatelli, D., Guzzi, P. H., & Giorgi, F. M. (n.d.). Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex. https://doi.org/10.1101/2020.09.09.289074	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462717/##https://www.tandfonline.com/doi/full/10.1080/07391102.2021.1886175	Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development##Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex	Praveen Kumar Sing, Umay Kulsum, Syed Beenish Rufai, S. Rashmi Mudliar, Sarman Singh##Francesco Ortuso, Daniele Mercatelli,Pietro Hiram Guzzi, Federico Manuel Giorgi	Asia(0.000049);Europe(0.000077)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=606412809d714f1000207e2a&&LOCATION=1:23010:T:C
23010T>C	1	23010	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V483A	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage	0.38	Tolerated	-1.71	-1.48712	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_STEIYQAGSTPCNGV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Protein-specific analysis (Topology based Machine Learning structure prediction)##Multiple sequence alignment followed by topology-based feature generation and convolutional neural network-assisted models for analysing the protein structure##Secondary Structure and Solvent Accessibility Prediction##Computational Analysis and Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	23010T>C-(V483A) has the highest frequency localized on the RBM has the positive binding affinity change. #Frequencies of S477N, N439K, V483A, and V367F are higher than those of other mutations, indicating these mutations have a stronger transmission capacity.#In the RBD region, S477G [CBCTT(S)CCCCC -> CBCTT(S)CCCEC], P479L [CTTSC(C)CCCCC -> CTTSC(C)CECCC], V483A [CCCCC(C)CTTTC -> CCCCC(C)CCTTC], nd F486L [CCCCT(T)TCBCS -> CCCEC(T)TCBCS] are four mutations having protein structure change potential.V483A and F486L are thus likely to make changes in both protein secondary structure and relative solvent accessibility in the RBD region. Also, V483A mutation can potentially alter ACE 2 receptor interaction.	Wang, R., Chen, J., Gao, K., Hozumi, Y., Yin, C., & Wei, G. (2020). Characterizing SARS-CoV-2 mutations in the United States. Research Square. https://doi.org/10.21203/rs.3.rs-49671/v1##Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009##Ortuso, F., Mercatelli, D., Guzzi, P. H., & Giorgi, F. M. (n.d.). Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex. https://doi.org/10.1101/2020.09.09.289074	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430589/##https://pubmed.ncbi.nlm.nih.gov/32710986/##https://www.nature.com/articles/s41598-021-83105-3##https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all##https://www.tandfonline.com/doi/full/10.1080/07391102.2021.1886175	Characterizing SARS-CoV-2 mutations in the United States##Mutations Strengthened SARS-CoV-2 Infectivity##Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)##Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding##Structural Genetics of circulating variants affecting the SARS-CoV-2 Spike / human ACE2 complex	Rui Wang, Jiahui Chen, Kaifu Gao, Yuta Hozumi , Changchuan Yin, and Guo-Wei Wei##Jiahui Chen, Rui Wang, Menglun Wang, Guo-Wei Wei##Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom##Francesco Ortuso, Daniele Mercatelli,Pietro Hiram Guzzi, Federico Manuel Giorgi		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef859ed&&LOCATION=1:23010:T:C
23010T>C	1	23010	T	C 	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V483A																																					
23009G>A	1	23009	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V483I	None	-	None	0.68	Tolerated	-1.71	1.50929	0.023622	Disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_STEIYQAGSTPCNGV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000630	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an decreased infectivity compared to the reference strain via cell line studies 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Asia(0.000037);Europe(0.000026)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef859e8&&LOCATION=1:23009:G:A
23090G>C	1	23090	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V510L	None	-	None	0.51	Tolerated	1.65	4.256	0.409449	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_QPYRVVVLSFELLHA	14	Surface glycoprotein_QPYRVVVL	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000190	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Asia(0.000012);Europe(0.000007)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85ae8&&LOCATION=1:23090:G:C
23090G>T	1	23090	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V510L	None	-	None	0.51	Tolerated	1.65	4.256	0.409449	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_QPYRVVVLSFELLHA	14	Surface glycoprotein_QPYRVVVL	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Infectivity of 106 pseudotyped viruses possessing 80 natural variants and 26 glycosylation mutants were tested using 293T-hACE2 cells, where a difference by 4-fold in RLU compared with the reference Wuhan-1 strain (GenBank: MN_908947) was deemed as being significant. This combination of co-occurring mutations were found to have significantly decreased infectivity in comparison to the reference strain	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85ae9&&LOCATION=1:23090:G:T
23405G>T	1	23405	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V615F	None	-	None	0.05	Deleterious	1.65	4.256	1	NA	NA	NA	NA	Surface glycoprotein_FGGVSVITPGTNTSNQVAVLYQDVNCTEV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0003200	Computational Analysis	Genome wide mutation prediction and analysis	Potential role in the virus escaping host immune response and thus developing resistance to drugs.	Durmaz, B., Abdulmajed, O., & Durmaz, R. ı. (2020). Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor. Medeniyet Medical Journal, 1. https://doi.org/10.5222/mmj.2020.98048	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584268/	Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor	Bengül Durmaz, Olkar Abdulmajed, and  Rıza Durmaz	Africa(0.000067);Asia(0.000097);Europe(0.000156)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85e88&&LOCATION=1:23405:G:T
23405G>A	1	23405	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V615I	None	-	None	0.85	Tolerated	1.65	4.256	1	NA	NA	NA	NA	Surface glycoprotein_FGGVSVITPGTNTSNQVAVLYQDVNCTEV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0003950	Computational Analysis	Genome wide mutation prediction and analysis	Potential role in the virus escaping host immune response and thus developing resistance to drugs.	Durmaz, B., Abdulmajed, O., & Durmaz, R. ı. (2020). Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor. Medeniyet Medical Journal, 1. https://doi.org/10.5222/mmj.2020.98048	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584268/	Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor	Bengül Durmaz, Olkar Abdulmajed, and  Rıza Durmaz	Asia(0.000171);Europe(0.000113);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85e85&&LOCATION=1:23405:G:A
23405G>C	1	23405	G	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V615L	None	-	None	0.66	Tolerated	1.65	4.256	1	NA	NA	NA	NA	Surface glycoprotein_FGGVSVITPGTNTSNQVAVLYQDVNCTEV	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000280	Experimental	pcDNA3.1.S2 recombinant plasmid (GenBank: MT_613044), constructed by inserted the codon-optimized S gene of SARS-CoV-2 (GenBank: MN_908947) into pcDNA3.1, was used as the template to generate the plasmid with mutagenesises in S gene.This was followed by production and titration of pseudotyped viruses and their quantification by RT-PCR	Sensitivity of the strains with amino acid changes to ten COVID-19 convalescent sera was determined. Modest differences between variants and reference strain (within 4-fold) were observed in their reactivity to grouped convalescent sera.These co-occurring mutations were found to have an increased infectivity compared to the reference strain via cell line studies 	Li, Q., Wu, J., Nie, J., Zhang, L., Hao, H., Liu, S., Zhao, C., Zhang, Q., Liu, H., Nie, L., Qin, H., Wang, M., Lu, Q., Li, X., Sun, Q., Liu, J., Zhang, L., Li, X., Huang, W., & Wang, Y. (2020). The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3635800	http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7366990/	The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity	Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie, Haiyang Qin, Meng Wang, Qiong Lu,  Xiaoyu Li, Qiyu Sun, Junkai Liu, Linqi Zhang, Xuguang Li, Weijin Huan and Youchun Wang	Asia(0.000024);Europe(0.000004)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85e86&&LOCATION=1:23405:G:C
23621G>A	1	23621	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	V687I	None	-	None	0.43	Tolerated	-3.06	-1.98797	0	NA	NA	NA	NA	Surface glycoprotein_SYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIA	NA	NA	Surface glycoprotein_SPRRARSVA	0.08	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0003680	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.000134);Europe(0.000234)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef86152&&LOCATION=1:23621:G:A
22018G>T	1	22018	G	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	W152C	B.1.427/B.1.429	https://outbreak.info/situation-reports?pango=B.1.427	Characteristic mutation of B.1.427/B.1.429 lineage																																		
22335G>A	1	22335	G	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Stop Gain	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	W258*	None	-	None	NA	NA	-0.949	-1.23717	0	NA	BetaCoV_S1-NTD	NA	NA	Surface glycoprotein_PGDSSSGWTAGA	NA	NA	Surface glycoprotein_WTAGAAAYY	0.03	NA	NA	nCoV-2019_73_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0034080	Computational Analysis	SARS-CoV-2 mutation analysis using MicroGMT software, followed by NCBI Structure program to characterize the changes of the biochemical properties of non-synonymous mutations	The furin cleavage site in the spike glycoprotein of the SARS-CoV-2 coronavirus is considered important for the virus to enter the host cells. Mutations predicted computationally might represent a new subgroup of SARS-CoV-2 coronavirus with reduced tropism and transmissibility as potential live-attenuated vaccine candidates.	Xing, Y., Li, X., Gao, X., & Dong, Q. (2020). Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein. Frontiers in Genetics, 11, 1. https://doi.org/10.3389/fgene.2020.00783	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379507/	Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein	Yue Xing, Xiao Li, Xiang Gao and  Qunfeng Dong	Africa(0.000869);Asia(0.000853);Europe(0.000685);Oceania(0.001001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef851c7&&LOCATION=1:22335:G:A
22868T>A	1	22868	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	W436R	None	-	None	0.03	Deleterious	1.65	2.13354	0.952756	disulf_bond	BetaCoV_S1-CTD	NA	NA	Surface glycoprotein_IAWNSNNLDSK	NA	NA	NA	NA	NA	NA	NA	S Reverse	NA	NA	NA	No co - mutations reported	NA	0.0000000				Ou, J., Zhou, Z., Dai, R., Zhao, S., Wu, X., Zhang, J., Lan, W., Cui, L., Wu, J., Seto, D., Chodosh, J., Zhang, G., & Zhang, Q. (n.d.). Emergence of SARS-CoV-2 spike RBD mutants that enhance viral infectivity through increased human ACE2 receptor binding affinity. https://doi.org/10.1101/2020.03.15.991844	https://www.biorxiv.org/content/10.1101/2020.03.15.991844v5.full	Emergence of SARS-CoV-2 spike RBD mutants that enhance viral infectivity through increased human ACE2 receptor binding affinity	Junxian Ou, Zhonghua Zhou, Ruixue Dai, Shan Zhao, Xiaowei Wu, Jing Zhang, Wendong Lan, Lilian Cui, Jianguo Wu, Donald Seto, James Chodosh, Gong Zhang,  Qiwei Zhang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8584d&&LOCATION=1:22868:T:A
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y145del	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0022660	Computational Analysis	Genome wide mutation prediction and analysis	Potential role in the virus escaping host immune response and thus developing resistance to drugs.	Durmaz, B., Abdulmajed, O., & Durmaz, R. ı. (2020). Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor. Medeniyet Medical Journal, 1. https://doi.org/10.5222/mmj.2020.98048	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584268/	Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor	Bengül Durmaz, Olkar Abdulmajed, and  Rıza Durmaz	Africa(0.000134);Asia(0.001803);Europe(0.000218);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
21995T>C	1	21995	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y145H	None	-	None	0.19	Tolerated	-3.2	0.168063	0	disulf_bond	BetaCoV_S1-NTD	NA	NA	NA	NA	NA	Surface glycoprotein_GVYYHKNNK	0.03	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001930	Computational Analysis	Genome wide mutation prediction and analysis	Potential role in the virus escaping host immune response and thus developing resistance to drugs.	Durmaz, B., Abdulmajed, O., & Durmaz, R. ı. (2020). Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor. Medeniyet Medical Journal, 1. https://doi.org/10.5222/mmj.2020.98048	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584268/	Mutations Observed in the SARS-CoV-2 Spike Glycoprotein and Their Effects in the Interaction of Virus with ACE-2 Receptor	Bengül Durmaz, Olkar Abdulmajed, and  Rıza Durmaz	Asia(0.000073);Europe(0.000064);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef84dd4&&LOCATION=1:21995:T:C
21644T>C	1	21644	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y28H	None	-	None	0.42	Tolerated	-3.2	0.551307	0	disulf_bond	BetaCoV_S1-NTD	NA	NA	NA	NA	NA	Surface glycoprotein_LPPAYTNSF	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0008490	Computational Analysis	Sequence alignments followed by Secondary structure predictions and  protein dynamics study	Effect of the mutations on the structural dynamics of Spike glycoprotein were measured using the differences of free energy (ΔΔG) between wild-type and mutant. The ΔΔG, as a consequence of mutation, correlates with the structural changes in three-dimensional structure of protein, and, thus, measures the effect of mutation on protein stability. Y28H was predicted to destabilize the protein structure with the ΔΔG value of −0.217 kcal/mol.	Chand, G. B., Banerjee, A., & Azad, G. K. (2020). Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics. Gene Reports, 21, 100891. https://doi.org/10.1016/j.genrep.2020.100891	https://pubmed.ncbi.nlm.nih.gov/33015411/	Identification of twenty-five mutations in Surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics	Gyanendra Bahadur Chand , Atanu Banerjee , Gajendra Kumar Azad	Asia(0.000475);Europe(0.000263);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef849b8&&LOCATION=1:21644:T:C
22831T>Y	1	22831	T	Y	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y423C	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Multiple sequence alignment followed by topology-based feature generation and convolutional neural network-assisted models for analysing the protein structure	Prediction of free adversarial free energy change due to mutations identified Y423C as a hotspot residue, significantly increasing the infectivity of the virus	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/	Mutations Strengthened SARS-CoV-2 Infectivity	Jiahui Chen, Rui Wang, Menglun Wang and Guo-Wei Wei		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef857e5&&LOCATION=1:22831:T:Y
22830A>T	1	22830	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y423F	None	-	None	0	Deleterious	1.65	2.25839	0.0472441	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_KIADYNYKL	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000010	Computational Analysis	Multiple sequence alignment followed by topology-based feature generation and convolutional neural network-assisted models for analysing the protein structure	Prediction of free adversarial free energy change due to mutations identified Y423F as a hotspot residue, significantly increasing the infectivity of the virus	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/	Mutations Strengthened SARS-CoV-2 Infectivity	Jiahui Chen, Rui Wang, Menglun Wang and Guo-Wei Wei	Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef857e2&&LOCATION=1:22830:A:T
22830A>C	1	22830	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y423S	None	-	None	0	Deleterious	1.65	2.25839	0.0472441	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_KIADYNYKL	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Multiple sequence alignment followed by topology-based feature generation and convolutional neural network-assisted models for analysing the protein structure	Prediction of free adversarial free energy change due to mutations identified Y423S as a hotspot residue, significantly increasing the infectivity of the virus	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/	Mutations Strengthened SARS-CoV-2 Infectivity	Jiahui Chen, Rui Wang, Menglun Wang and Guo-Wei Wei		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef857e1&&LOCATION=1:22830:A:C
22908A>G	1	22908	A	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y449C	None	-	None	0.07	Tolerated	NA	-1.86167	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking and Computational Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein ; Study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in Y449 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020a). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858bd&&LOCATION=1:22908:A:G
22907T>G	1	22907	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y449D	None	-	None	0.08	Tolerated	NA	-9.60239	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000240	Computational Analysis , Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking and Computational Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein ; Study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Y449 is one of the key residues contributing to the binding to the host receptor ACE2. Antibodies binding to these regions may block the virus binding to the host cell receptor   ;  Mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505 consistent with the destabilizing effect of surface-exposed hydrophobic patches but these hydrophobic residues form ACE2-packing contacts and are required for binding. 	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355.## Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012https://doi.org/10.3390/vaccines8030355#	https://pubmed.ncbi.nlm.nih.gov/32635180/#https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design#Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom	Europe(0.000024)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858bb&&LOCATION=1:22907:T:G
22908A>T	1	22908	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y449F	None	-	None	0.34	Tolerated	NA	-1.86167	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000090	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking and Computational Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein ; Study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in Y449 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020a). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Europe(0.000009)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858be&&LOCATION=1:22908:A:T
22907T>C	1	22907	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y449H	None	-	None	0.32	Tolerated	NA	-9.60239	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0009640	Computational Analysis , Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking and Computational Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein ; Study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Y449 is one of the key residues contributing to the binding to the host receptor ACE2. Antibodies binding to these regions may block the virus binding to the host cell receptor   ;  Mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505 consistent with the destabilizing effect of surface-exposed hydrophobic patches but these hydrophobic residues form ACE2-packing contacts and are required for binding. 	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355.## Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012https://doi.org/10.3390/vaccines8030355#	https://pubmed.ncbi.nlm.nih.gov/32635180/#https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design#Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom	Africa(0.000535);Asia(0.000085);Europe(0.000177);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858ba&&LOCATION=1:22907:T:C
22909T>A	1	22909	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Stop Gain	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y449X	None	-	None	NA	NA	-3.3	-8.22904	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking and Computational Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein ; Study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Residues in S1-2 region of RBD domain were identified as the key residues contributing to the binding to the host receptor ACE2. Antibodies targeting this region may block the virus binding to the host cell receptor and the subsequent membrane fusion between virus and host cell. Variations in Y449 residue might potentially alter viral binding properties.	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020a). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858bf&&LOCATION=1:22909:T:A
22909T>G	1	22909	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Stop Gain	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y449X	None	-	None	NA	NA	-3.3	-8.22904	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis , Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking and Computational Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein ; Study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Y449is one of the key residues contributing to the binding to the host receptor ACE2. Antibodies binding to these regions may block the virus binding to the host cell receptor   ;  Mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505 consistent with the destabilizing effect of surface-exposed hydrophobic patches but these hydrophobic residues form ACE2-packing contacts and are required for binding. 	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355.## Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012https://doi.org/10.3390/vaccines8030355#	https://pubmed.ncbi.nlm.nih.gov/32635180/##https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design#Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858c0&&LOCATION=1:22909:T:G
22920A>T	1	22920	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y453F	None	-	None	0.62	Tolerated	1.65	2.25839	0.173228	disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_YLYRLFRKSNLKPFE	9.2	Surface glycoprotein_NYNYLYRLF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0015140	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Africa(0.000200);Asia(0.000037);Europe(0.001277)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef858e0&&LOCATION=1:22920:A:T
23028A>T	1	23028	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y489F	None	-	None	0.69	Tolerated	-3.3	0.260787	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000680	Computational Analysis	Multiple sequence alignment followed by topology-based feature generation and convolutional neural network-assisted models for analysing the protein structure	Prediction of free adversarial free energy change due to mutations identified Y423F as a hotspot residue, significantly increasing the infectivity of the virus	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/	Mutations Strengthened SARS-CoV-2 Infectivity	Jiahui Chen, Rui Wang, Menglun Wang and Guo-Wei Wei	Africa(0.000067);Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a20&&LOCATION=1:23028:A:T
23027T>C	1	23027	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y489H	None	-	None	0.54	Tolerated	-3.21	1.25959	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000160	Computational Analysis	Multiple sequence alignment followed by topology-based feature generation and convolutional neural network-assisted models for analysing the protein structure	Prediction of free adversarial free energy change due to mutations identified Y423F as a hotspot residue, significantly increasing the infectivity of the virus	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/	Mutations Strengthened SARS-CoV-2 Infectivity	Jiahui Chen, Rui Wang, Menglun Wang and Guo-Wei Wei	Europe(0.000016)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a1e&&LOCATION=1:23027:T:C
23027T>A	1	23027	T	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y489N	None	-	None	0.3	Tolerated	-3.21	1.25959	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	Surface glycoprotein_YFPLQSYGF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000010	Computational Analysis	Multiple sequence alignment followed by topology-based feature generation and convolutional neural network-assisted models for analysing the protein structure	Prediction of free adversarial free energy change due to mutations identified Y423F as a hotspot residue, significantly increasing the infectivity of the virus	Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020). Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology, 432(19), 5212–5226. https://doi.org/10.1016/j.jmb.2020.07.009	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/	Mutations Strengthened SARS-CoV-2 Infectivity	Jiahui Chen, Rui Wang, Menglun Wang and Guo-Wei Wei	Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85a1d&&LOCATION=1:23027:T:A
	1				S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y489W	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.000001	Computational Analysis and Experimental	Rosetta Flex ddG calculation is an Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity upon Mutation. Mutations potentially impacting the binding energies were further validated using SPR assay. The affinity between SARS-CoV-2 Spike Protein (RBD His Tag) and hACE2 was measured using a Reichert4SPR system (Reichert Technologies, Depew, NY, USA) in single-cycle mode. 	Y489W mutations is found to decrease the stability with a ddG value of -1.01	Xue, T., Wu, W., Guo, N., Wu, C., Huang, J., Lai, L., Liu, H., Li, Y., Wang, T., & Wang, Y. (n.d.). Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay. https://doi.org/10.1101/2020.12.24.424245	https://www.biorxiv.org/content/10.1101/2020.12.24.424245v1.full.pdf	Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay	Ting Xue, Weikun Wu, Ning Guo, Chengyong Wu, Jian Huang, Lipeng Lai, Hong Liu, Yalun Li, Tianyuan Wang and Yuxi Wang	Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23075T>G	1	23075	T	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y505D	None	-	None	0.2	Tolerated	-2.08	0.0110866	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000130	Computational Analysis , Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking and Computational Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein ; This study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Y505 is one of the key residues contributing to the binding to the host receptor ACE2. Antibodies binding to these regions may block the virus binding to the host cell receptor   ;  Mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505 consistent with the destabilizing effect of surface-exposed hydrophobic patches but these hydrophobic residues form ACE2-packing contacts and are required for binding. 	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/ , https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom	Asia(0.000012);Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85ab8&&LOCATION=1:23075:T:G
23076A>T	1	23076	A	T	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y505F	None	-	None	0.66	Tolerated	0.461	0.885039	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000010	Computational Analysis , Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking and Computational Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein ; This study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Y505 is one of the key residues contributing to the binding to the host receptor ACE2. Antibodies binding to these regions may block the virus binding to the host cell receptor   ;  Mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505 consistent with the destabilizing effect of surface-exposed hydrophobic patches but these hydrophobic residues form ACE2-packing contacts and are required for binding. 	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/ , https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom	Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85abb&&LOCATION=1:23076:A:T
23075T>C	1	23075	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y505H	None	-	None	0.51	Tolerated	-2.08	0.0110866	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000840	Computational Analysis	Multiple sequence alignment followed by topology-based feature generation and convolutional neural network-assisted models for analysing the protein structure.##	Infectivity strengthening mutation ; Y505 is one of the key residues contributing to the binding to the host receptor ACE2. Antibodies binding to these regions may block the virus binding to the host cell receptor 	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375973/ , https://pubmed.ncbi.nlm.nih.gov/32635180/	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang	Asia(0.000037);Europe(0.000047)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85ab7&&LOCATION=1:23075:T:C
23075T>C	1	23075	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y505H	None	-	None	0.51	Tolerated	-2.08	0.0110866	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein		Enhances RBD expression but abolishes Binding affinity 	Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., King, N. P., Veesler, D., & Bloom, J. D. (2020). Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding. Cell, 182(5), 1295-1310.e20. https://doi.org/10.1016/j.cell.2020.08.012	https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding	Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85ab7&&LOCATION=1:23075:T:C
23076A>C	1	23076	A	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y505S	None	-	None	0.38	Tolerated	0.461	0.885039	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000670	Computational Analysis , Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking and Computational Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein ; This study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Y505 is one of the key residues contributing to the binding to the host receptor ACE2. Antibodies binding to these regions may block the virus binding to the host cell receptor   ;  Mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505 consistent with the destabilizing effect of surface-exposed hydrophobic patches but these hydrophobic residues form ACE2-packing contacts and are required for binding. 	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/ , https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom	Africa(0.000067)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85aba&&LOCATION=1:23076:A:C
	1				S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y505W	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis and Experimental	Rosetta Flex ddG calculation is an Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity upon Mutation. Mutations potentially impacting the binding energies were further validated using SPR assay. The affinity between SARS-CoV-2 Spike Protein (RBD His Tag) and hACE2 was measured using a Reichert4SPR system (Reichert Technologies, Depew, NY, USA) in single-cycle mode. 	Y505W mutations is found to increase the stability with a ddG value of -1.23	Xue, T., Wu, W., Guo, N., Wu, C., Huang, J., Lai, L., Liu, H., Li, Y., Wang, T., & Wang, Y. (n.d.). Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay. https://doi.org/10.1101/2020.12.24.424245	https://www.biorxiv.org/content/10.1101/2020.12.24.424245v1.full.pdf	Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay	Ting Xue, Weikun Wu, Ning Guo, Chengyong Wu, Jian Huang, Lipeng Lai, Hong Liu, Yalun Li, Tianyuan Wang and Yuxi Wang		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
23077C>A	1	23077	C	A	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Stop Gain	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y505X	None	-	None	NA	NA	-3.3	-1.98652	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_QPYRVVVLSFELLHA	14	Surface glycoprotein_QPYRVVVL	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis , Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking and Computational Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein ; This study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Y505 is one of the key residues contributing to the binding to the host receptor ACE2. Antibodies binding to these regions may block the virus binding to the host cell receptor   ;  Mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505 consistent with the destabilizing effect of surface-exposed hydrophobic patches but these hydrophobic residues form ACE2-packing contacts and are required for binding. 	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/ , https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85abc&&LOCATION=1:23077:C:A
23077C>G	1	23077	C	G	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Stop Gain	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y505X	None	-	None	NA	NA	-3.3	-1.98652	0	Disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_QPYRVVVLSFELLHA	14	Surface glycoprotein_QPYRVVVL	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis , Computational Analysis Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein	B and T cell Epitope prediction followed by Peptide Modeling and Molecular Docking and Computational Deep Mutational Scanning of Amino acid mutations in RBD in Spike protein ; This study includes RBD cloning, where The Spike receptor binding domain (RBD) from SARS-CoV-2 and additional sarbecovirus homologs  were ordered as yeast codon-optimized gBlocks (IDT) and cloned into the pETcon yeast surface-display expression vector. This was followed by library mutagenesis, sequencing and variant phenotype calculation for ACE2-binding affinity.	Y505 is one of the key residues contributing to the binding to the host receptor ACE2. Antibodies binding to these regions may block the virus binding to the host cell receptor   ;  Mutations to polar amino acids enhance expression at interface residues Y449, L455, F486, and Y505 consistent with the destabilizing effect of surface-exposed hydrophobic patches but these hydrophobic residues form ACE2-packing contacts and are required for binding. 	Wang, D., Mai, J., Zhou, W., Yu, W., Zhan, Y., Wang, N., Epstein, N. D., & Yang, Y. (2020). Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Vaccines, 8(3), 355. https://doi.org/10.3390/vaccines8030355	https://pubmed.ncbi.nlm.nih.gov/32635180/ , https://www.sciencedirect.com/science/article/pii/S0092867420310035?dgcid=rss_sd_all	Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design	Dongliang Wang , Jinhui Mai , Wenfeng Zhou , Wanting Yu , Yang Zhan , Naidong Wang , Neal D. Epstein  and Yi Yang##Tyler N.Starr, Allison J.Greaney, Sarah K.Hilton, DanielEllis, Katharine H.D.Crawford, Adam S.Dingens, Mary JaneNavarro, John E.Bowen, M. AlejandraTortorici, Alexandra C.Walls, Neil P.King, DavidVeesler, Jesse D.Bloom		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85abd&&LOCATION=1:23077:C:G
23084T>C	1	23084	T	C	S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Non Synonymous SNV	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Y508H	None	-	None	0.56	Tolerated	-3.3	-1.61197	0	disulf_bond	BetaCoV_S1-CTD	NA	NA	NA	Surface glycoprotein_QPYRVVVLSFELLHA	14	Surface glycoprotein_QPYRVVVL	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0019510	Experimental	Large collection of highly-potent fully human neutralizing antibodies targeting the RBD of the spike protein of SARS-CoV-2 was generated utilizing genetically-humanized mice and B cells from convalescent humans. Efficacy of antiviral antibodies against the breadth of spike RBD variants represented in publicly available SARS-CoV-2 sequences was identified using the VSV pseudoparticle system expressing the SARS-CoV-2 spike variants.	Antibodies targeting the spike protein of SARS-CoV-2 present a promising approach to combat the COVID19 pandemic; however, concerns remain that mutations can yield antibody resistance. The variant was encoded into pVSV-SARS-CoV-2-S (mNeon) pseudoparticles and neutralization assays were performed in Vero cells. There was no observed neutralization with hIgG1 isotype control (N/A).	Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., & Kyratsous, C. A. (2020). Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science, eabd0831. https://doi.org/10.1126/science.abd0831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299283/	Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies	Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, and  Christos A. Kyratsous	Africa(0.001670);Asia(0.000049);Europe(0.000232)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef85ad4&&LOCATION=1:23084:T:C
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Deletion	Deletion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Δ144/145																												Experimental	S genes were cloned directly from clinical material obtained 72 days after COVID-19 diagnosis. This was followed by sequence analysis and immunofluroscence assays	With indirect immunofluorescence, the 48A- neutralizing monoclonal antibody did not bind to the S protein when carrying the deletions: Δ69–70 + Δ144/145 (RDR1 + 2), Δ141–145 or Δ144/145 or Δ146 in RDR2, and Δ243–244 in RDR4	Ribes, M., Chaccour, C., & Moncunill, G. (2021). Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain. Signal transduction and targeted therapy, 6(1), 164.https://doi.org/10.1038/s41392-021-00601-8##McCarthy, K. R., Rennick, L. J., Nambulli, S., Robinson-McCarthy, L. R., Bain, W. G., Haidar, G., & Duprex, W. P. (2021). Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science (New York, N.Y.), 371(6534), 1139–1142. https://doi.org/10.1126/science.abf6950##Xie, X., Liu, Y., Liu, J., Zhang, X., Zou, J., Fontes-Garfias, C. R., Xia, H., Swanson, K. A., Cutler, M., Cooper, D., Menachery, V. D., Weaver, S. C., Dormitzer, P. R., & Shi, P. Y. (2021). Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nature medicine, 27(4), 620–621. https://doi.org/10.1038/s41591-021-01270-4	https://pubmed.ncbi.nlm.nih.gov/33895775/##https://pubmed.ncbi.nlm.nih.gov/33536258/	Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain##Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape	Marta Ribes, Carlos Chaccour, Gemma Moncunill##Kevin R McCarthy, Linda J Rennick, Sham Nambulli, Lindsey R Robinson-McCarthy, William G Bain, Ghady Haidar, W Paul Duprex##Xuping Xie, Yang Liu, Jianying Liu, Xianwen Zhang, Jing Zou, Camila R Fontes-Garfias, Hongjie Xia, Kena A Swanson, Mark Cutler, David Cooper, Vineet D Menachery, Scott C Weaver, Philip R Dormitzer, Pei-Yong Shi		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Deletion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Δ157-158	B.1.617.2	https://outbreak.info/situation-reports?pango=B.1.617.2	Characteristic mutation of B.1.617.2 lineage																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Deletion	Deletion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Δ19-S 																												Experimental	Generation of stable cell lines with hACE-2-mCheny, SARS-CoV-2 Spike-full and -C terminal Δ19-EGFP	Widely used to increase SARS-CoV-2 pseudovirus production for in vitro assays. Comparison of cell fusion occurring via Δ19-S expressing cells shows defective nuclear fusion and syncytia formation compared to WT-S. This distinction between the Δ19-S variant and WT-S protein may have downstream implications for studies that utilize pseudovirus-based entry assays.	Chen, C. H., Badeti, S., Cho, J. H., Naghizadeh, A., Wang, X., & Liu, D. (2021). Deletion of ER-retention Motif on SARS-CoV-2 Spike Protein Reduces Cell Hybrid During Cell-cell Fusion. Research square, rs.3.rs-380389. https://doi.org/10.21203/rs.3.rs-380389/v1	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043463/	Deletion of ER-retention Motif on SARS-CoV-2 Spike Protein Reduces Cell Hybrid During Cell-cell Fusion	Chih-Hsiung Chen, Saiaditya Badeti, Jong Hyun Cho, Alireza Naghizadeh, Xuening Wang, and Dongfang Liu		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Deletion	Deletion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Δ220																												Experimental	S genes were cloned directly from clinical material obtained 72 days after COVID-19 diagnosis. This was followed by sequence analysis and immunofluroscence assays		Ribes, M., Chaccour, C., & Moncunill, G. (2021). Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain. Signal transduction and targeted therapy, 6(1), 164.https://doi.org/10.1038/s41392-021-00601-8##McCarthy, K. R., Rennick, L. J., Nambulli, S., Robinson-McCarthy, L. R., Bain, W. G., Haidar, G., & Duprex, W. P. (2021). Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science (New York, N.Y.), 371(6534), 1139–1142. https://doi.org/10.1126/science.abf6950##Xie, X., Liu, Y., Liu, J., Zhang, X., Zou, J., Fontes-Garfias, C. R., Xia, H., Swanson, K. A., Cutler, M., Cooper, D., Menachery, V. D., Weaver, S. C., Dormitzer, P. R., & Shi, P. Y. (2021). Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nature medicine, 27(4), 620–621. https://doi.org/10.1038/s41591-021-01270-4	https://pubmed.ncbi.nlm.nih.gov/33895775/##https://pubmed.ncbi.nlm.nih.gov/33536258/	Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain##Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape	Marta Ribes, Carlos Chaccour, Gemma Moncunill##Kevin R McCarthy, Linda J Rennick, Sham Nambulli, Lindsey R Robinson-McCarthy, William G Bain, Ghady Haidar, W Paul Duprex##Xuping Xie, Yang Liu, Jianying Liu, Xianwen Zhang, Jing Zou, Camila R Fontes-Garfias, Hongjie Xia, Kena A Swanson, Mark Cutler, David Cooper, Vineet D Menachery, Scott C Weaver, Philip R Dormitzer, Pei-Yong Shi		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
	1				S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Single Nucleotide Variation	Deletion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Δ241-243	B.1.351	https://outbreak.info/situation-reports?pango=B.1.351	Characteristic mutation of B.1.351 lineage																																	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Deletion	Deletion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Δ243–244																												Experimental	S genes were cloned directly from clinical material obtained 72 days after COVID-19 diagnosis. This was followed by sequence analysis and immunofluroscence assays	With indirect immunofluorescence, the 48A- neutralizing monoclonal antibody did not bind to the S protein when carrying the deletions: Δ69–70 + Δ144/145 (RDR1 + 2), Δ141–145 or Δ144/145 or Δ146 in RDR2, and Δ243–244 in RDR4	Ribes, M., Chaccour, C., & Moncunill, G. (2021). Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain. Signal transduction and targeted therapy, 6(1), 164.https://doi.org/10.1038/s41392-021-00601-8##McCarthy, K. R., Rennick, L. J., Nambulli, S., Robinson-McCarthy, L. R., Bain, W. G., Haidar, G., & Duprex, W. P. (2021). Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science (New York, N.Y.), 371(6534), 1139–1142. https://doi.org/10.1126/science.abf6950##Xie, X., Liu, Y., Liu, J., Zhang, X., Zou, J., Fontes-Garfias, C. R., Xia, H., Swanson, K. A., Cutler, M., Cooper, D., Menachery, V. D., Weaver, S. C., Dormitzer, P. R., & Shi, P. Y. (2021). Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nature medicine, 27(4), 620–621. https://doi.org/10.1038/s41591-021-01270-4	https://pubmed.ncbi.nlm.nih.gov/33895775/##https://pubmed.ncbi.nlm.nih.gov/33536258/	Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain##Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape	Marta Ribes, Carlos Chaccour, Gemma Moncunill##Kevin R McCarthy, Linda J Rennick, Sham Nambulli, Lindsey R Robinson-McCarthy, William G Bain, Ghady Haidar, W Paul Duprex##Xuping Xie, Yang Liu, Jianying Liu, Xianwen Zhang, Jing Zou, Camila R Fontes-Garfias, Hongjie Xia, Kena A Swanson, Mark Cutler, David Cooper, Vineet D Menachery, Scott C Weaver, Philip R Dormitzer, Pei-Yong Shi		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Deletion	Deletion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	Δ69–70																												Experimental	S genes were cloned directly from clinical material obtained 72 days after COVID-19 diagnosis. This was followed by sequence analysis and immunofluroscence assays	With indirect immunofluorescence, the 48A- neutralizing monoclonal antibody did not bind to the S protein when carrying the deletions: Δ69–70 + Δ144/145 (RDR1 + 2), Δ141–145 or Δ144/145 or Δ146 in RDR2, and Δ243–244 in RDR4.##Three severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viruses containing key spike mutations from the newly emerged United Kingdom (UK) and South African (SA) variants: N501Y from UK and SA; 69/70-deletion + N501Y + D614G from UK; and E484K + N501Y + D614G from SA were engineered. Neutralization geometric mean titers (GMTs) of 20 BTN162b2 vaccine-elicited human sera against the three mutant viruses were 0.81- to 1.46-fold of the GMTs against parental virus, indicating small effects of these mutations on neutralization by sera elicited by two BNT162b2 doses.	Ribes, M., Chaccour, C., & Moncunill, G. (2021). Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain. Signal transduction and targeted therapy, 6(1), 164.https://doi.org/10.1038/s41392-021-00601-8##McCarthy, K. R., Rennick, L. J., Nambulli, S., Robinson-McCarthy, L. R., Bain, W. G., Haidar, G., & Duprex, W. P. (2021). Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science (New York, N.Y.), 371(6534), 1139–1142. https://doi.org/10.1126/science.abf6950##Xie, X., Liu, Y., Liu, J., Zhang, X., Zou, J., Fontes-Garfias, C. R., Xia, H., Swanson, K. A., Cutler, M., Cooper, D., Menachery, V. D., Weaver, S. C., Dormitzer, P. R., & Shi, P. Y. (2021). Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nature medicine, 27(4), 620–621. https://doi.org/10.1038/s41591-021-01270-4	https://pubmed.ncbi.nlm.nih.gov/33895775/##https://pubmed.ncbi.nlm.nih.gov/33536258/##https://pubmed.ncbi.nlm.nih.gov/33558724/	Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain##Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape##Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera	Marta Ribes, Carlos Chaccour, Gemma Moncunill##Kevin R McCarthy, Linda J Rennick, Sham Nambulli, Lindsey R Robinson-McCarthy, William G Bain, Ghady Haidar, W Paul Duprex##Xuping Xie, Yang Liu, Jianying Liu, Xianwen Zhang, Jing Zou, Camila R Fontes-Garfias, Hongjie Xia, Kena A Swanson, Mark Cutler, David Cooper, Vineet D Menachery, Scott C Weaver, Philip R Dormitzer, Pei-Yong Shi		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
					S	43740568	https://www.ncbi.nlm.nih.gov/gene/43740568	NC_045512.2:21563-25384	Deletion	Deletion	Surface glycoprotein	1273 amino acids 	QHD43416.1	https://www.ncbi.nlm.nih.gov/protein/QHD43416.1	ΔPRRA																												Experimental	Both wild-type and mutant viruses were derived from the SARS-CoV-2 USA-WA1/2020 infectious clone. For ΔPRRA construction, the mutation was introduced into a subclone puc57-CoV2-F6 by using overlap PCR with primers ΔPRRA-F (5′-GACTAATTCTCGTAGTGTAGCTAGTCAATCCATC-3′) and ΔPRRA-R (5ʹ-GACTAGCTACACTACGAGAATTAGTCTGAGTC-3′). This was followed by deep sequencing analysis, Plaque-reduction neutralization test and infection studies	Replicates of ΔPRRA SARS-CoV-2 had faster kinetics, improved fitness in Vero E6 cells and reduced spike protein processing, as compared to parental SARS-CoV-2. However, the ΔPRRA mutant had reduced replication in a human respiratory cell line and was attenuated in both hamster and K18-hACE2 transgenic mouse models of SARS-CoV-2 pathogenesis. Despite reduced disease, the ΔPRRA mutant conferred protection against rechallenge with the parental SARS-CoV-2. Importantly, the neutralization values of sera from patients with coronavirus disease 2019 (COVID-19) and monoclonal antibodies against the receptor-binding domain of SARS-CoV-2 were lower against the ΔPRRA mutant than against parental SARS-CoV-2, probably owing to an increased ratio of particles to plaque-forming units in infections with the former. 	Johnson, B. A., Xie, X., Bailey, A. L., Kalveram, B., Lokugamage, K. G., Muruato, A., Zou, J., Zhang, X., Juelich, T., Smith, J. K., Zhang, L., Bopp, N., Schindewolf, C., Vu, M., Vanderheiden, A., Winkler, E. S., Swetnam, D., Plante, J. A., Aguilar, P., . . . Menachery, V. D. (2021). Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature, 591(7849), 293–299. https://doi.org/10.1038/s41586-021-03237-4	https://pubmed.ncbi.nlm.nih.gov/33494095/	Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis	Bryan A Johnson # 1, Xuping Xie # 2, Adam L Bailey # 3, Birte Kalveram 4, Kumari G Lokugamage 1, Antonio Muruato 1, Jing Zou 2, Xianwen Zhang 2, Terry Juelich 4, Jennifer K Smith 4, Lihong Zhang 4, Nathen Bopp 4, Craig Schindewolf 1, Michelle Vu 1, Abigail Vanderheiden 5 6, Emma S Winkler 3 7, Daniele Swetnam 2, Jessica A Plante 1, Patricia Aguilar 4, Kenneth S Plante 1, Vsevolod Popov 4, Benhur Lee 8, Scott C Weaver 1 9, Mehul S Suthar 5 6 10, Andrew L Routh 2, Ping Ren 4, Zhiqiang Ku 11, Zhiqiang An 11, Kari Debbink 12, Michael S Diamond 3 7 13, Pei-Yong Shi 2 9, Alexander N Freiberg 4 9, Vineet D Menachery 14 15		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	
25909G>T	1	25909	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	 D173Y	None	-	None	0	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_86_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0003350	Computational Analysis	Protein 3a alignment and detection of nonsynonymous amino acid changes followed by domains, motifs,  membrane topology and phylogenetic analysis	Signature mutations within SARS-CoV-2 ORF3a cause the isolates to cluster into defined phylogenetic clades. Microclonality within the ORF3a gene tree defined by the nonsynonymous mutations separating the isolates into distinct subpopulations, highlighted that Q57H clade with the Q57H mutation were identified to contain second mutations which includes D173Y, W131C, and L129F. 	Issa, E., Merhi, G., Panossian, B., Salloum, T., & Tokajian, S. (2020). SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis. MSystems, 5(3), 1. https://doi.org/10.1128/msystems.00266-20	https://pubmed.ncbi.nlm.nih.gov/32371472/	SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis	Elio Issa, Georgi Merhi, Balig Panossian, Tamara Salloum, Sima Tokajian	Asia(0.000110);Europe(0.000225);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87bda&&LOCATION=1:25909:G:T
26152G>A	1	26152	G	A	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	 G254R	None	-	None	0	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0080900	Computational Analysis	Sequences were aligned using MUSCLE v3.8.31 (6). PROVEAN was used to predict the functional effects of amino acid substitutions (7). ExPASy and PROSPER were used for motif scanning and protease site prediction, respectively (8, 9). The Immune epitope database analysis resource (IEDB-AR) was used for epitopes prediction using a 0.5 threshold and default settings	This mutation was found to result in decreased intensity of specific epitopes	Issa, E., Merhi, G., Panossian, B., Salloum, T., & Tokajian, S. (n.d.). SARS-CoV-2 and ORF3a: Non-Synonymous Mutations and Polyproline Regions. https://doi.org/10.1101/2020.03.27.012013	https://msystems.asm.org/content/5/3/e00266-20 	SARS-CoV-2 and ORF3a: Non-Synonymous Mutations and Polyproline Regions	Elio Issa, Georgi Merhi, Balig Panossian, Tamara Salloum, ProfileSima Tokajian	Africa(0.001737);Asia(0.003350);Europe(0.002169);Oceania(0.000834);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87ea6&&LOCATION=1:26152:G:A
25981G>T	1	25981	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	 V197L	None	-	None	0	Deleterious	0.744	2.7612	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_85_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000100	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Found to be a diseased type with no polarity change.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	Europe(0.000010);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87cb1&&LOCATION=1:25981:G:T
25819G>T	1	25819	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	A143S	None	-	None	0	Deleterious	0.698	2.57435	1	NA	NA	NA	NA	NA	ORF3a protein_KNPLLYDANYFLCWH	13	ORF3a protein_NPLLYDANY	0.03	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0069800	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Enhance the viral uptake by the host, thereby increasing the infectivity rate.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	Africa(0.000535);Asia(0.002667);Europe(0.002944);Oceania(0.000834);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87ac7&&LOCATION=1:25819:G:T
25552G>T	1	25552	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	A54S	None	-	None	0	Deleterious	0.738	2.76406	1	NA	NA	NA	Transmembrane	NA	ORF3a protein_ALLAVFQSASKIITL	11	NA	NA	NA	NA	NA	NA	NA	NA	NA	Disease type Mutation	NA	0.0000000	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Disease type mutation with a change in polarity from hydrophobic to hydrophilic. The mutation might contribute to structural changes of the ORF3a protein.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8775d&&LOCATION=1:25552:G:T
25835G>T	1	25835	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	C148Y	None	-	None	0	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	ORF3a protein_KNPLLYDANYFLCWH	13	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0107480	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Enhance the viral uptake by the host, thereby increasing the infectivity rate.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	Africa(0.005613);Asia(0.002789);Europe(0.002068);Oceania(0.000278);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87afc&&LOCATION=1:25835:G:T
25855G>T	1	25855	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	D155Y	None	-	None	0	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	25563G>T	0.0000000	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Facilitate the tetramerization process in SARS-COV2 and thereby assisting the ion channel formation and favouring the virus with its infectivity. These co-occurring mutations (Q to H, D to Y) are located near TRAF and  ion channel respectively, suggesting that it might have effect on NLRP3 inflammasome activation.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87b37&&LOCATION=1:25855:G:T
25521C>T	1	25521	C	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	F43F	None	-	None																						No co - mutations reported	NA	0.0000000	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef876eb&&LOCATION=1:25521:C:T
25906G>T	1	25906	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	G172C	None	-	None	0	Deleterious	0.744	2.7612	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_86_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. G172C was predicted to have DDG value of -0.83 kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87bd0&&LOCATION=1:25906:G:T
25444G>A	1	25444	G	A 	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	G18S 	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Neutral Mutation	NA	0.0000000	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Neutral type mutation with a polarity change from hydrophobic to hydrophilic. Although this is a neutral mutation, the change in polarity may bear some significance in structural properties.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef875df&&LOCATION=1:25444:G:A
26062G>T	1	26062	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	G224C 	None	-	None	0	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	ORF3a protein_STDTGVEHVTFFIY	0.02	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000380	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Found to be a diseased type polarity changed from hydrophobic to hydrophilic. This mutation may change the structure and functions of the protein.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	Asia(0.000037);Europe(0.000001);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87da1&&LOCATION=1:26062:G:T
26144G>T	1	26144	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	G251V 	None	-	None	0	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hypermutable low-fitness site	No co - mutations reported	NA	0.0074510	Computational Analysis	Sequences were aligned using MUSCLE v3.8.31 (6). PROVEAN was used to predict the functional effects of amino acid substitutions (7). ExPASy and PROSPER were used for motif scanning and protease site prediction, respectively (8, 9). The Immune epitope database analysis resource (IEDB-AR) was used for epitopes prediction using a 0.5 threshold and default settings	Motif scanning demonstrated that G251V resulted in the loss of a phosphatidylinositol-specific phospholipase X-box domain (PIPI_CX_DOMAIN; 203-275 aa). The G251V substitution creates a serine protease cleavage site. The G251V substitution in ORF3a is predicted to be  linked to the loss of a putative epitope the impact of which on viral spread and pathogenesis requires further experimental studies. This mutation is also found to decrease the stability of the protein with ΔG value of -0.45128408	Issa, E., Merhi, G., Panossian, B., Salloum, T., & Tokajian, S. (n.d.). SARS-CoV-2 and ORF3a: Non-Synonymous Mutations and Polyproline Regions. https://doi.org/10.1101/2020.03.27.012013##Khan, M. I., Khan, Z. A., Baig, M. H., Ahmad, I., Farouk, A.-E. A., Song, Y. G., & Dong, J.-J. (2020). Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLOS ONE, 15(9), e0238344. https://doi.org/10.1371/journal.pone.0238344	https://msystems.asm.org/content/5/3/e00266-20##https://pubmed.ncbi.nlm.nih.gov/32881907/	SARS-CoV-2 and ORF3a: Non-Synonymous Mutations and Polyproline Regions##Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight	Elio Issa, Georgi Merhi, Balig Panossian, Tamara Salloum, ProfileSima Tokajian##Mohd Imran Khan, Zainul A Khan, Mohammad Hassan Baig, Irfan Ahmad, Abd-ElAziem Farouk, Young Goo Song, Jae-Jun Dong	Africa(0.000134);Asia(0.006529);Europe(0.000343);Oceania(0.000445);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87e8e&&LOCATION=1:26144:G:T
25624C>T	1	25624	C	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	H78Y 	None	-	None	1.65	3.32175	0.299213	0.06	Tolerable 	NA	NA	NA	Transmembrane | NA	NA	ORF3a protein_KKRWQLALSKGVHFV 	4.8	ORF3a protein_ALSKGVHFV 	0.03	NA	NA	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	25429G>T	0.0077880	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	H78Y is  a neutral mutation with no change in polarity potentially predicted to be a  virulence promoting factor. H78Y mutation was observed with V13L which is a disease mutation with no change in polarity. The occurrence of a neutral mutation with a disease mutation leads to the assumption that the virus first might have evolved in terms of virulence then enhanced its functional activity. Although there is no change in polarity but it may effect the chemical properties	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	Africa(0.004076);Asia(0.002412);Europe(0.001077);Oceania(0.000223);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87869&&LOCATION=1:25624:C:T
25810C>G	1	25810	C	G	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	L140V	None	-	None	0	Deleterious	-0.337	0.799268	0.952756	NA	NA	NA	NA	NA	ORF3a protein_KNPLLYDANYFLCWH	13	ORF3a protein_NPLLYDANY	0.03	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0077880	Computational Analysis	Sequence analysis and stability prediction followed by Molecular dynamics simulations of the protein and their complexes	L140V predicted to decrease protein stability with ΔG value of -0.90740107	Khan, M. I., Khan, Z. A., Baig, M. H., Ahmad, I., Farouk, A.-E. A., Song, Y. G., & Dong, J.-J. (2020). Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLOS ONE, 15(9), e0238344. https://doi.org/10.1371/journal.pone.0238344	https://pubmed.ncbi.nlm.nih.gov/32881907/	Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight	Mohd Imran Khan, Zainul A Khan, Mohammad Hassan Baig, Irfan Ahmad, Abd-ElAziem Farouk, Young Goo Song, Jae-Jun Dong	Africa(0.004076);Asia(0.002412);Europe(0.001077);Oceania(0.000223);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87aab&&LOCATION=1:25810:C:G
25528C>T	1	25528	C	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	L46F	None	-	None																						No co - mutations reported	NA	0.0000840	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria	Asia(0.000024);Europe(0.000060);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87702&&LOCATION=1:25528:C:T
25677G>C	1	25677	G	C	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	L95F	None	-	None	0	Deleterious	-3.09	-0.882386	0	NA	NA	NA	Transmembrane	NA	NA	NA	ORF3a protein_TVYSHLLLV	0.14	NA	NA	NA	NA	NA	NA	NA	Disease type Mutation	NA	0.0000000	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Disease type mutation with no polarity change.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8790e&&LOCATION=1:25677:G:C
25677G>T	1	25677	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	L95F	None	-	None	0	Deleterious	-3.09	-0.882386	0	NA	NA	NA	Transmembrane	NA	NA	NA	ORF3a protein_TVYSHLLLV	0.14	NA	NA	NA	NA	NA	NA	NA	Disease type Mutation	NA	0.0000000	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Disease type mutation with no polarity change.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8790f&&LOCATION=1:25677:G:T
25517C>G	1	25517	C	G	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	P42R	None	-	None	0	Deleterious	1.65	3.2969	1	NA	NA	NA	Transmembrane	NA	NA	NA	ORF3a protein_IPIQASLPF	-1	NA	NA	NA	NA	NA	NA	NA	Disease type Mutation	NA	0.0014160	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Disease type mutation with a change in polarity from hydrophobic to hydrophilic. The mutation might contribute to structural changes of the ORF3a protein.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	Africa(0.001336);Asia(0.000037);Europe(0.000043);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef876d8&&LOCATION=1:25517:C:G
25947G>C	1	25947	G	C	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	Q185H 	None	-	None	0	Deleterious	0.52	1.07954	1	NA	NA	NA	NA	NA	NA	NA	ORF3a protein_SEHDYQIGGYTEKW	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.7142960	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Found to be a diseased type with no polarity change and so the structure of ORF3a protein may vary.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	Africa(0.354938);Asia(0.170266);Europe(0.000001);Europe(0.066156);Oceania(0.122935);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87c49&&LOCATION=1:25947:G:C
25947G>T	1	25947	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	Q185H 	None	-	None	0	Deleterious	0.52	1.07954	1	NA	NA	NA	NA	NA	NA	NA	ORF3a protein_SEHDYQIGGYTEKW	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.7142960	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Found to be a diseased type with no polarity change and so the structure of ORF3a protein may vary.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	Africa(0.354938);Asia(0.170266);Europe(0.000001);Europe(0.066156);Oceania(0.122935);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87c4a&&LOCATION=1:25947:G:T
25505A>T	1	25505	A	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	Q38L	None	-	None	0	Deleterious	1.65	2.23123	1	NA	NA	NA	Transmembrane	NA	ORF3a protein_SDFVRATATIPIQAS	14	ORF3a protein_IPIQASLPF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0016300	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to increase the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. Q38L was predicted to have DDG value of 0.12 kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Africa(0.001002);Asia(0.000158);Europe(0.000470);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef876ae&&LOCATION=1:25505:A:T
25563G>T	1	25563	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	Q57H	B.1.351## B.1.427/B.1.429##B.1.616##B.1.621	https://outbreak.info/situation-reports?pango=B.1.351## https://outbreak.info/situation-reports?pango=B.1.427##https://outbreak.info/situation-reports?pango=B.1.616##https://outbreak.info/situation-reports?pango=B.1.621	None	0	Deleterious	-3.3	-1.17891	0.929134	NA	NA	NA	NA	NA	ORF3a protein_ALLAVFQSASKIITL | NA 	11 | NA	ORF3a protein_SASKIITLK | NA	-1|NA	NA	NA	NA	NA	NA	NA	Hypermutable low-fitness site | NA	Functional consequences induced by co - occurring mutations	25855:G>T	0.2997760	Computational Analysis	Estimation of Nucleotide Conservation using Shannon Entropy calculation	These co-occurring mutations (Q to H, D to Y) are located near TRAF and  ion channel respectively, suggesting that it might have effect on NLRP3 inflammasome activation.##This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. Q57H was predicted to have DDG value of 0.12 kcal/mol	Hassan, S. S., Choudhury, P. P., Basu, P., & Jana, S. S. (2020). Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes. Genomics, 112(5), 3226–3237. https://doi.org/10.1016/j.ygeno.2020.06.016##Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291963/##https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes##Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Sk. Sarif Hassan , Pabitra Pal Choudhury , Pallab Basu , Siddhartha Sankar Jana##Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Africa(0.256181);Asia(0.022704);Europe(0.000003);Europe(0.015103);Oceania(0.005785);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87788&&LOCATION=1:25563:G:T
25563G>C	1	25563	G	C	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	Q57H	B.1.351## B.1.427/B.1.429##B.1.616##B.1.621	https://outbreak.info/situation-reports?pango=B.1.351## https://outbreak.info/situation-reports?pango=B.1.427##https://outbreak.info/situation-reports?pango=B.1.616##https://outbreak.info/situation-reports?pango=B.1.621	None	0	Deleterious	-3.3	-1.17891	0.929134	NA	NA	NA	NA	NA	ORF3a protein_ALLAVFQSASKIITL	11	ORF3a protein_SASKIITLK	-1	NA	NA	NA	NA	NA	NA	Hypermutable low-fitness site	No co - mutations reported	NA	0.0033190	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to increase the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. Q57H was predicted to have DDG value of -0.90 kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Africa(0.001002);Asia(0.000572);Europe(0.001634);Oceania(0.000111);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87785&&LOCATION=1:25563:G:C
25793G>T	1	25793	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	R134L	None	-	None	0.03	Deleterious	-3.3	-0.0415591	0.937008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0621540	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Facilitate the tetramerization process in SARS-COV2 and thereby assisting the ion channel formation and favouring the virus with its infectivity. Here the change in mutations may lead to changes in tetramerization properties of the protein.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	Africa(0.005680);Asia(0.045286);Europe(0.010131);Oceania(0.001057);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87a7e&&LOCATION=1:25793:G:T
25904C>T	1	25904	C	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	S171L	B.1.351	https://outbreak.info/situation-reports?pango=B.1.351	Characteristic mutation of B.1.351 lineage. 	0.05	Deleterious	-0.194	1.07954	0.92126	NA	NA	NA	NA	NA	NA 	NA 	NA 	NA 	NA	NA	NA	NA	NA	NA	NA 	Functional consequences induced by co - occurring mutations	25563:G>T	0.0001350	Computational Analysis	Estimation of Nucleotide Conservation using Shannon Entropy calculation##The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	These co-occurring mutations (Q to H, S to L) are located near TRAF and  caveolin binding domains respectively, suggesting that it might have effect on NLRP3 inflammasome activation.	Hassan, S. S., Choudhury, P. P., Basu, P., & Jana, S. S. (2020). Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes. Genomics, 112(5), 3226–3237. https://doi.org/10.1016/j.ygeno.2020.06.016	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291963/	Molecular conservation and differential mutation on ORF3a gene in Indian SARS-CoV2 genomes	Sk. Sarif Hassan , Pabitra Pal Choudhury , Pallab Basu , Siddhartha Sankar Jana	Asia(0.000012);Europe(0.000012);Oceania(0.000111);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87bc7&&LOCATION=1:25904:C:T
26149T>C	1	26149	T	C	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	S253P	P.1	https://outbreak.info/situation-reports?pango=P.1	Characteristic mutation of P.1 lineage 																																		
25469C>T	1	25469	C	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	S26L	B.1.617.1##B.1.617.2	https://outbreak.info/situation-reports?pango=B.1.617.1##https://outbreak.info/situation-reports?pango=B.1.617.2	Characteristic mutation of B.1.617.1 and B.1.617.2 lineages																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
25511C>T	1	25511	C	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	S40L	None	-	None	0.02	Deleterious	1.65	3.2969	1	NA	NA	NA	Transmembrane	NA	ORF3a protein_SDFVRATATIPIQAS	14	ORF3a protein_IPIQASLPF	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0004650	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to increase the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. S40L was predicted to have DDG value of 0.40 kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Africa(0.000134);Asia(0.000195);Europe(0.000136);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef876c4&&LOCATION=1:25511:C:T
25844C>T	1	25844	C	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	T151I	None	-	None	0	Deleterious	1.65	3.32175	0.338583	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0082460	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Facilitate the tetramerization process in SARS-COV2 and thereby assisting the ion channel formation and favouring the virus with its infectivity	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	Africa(0.001270);Asia(0.001218);Europe(0.003755);Oceania(0.002003);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87b13&&LOCATION=1:25844:C:T
26015C>T	1	26015	C	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	T208I	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87d16&&LOCATION=1:26015:C:T
26204C>T	1	26204	C	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	T271I	None	-	None	0	Deleterious	1.65	3.32175	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_87_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0010750	Computational Analysis	Sequences were aligned using MUSCLE v3.8.31 (6). PROVEAN was used to predict the functional effects of amino acid substitutions (7). ExPASy and PROSPER were used for motif scanning and protease site prediction, respectively (8, 9). The Immune epitope database analysis resource (IEDB-AR) was used for epitopes prediction using a 0.5 threshold and default settings	This mutation was found to result in decreased intensity of specific epitopes	Issa, E., Merhi, G., Panossian, B., Salloum, T., & Tokajian, S. (n.d.). SARS-CoV-2 and ORF3a: Non-Synonymous Mutations and Polyproline Regions. https://doi.org/10.1101/2020.03.27.012013	https://msystems.asm.org/content/5/3/e00266-20	SARS-CoV-2 and ORF3a: Non-Synonymous Mutations and Polyproline Regions	Elio Issa, Georgi Merhi, Balig Panossian, Tamara Salloum, ProfileSima Tokajian	Africa(0.000267);Asia(0.000244);Europe(0.000230);Oceania(0.000334);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87f69&&LOCATION=1:26204:C:T
25429G>T	1	25429	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	V13L	None	-	None	0.509	0.526157	0.0708661	0.1	Tolerable	NA	NA	NA	NA	NA	ORF3a protein_MDLFMRIFTIGTVTL	16	ORF3a protein_RIFTIGTVTLK	-1	NA	NA	NA	NA	NA	NA	NA	Functional consequences induced by co - occurring mutations	25624C>T	0.0526100	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	H78Y is  a neutral mutation with no change in polarity potentially predicted to be a  virulence promoting factor. H78Y mutation was observed with V13L which is a disease mutation with no change in polarity. The occurrence of a neutral mutation with a disease mutation leads to the assumption that the virus first might have evolved in terms of virulence then enhanced its functional activity. Although there is no change in polarity but it may effect the chemical properties	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	Africa(0.005145);Asia(0.023337);Europe(0.000001);Europe(0.020011);Oceania(0.004116);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef875af&&LOCATION=1:25429:G:T
25555G>T	1	25555	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	V55F 	None	-	None	0	Deleterious	1.65	4.256	1	NA	NA	NA	Transmembrane	NA	ORF3a protein_ALLAVFQSASKIITL	11	NA	NA	NA	NA	NA	NA	NA	NA	NA	Disease type Mutation	NA	0.0526100	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Disease type mutation with no polarity change. But the mutation may cause an increase in pathogenesis.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	Africa(0.005145);Asia(0.023337);Europe(0.000001);Europe(0.020011);Oceania(0.004116);	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87768&&LOCATION=1:25555:G:T
25775G>T	1	25775	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	W128L	None	-	None	0	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	ORF3a protein_QSINFVRIIMRLWLC	5.4	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0023528	Computational Analysis	Sequence analysis and stability prediction followed by Molecular dynamics simulations of the protein and their complexes	W128L  predicted to decrease protein stability with ΔG value of -0.90740107	Khan, M. I., Khan, Z. A., Baig, M. H., Ahmad, I., Farouk, A.-E. A., Song, Y. G., & Dong, J.-J. (2020). Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLOS ONE, 15(9), e0238344. https://doi.org/10.1371/journal.pone.0238344	https://pubmed.ncbi.nlm.nih.gov/32881907/	Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight	Mohd Imran Khan, Zainul A Khan, Mohammad Hassan Baig, Irfan Ahmad, Abd-ElAziem Farouk, Young Goo Song, Jae-Jun Dong	Asia(0.000418498),Europe(0.000438404),NorthAmerica(0.000231678),SouthAmerica(0.00126422)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A21563-25384&hgt.positionInput=NC_045512.2%3A21563-25384&goButton=go&db=wuhCor1&c=NC_045512v2&l=265&r=21555&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87a45&&LOCATION=1:25775:G:T
25785G>C	1	25785	G	C	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	W131C	None	-	None	0	Deleterious	0.748	2.7612	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Disease type Mutation	NA	0.0000000	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Disease type mutation with a change in polarity from hydrophobic to hydrophilic. The mutation might contribute to structural changes of the ORF3a protein.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	NA	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87a63&&LOCATION=1:25785:G:C
25785G>T	1	25785	G	T	ORF3a	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF3a Protein	275 amino acids	QHD43417.1	https://www.ncbi.nlm.nih.gov/protein/QHD43417.1	W131C	None	-	None	0	Deleterious	0.748	2.7612	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Disease type Mutation	NA	0.0000000	Computational Analysis	Frequency Probability of Amino Acids and K-means Clustering Algorithm. K-means algorithm is an iterative algorithm that tries to form equivalence classes from the feature vectors into K (pre-defined) clusters where each data point belongs to only one cluster	Disease type mutation with a change in polarity from hydrophobic to hydrophilic. The mutation might contribute to structural changes of the ORF3a protein.	Hassan, S. S., Attrish, D., Ghosh, S., Choudhury, P. P., & Roy, B. (n.d.). Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2. https://doi.org/10.1101/2020.08.04.236653	https://www.biorxiv.org/content/10.1101/2020.08.04.236653v1.full	Pathogenetic Perspective of Missense Mutations of ORF3a Protein of SARS-CoV2	Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Bidyut Roy	NA	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87a65&&LOCATION=1:25785:G:T
27281G>T	1	27281	G	T	ORF6	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Single Nucleotide Variation	Non Synonymous SNV	ORF6 Protein	61 amino acids 	QHD43420.1	https://www.ncbi.nlm.nih.gov/protein/QHD43420.1	W27L	None	-	None	0	Deleterious	-0.309	1.56072	0.952756	NA	NA	NA	NA	NA	ORF6 protein_LIIMRTFKVSIWNLD	5.9	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0086580	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. W27L was predicted to have DDG value of -0.96 kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Africa(0.006014);Asia(0.000560);Europe(0.000916);Oceania(0.001168)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88bcb&&LOCATION=1:27281:G:T
					ORF6	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Deletion	Deletion	ORF6 Protein	61 amino acids 	QHD43420.1	https://www.ncbi.nlm.nih.gov/protein/QHD43420.1	Δ2-3	B.1.525	https://outbreak.info/situation-reports?pango=B.1.525	Characteristic mutation ofB.1.525lineage																												Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo			
					ORF6	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Deletion	Deletion	ORF6 Protein	61 amino acids 	QHD43420.1	https://www.ncbi.nlm.nih.gov/protein/QHD43420.1	Δ23-31	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage																																		
Δ27264-27290	1	27264-27290	TTTTAAAGTTTCCATTTGGAATCTTGA	-	ORF6	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Deletion	In frame Deletion	ORF6 Protein	61 amino acids 	QHD43420.1	https://www.ncbi.nlm.nih.gov/protein/QHD43420.1	ΔFKVSIWNLD	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Experimental	SARS-CoV-2 Hong Kong/VM20001061/2020 was isolated from a nasopharyngeal aspirate and throat swab from 39-year-old male patient in Hong Kong and passaged 5 times in African green monkey (Cercopithecus aethiops) kidney epithelial cells (Vero E6) cells. Genomic RNA was extracted, which was followed by sequencing, alignment and protein structure prediction. 	This mutation was predicted to manifest as an in-frame deletion of 9 aa ΔFKVSIWNLD (SARS-CoV-2 p6Δ22-30). The function of p6 in SARS-CoV-2 has not yet been fully determined. However, based on its similarity to the SARS-CoV p6, it appears likely that it plays a role as an antagonist of interferon signaling, thus assisting in the viral suppression of the innate immune system.	Riojas, M. A., Frank, A. M., Puthuveetil, N. P., Flores, B., Parker, M., King, S. P., Peiris, M., Chu, D. K. W., Benton, B., Bradford, R., Hazbón, M. H., & Rashid, S. (2020). A Rare Deletion in SARS-CoV-2 ORF6 Dramatically Alters the Predicted Three-Dimensional Structure of the Resultant Protein. bioRxiv : The Preprint Server for Biology. https://doi.org/10.1101/2020.06.09.134460	https://www.biorxiv.org/content/10.1101/2020.06.09.134460v1.full.pdf+html	A Rare Deletion in SARS-CoV-2 ORF6 Dramatically Alters the Predicted Three-Dimensional Structure of the Resultant Protein	Marco A. Riojas, Andrew M. Frank, Nikhita P. Puthuveetil, Beth Flores,  Michael Parker, Stephen P. King, Malik Peiris,  Daniel K. W. Chu, Briana Benton,  Rebecca Bradford,  Manzour Hernando Hazbón, Sujatha Rashid	NA	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A25393%2D26220&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
Δ27264-27290	1	27264			ORF6	43740569	https://www.ncbi.nlm.nih.gov/gene/43740569	NC_045512.2:25393-26220	Deletion	Deletion	ORF6 Protein	61 amino acids 	QHD43420.1	https://www.ncbi.nlm.nih.gov/protein/QHD43420.1	ΔFKVSIWNLD																												Genome sequence analysis followed by protein structure modelling	Computational Prediction	This deletion is predicted to result in a dramatic alteration in the three-dimensional structure of the resultant protein (p6 Δ22-30 ), possibly with significant functional implications. Analysis of the original clinical sample indicates that the deletion was not present, while sequencing of subsequent passages of the strain identifies the deletion as a majority variant. This suggests that the deletion originated ab initio during passaging and subsequently propagated into the majority, possibly due to the removal of selective pressure through the IFN-deficient Vero E6 cell line. This deletion is predicted to cause a shift from N-endo to N-ecto in the transmembrane localization of the SARS-CoV-2 p6 Δ22-30 N-terminus, possibly leading to the ablation of its native function.	Riojas, M. A., Frank, A. M., Puthuveetil, N. P., Flores, B., Parker, M., King, S. P., Peiris, M., Chu, D., Benton, B., Bradford, R., Hazbón, M. H., & Rashid, S. (2020). A Rare Deletion in SARS-CoV-2 ORF6 Dramatically Alters the Predicted Three-Dimensional Structure of the Resultant Protein. bioRxiv : the preprint server for biology, 2020.06.09.134460. https://doi.org/10.1101/2020.06.09.134460	https://pubmed.ncbi.nlm.nih.gov/32577643/	A Rare Deletion in SARS-CoV-2 ORF6 Dramatically Alters the Predicted Three-Dimensional Structure of the Resultant Protein				
Δ26320–26331	1	26320			E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Deletion	Deletion	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	12-bp deletion																												Cell line studies followed by ELISA and neutralization assays	Experimental	A 12-bp deletion in the E gene is predicted to be  important for SARS-CoV-2 replication and immunogenicity. The 12-bp deletion sequence (26320–26331) , located at the TMD of E gene, which is responsible for E protein homo-oligomeric multimer formation and influences the ion channel activity of the E protein as a viroporin. The ion channel activity of E viroporin is important for viral replication and pathogenesis. Mutations at the TMD residues V25F and N15A could block the ion channel activity of the CoV E viroporin, while mutations close to V25F such as F26L or L27S could compensate for the loss of ion channel activity.	Sun, Y. S., Xu, F., An, Q., Chen, C., Yang, Z. N., Lu, H. J., Chen, J. C., Yao, P. P., Jiang, J. M., & Zhu, H. P. (2020). A SARS-CoV-2 variant with the 12-bp deletion at E gene. Emerging microbes & infections, 9(1), 2361–2367. https://doi.org/10.1080/22221751.2020.1837017	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598948/	A SARS-CoV-2 variant with the 12-bp deletion at E gene	Yi-Sheng Sun, Fang Xu, Qi An, Chen Chen, Zhang-Nv Yang, Hang-Jing Lu, Jian-Cai Chen, Ping-Ping Yao, Jian-Min Jiang, and Han-Ping Zhu		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
26351C>T	1	26351	C	T	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	A36V	None	-	None	0	Deleterious	1.65	3.32175	1	NA	NA	NA	Transmembrane	NA	Envelope protein_FLLVTLAILTALRLC	19	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000740	Computational Analysis	From the NCBI virus database, all the protein sequences of 3617 SARS-CoV2 genomes were fetched. Then the amino acid sequences of envelope protein of SARS-CoV2 are exported in fasta format using file operations through Matlab. These sequences (fasta formatted) are blasted using Clustal-Omega and found the mismatched and from their mutations and their associated positions were detected	Predicted to have potential changes in R group side chain	Hassan, S. S., Choudhury, P. P., & Roy, B. (2020). SARS-CoV2 envelope protein: non-synonymous mutations and its consequences. Genomics, 112(6), 3890–3892. https://doi.org/10.1016/j.ygeno.2020.07.001	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335631/	SARS-CoV2 envelope protein: non-synonymous mutations and its consequences	Sk. Sarif Hassan, Pabitra Pal Choudhury and  Bidyut Roy	Asia(0.000049);Europe(0.000025)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88113&&LOCATION=1:26351:C:T
26458G>C	1	26458	G	C	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	D72H	None	-	None	0	Deleterious	1.65	4.256	1	.	Intravirion	.	.	.	.	.	.	.	.	.	.	.	NA	NA	NA	No co - mutations reported	NA	0.000025000	Computational Analysis	Genome Analysis and protein structure modelling	Effects of mutation on E protein structure stability using Gibbs free energy (ΔΔG = ΔGmutant − ΔGWT) in FoldX.	Rahman, M. S., Hoque, M. N., Islam, M. R., Islam, I., Mishu, I. D., Rahaman, M. M., Sultana, M., & Hossain, M. A. (2021). Mutational insights into the envelope protein of SARS-CoV-2. Gene reports, 22, 100997. https://doi.org/10.1016/j.genrep.2020.100997	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723457/	Mutational insights into the envelope protein of SARS-CoV-2	M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Israt Islam, Israt Dilruba Mishu, Md. Mizanur Rahaman, Munawar Sultana and M. Anwar Hossain	Europe(0.000025)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88241&&LOCATION=1:26458:G:C
26458G>T	1	26458	G	T	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	D72Y	None	-	None	0	Deleterious	1.65	4.256	1	NA	Intravirion	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0009750	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Gene E is relatively stable and a potential target for vaccine and drug development because of the negligible occurrence of deletion and insertion mutations. This mutation was found to possess changes in R group side chain and potentially alter solvent accessibility through computational solvent accessibility prediction using SCRATCH-1D software suite.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769##Hassan, S. S., Choudhury, P. P., & Roy, B. (2020). SARS-CoV2 envelope protein: non-synonymous mutations and its consequences. Genomics, 112(6), 3890–3892. https://doi.org/10.1016/j.ygeno.2020.07.001	https://www.nature.com/articles/s41598-021-83105-3##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335631/	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)##SARS-CoV2 envelope protein: non-synonymous mutations and its consequences	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek##Sk. Sarif Hassan, Pabitra Pal Choudhury and Bidyut Roy	Africa(0.000735);Asia(0.000158);Europe(0.000082)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88243&&LOCATION=1:26458:G:T
26305C>T	1	26305	C	T	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	L21F	None	-	None	0.23	Tolerable	-1.55	0.612417	0.992126	.	.	.	Transmembrane	.	Envelope protein_TLIVNSVLLFLAFVV	19	.	.	.	.	nCoV-2019_86_RIGHT	.	NA	NA	NA	No co - mutations reported	NA	0.023209000	Computational Analysis	Genome Analysis and protein structure modelling	Effects of mutation on E protein structure stability using Gibbs free energy (ΔΔG = ΔGmutant − ΔGWT) in FoldX.	Rahman, M. S., Hoque, M. N., Islam, M. R., Islam, I., Mishu, I. D., Rahaman, M. M., Sultana, M., & Hossain, M. A. (2021). Mutational insights into the envelope protein of SARS-CoV-2. Gene reports, 22, 100997. https://doi.org/10.1016/j.genrep.2020.100997	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723457/	Mutational insights into the envelope protein of SARS-CoV-2	M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Israt Islam, Israt Dilruba Mishu, Md. Mizanur Rahaman, Munawar Sultana and M. Anwar Hossain	Africa(0.017506);Asia(0.002253);Europe(0.002894);Oceania(0.000556)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88084&&LOCATION=1:26305:C:T
					E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	L26F	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Viral genome sequence analysis followed by mutation prediction	L26F mutation in TMD of the envelope proteinchanges the  R-group property from Hydrophobic to Hydrophilic ,thereby  affecting the ion channel activity of the envelope protein.	Hassan, S. S., Choudhury, P. P., & Roy, B. (2020). SARS-CoV2 envelope protein: non-synonymous mutations and its consequences. Genomics, 112(6), 3890–3892. https://doi.org/10.1016/j.ygeno.2020.07.001	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335631/	SARS-CoV2 envelope protein: non-synonymous mutations and its consequences	Sk. Sarif Hassan, Pabitra Pal Choudhury and  Bidyut Roy		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
26354T>A	1	26354	T	A	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids 	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	L37H	None	-	None	0	Deleterious	1.65	2.20065	1	NA	NA	NA	Transmembrane	NA	Envelope protein_FLLVTLAILTALRLC	19	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000270	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Gene E is relatively stable and a potential target for vaccine and drug development because of the negligible occurrence of deletion and insertion mutations. This mutation was found to possess changes in R group side chain and potentially alter solvent accessibility through computational solvent accessibility prediction using SCRATCH-1D software suite.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769##Hassan, S. S., Choudhury, P. P., & Roy, B. (2020). SARS-CoV2 envelope protein: non-synonymous mutations and its consequences. Genomics, 112(6), 3890–3892. https://doi.org/10.1016/j.ygeno.2020.07.001	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)##SARS-CoV2 envelope protein: non-synonymous mutations and its consequences	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek##Sk. Sarif Hassan, Pabitra Pal Choudhury and Bidyut Roy	Asia(0.000024);Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88119&&LOCATION=1:26354:T:A
26354T>G	1	26354	T	G	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids 	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	L37R	None	-	None	0.01	Deleterious	1.65	2.20065	1	NA	NA	NA	Transmembrane	NA	Envelope protein_FLLVTLAILTALRLC	19	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000010	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Gene E is relatively stable and a potential target for vaccine and drug development because of the negligible occurrence of deletion and insertion mutations. This mutation was found to potentially alter solvent accessibility through computational solvent accessibility prediction using SCRATCH-1D software suite.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8811b&&LOCATION=1:26354:T:G
26359T>A	1	26359	T	A	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	L39M	None	-	None	0	Deleterious	1.65	2.20065	1	NA	Intravirion	NA	NA	NA	Envelope protein_FLLVTLAILTALRLC	19	NA	NA	NA	NA	NA	SARS-CoV-2_IBS_E2_R	NA	NA	NA	No co - mutations reported	NA	0.0000190	Computational Analysis	From the NCBI virus database, all the protein sequences of 3617 SARS-CoV2 genomes were fetched. Then the amino acid sequences of envelope protein of SARS-CoV2 are exported in fasta format using file operations through Matlab. These sequences (fasta formatted) are blasted using Clustal-Omega and found the mismatched and from their mutations and their associated positions were detected	Predicted to have potential changes in R group side chain	Hassan, S. S., Choudhury, P. P., & Roy, B. (2020). SARS-CoV2 envelope protein: non-synonymous mutations and its consequences. Genomics, 112(6), 3890–3892. https://doi.org/10.1016/j.ygeno.2020.07.001	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335631/	SARS-CoV2 envelope protein: non-synonymous mutations and its consequences	Sk. Sarif Hassan, Pabitra Pal Choudhury and  Bidyut Roy	Asia(0.000012);Europe(0.000007)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8812a&&LOCATION=1:26359:T:A
26461C>T	1	26461	C	T	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	L73F	None	-	None	0	Deleterious	0.756	1.82694	1	NA	Intravirion	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hypermutable low-fitness site	No co - mutations reported	NA	0.0045620	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Gene E is relatively stable and a potential target for vaccine and drug development because of the negligible occurrence of deletion and insertion mutations. This mutation was found to possess changes in R group side chain and potentially alter solvent accessibility through computational solvent accessibility prediction using SCRATCH-1D software suite.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769##Hassan, S. S., Choudhury, P. P., & Roy, B. (2020). SARS-CoV2 envelope protein: non-synonymous mutations and its consequences. Genomics, 112(6), 3890–3892. https://doi.org/10.1016/j.ygeno.2020.07.001	https://www.nature.com/articles/s41598-021-83105-3##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335631/	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)##SARS-CoV2 envelope protein: non-synonymous mutations and its consequences	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek##Sk. Sarif Hassan, Pabitra Pal Choudhury and Bidyut Roy	Africa(0.001069);Asia(0.001413);Europe(0.001468);Oceania(0.000612)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8824e&&LOCATION=1:26461:C:T
26456C>T	1	26456	C	T	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	P71L	B.1.351	https://outbreak.info/situation-reports?pango=B.1.351	Characteristic mutation of B.1.351 lineage.	0	Deleterious	-0.0954	1.26639	1	NA	Intravirion	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.3128550	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Gene E is relatively stable and a potential target for vaccine and drug development because of the negligible occurrence of deletion and insertion mutations. This mutation was found to possess changes in R group side chain and potentially alter solvent accessibility through computational solvent accessibility prediction using SCRATCH-1D software suite.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769##Hassan, S. S., Choudhury, P. P., & Roy, B. (2020). SARS-CoV2 envelope protein: non-synonymous mutations and its consequences. Genomics, 112(6), 3890–3892. https://doi.org/10.1016/j.ygeno.2020.07.001	https://www.nature.com/articles/s41598-021-83105-3##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335631/	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)##SARS-CoV2 envelope protein: non-synonymous mutations and its consequences	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek##Sk. Sarif Hassan, Pabitra Pal Choudhury and Bidyut Roy	Africa(0.284512);Asia(0.013167);Europe(0.010114);Oceania(0.005062)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8823b&&LOCATION=1:26456:C:T
26450G>T	1	26450	G	T	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	R69I	None	-	None	0.03	Deleterious	0.715	2.57435	1	.	Intravirion	.	.	.	Envelope protein_FYVYSRVKNLNSSRV	15	.	.	.	.	.	.	NA	NA	NA	No co - mutations reported	NA	0.000809000	Computational Analysis	Genome Analysis and protein structure modelling	Effects of mutation on E protein structure stability using Gibbs free energy (ΔΔG = ΔGmutant − ΔGWT) in FoldX.	Rahman, M. S., Hoque, M. N., Islam, M. R., Islam, I., Mishu, I. D., Rahaman, M. M., Sultana, M., & Hossain, M. A. (2021). Mutational insights into the envelope protein of SARS-CoV-2. Gene reports, 22, 100997. https://doi.org/10.1016/j.genrep.2020.100997	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723457/	Mutational insights into the envelope protein of SARS-CoV-2	M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Israt Islam, Israt Dilruba Mishu, Md. Mizanur Rahaman, Munawar Sultana and M. Anwar Hossain	Africa(0.000401);Asia(0.000171);Europe(0.000181);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8822b&&LOCATION=1:26450:G:T
26408C>T	1	26408	C	T	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	S55F	None	-	None	0.01	Deleterious	0.737	1.73352	0.692913	.	Intravirion	.	.	.	Envelope protein_LVKPSFYVYSRVKNL	17	Envelope protein_SLVKPSFYV	0.04	.	.	.	.	NA	NA	NA	No co - mutations reported	NA	0.002315000	Computational Analysis	Genome Analysis and protein structure modelling	Effects of mutation on E protein structure stability using Gibbs free energy (ΔΔG = ΔGmutant − ΔGWT) in FoldX.	Rahman, M. S., Hoque, M. N., Islam, M. R., Islam, I., Mishu, I. D., Rahaman, M. M., Sultana, M., & Hossain, M. A. (2021). Mutational insights into the envelope protein of SARS-CoV-2. Gene reports, 22, 100997. https://doi.org/10.1016/j.genrep.2020.100997	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723457/	Mutational insights into the envelope protein of SARS-CoV-2	M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Israt Islam, Israt Dilruba Mishu, Md. Mizanur Rahaman, Munawar Sultana and M. Anwar Hossain	Africa(0.000401);Asia(0.001389);Europe(0.000414);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef881b5&&LOCATION=1:26408:C:T
26447C>G	1	26447	C	G	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	S68C	None	-	None	0	Deleterious	1.65	3.32175	1	NA	Intravirion	NA	NA	NA	Envelope protein_FYVYSRVKNLNSSRV	15	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0002180	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Gene E is relatively stable and a potential target for vaccine and drug development because of the negligible occurrence of deletion and insertion mutations. This mutation was found to possess changes in R group side chain and potentially alter solvent accessibility through computational solvent accessibility prediction using SCRATCH-1D software suite.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769##Hassan, S. S., Choudhury, P. P., & Roy, B. (2020). SARS-CoV2 envelope protein: non-synonymous mutations and its consequences. Genomics, 112(6), 3890–3892. https://doi.org/10.1016/j.ygeno.2020.07.001	https://www.nature.com/articles/s41598-021-83105-3##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335631/	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)##SARS-CoV2 envelope protein: non-synonymous mutations and its consequences	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek##Sk. Sarif Hassan, Pabitra Pal Choudhury and Bidyut Roy	Asia(0.000183);Europe(0.000035)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88221&&LOCATION=1:26447:C:G
26447C>T	1	26447	C	T	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	S68F	None	-	None	0	Deleterious	1.65	3.32175	1	NA	Intravirion	NA	NA	NA	Envelope protein_FYVYSRVKNLNSSRV	15	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0052190	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Gene E is relatively stable and a potential target for vaccine and drug development because of the negligible occurrence of deletion and insertion mutations. This mutation was found to possess changes in R group side chain and potentially alter solvent accessibility through computational solvent accessibility prediction using SCRATCH-1D software suite.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769##Hassan, S. S., Choudhury, P. P., & Roy, B. (2020). SARS-CoV2 envelope protein: non-synonymous mutations and its consequences. Genomics, 112(6), 3890–3892. https://doi.org/10.1016/j.ygeno.2020.07.001	https://www.nature.com/articles/s41598-021-83105-3##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335631/	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)##SARS-CoV2 envelope protein: non-synonymous mutations and its consequences	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek##Sk. Sarif Hassan, Pabitra Pal Choudhury and Bidyut Roy	Africa(0.000802);Asia(0.002180);Europe(0.001236);Oceania(0.001001)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88222&&LOCATION=1:26447:C:T
26333C>T	1	26333	C	T	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	T30I	None	-	None	0.17	Tolerable	1.65	3.32175	1	.	.	.	Transmembrane	.	Envelope protein_SVLLFLAFVVFLLVT	17	.	.	.	.	.	.	NA	NA	NA	No co - mutations reported	NA	0.000973000	Computational Analysis	Genome Analysis and protein structure modelling	Effects of mutation on E protein structure stability using Gibbs free energy (ΔΔG = ΔGmutant − ΔGWT) in FoldX.	Rahman, M. S., Hoque, M. N., Islam, M. R., Islam, I., Mishu, I. D., Rahaman, M. M., Sultana, M., & Hossain, M. A. (2021). Mutational insights into the envelope protein of SARS-CoV-2. Gene reports, 22, 100997. https://doi.org/10.1016/j.genrep.2020.100997	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723457/	Mutational insights into the envelope protein of SARS-CoV-2	M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Israt Islam, Israt Dilruba Mishu, Md. Mizanur Rahaman, Munawar Sultana and M. Anwar Hossain	Africa(0.000267);Asia(0.000268);Europe(0.000327);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef880db&&LOCATION=1:26333:C:T
26270C>T	1	26270	C	T	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	T9I	None	-	None	0.84	Tolerable	1.65	3.32175	1	.	Virion_surface	.	.	.	Envelope protein_SEETGTLIVNSVLLF	14	.	.	.	.	.	SARS-CoV-2_IBS_E1_F | SARS-CoV-2_IBS_E2_F | E gene Forward | CDCV_GERMANY_E gene_1	NA	NA	NA	No co - mutations reported	NA	0.002714000	Computational Analysis	Genome Analysis and protein structure modelling	Effects of mutation on E protein structure stability using Gibbs free energy (ΔΔG = ΔGmutant − ΔGWT) in FoldX.	Rahman, M. S., Hoque, M. N., Islam, M. R., Islam, I., Mishu, I. D., Rahaman, M. M., Sultana, M., & Hossain, M. A. (2021). Mutational insights into the envelope protein of SARS-CoV-2. Gene reports, 22, 100997. https://doi.org/10.1016/j.genrep.2020.100997	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723457/	Mutational insights into the envelope protein of SARS-CoV-2	M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Israt Islam, Israt Dilruba Mishu, Md. Mizanur Rahaman, Munawar Sultana and M. Anwar Hossain	Africa(0.000468);Asia(0.000365);Europe(0.001714);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8802a&&LOCATION=1:26270:C:T
26314G>A	1	26314	G	A	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	V24M	None	-	None	0.05	Deleterious	1.65	4.256	1	.	.	.	Transmembrane	.	Envelope protein_TLIVNSVLLFLAFVV	19	.	.	.	.	nCoV-2019_86_RIGHT	.	NA	NA	NA	No co - mutations reported	NA	0.000817000	Computational Analysis	Genome Analysis and protein structure modelling	Effects of mutation on E protein structure stability using Gibbs free energy (ΔΔG = ΔGmutant − ΔGWT) in FoldX.	Rahman, M. S., Hoque, M. N., Islam, M. R., Islam, I., Mishu, I. D., Rahaman, M. M., Sultana, M., & Hossain, M. A. (2021). Mutational insights into the envelope protein of SARS-CoV-2. Gene reports, 22, 100997. https://doi.org/10.1016/j.genrep.2020.100997	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723457/	Mutational insights into the envelope protein of SARS-CoV-2	M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Israt Islam, Israt Dilruba Mishu, Md. Mizanur Rahaman, Munawar Sultana and M. Anwar Hossain	Africa(0.000334);Asia(0.000085);Europe(0.000342);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8809e&&LOCATION=1:26314:G:A
26416G>T	1	26416	G	T	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	V58F	None	-	None	0.02	Deleterious	0.72	2.57435	1	.	Intravirion	.	.	.	Envelope protein_LVKPSFYVYSRVKNL	17	Envelope protein_SLVKPSFYV	0.04	.	.	.	.	NA	NA	NA	No co - mutations reported	NA	0.003445000	Computational Analysis	Genome Analysis and protein structure modelling	Effects of mutation on E protein structure stability using Gibbs free energy (ΔΔG = ΔGmutant − ΔGWT) in FoldX.	Rahman, M. S., Hoque, M. N., Islam, M. R., Islam, I., Mishu, I. D., Rahaman, M. M., Sultana, M., & Hossain, M. A. (2021). Mutational insights into the envelope protein of SARS-CoV-2. Gene reports, 22, 100997. https://doi.org/10.1016/j.genrep.2020.100997	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723457/	Mutational insights into the envelope protein of SARS-CoV-2	M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Israt Islam, Israt Dilruba Mishu, Md. Mizanur Rahaman, Munawar Sultana and M. Anwar Hossain	Africa(0.002005);Asia(0.000207);Europe(0.001233)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef881ce&&LOCATION=1:26416:G:T
26428G>T	1	26428	G	T	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	V62F	None	-	None	0.15	Tolerable	1.65	4.256	1	.	Intravirion	.	.	.	Envelope protein_LVKPSFYVYSRVKNL	17	Envelope protein_YVYSRVKNL	0.02	.	.	.	.	NA	NA	NA	No co - mutations reported	NA	0.003736000	Computational Analysis	Genome Analysis and protein structure modelling	Effects of mutation on E protein structure stability using Gibbs free energy (ΔΔG = ΔGmutant − ΔGWT) in FoldX.	Rahman, M. S., Hoque, M. N., Islam, M. R., Islam, I., Mishu, I. D., Rahaman, M. M., Sultana, M., & Hossain, M. A. (2021). Mutational insights into the envelope protein of SARS-CoV-2. Gene reports, 22, 100997. https://doi.org/10.1016/j.genrep.2020.100997	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723457/	Mutational insights into the envelope protein of SARS-CoV-2	M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Israt Islam, Israt Dilruba Mishu, Md. Mizanur Rahaman, Munawar Sultana and M. Anwar Hossain	Africa(0.000935);Asia(0.001376);Europe(0.000001);Europe(0.000979);Oceania(0.000445)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef881ee&&LOCATION=1:26428:G:T
26467G>C	1	26467	G	C	E	43740570	https://www.ncbi.nlm.nih.gov/gene/43740570	NC_045512.2:26245-26472	Single Nucleotide Variation	Non Synonymous SNV	Envelope protein	75 amino acids	QHD43418.1	https://www.ncbi.nlm.nih.gov/protein/QHD43418.1	V75L	None	-	None	0	Deleterious	1.65	4.256	1	.	Intravirion	.	.	.	.	.	.	.	.	.	.	.	NA	NA	NA	No co - mutations reported	NA	0.000109000	Computational Analysis	Genome Analysis and protein structure modelling	Effects of mutation on E protein structure stability using Gibbs free energy (ΔΔG = ΔGmutant − ΔGWT) in FoldX.	Rahman, M. S., Hoque, M. N., Islam, M. R., Islam, I., Mishu, I. D., Rahaman, M. M., Sultana, M., & Hossain, M. A. (2021). Mutational insights into the envelope protein of SARS-CoV-2. Gene reports, 22, 100997. https://doi.org/10.1016/j.genrep.2020.100997	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723457/	Mutational insights into the envelope protein of SARS-CoV-2	M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, Israt Islam, Israt Dilruba Mishu, Md. Mizanur Rahaman, Munawar Sultana and M. Anwar Hossain	Asia(0.000061);Europe(0.000048)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26245%2D26472&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88263&&LOCATION=1:26467:G:C
26727G>T	1	26727	G	T	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	A69S	None	-	None	0.08	Tolerated	1.65	4.256	1	NA	NA	NA	Transmembrane	NA	Membrane glycoprotein_TLACFVLAAVYRINW	11	NA	NA	Membrane glycoprotein	TLACFVLAAV	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0017810	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. This distinct nonsynonymous mutation was predicted to impact protein structure through in-silico secondary structure analysis procedure using Dictionary of Protein Secondary Structure (DSSP) 	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.000401);Asia(0.000548);Europe(0.000443);Oceania(0.000389)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88555&&LOCATION=1:26727:G:T
26728C>T	1	26728	C	T	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	A69V	None	-	None	0.03	Deleterious	1.65	3.2857	1	NA	NA	NA	Transmembrane	NA	Membrane glycoprotein_TLACFVLAAVYRINW	11	NA	NA	Membrane glycoprotein	TLACFVLAAV	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0005770	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. This distinct nonsynonymous mutation was predicted to impact protein structure through in-silico secondary structure analysis procedure using Dictionary of Protein Secondary Structure (DSSP) 	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.000067);Asia(0.000280);Europe(0.000119);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88557&&LOCATION=1:26728:C:T
26713G>T	1	26713	G	T	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	C64F	None	-	None	0.02	Deleterious	1.65	4.256	1	NA	NA	NA	Transmembrane	NA	Membrane glycoprotein_TLACFVLAAVYRINW	11	NA	NA	Membrane glycoprotein	TLACFVLAAV	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0003930	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. This distinct nonsynonymous mutation was predicted to impact protein structure through in-silico secondary structure analysis procedure using Dictionary of Protein Secondary Structure (DSSP) 	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.000067);Asia(0.000256);Europe(0.000070)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88527&&LOCATION=1:26713:G:T
27090G>A	1	27090	G	A	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	D190N	None	-	None	0.65	Tolerated	1.65	4.256	1	NA	Intravirion	NA	NA	Membrane glycoprotein_ITVATSRTLSYYKLGASQRVAGDSGFAA	Membrane glycoprotein_LSYYKLGASQRVAGD	12	Membrane glycoprotein_ASQRVAGDSGFAAY	0.05	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000030	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88992&&LOCATION=1:27090:G:A
27147G>T	1	27147	G	T	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	D209Y	None	-	None	0.04	Deleterious	1.65	4.256	1	NA	Intravirion	NA	NA	Membrane glycoprotein_NYKLNTDHSSSSDNIA	NA	NA	NA	NA	NA	NA	nCoV-2019_90_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0030670	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. This distinct nonsynonymous mutation was predicted to impact protein structure through in-silico secondary structure analysis procedure using SCRATCH-1D software suite	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.001069);Asia(0.000804);Europe(0.000971);Oceania(0.000223)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88a30&&LOCATION=1:27147:G:T
26895C>T	1	26895	C	T	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	H125Y	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage 																																		
26985C>T	1	26985	C	T	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	H155Y	None	-	None	0.06	Tolerated	0.474	0.482614	0.984252	NA	Intravirion	NA	NA	NA	NA	NA	Membrane glycoprotein_HLRIAGHHL	0.14	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0078440	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. This distinct nonsynonymous mutation was predicted to impact protein structure through in-silico secondary structure analysis procedure using SCRATCH-1D software suite	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.005078);Asia(0.001352);Europe(0.000746);Oceania(0.000668)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8885d&&LOCATION=1:26985:C:T
26767T>C	1	26767	T	C	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	I82T	B.1.525##B.1.617.2	https://outbreak.info/situation-reports?pango=B.1.525##https://outbreak.info/situation-reports?pango=B.1.617.2	Characteristic mutation of B.1.525 and B.1.617.2 lineages																									Genome sequence analysis followed by phylogenetic analysis and protein structure modelling	Computational Prediction	M:I82T mutation lies within TM3, the third of three membrane spanning helices implicated in glucose transport. The frequency of this mutation increased in the USA from 0.014% in October 2020 to 1.62% in February 2021, a 116-fold change. While constituting 0.7% of the isolates overall, M:I82T sub-B.1 lineage accounted for 14.4% of B.1 lineage isolates in February 2021. The rapid emergence of this B.1.I82T clade, recently named Pangolin B.1.575 lineage, suggests that this M gene mutation is more biologically fit, perhaps related to glucose uptake during viral replication.	Shen, L., Bard, J. D., Triche, T. J., Judkins, A. R., Biegel, J. A., & Gai, X. (2021). Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications. Emerging microbes & infections, 10(1), 885–893. https://doi.org/10.1080/22221751.2021.1922097##Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411##Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33896413/##https://pubmed.ncbi.nlm.nih.gov/33961693/##https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications##Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees##Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria 	Lishuang Shen, Jennifer Dien Bard, Timothy J Triche, Alexander R Judkins, Jaclyn A Biegel, Xiaowu Gai##Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2##Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
	1				M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	N113B	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000130	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Europe(0.000013)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
26890C>T	1	26890	C	T	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	P123L	None	-	None	0.27	Tolerated	1.65	3.2857	1	NA	Intravirion	NA	NA	NA	NA	NA	Membrane glycoprotein_VPLHGTIL	0.17	NA	NA	nCoV-2019_88_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0002300	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. This distinct nonsynonymous mutation was predicted to impact protein structure through in-silico secondary structure analysis procedure using SCRATCH-1D software suite	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.000067);Asia(0.000049);Europe(0.000003);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88744&&LOCATION=1:26890:C:T
26916C>T	1	26916	C	T	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	P132S	None	-	None	0.04	Deleterious	1.65	3.2857	1	NA	Intravirion	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001910	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. This distinct nonsynonymous mutation was predicted to impact protein structure through in-silico secondary structure analysis procedure using SCRATCH-1D software suite	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.000134);Asia(0.000012);Europe(0.000045)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88791&&LOCATION=1:26916:C:T
26995G>T	1	26995	G	T	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	R158L	None	-	None	0.23	Tolerated	1.65	4.256	1	NA	Intravirion	NA	NA	NA	NA	NA	Membrane glycoprotein_RIAGHHLGR	0.05	Membrane glycoprotein	GRCDIKDLPKEITVATSR, PKEITVATSRTLSYYKL, TSRTLSYYKLGASQRV	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0006190	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. This distinct nonsynonymous mutation was predicted to impact protein structure through in-silico secondary structure analysis procedure using SCRATCH-1D software suite	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.000134);Asia(0.000110);Europe(0.000097);Oceania(0.000278)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88879&&LOCATION=1:26995:G:T
27163G>T	1	27163	G	T	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	S214I	None	-	None	0.19	Tolerated	0.509	0.590425	1	NA	Intravirion	NA	NA	Membrane glycoprotein_NYKLNTDHSSSSDNIA	NA	NA	NA	NA	NA	NA	nCoV-2019_90_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0067390	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. This distinct nonsynonymous mutation was predicted to impact protein structure through in-silico secondary structure analysis procedure using SCRATCH-1D software suite	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.000334);Asia(0.000755);Europe(0.001589);Oceania(0.004061)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88a60&&LOCATION=1:27163:G:T
27046C>T	1	27046	C	T	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	T175M	None	-	None	0.13	Tolerated	1.65	3.2857	1	NA	Intravirion	NA	NA	Membrane glycoprotein_ITVATSRTLSYYKLGASQRVAGDSGFAA	Membrane glycoprotein_KEITVATSRTLSYYK	11	Membrane glycoprotein_KEITVATSRTL	0.14	Membrane glycoprotein	GRCDIKDLPKEITVATSR, PKEITVATSRTLSYYKL, TSRTLSYYKLGASQRV	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0002320	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria	Europe(0.000009);Oceania(0.000223)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88918&&LOCATION=1:27046:C:T
27030G>A	1	27030	G	A	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	V170I	None	-	None	0.11	Tolerated	1.65	4.256	1	NA	Intravirion	NA	NA	Membrane glycoprotein_ITVATSRTLSYYKLGASQRVAGDSGFAA	Membrane glycoprotein_KEITVATSRTLSYYK	11	Membrane glycoprotein_KEITVATSRTL	0.14	Membrane glycoprotein	GRCDIKDLPKEITVATSR, PKEITVATSRTLSYYKL, TSRTLSYYKLGASQRV	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0025690	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. This distinct nonsynonymous mutation was predicted to impact protein structure through in-silico secondary structure analysis procedure using SCRATCH-1D software suite	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.000869);Asia(0.000597);Europe(0.000435);Oceania(0.000668)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef888e5&&LOCATION=1:27030:G:A
26730G>T	1	26730	G	T	M	43740571	https://www.ncbi.nlm.nih.gov/gene/43740571	NC_045512.2:26523-27191	Single Nucleotide Variation	Non Synonymous SNV	Membrane glycoprotein	222 amino acids 	QHD43419.1	https://www.ncbi.nlm.nih.gov/protein/QHD43419.1	V70F	None	-	None	0.39	Tolerated	1.65	4.256	1	NA	NA	NA	Transmembrane	NA	Membrane glycoprotein_TLACFVLAAVYRINW	11	NA	NA	Membrane glycoprotein	TLACFVLAAV	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0158741	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	M gene is found to possess negligible insertional and deletion mutations. This distinct nonsynonymous mutation was predicted to impact protein structure through in-silico secondary structure analysis procedure using Dictionary of Protein Secondary Structure (DSSP) 	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Asia(0.00272023), Australia(0.00220426), Europe(0.000478259), NorthAmerica(0.00162175), SouthAmerica(0.00884956)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A26523%2D27191&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef88560&&LOCATION=1:26730:G:T
					N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	A12G	B.1.525	https://outbreak.info/situation-reports?pango=B.1.525	Characteristic mutation of B.1.525 lineage 																												Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo			
28896C>G	1	28896	C	G	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	A208G	None	-	None	0	Deleterious	1.65	3.25353	1	NA	NA	NA	Transmembrane	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	NA	NA	NA	N gene Forward	NA	NA	NA	No co - mutations reported	NA	0.008522	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria	Africa(0.006682);Asia(0.000438);Europe(0.000790);Oceania(0.000612)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89f17&&LOCATION=1:28896:C:G
28904C>T	1	28904	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	A211S	None	-	None	0	Deleterious	-0.324	2.47383	1	NA	NA	NA	Transmembrane	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0016800	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.000200);Asia(0.000585);Europe(0.000728);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89f3f&&LOCATION=1:28904:C:T
28932C>T	1	28932	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	A220V	B.1.620	https://outbreak.info/situation-reports?pango=B.1.620	Characteristic mutation of B.1.620 lineage																																		
29465G>T	1	29465	G	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	A398S	None	-	None	0.12	Tolerated	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	Nucleocapsid phosphoprotein_LPAADLDDF	0.06	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0008920	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.000267);Asia(0.000195);Europe(0.000152);Oceania(0.000278)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a609&&LOCATION=1:29465:G:T
28338A>G	1	28338	A	G	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	D22G	None	-	None	0	Deleterious	1.65	2.29773	1	NA	9b	NA	NA	Nucleocapsid phosphoprotein_DSTGSNQNGE	NA	NA	NA	NA	NA	NA	NA	WH-NIC N-Forward | 2019-nCoV_N1-R	NA	NA	NA	No co - mutations reported	NA	0.00536	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria	Africa(0.000401);Asia(0.000158);Europe(0.000462);Oceania(0.004339)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89879&&LOCATION=1:28338:A:G
25456G>T	1	25456	G	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	D22Y	None	-	None	0.01	Deleterious	0.509	0.526157	0.598425	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0032820	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.002005);Asia(0.000536);Europe(0.000463);Oceania(0.000278)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef87609&&LOCATION=1:25456:G:T
29403A>G	1	29403	A	G	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	D377G	None	-	None	0.29	Tolerated	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nucleocapsid phosphoprotein	YKTFPPTEPKKDKKKK	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0009930	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. D377G was predicted to have DDG value of -0.44 kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Africa(0.000334);Asia(0.000256);Europe(0.000236);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a54b&&LOCATION=1:29403:A:G
29402G>T	1	29402	G	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	D377Y	B.1.617.1##B.1.617.2##B.1.617.3	https://outbreak.info/situation-reports?pango=B.1.617.1##https://outbreak.info/situation-reports?pango=B.1.617.2##https://outbreak.info/situation-reports?pango=B.1.617.3	Characterisitc mutation of B.1.617.1,  B.1.617.2 and  B.1.617.3 lineages																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
29470T>A	1	29470	T	A	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	D399E	None	-	None	0.94	Tolerated	-3.3	-1.09052	0.724409	NA	NA	NA	NA	NA	NA	NA	Nucleocapsid phosphoprotein_LPAADLDDF	0.06	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000030	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a616&&LOCATION=1:29470:T:A
29468G>C	1	29468	G	C	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	D399H	None	-	None	0.04	Deleterious	1.65	4.256	0.992126	NA	NA	NA	NA	NA	NA	NA	Nucleocapsid phosphoprotein_LPAADLDDF	0.06	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0004450	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.000200);Asia(0.000073);Europe(0.000172)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a611&&LOCATION=1:29468:G:C
					N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	D3L	B.1.1.7	https://outbreak.info/situation-reports?pango=B.1.1.7	Characteristic mutation of B.1.1.7 lineage.																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group			
29474G>T	1	29474	G	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	D401Y 	None	-	None	0.01	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	Nucleocapsid phosphoprotein_LPAADLDDF	0.06	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0080920	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.004610);Asia(0.002399);Europe(0.000638);Oceania(0.000445)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a625&&LOCATION=1:29474:G:T
29477G>T	1	29477	G	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	D402Y	None	-	None	0.07	Tolerated	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	Nucleocapsid phosphoprotein_LPAADLDDF	0.06	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0034110	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.001871);Asia(0.000950);Europe(0.000423);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a630&&LOCATION=1:29477:G:T
28461A>G	1	28461	A	G	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	D63G	B.1.617.2	https://outbreak.info/situation-reports?pango=B.1.617.2	Characterisitc mutation of B.1.617.2 lineage 																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
29095C>T	1	29095	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	F274F	None	-	None	1	Tolerable	1.65	0.803039	0.992126	NA	NA	NA	NA	NA	NA	NA	nucleocapsid phosphoprotein_KAYNVTQAF	0.07	Nucleocapsid phosphoprotein	YNVTQAFGRRGPEQTQGNF	NA	NA	NA	NA	NA	No co - mutations reported	NA	2.327832	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria	Africa(0.310437);Asia(0.633244);Europe(0.000012);Europe(0.577664);Oceania(0.806475)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a1c7&&LOCATION=1:29095:C:T
25445G>T	1	25445	G	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	G18V	None	-	None	0.31	Tolerated	-3.3	0.632724	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0067730	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.002673);Asia(0.000865);Europe(0.000843);Oceania(0.002392)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef875e4&&LOCATION=1:25445:G:T
28883G>A	1	28883	G	A	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	G204R	B.1.1.7## P.1## P.3	https://outbreak.info/situation-reports?pango=B.1.1.7##https://outbreak.info/situation-reports?pango=P.1##https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of  B.1.1.7, P.1 and P.3 lineages.	0.03	Deleterious	1.65	4.256	1	NA	NA	NA	Transmembrane	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	NA	NA	NA	N gene Forward	NA	NA	NA	Variant associated with viral transmission and cell signalling. 	NA	0.0035680	Computational Analysis	Sequence and Protein structure analysis	Three‐dimensional structure  analysis on I‐tasser, and implication of these mutations analyzed by CUPSAT points out that this mutation reduces protein stability while favouring torsion.	Benvenuto, D., Demir, A. B., Giovanetti, M., Bianchi, M., Angeletti, S., Pascarella, S., Cauda, R., Ciccozzi, M., & Cassone, A. (2020). Evidence for Mutations in SARS-CoV-2 Italian Isolates Potentially Affecting Virus Transmission. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3596454##Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (n.d.). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism. https://doi.org/10.1101/2020.06.07.138800## Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428##Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://www.ncbi.nlm.nih.gov/research/coronavirus/publication/32492183##https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub## https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/##https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.##Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism##SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant##Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Benvenuto, Domenico; Demir, Ayse Banu; Giovanetti, Marta; Bianchi, Martina; Angeletti, Silvia; Pascarella, Stefano; Cauda, Roberto; Ciccozzi, Massimo; Cassone, Antonio##Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen##Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group##Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6	Africa(0.002138);Asia(0.000183);Europe(0.000357);Oceania(0.000890)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89eda&&LOCATION=1:28883:G:A
28883G>C	1	28883	G	C	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	G204R	B.1.1.7## P.1## P.3	https://outbreak.info/situation-reports?pango=B.1.1.7##https://outbreak.info/situation-reports?pango=P.1##https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of  B.1.1.7, P.1 and P.3 lineages.	0.03	Deleterious	1.65	4.256	1	NA	NA	NA	Transmembrane	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	NA	NA	NA	N gene Forward	NA	NA	NA	Variant associated with viral transmission and cell signalling. Functional consequences induced by co - occurring mutations	28881G>A | 28882G>A 	0.0023000	Computational Analysis	Sequence and Protein structure analysis	Three‐dimensional structure  analysis on I‐tasser, and implication of these mutations analyzed by CUPSAT points out that this mutation reduces protein stability while favouring torsion.##The triple site mutation 28881-28883 that brings change in two amino acid 203-204:RG>KR, is known to play a critical role in virion assembly and structure. The mutated 203/204 region of N protein affects the SR (serine-arginine)-rich motif of the protein (a crucial region for controlling viral transcription and replication) by introducing lysin in between them that might hamper the phosphorylation at serine residue required for normal functioning of N protein. Significant reduction in pathogenicity has been observed with the deletion of SR domain, therefore it is important to target 203-204:RG>KR positions of the N protein to design the drugs for controlling the disease.  	Benvenuto, D., Demir, A. B., Giovanetti, M., Bianchi, M., Angeletti, S., Pascarella, S., Cauda, R., Ciccozzi, M., & Cassone, A. (2020). Evidence for Mutations in SARS-CoV-2 Italian Isolates Potentially Affecting Virus Transmission. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3596454##Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (n.d.). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism. https://doi.org/10.1101/2020.06.07.138800## Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428##Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://www.ncbi.nlm.nih.gov/research/coronavirus/publication/32492183##https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub## https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/##https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.##Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism##SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant##Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Benvenuto, Domenico; Demir, Ayse Banu; Giovanetti, Marta; Bianchi, Martina; Angeletti, Silvia; Pascarella, Stefano; Cauda, Roberto; Ciccozzi, Massimo; Cassone, Antonio##Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen##Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group##Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6	Africa(0.000802);Asia(0.000816);Europe(0.000626);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89edb&&LOCATION=1:28883:G:C
28373G>T	1	28373	G	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	G34W	None	-	None	0.01	Deleterious	1.65	4.256	1	NA	9b	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	WH-NIC N-Reverse	NA	NA	NA	No co - mutations reported	NA	0.0695210	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.005212);Asia(0.024007);Europe(0.001586);Oceania(0.038716)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef898e3&&LOCATION=1:28373:G:T
28744C>T	1	28744	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	I157I	None	-	None	0.2	Tolerable	-0.351	0.914425	0.992126	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2019-nCoV_N3-R | SARS-CoV-2_IBS_N1_F | SARS-CoV-2_IBS_N2_F	NA	NA	NA	No co - mutations reported	NA	0.001046	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria	Africa(0.000200);Asia(0.000572);Europe(0.000218);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89d26&&LOCATION=1:28744:C:T
29148T>C	1	29148	T	C	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	I292T	None	-	None	0.07	Tolerable	0.488	0.914425	1	NA	NA	NA	NA	NA	NA	NA	nucleocapsid phosphoprotein_QELIRQGTDYKHW	0.11	Nucleocapsid phosphoprotein	IRQGTDYKHWPQIAQFA, QFAPSASAFFGMSRIGM, FFGMSRIGMEVTPSGTW	NA	HKU_N_Forward	NA	NA	NA	No co - mutations reported	NA	0.000013	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria	Asia(0.000012);Europe(0.000001)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a254&&LOCATION=1:29148:T:C
29392G>C	1	29392	G	C	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	K373N	None	-	None	0.16	Tolerated	1.65	3.25353	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_97_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0012010	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to increase the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. K373N was predicted to have DDG value of -0.10 kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Africa(0.000267);Asia(0.000365);Europe(0.000291);Oceania(0.000278)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a52b&&LOCATION=1:29392:G:C
29392G>T	1	29392	G	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	K373N	None	-	None	0.29	Tolerated	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	Nucleocapsid phosphoprotein	YKTFPPTEPKKDKKKK	NA	NA	NA	NA	NA	No co - mutations reported	NA	2.3916740	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to increase the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. K373N was predicted to have DDG value of -0.10 kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Africa(0.326340);Asia(0.634779);Europe(0.000012);Europe(0.622232);Oceania(0.808311)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a52d&&LOCATION=1:29392:G:T
28688T>C	1	28688	T	C	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	L139L	None	-	None	0.57	Tolerable	-2.12	0.134724	0.992126	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_95_LEFT	2019-nCoV_N3-F	NA	NA	NA	No co - mutations reported	NA	0.001744	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria	Africa(0.000134);Asia(0.001023);Europe(0.000531);Oceania(0.000056)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89c72&&LOCATION=1:28688:T:C
28849C>T	1	28849	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	N192N	None	-	None	0.36	Tolerable	-3.3	-0.533591	0.984252	NA	NA	NA	NA	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	NA	NA	NA	SARS-CoV-2_IBS_N1_R | SARS-CoV-2_IBS_N2_R	NA	NA	NA	No co - mutations reported	NA	0.002226	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria	Africa(0.000200);Asia(0.001998);Europe(0.000028)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89e62&&LOCATION=1:28849:C:T
28311C>T	1	28311	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	P13L	None	-	None	0	Deleterious	1.65	3.27687	1	NA	9b	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.006345	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria	Africa(0.000334);Asia(0.000378);Europe(0.000015);Oceania(0.005618)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8981e&&LOCATION=1:28311:C:T
29179G>T	1	29179	G	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	P302P	None	-	None	1	Tolerable	-0.391	1.47135	1	NA	NA	NA	NA	NA	nucleocapsid phosphoprotein_WPQIAQFAPSASAFF	11	NA	NA	Nucleocapsid phosphoprotein	IRQGTDYKHWPQIAQFA, QFAPSASAFFGMSRIGM, FFGMSRIGMEVTPSGTW	NA	2019-nCoV_N2-F	NA	NA	NA	No co - mutations reported	NA	0.073065	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria	Africa(0.032474);Asia(0.038233);Europe(0.000002);Europe(0.001633);Oceania(0.000723)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a2b1&&LOCATION=1:29179:G:T
29303C>T	1	29303	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	P344S	None	-	None	0.54	Tolerated	1.65	2.25106	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0011880	Computational Analysis	Sequence analysis and stability prediction followed by Molecular dynamics simulations of the protein and their complexes	P344S predicted to decrease protein stability with ΔG value of -1.2252261	Khan, M. I., Khan, Z. A., Baig, M. H., Ahmad, I., Farouk, A.-E. A., Song, Y. G., & Dong, J.-J. (2020). Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLOS ONE, 15(9), e0238344. https://doi.org/10.1371/journal.pone.0238344	https://pubmed.ncbi.nlm.nih.gov/32881907/	Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight	Mohd Imran Khan, Zainul A Khan, Mohammad Hassan Baig, Irfan Ahmad, Abd-ElAziem Farouk, Young Goo Song, Jae-Jun Dong	Asia(0.000061);Europe(0.001127)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a42c&&LOCATION=1:29303:C:T
	1				N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	P365H	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.1332930	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.026660);Asia(0.073726);Europe(0.017777);Oceania(0.015130)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8824e&&LOCATION=1:
28512C>G	1	28512	C	G	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	P80R	P.1	https://outbreak.info/situation-reports?pango=P.1	Characteristic mutation of P.1 lineage 																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6			
28826C>T	1	28826	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	R185C	None	-	None	0.01	Deleterious	1.65	3.25353	1	NA	NA	NA	NA	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	Nucleocapsid phosphoprotein 	SRGGSQASSRSSSRSR	NA	NIID-N1-R | CDCV_GERMANY_N gene_2	NA	NA	Hypermutable low-fitness site	No co - mutations reported	NA	0.0620310	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.049178);Asia(0.008733);Europe(0.001784);Oceania(0.002336)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89e1a&&LOCATION=1:28826:C:T
28881G>A	1	28881	G	A	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	R203K	B.1.1.7## P.1## P.3	https://outbreak.info/situation-reports?pango=B.1.1.7##https://outbreak.info/situation-reports?pango=P.1##https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of  B.1.1.7, P.1 and P.3 lineages.	0	Deleterious	1.65	4.256	1	NA	NA	NA	Transmembrane	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	NA	NA	NA	N gene Forward	NA	NA	NA	Variant associated with viral transmission and cell signalling. Functional consequences induced by co - occurring mutations	28882G>A | 28883G>C	0.6972320	Computational Analysis	Sequence and Protein structure analysis	Arginine is a chiral and polar amino acid which frequently occurs at the N‐termini of alpha helices while lysine is a chiral and polar amino acid. Using the three‐dimensional structure  on I‐tasser, the implication of these mutations has been analyzed by CUPSAT. The results points out that this mutation reduces protein stability while favouring torsion.##The triple site mutation 28881-28883 that brings change in two amino acid 203-204:RG>KR, is known to play a critical role in virion assembly and structure. The mutated 203/204 region of N protein affects the SR (serine-arginine)-rich motif of the protein (a crucial region for controlling viral transcription and replication) by introducing lysin in between them that might hamper the phosphorylation at serine residue required for normal functioning of N protein. Significant reduction in pathogenicity has been observed with the deletion of SR domain, therefore it is important to target 203-204:RG>KR positions of the N protein to design the drugs for controlling the disease.  	Benvenuto, D., Demir, A. B., Giovanetti, M., Bianchi, M., Angeletti, S., Pascarella, S., Cauda, R., Ciccozzi, M., & Cassone, A. (2020). Evidence for Mutations in SARS-CoV-2 Italian Isolates Potentially Affecting Virus Transmission. SSRN Electronic Journal, 1. https://doi.org/10.2139/ssrn.3596454##Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (n.d.). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism. https://doi.org/10.1101/2020.06.07.138800##Rehman, S., Mahmood, T., Aziz, E., & Batool, R. (2020). Identification of novel mutations in SARS-COV-2 isolates from Turkey. Archives of Virology, 165(12), 2937–2944. https://doi.org/10.1007/s00705-020-04830-0##Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428##Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://www.ncbi.nlm.nih.gov/research/coronavirus/publication/32492183##https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538173/##https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/##https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.##Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism##Identication of novel mutations in SARS-COV-2 isolates from Turkey##SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant##Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Benvenuto, Domenico; Demir, Ayse Banu; Giovanetti, Marta; Bianchi, Martina; Angeletti, Silvia; Pascarella, Stefano; Cauda, Roberto; Ciccozzi, Massimo; Cassone, Antonio##Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen##Shazia Rehman, Tariq Mahmood, Ejaz Aziz, Riffat Batool##Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group##Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6	Africa(0.046171);Asia(0.099012);Europe(0.524013);Oceania(0.028036)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89ed1&&LOCATION=1:28881:G:A
28881G>T	1	28881	G	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	R203M	B.1.617.1##B.1.617.2##B.1.617.3	https://outbreak.info/situation-reports?pango=B.1.617.1##https://outbreak.info/situation-reports?pango=B.1.617.2##https://outbreak.info/situation-reports?pango=B.1.617.3	Characterisitc mutation of B.1.617.1,  B.1.617.2 and  B.1.617.3 lineages																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
28882G>A	1	28882	G	A	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	R203R	None	-	None	0	Deleterious	0.646	2.25106	1	NA	NA	NA	Transmembrane	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	NA	NA	NA	N gene Forward	NA	NA	NA	Functional consequences induced by co - occurring mutations	28881G>A  | 28883G>C	0.0040540	Computational Analysis	Sequence and mutation analysis followed by secondary structure predictions.	The triple site mutation 28881-28883 that brings change in two amino acid 203-204:RG>KR, is known to play a critical role in virion assembly and structure. The mutated 203/204 region of N protein affects the SR (serine-arginine)-rich motif of the protein (a crucial region for controlling viral transcription and replication) by introducing lysin in between them that might hamper the phosphorylation at serine residue required for normal functioning of N protein. Significant reduction in pathogenicity has been observed with the deletion of SR domain, therefore it is important to target 203-204:RG>KR positions of the N protein to design the drugs for controlling the disease. 	Rehman, S., Mahmood, T., Aziz, E., & Batool, R. (2020). Identification of novel mutations in SARS-COV-2 isolates from Turkey. Archives of Virology, 165(12), 2937–2944. https://doi.org/10.1007/s00705-020-04830-0	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538173/	Identication of novel mutations in SARS-COV-2 isolates from Turkey	Shazia Rehman, Tariq Mahmood, Ejaz Aziz, Riffat Batool	Africa(0.000468);Asia(0.002022);Europe(0.001175);Oceania(0.000389)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89ed5&&LOCATION=1:28882:G:A
28391C>T	1	28391	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	R40C	None	-	None	0.02	Deleterious	0.701	1.51443	0.937008	NA	9b	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0015960	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Africa(0.000668);Asia(0.000183);Europe(0.000001);Europe(0.000577);Oceania(0.000167)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8991d&&LOCATION=1:28391:C:T
28392G>T	1	28392	G	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	R40L	None	-	None	0.03	Deleterious	1.65	4.256	1	NA	9b	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000772	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	NorthAmerica(0.000077226)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89922&&LOCATION=1:28392:G:T
28821C>A	1	28821	C	A	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	S183Y	None	-	None	0	Deleterious	1.65	3.25353	1	NA	NA	NA	NA	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	Nucleocapsid phosphoproteinÂ 	SRGGSQASSRSSSRSR	NA	NIID-N1-R | CDCV_GERMANY_N gene_2	NA	NA	NA	No co - mutations reported	NA		Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89e08&&LOCATION=1:28821:C:A
28833C>T	1	28833	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	S187L	None	-	None	0	Deleterious	-0.232	1.02581	0.669291	NA	NA	NA	NA	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	Nucleocapsid phosphoproteinÂ 	SRGGSQASSRSSSRSR	NA	NIID-N1-R | CDCV_GERMANY_N gene_2 | SARS-CoV-2_IBS_N1_R	NA	NA	NA	No co - mutations reported	NA		Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89e31&&LOCATION=1:28833:C:T
28836C>T	1	28836	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	S188L	None	-	None	0	Deleterious	1.65	3.25353	1	NA	NA	NA	NA	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	Nucleocapsid phosphoproteinÂ 	SRGGSQASSRSSSRSR	NA	SARS-CoV-2_IBS_N1_R | SARS-CoV-2_IBS_N2_R	NA	NA	NA	No co - mutations reported	NA		Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89e39&&LOCATION=1:28836:C:T
28854C>T	1	28854	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	S194L	None	-	None	NA	NA	1.65	3.25353	1	NA	NA	NA	NA	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	NA	NA	NA	SARS-CoV-2_IBS_N2_R	NA	NA	Hypermutable low-fitness site	No co - mutations reported	NA	0.1745572	Computational Analysis	Protein structure prediction using C-I-TASSER follwed by Molecular docking and hotspot prediction using HADDOCK web-server 	S194L exhibited significant difference in protein structural morphology from their control. Enhanced interaction between each SARS-CoV-2 N mutant (S194L or R203K/G204R) and E might promote virus release, while decreased binding affinity of S194L N-M might attenuate virus assembly.	Wu, S., Tian, C., Liu, P., Guo, D., Zheng, W., Huang, X., Zhang, Y., & Liu, L. (2020). Effects of SARS‐CoV‐2 mutations on protein structures and intraviral protein–protein interactions. Journal of Medical Virology, 1. https://doi.org/10.1002/jmv.26597	https://onlinelibrary.wiley.com/doi/10.1002/jmv.26597	Effects of SARS-CoV-2 Mutations on Protein Structures and Intraviral Protein-Protein Interactions	Siqi Wu, Chang Tian, Panpan Liu, Dongjie Guo, Wei Zheng,  Xiaoqiang Huang,  Yang Zhang, Lijun Liu	Africa(0.00582072),Asia(0.0740741),Australia(0.0102866),Europe(0.0389383),NorthAmerica(0.0441733),SouthAmerica(0.00126422)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89e74&&LOCATION=1:28854:C:T
28878G>A	1	28878	G	A	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	S202N	None	-	None	0	Deleterious	1.65	4.256	1	NA	NA	NA	Transmembrane	Nucleocapsid phosphoprotein_RGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0930133	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to increase the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. S202N was predicted to have DDG value of -0.78 kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Africa(0.0500582),Asia(0.0315966),Australia(0.00587803),Europe(0.00115579),NorthAmerica(0.00432466)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89ec4&&LOCATION=1:28878:G:A
28977C>T	1	28977	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	S235F	B.1.1.7	https://outbreak.info/situation-reports?pango=B.1.1.7	Characteristic mutation of B.1.1.7 lineage.	0.07	Tolerable	1.65	3.25353	1	NA	NA	NA	NA	Nucleocapsid phosphoprotein_SKMSGKGQQQQGQTVTKKSA	nucleocapsid phosphoprotein_LLLLDRLNQLESKMS	9.5	NA	NA	NA	NA	NA	N gene Reverse	NA	NA	NA	No co - mutations reported	NA		Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086##Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://pubmed.ncbi.nlm.nih.gov/33181329/##https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays##SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria##Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a068&&LOCATION=1:28977:C:T
29227G>T	1	29227	G	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	S318S	None	-	None	1	Tolerable	-2.29	0.134724	1	NA	NA	NA	NA	NA	nucleocapsid phosphoprotein_QFAPSASAFFGMSRI	17	nucleocapsid phosphoprotein_ASAFFGMSR	0.05	Nucleocapsid phosphoprotein	IRQGTDYKHWPQIAQFA, QFAPSASAFFGMSRIGM, FFGMSRIGMEVTPSGTW	NA	2019-nCoV_N2-R				No co - mutations reported	NA		Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8824e&&LOCATION=1:29227:G:T
28887C>T	1	28887	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	T205I	B.1.351##B.1.525##B.1.427/B.1.429##B.1.621	https://outbreak.info/situation-reports?pango=B.1.351##https://outbreak.info/situation-reports?pango=B.1.525##https://outbreak.info/situation-reports?pango=B.1.427##https://outbreak.info/situation-reports?pango=B.1.621	Characteristic mutation of B.1.351,B.1.427/B.1.429 and B.1.621 lineages 																												Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo			
29247C>T	1	29247	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	T325I	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage																																		
29445C>T	1	29445	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	T391I	None	-	None	0.09	Tolerated	-0.0985	1.24858	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0008993	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Europe(0.000358694),NorthAmerica(0.000540582)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a5c7&&LOCATION=1:29445:C:T
29451C>T	1	29451	C	T	N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Non Synonymous SNV	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	T393I	None	-	None	0.13	Tolerated	1.65	3.25353	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0099954	Computational Analysis	SARS-CoV-2 Mutation Detection followed by Prediction of Secondary structure and Solvent accessibility. 	Through In-silico secondary structure prediction using Dictionary of Protein Secondary Structure (DSSP) and solvent accessibility analysis using SCRATCH-1D software suite, this variation was found have a potential to change both protein structure and solvent accessibility.	Nguyen, T. T., Pathirana, P. N., Nguyen, T., Nguyen, H., Bhatti, A., Nguyen, D. C., Nguyen, D. T., Nguyen, N. D., Creighton, D., & Abdelrazek, M. (2020). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus). Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus), 1. https://doi.org/10.1101/2020.07.10.171769	https://www.nature.com/articles/s41598-021-83105-3	Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus)	Thanh Thi Nguyen, Pubudu N. Pathirana, Thin Nguyen, Henry Nguyen, Asim Bhatti, Dinh C. Nguyen, Dung Tien Nguyen, Ngoc Duy Nguyen, Douglas Creighton, Mohamed Abdelrazek	Asia(0.00104624),Australia(0.000734754),Europe(0.0012355),NorthAmerica(0.00571473),SouthAmerica(0.00126422)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A28274%2D29533&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8a5d7&&LOCATION=1:29451:C:T
					N	43740575	https://www.ncbi.nlm.nih.gov/gene/43740575	NC_045512.2:28274-29533	Single Nucleotide Variation	Deletion	Nucleocapsid phosphoprotein	419 amino acids 	QHD43423.2	https://www.ncbi.nlm.nih.gov/protein/1798172432	Δ3	B.1.525	https://outbreak.info/situation-reports?pango=B.1.525	Characteristic mutation of B.1.525 lineage 																												Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo			
28077G>T	1	28077	G	T	ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Single Nucleotide Variation	Non Synonymous SNV	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1	 V62L	None	-	None	0.34	Tolerated	0.427	1.02486	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hypermutable low-fitness site	No co - mutations reported	NA	0.0261430	Computational Analysis	Modelling of wild type (NCBI reference genome) ORF8 and mutant ORF8 (mORF8; triple mutations S24L, V62L and L84S was performed using I-TASSER (Iterative Threading ASSEmbly Refinement) with human complement factor 1 (F1; PDB id: 2xrc) as template. MD simulations were carried using gromacs v2016. Simulations of F1-C3b and ORF8-C3b complexes were carried at 300 K in a cubical box with 10 nm spacing from box edges.	Mutation induced structural stability analysis displayed S24L and V62L substitutions to have minor stabilization effects on ORF8 architecture. 	Singh, J., Kar, S., Hasnain, S. E., & Ganguly, S. (n.d.). SARS-CoV-2 ORF8 can fold into human factor 1 catalytic domain binding site on complement C3b: Predict functional mimicry. https://doi.org/10.1101/2020.06.08.107011	https://www.biorxiv.org/content/10.1101/2020.06.08.107011v2.full	SARS-CoV-2 ORF8 can fold into human factor 1 catalytic domain binding site on complement C3b: Predict functional mimicry	Jasdeep Singh, Sudeshna Kar, Seyed Ehtesham Hasnain, Surajit Ganguly	Africa(0.008620);Asia(0.009025);Europe(0.003158);Oceania(0.005340)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A27894-28259&hgt.positionInput=NC_045512.2%3A27894-28259&goButton=go&db=wuhCor1&c=NC_045512v2&l=25392&r=26220&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8955c&&LOCATION=1:28077:G:T
					ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Deletion	Deletion	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1	∆382																												As part of the COVID-19 outbreak investigation in Singapore, all patients with SARS-CoV-2 infection were interviewed to elucidate activity histories from 14 days preceding symptom onset until isolation in hospital, including recent travel history and possible contact with confirmed cases. . To detect the 382-nucleotide deletion in the SARS-CoV-2 genome, two specific PCR primers (forward 5ʹ-TGTTAGAGGTACAACAGTACTTT-3ʹ; reverse 5ʹ-GGTAGTAGAAATACCATCTTGGA-3ʹ) flanking the deleted region were used. Clinical outcomes were duly compared.	Experimental	Development of hypoxia requiring supplemental oxygen was less frequent in the ∆382 variant group (0 [0%] of 29 patients) than in the wild-type only group (26 [28%] of 92; absolute difference 28% [95% CI 14–28]). After adjusting for age and presence of comorbidities, infection with the ∆382 variant only was associated with lower odds of developing hypoxia requiring supplemental oxygen (adjusted odds ratio 0·07 [95% CI 0·00–0·48]) compared with infection with wild-type virus only.	Young, B. E., Fong, S. W., Chan, Y. H., Mak, T. M., Ang, L. W., Anderson, D. E., Lee, C. Y., Amrun, S. N., Lee, B., Goh, Y. S., Su, Y., Wei, W. E., Kalimuddin, S., Chai, L., Pada, S., Tan, S. Y., Sun, L., Parthasarathy, P., Chen, Y., Barkham, T., … Ng, L. (2020). Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet (London, England), 396(10251), 603–611. https://doi.org/10.1016/S0140-6736(20)31757-8	https://pubmed.ncbi.nlm.nih.gov/32822564/	Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study			https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A27894-28259&hgt.positionInput=NC_045512.2%3A27894-28259&goButton=go&db=wuhCor1&c=NC_045512v2&l=25392&r=26220&pix=950&dinkL=2.0&dinkR=2.0	
28087C>T	1	28087	C	T	ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Single Nucleotide Variation	Non Synonymous SNV	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1	A65V	None	-	None	0.46	Tolerated	0.122	-0.639669	0.00787402	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_93_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0206160	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to increase the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. A65V was predicted to have DDG value of 0.02  kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Africa(0.003675);Asia(0.003508);Europe(0.007314);Oceania(0.006119)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A27894-28259&hgt.positionInput=NC_045512.2%3A27894-28259&goButton=go&db=wuhCor1&c=NC_045512v2&l=25392&r=26220&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef8957d&&LOCATION=1:28087:C:T
28167G>A	1	28167	G	A	ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Single Nucleotide Variation	Non Synonymous SNV	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1	E92K	P.1	https://outbreak.info/situation-reports?pango=P.1	Characteristic mutation of P.1 lineage 																																		
					ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Single Nucleotide Variation	Non Synonymous SNV	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1	K2Q	P.3	https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of P.3 lineage																																		
28144T>C	1	28144	T	C	ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Single Nucleotide Variation	Non Synonymous SNV	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1	L84S	None	-	None	0.37	Tolerated	-0.206	-1.52089	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.1209470	Computational Analysis	Mutation analysis followed by Epitope prediction and antigenic peptide binding analysis	Distinct differences observed in MHC class I and class II binding features. DRB3*02:02, DRB1*09:01, and DRB1*04:01, that do not allow binding of the wildtype, but accommodate the SARS-CoV-2 ORF8 (L84S) variant. ORF8 L84S variant annuls binding to two MHC class II alleles that the wildtype virus allows: HLA-DPA1*01:03/DPB1*02:01 and DRB1*15:01. DPA1 and DPB1 encode different amino acid residues in the peptide-binding groove of MHC class II alleles that determine which peptides can be presented to CD4+ T-cells. HLA-DPA1*01:03-DPB1*04:02 (but not DPB1*02:01) was associated with an increased risk of developing narcolepsy. Mutational effects analysis predicted that  mutations occurring in surface glycoprotein, ORF3a and ORF6 were predicted to alter the molecular consequences, including loss of sulfation in surface glycoprotein and loss of proteolytic cleavage in ORF3a and loss of allosteric site in ORF6. L84S mutation is found to decrease the stability of the protein with DDG value of -2.29 kcal/mol.	de Sousa, E., Ligeiro, D., Lérias, J. R., Zhang, C., Agrati, C., Osman, M., El-Kafrawy, S. A., Azhar, E. I., Ippolito, G., Wang, F.-S., Zumla, A., & Maeurer, M. (2020). Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants. International Journal of Infectious Diseases, 98, 454–459. https://doi.org/10.1016/j.ijid.2020.07.016##Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368421/##https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants##Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Eric de Sousa, Dário Ligeiro, Joana R. Lérias, Chao Zhang, Chiara Agrati, Mohamed Osman, Sherif A. El-Kafrawy, Esam I. Azhar, Giuseppe Ippolito, Fu-Sheng Wang, Alimuddin Zumla, Markus Maeurera##Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Africa(0.049579);Asia(0.017405);Europe(0.000002);Europe(0.004064);Oceania(0.049897)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A27894-28259&hgt.positionInput=NC_045512.2%3A27894-28259&goButton=go&db=wuhCor1&c=NC_045512v2&l=25392&r=26220&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef89626&&LOCATION=1:28144:T:C
	1				ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Stoploss	Stop gain	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1	Q27*	B.1.1.7	https://outbreak.info/situation-reports?pango=B.1.1.7	Characteristic mutation of B.1.1.7 lineage																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group			
28048G>T	1	28048	G	T	ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Single Nucleotide Variation	Non Synonymous SNV	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1	R52I	B.1.1.7	https://outbreak.info/situation-reports?pango=B.1.1.7	Characteristic mutation of B.1.1.7 lineage																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group			
27964C>T	1	27964	C	T	ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Single Nucleotide Variation	Non Synonymous SNV	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1	S24L	None	-	None	0.1	Tolerated	0.174	0.143638	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0191080	Computational Analysis	Protein-specific analysis (Topology based Machine Learning structure prediction)	27964C>T-(S24L) on ORF8, is found to have an unusually strong gender dependence. Upward trend of the S24L ratio over time reveals that S24L may enhance SARS-CoV-2’s ability to spread. 	Wang, R., Chen, J., Gao, K., Hozumi, Y., Yin, C., & Wei, G. (2020). Characterizing SARS-CoV-2 mutations in the United States. Research Square. https://doi.org/10.21203/rs.3.rs-49671/v1	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430589/	Characterizing SARS-CoV-2 mutations in the United States	Rui Wang, Jiahui Chen, Kaifu Gao, Yuta Hozumi , Changchuan Yin, and Guo-Wei Wei	Africa(0.001403);Asia(0.002716);Europe(0.002139);Oceania(0.012850)	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A27894-28259&hgt.positionInput=NC_045512.2%3A27894-28259&goButton=go&db=wuhCor1&c=NC_045512v2&l=25392&r=26220&pix=950&dinkL=2.0&dinkR=2.0	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54b06dcd0a2abef893fc&&LOCATION=1:27964:C:T
28111A>G	1	28111	A	G	ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Single Nucleotide Variation	Non Synonymous SNV	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1	Y73C	B.1.1.7	https://outbreak.info/situation-reports?pango=B.1.1.7	Characteristic mutation of B.1.1.7 lineage																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group			
					ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Single Nucleotide Variation	Deletion	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1	Δ119-120	B.1.617.2	https://outbreak.info/situation-reports?pango=B.1.617.2	Characteristic mutation of  B.1.617.2 lineage																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
Δ27848-28229	1	27848-28229		-	ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Deletion	Deletion	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1		None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis and Experimental 	PCR and Multiplex microbead based Immuno assay####Virus culture, RNA extraction, and sequencing followed by phylogenetic analysis	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with a 382-nucleotide deletion (∆382) in the open reading frame 8 (ORF8) region of the genome have been detected in Singapore and other countries. ∆382 variant only was associated with lower odds of developing hypoxia requiring supplemental oxygen (adjusted odds ratio 0·07 [95% CI 0·00–0·48]) compared with infection with wild-type virus only. In conclusion, the ∆382 variant of SARS-CoV-2 seems to be associated with a milder infection. The observed clinical effects of deletions in ORF8 could have implications for the development of treatments and vaccines.##A comparison of subgenomic RNA reads predicted from the sequence data  suggests that Δ382 viruses may have altered levels of transcription compared to wild-type viruses, including those of the ORF6 and N genes which are known SARS-CoV interferon (IFN) antagonists, raising the possibility that infection with Δ382 viruses might result in an altered innate immune response. 	Young, B. E., Fong, S.-W., Chan, Y.-H., Mak, T.-M., Ang, L. W., Anderson, D. E., Lee, C. Y.-P., Amrun, S. N., Lee, B., Goh, Y. S., Su, Y. C. F., Wei, W. E., Kalimuddin, S., Chai, L. Y. A., Pada, S., Tan, S. Y., Sun, L., Parthasarathy, P., Chen, Y. Y. C., … Ng, L. F. P. (2020). Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. The Lancet, 396(10251), 603–611. https://doi.org/10.1016/s0140-6736(20)31757-8## Su, Y. C. F., Anderson, D. E., Young, B. E., Linster, M., Zhu, F., Jayakumar, J., Zhuang, Y., Kalimuddin, S., Low, J. G. H., Tan, C. W., Chia, W. N., Mak, T. M., Octavia, S., Chavatte, J.-M., Lee, R. T. C., Pada, S., Tan, S. Y., Sun, L., Yan, G. Z., … Smith, G. J. D. (2020). Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2. MBio, 11(4), 1. https://doi.org/10.1128/mbio.01610-20	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434477/##https://pubmed.ncbi.nlm.nih.gov/32694143/	Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study##Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2	Barnaby E Young, Siew-Wai Fong, Yi-Hao Chan, Tze-Minn Mak, Li Wei Ang, Danielle E Anderson, Cheryl Yi-Pin Lee, Siti Naqiah Amrun, Bernett Lee, Yun Shan Goh, Yvonne C F Su, Wycliffe E Wei, Shirin Kalimuddin, Louis Yi Ann Chai, Surinder Pada, Seow Yen Tan, Louisa Sun, Purnima Parthasarathy, Yuan Yi Constance Chen, Timothy Barkham, Raymond Tzer Pin Lin, Sebastian Maurer-Stroh, Yee-Sin Leo, Lin-Fa Wang, Laurent Renia, Vernon J Lee, Gavin J D Smith, David Chien Lye, Lisa F P Ng##Yvonne C F Su, Danielle E Anderson, Barnaby E Young, Martin Linster , Feng Zhu, Jayanthi Jayakumar, Yan Zhuang, Shirin Kalimuddin, Jenny G H Low, Chee Wah Tan, Wan Ni Chia , Tze Minn Mak, Sophie Octavia, Jean-Marc Chavatte, Raphael T C Lee , Surinder Pada, Seow Yen Tan, Louisa Sun , Gabriel Z Yan , Sebastian Maurer-Stroh , Ian H Mendenhall , Yee-Sin Leo , David Chien Lye, Lin-Fa Wang, Gavin J D Smith	NA	https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A27894-28259&hgt.positionInput=NC_045512.2%3A27894-28259&goButton=go&db=wuhCor1&c=NC_045512v2&l=25392&r=26220&pix=950&dinkL=2.0&dinkR=2.0	
Δ28254		28254		-	ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Single Nucleotide Variation	Non Synonymous SNV	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1		None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	NA	Computational	Genome Sequence and Phylogenetic Analyses	Deletion predicted to significantly impact ORF8 protein structure and function	Pereira F. (2020). Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 85, 104525. https://doi.org/10.1016/j.meegid.2020.104525	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467077/	Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene	Filipe Pereira		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A27894-28259&hgt.positionInput=NC_045512.2%3A27894-28259&goButton=go&db=wuhCor1&c=NC_045512v2&l=25392&r=26220&pix=950&dinkL=2.0&dinkR=2.0	
Δ28090 -28095		28090 - 28095		-	ORF8	43740577	https://www.ncbi.nlm.nih.gov/gene/43740577	NC_045512.2:27894-28259	Single Nucleotide Variation	Non Synonymous SNV	ORF8 Protein	121 amino acids	QHD43422.1	https://www.ncbi.nlm.nih.gov/protein/QHD43422.1		None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	NA	Computational	Genome Sequence and Phylogenetic Analyses	Deletion predicted to significantly impact ORF8 protein structure and function	Pereira F. (2020). Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 85, 104525. https://doi.org/10.1016/j.meegid.2020.104525	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467077/	Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene	Filipe Pereira		https://genome.ucsc.edu/cgi-bin/hgTracks?hgtgroup_map_close=0&hgtgroup_genes_close=0&hgtgroup_uniprot_close=0&hgtgroup_immu_close=0&hgtgroup_rna_close=0&hgtgroup_regulation_close=0&hgtgroup_compGeno_close=0&hgtgroup_varRep_close=0&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E&position=NC_045512.2%3A27894-28259&hgt.positionInput=NC_045512.2%3A27894-28259&goButton=go&db=wuhCor1&c=NC_045512v2&l=25392&r=26220&pix=950&dinkL=2.0&dinkR=2.0	
14408C>T	1	14408	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	 P4715L	None	-	None	0.31	Tolerated	1.65	3.30748	1	NA	NA	NA	NA	NA	NA	NA	orf1ab_TVFPPTSFGPLVRK	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	4.7050660	Computational Analysis	Multiple sequence alignment (MSA) and analysis of mutational spectra	Nsp12 is important for its RNA‐dependent RNA polymerase (RdRp) activity and Pro→Leu in 4715 at this domain is a found to be a significant alteration as these domains majorly function either as replicase or helicase.	Banerjee, S., Seal, S., Dey, R., Mondal, K. K., & Bhattacharjee, P. (2020). Mutational spectra of SARS‐CoV‐2 orf1ab polyprotein and signature mutations in the United States of America. Journal of Medical Virology, 1. https://doi.org/10.1002/jmv.26417	https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26417	Mutational spectra of SARS‐CoV‐2 orf1ab polyprotein and signature mutations in the United States of America	Shuvam Banerjee , Sohan Seal , Riju Dey,  Kousik Kr. Mondal, Pritha Bhattacharjee	Africa(0.876601),Asia(0.599707),Australia(0.630419),Europe(0.867323),NorthAmerica(0.81319),SouthAmerica(0.917826)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7f717&&LOCATION=1:14408:C:T
17110G>T	1	17110	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A1215S	B.1.620	https://outbreak.info/situation-reports?pango=B.1.620	Characteristic mutation of B.1.620 lineage																																		
17339C>T	1	17339	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A1291V	P.3	https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of P.3 lineage 																																	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
5388C>A	1	5388	C	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A1708D	B.1.1.7	https://outbreak.info/situation-reports?pango=B.1.1.7	Characteristic mutation of B.1.1.7 lineage 																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
5736C>T	1	5736	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A1824V	None	-	None	0.1	Tolerated	1.65	3.32318	1	NA	Peptidase_C16	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0003164	Computational Analysis	Sequence and mutation analysis followed by secondary structure predictions.	The triple site mutation 28881-28883 that brings change in two amino acid 203-204:RG>KR, is known to play a critical role in virion assembly and structure. The mutated 203/204 region of N protein affects the SR (serine-arginine)-rich motif of the protein (a crucial region for controlling viral transcription and replication) by introducing lysin in between them that might hamper the phosphorylation at serine residue required for normal functioning of N protein. Significant reduction in pathogenicity has been observed with the deletion of SR domain, therefore it is important to target 203-204:RG>KR positions of the N protein to design the drugs for controlling the disease.  	Rehman, S., Mahmood, T., Aziz, E., & Batool, R. (2020). Identification of novel mutations in SARS-COV-2 isolates from Turkey. Archives of Virology, 165(12), 2937–2944. https://doi.org/10.1007/s00705-020-04830-0	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538173/	Identication of novel mutations in SARS-COV-2 isolates from Turkey	Shazia Rehman, Tariq Mahmood, Ejaz Aziz, Riffat Batool	Europe(0.00023913),NorthAmerica(0.000077226)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef79529&&LOCATION=1:5736:C:T
881G>A	1	881	G	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A206T	None	-	None	0.01	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001968	Computational Analysis	Sequence and mutation analysis followed by secondary structure predictions.	The triple site mutation 28881-28883 that brings change in two amino acid 203-204:RG>KR, is known to play a critical role in virion assembly and structure. The mutated 203/204 region of N protein affects the SR (serine-arginine)-rich motif of the protein (a crucial region for controlling viral transcription and replication) by introducing lysin in between them that might hamper the phosphorylation at serine residue required for normal functioning of N protein. Significant reduction in pathogenicity has been observed with the deletion of SR domain, therefore it is important to target 203-204:RG>KR positions of the N protein to design the drugs for controlling the disease.  	Rehman, S., Mahmood, T., Aziz, E., & Batool, R. (2020). Identification of novel mutations in SARS-COV-2 isolates from Turkey. Archives of Virology, 165(12), 2937–2944. https://doi.org/10.1007/s00705-020-04830-0	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538173/	Identication of novel mutations in SARS-COV-2 isolates from Turkey	Shazia Rehman, Tariq Mahmood, Ejaz Aziz, Riffat Batool	Europe(0.000119565),NorthAmerica(0.000077226)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef75bf8&&LOCATION=1:881:G:A
7296C>T	1	7296	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A2344V	B.1.617.3	https://outbreak.info/situation-reports?pango=B.1.617.3	Characteristic mutation of B.1.617.3 lineage																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
9802G>T	1	9802	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A3179A	None	-	None	1	Tolerated	-0.834	0.406276	1	NA	NA	NA	Transmembrane	NA	NA	NA	orf1ab_ALCTFLLNK	0.14	NA	NA	nCoV-2019_33_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0039630	Computational Analysis	Multiple Sequence Alignment (MSA) and Mutation analysis followed by RNA Secondary Structure prediction and Base Pair Probability Analysis. Potential miRNA Binding Sites and Splice sites were also analysed	One of the two recurring synonymous mutations, potentially disrupting the miR-18b binding site of Nsp4. The miR-18b miRNA was reported to be downregulated in viral infections such as HBV and Ebola while its expression in patients with cardiovascular disease is upregulated	Hosseini Rad SM, A., & McLellan, A. D. (2020). Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting. International Journal of Molecular Sciences, 21(13), 4807. https://doi.org/10.3390/ijms21134807	https://pubmed.ncbi.nlm.nih.gov/32645951/	Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting	Ali Hosseini Rad Sm , Alexander D McLellan	Asia(0.000209249),Australia(0.000734754),Europe(0.00271014),NorthAmerica(0.000308904)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7c37f&&LOCATION=1:9802:G:T
10634G>T	1	10634	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A3457S	B.1.617.3	https://outbreak.info/situation-reports?pango=B.1.617.3	Characteristic mutation of B.1.617.3 lineage																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
11322C>T	1	11322	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A3686V	B.1.617.3	https://outbreak.info/situation-reports?pango=B.1.617.3	Characteristic mutation of B.1.617.3 lineage																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A406V	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001420	Computational Analysis	Sequence analysis and stability prediction followed by Molecular dynamics simulations of the protein and their complexes	A406V predicted to decrease protein stability with ΔG value of -0.76907034	Khan, M. I., Khan, Z. A., Baig, M. H., Ahmad, I., Farouk, A.-E. A., Song, Y. G., & Dong, J.-J. (2020). Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight. PLOS ONE, 15(9), e0238344. https://doi.org/10.1371/journal.pone.0238344	https://pubmed.ncbi.nlm.nih.gov/32881907/	Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight	Mohd Imran Khan, Zainul A Khan, Mohammad Hassan Baig, Irfan Ahmad, Abd-ElAziem Farouk, Young Goo Song, Jae-Jun Dong	Africa(0.000067);Asia(0.000037);Europe(0.000038)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
13487C>T	1	13487	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A7V	None	-	None	1	Tolerated	1.65	3.31844	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001560	Computational Analysis	Mining of Single Nucleotide Polymorphisms(SNPs) in SARS-CoV-2 followed by Viral RNA-host miRNA interaction analysis and Prediction of the secondary structures of the Internal Ribosome Entry Site (IRES)	Mutations in this position can destroy the viral translation process and render the virus less virulent. On the basis of host miRNA binding and the putative alterations in the Internal Ribosome Entry Site (IRES) structure,  this mutation can alter the binding pattern of host miRNAs which can ultimately result in alternative responses from these binding. Also, mutations in IRES are found to disrupt its secondary structure  leading to variabilty in viral infection among countries. 	Islam, A. B. M. M. K., Abul Bashar Mir Md, & Khan, M. A.-A.-K. (n.d.). SARS-CoV-2 mutations altering regulatory properties: deciphering host’s and virus’s perspectives. https://doi.org/10.1101/2020.06.15.150482	https://www.biorxiv.org/content/10.1101/2020.06.15.150482v1.full	SARS-CoV-2 mutations altering regulatory properties: deciphering host’s and virus’s perspectives	Abul Bashar Mir Md. Khademul Islam, Abdullah-Al-Kamran Khan	Asia(0.000122);Europe(0.000034)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7ecdd&&LOCATION=1:13487:C:T
2891G>A	1	2891	G	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A876T	None	-	None	0.28	Tolerated	0.695	2.51597	0.992126	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_9_RIGHT_alt2		NA	NA	NA	No co - mutations reported	NA	0.0000030	Computational Analysis	Computational Mutation analysis	Potential alterations in protein structure thereby causing alterations in binding ability	Weber, S., Ramirez, C., & Doerfler, W. (2020). Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world. Virus research, 289, 198170. https://doi.org/10.1016/j.virusres.2020.198170	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513834/	Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world	Stefanie Weber, Christina Ramirez and Walter Doerflera	Europe(0.000003)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef77355&&LOCATION=1:2891:G:A
5385C>T	1	5385	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A889V	None	-	None	0.1	Tolerated	1.65	3.32318	1	Peptidase_C16	NA	NA	NA	NA	NA	NA	orf1ab_YYRARAGEAANF	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000170	Computational Analysis	In silico mutation analysis followed by observation of mutational effect on the protein structure using PLPro crystal structures and SWISS-MODEL protein modelling	Amino acid change predicted to potentially increase the stabillity of the protein	Hossain, M. U., Bhattacharjee, A., Emon, M. T. H., Chowdhury, Z. M., Mosaib, M. G., Moniruzzaman, M., Rahman, M. H., Islam, M. N., Ahmed, I., Amin, M. R., Rashed, A., Das, K. C., Keya, C. A., & Salimullah, M. (n.d.). Novel Mutations in NSP1 and PLPro of SARS-CoV-2 NIB-1 Genome Mount for Effective Therapeutics. https://doi.org/10.1101/2020.12.02.408229	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017899/	Novel Mutations in NSP1 and PLPro of SARS-CoV-2 NIB-1 Genome Mount for Effective Therapeutics	Mohammad Uzzal Hossain, Arittra Bhattacharjee, Md. Tabassum Hossain Emon, Zeshan Mahmud Chowdhury, Md. Golam Mosaib, Md. Moniruzzaman, Md. Hadisur Rahman, Md. Nazrul Islam, Irfan Ahmed, Md. Ruhul Amin, Asif Rashed, Keshob Chandra Das, Chaman Ara Keya, Md. Salimullah	Asia(0.000012);Europe(0.000005)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef79113&&LOCATION=1:5385:C:T
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	A895V	None	-	None																												Soliman, M. S., AbdelFattah, M., Aman, S., Ibrahim, L. M., & Aziz, R. K. (2020). A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions. Omics : a journal of integrative biology, 10.1089/omi.2020.0194. Advance online publication. https://doi.org/10.1089/omi.2020.0194	https://pubmed.ncbi.nlm.nih.gov/33253058/	A Gapless, Unambiguous RNA Metagenome-Assembled Genome Sequence of a Unique SARS-CoV-2 Variant Encoding Spike S813I and ORF1a A859V Substitutions	May S Soliman , May AbdelFattah, Soad M N Aman, Lamyaa M Ibrahim, Ramy K Aziz 		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
13506C>T	1	13506	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	C13C	None	-	None	1	Tolerated	1.65	3.31844	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0009291	Computational Analysis	Mining of Single Nucleotide Polymorphisms(SNPs) in SARS-CoV-2 followed by Viral RNA-host miRNA interaction analysis and Prediction of the secondary structures of the Internal Ribosome Entry Site (IRES)	Mutations in this position can destroy the viral translation process and render the virus less virulent. On the basis of host miRNA binding and the putative alterations in the Internal Ribosome Entry Site (IRES) structure,  this mutation can alter the binding pattern of host miRNAs which can ultimately result in alternative responses from these binding. Also, mutations in IRES are found to disrupt its secondary structure  leading to variabilty in viral infection among countries. 	Islam, A. B. M. M. K., Abul Bashar Mir Md, & Khan, M. A.-A.-K. (n.d.). SARS-CoV-2 mutations altering regulatory properties: deciphering host’s and virus’s perspectives. https://doi.org/10.1101/2020.06.15.150482	https://www.biorxiv.org/content/10.1101/2020.06.15.150482v1.full	SARS-CoV-2 mutations altering regulatory properties: deciphering host’s and virus’s perspectives	Abul Bashar Mir Md. Khademul Islam, Abdullah-Al-Kamran Khan	Australia(0.000734754),Europe(0.0000398549),NorthAmerica(0.000154452)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7ed15&&LOCATION=1:13506:C:T
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	D1138Y	B.1.427/B.1.429	https://outbreak.info/situation-reports?pango=B.1.427	Charactersitic mutation of B.1.427/B.1.429 lineage																																	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
18128A>G	1	18128	A	G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	D1554G	P.3	https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of P.3 lineage 																																	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
9203G>A	1	9203	G	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	D2980N	P.3	https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of P.3 lineage 																																	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
10329A>G	1	10329	A	G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	D3355G	None	-	None	0.01	Deleterious	1.65	2.2675	0.96063	NA	Peptidase_C30	NA	NA	NA	orf1ab polyprotein_QNCVLKLKVDTANPK	14	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0005730	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. D3355G was predicted to have DDG value of -0.95  kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Asia(0.000418498),NorthAmerica(0.000154452)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7c9a5&&LOCATION=1:10329:A:G
11308C>A/G	1	11308	C	A/G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	D3681E	P.3	https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of P.3 lineage 																																	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
490T>A	1	490	T	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	D75E	None	-	None	0.4	Tolerated	-3.3	-1.9324	0.740157	NA	NA	NA	NA	NA	orf1ab polyprotein_QPYVFIKRSDARTAP	19	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0048460	Computational Analysis	Multiple sequence alignment followed by Mutation analysis, Protein structure prediction and functional implications of the mutations	The relative abundance of a mutation can be taken as a surrogate of viral viability, which would be dictated by the effect of the mutation on protein stability and its function with respect to specific biomolecular events during host-pathogen interaction. D75E mutant has relatively low values of differences in Grantham's index or Kyte-Doolittle index and comparable H-bonding or salt-bridge capacity showed a dramatic decrease in relative abundance. 	Laha, S., Chakraborty, J., Das, S., Manna, S. K., Biswas, S., & Chatterjee, R. (2020). Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission. Infection, Genetics and Evolution, 85, 104445. https://doi.org/10.1016/j.meegid.2020.104445	https://reader.elsevier.com/reader/sd/pii/S1567134820302768?token=338AC50A40D839C11FE8EC0F73EE52B342F47E580D74A3997A06DB442157203A1C3059D3F88EB1104BFAB967FB300D2C	Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission	Sayantan Laha, Joyeeta Chakraborty, Shantanab Das, Soumen Kanti Manna, Sampa Biswas, RaghunathChatterjee	Africa(0.000468);Asia(0.000317);Europe(0.000056);Oceania(0.004005)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef75722&&LOCATION=1:490:T:A
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	E1084D	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. E1084D was predicted to have DDG value of -0.75  kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	NA	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
17259G>T	1	17259	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	E1264D	P.1	https://outbreak.info/situation-reports?pango=P.1	Characteristic mutation of P.1. lineage 																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
14202G>T	1	14202	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	E245D	None	-	None	0	Deleterious	0.745	2.75591	1	NA	NA	NA	NA	NA	NA	NA	orf1ab_AESHVDTDL	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7f4dc&&LOCATION=1:14202:G:T
18736T>C	1	18736	T	C	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	F6158L	None	-	None	0.3	Tolerated	1.65	2.21939	1	NA	NA	NA	NA	NA	orf1ab polyprotein_IGFDYVYNPFMIDVQ	16	orf1ab_HSIGFDYVY	0.07	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0469810	Computational Analysis	Multiple sequence alignment followed by Mutation analysis, Protein structure prediction and functional implications of the mutations	The relative abundance of a mutation can be taken as a surrogate of viral viability, which would be dictated by the effect of the mutation on protein stability and its function with respect to specific biomolecular events during host-pathogen interaction. Mutants with relatively low values of differences in Grantham's index or Kyte-Doolittle index and comparable H-bonding or salt-bridge capacity showed a dramatic decrease in relative abundance. F6158L is a mutation with very low differences in Grantham's index and reversal in the difference in apparent partitioning energy showed low abundance.	Laha, S., Chakraborty, J., Das, S., Manna, S. K., Biswas, S., & Chatterjee, R. (2020). Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission. Infection, Genetics and Evolution, 85, 104445. https://doi.org/10.1016/j.meegid.2020.104445	https://reader.elsevier.com/reader/sd/pii/S1567134820302768?token=338AC50A40D839C11FE8EC0F73EE52B342F47E580D74A3997A06DB442157203A1C3059D3F88EB1104BFAB967FB300D2C	Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission	Sayantan Laha, Joyeeta Chakraborty, Shantanab Das, Soumen Kanti Manna, Sampa Biswas, RaghunathChatterjee	Asia(0.00125549),Australia(0.0242469),Europe(0.00155434),NorthAmerica(0.0199243)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef827e7&&LOCATION=1:18736:T:C
3037C>U	1	3037	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	F924F	None	-	None	0.66	Tolerated	-3.3	-2.0989	0.00787402	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hypermutable low-fitness site	No co - mutations reported	NA	4.7681460	Computational Analysis	Multiple Sequence Alignment (MSA) and Mutation analysis followed by RNA Secondary Structure prediction and Base Pair Probability Analysis. Potential miRNA Binding Sites and Splice sites were also analysed	The C3037U conserved, but synonymous, mutation within Nsp3 sequence abolishes the miR-197-5p target sequence. This mutation was introduced in early January 2020 , and is frequently linked to dominant D614G mutation. Interestingly an analysis carried out by van Dorp et al. showed that C3037U mutation is a homoplasy that has independently emerged 39 times in global lineages and has a positive association with clade expansion	Hosseini Rad SM, A., & McLellan, A. D. (2020). Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting. International Journal of Molecular Sciences, 21(13), 4807. https://doi.org/10.3390/ijms21134807	https://pubmed.ncbi.nlm.nih.gov/32645951/	Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting	Ali Hosseini Rad Sm , Alexander D McLellan	Africa(0.928987),Asia(0.605775),Australia(0.634827),Europe(0.868439),NorthAmerica(0.811028),SouthAmerica(0.91909)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef77575&&LOCATION=1:3037:C:T
13507G>A	1	13507	G	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	G14S	None	-	None	0.23	Tolerated	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001171	Computational Analysis	Mining of Single Nucleotide Polymorphisms(SNPs) in SARS-CoV-2 followed by Viral RNA-host miRNA interaction analysis and Prediction of the secondary structures of the Internal Ribosome Entry Site (IRES)	Mutations in this position can destroy the viral translation process and render the virus less virulent. On the basis of host miRNA binding and the putative alterations in the Internal Ribosome Entry Site (IRES) structure,  this mutation can alter the binding pattern of host miRNAs which can ultimately result in alternative responses from these binding. Also, mutations in IRES are found to disrupt its secondary structure  leading to variabilty in viral infection among countries. 	Islam, A. B. M. M. K., Abul Bashar Mir Md, & Khan, M. A.-A.-K. (n.d.). SARS-CoV-2 mutations altering regulatory properties: deciphering host’s and virus’s perspectives. https://doi.org/10.1101/2020.06.15.150482	https://www.biorxiv.org/content/10.1101/2020.06.15.150482v1.full	SARS-CoV-2 mutations altering regulatory properties: deciphering host’s and virus’s perspectives	Abul Bashar Mir Md. Khademul Islam, Abdullah-Al-Kamran Khan	Europe(0.0000398549),NorthAmerica(0.000077226)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7ed16&&LOCATION=1:13507:G:A
7790G>T	1	7790	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	G1691C	None	-	None	0	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	NA	NA	orf1ab_GEIPVAYRKVLL	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000160	Computational Analysis	In silico mutation analysis followed by observation of mutational effect on the protein structure using PLPro crystal structures and SWISS-MODEL protein modelling	The wildtype residue Glycine, is essential for protein felxibility. This mutation  might potentially abolish the function of the protein	Hossain, M. U., Bhattacharjee, A., Emon, M. T. H., Chowdhury, Z. M., Mosaib, M. G., Moniruzzaman, M., Rahman, M. H., Islam, M. N., Ahmed, I., Amin, M. R., Rashed, A., Das, K. C., Keya, C. A., & Salimullah, M. (n.d.). Novel Mutations in NSP1 and PLPro of SARS-CoV-2 NIB-1 Genome Mount for Effective Therapeutics. https://doi.org/10.1101/2020.12.02.408229	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017899/	Novel Mutations in NSP1 and PLPro of SARS-CoV-2 NIB-1 Genome Mount for Effective Therapeutics	Mohammad Uzzal Hossain, Arittra Bhattacharjee, Md. Tabassum Hossain Emon, Zeshan Mahmud Chowdhury, Md. Golam Mosaib, Md. Moniruzzaman, Md. Hadisur Rahman, Md. Nazrul Islam, Irfan Ahmed, Md. Ruhul Amin, Asif Rashed, Keshob Chandra Das, Chaman Ara Keya, Md. Salimullah	Asia(0.000012);Europe(0.000004)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef7acbe&&LOCATION=1:7790:G:T
355C>T	1	355	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	G30G	None	-	None	0.85	Tolerable	-3.3	-0.0684252	0.992126	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef75591&&LOCATION=1:355:C:T
1440G>A	1	1440	G	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	G392D	None	-	None	0.73	Tolerated	-0.619	0.374063	0.968504	NA	NA	NA	NA	NA	NA	NA	orf1ab_AEYHNESGL	0.04	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Computational Mutation analysis	Potential alterations in protein structure thereby causing alterations in binding ability	Weber, S., Ramirez, C., & Doerfler, W. (2020). Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world. Virus research, 289, 198170. https://doi.org/10.1016/j.virusres.2020.198170	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513834/	Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world	Stefanie Weber, Christina Ramirez and Walter Doerflera		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef76289&&LOCATION=1:1440:G:A
15451G>A	1	15451	G	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	G662S	B.1.617.2	https://outbreak.info/situation-reports?pango=B.1.617.2	Characteristic mutation of B.1.617.2 lineage																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
6954T>C	1	6954	T	C	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	I2230T	B.1.1.7	https://outbreak.info/situation-reports?pango=B.1.1.7	Characteristic mutation of B.1.1.7 lineage 																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
1163A>T	1	1163	A	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	I300F	None	-	None	0.04	Deleterious	1.65	2.27841	0.897638	NA	NA	NA	NA	NA	orf1ab polyprotein_FMGRIRSVYPVASPN	20	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.2463354	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. I300F was predicted to have DDG value of -1.79  kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Asia(0.0357815),Australia(0.199118),Europe(0.0113587),NorthAmerica(0.000077226)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef75f41&&LOCATION=1:1163:A:T
5230G>C/T	1	5230	G	C/T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	K1655N	B.1.351	https://outbreak.info/situation-reports?pango=B.1.351	Characteristic mutation of  B.1.351 lineage 																																	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
5648A>C	1	5648	A	C 	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	K1795Q	P.1	https://outbreak.info/situation-reports?pango=P.1	Characteristic mutation of P.1. lineage 																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
20396A>G	1	20396	A	G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	K2310R	B.1.617.1	https://outbreak.info/situation-reports?pango=B.1.617.1	Characteristic mutation of B.1.617.1 lineage 																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
21488A>G	1	21488	A	G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	K2674R	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage																																		
10323A>G	1	10323	A	G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	K3353R	B.1.351	https://outbreak.info/situation-reports?pango=B.1.351	Characteristic mutation of B.1.351 lineage.	0.24	Tolerated	1.65	2.2675	1	NA	Peptidase_C30	NA	NA	NA	orf1ab polyprotein_QNCVLKLKVDTANPK	14	NA	NA	NA	NA	NA	NA	NA	NA	hypermutable low-fitness site	No co - mutations reported	NA	0.0443873	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to increase the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. K3353R was predicted to have DDG value of -0.13  kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Africa(0.00814901),Asia(0.00230174),Australia(0.000734754),Europe(0.0126739),NorthAmerica(0.00409298),SouthAmerica(0.0164349)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7c991&&LOCATION=1:10323:A:G
17074C>T	1	17074	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	L1203F	P.3	https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of P.3 lineage 																																	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
18508C>T	1	18508	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	L1681F	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage																																		
18877C>T	1	18877C	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	L270L	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.3075713	Computational Analysis	Mutation density calculation and statistical analysis	RdRp mutations were found to be contributors to the evolution of the SARS-CoV-2 genome. Also, nsp14 is found as a source of increased mutation rate in SARS-CoV-2 genomes. 18877C>T mutation is associated with increase in both genome-wide mutational load, as well as mutation density in M and E genes, which is  an alternative indicator of mutational rate and virus evolution.	Eskier, D. ğ., Suner, A. ı., Oktay, Y., & Karakülah, G. (2020). Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load. PeerJ, 8, e10181. https://doi.org/10.7717/peerj.10181	https://www.biorxiv.org/content/10.1101/2020.08.12.248732v1.full	Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load	Doğa Eskier, Aslı Suner, Yavuz Oktay, Gökhan Karakülah	Africa(0.0349243),Asia(0.137267),Australia(0.0183688),Europe(0.0231557),NorthAmerica(0.0483435),SouthAmerica(0.045512)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8298f&&LOCATION=1:18877:C:T
9803G>T	1	9803	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	L3180L	None	-	None	0.68	Tolerated	0.431	0.280055	0.992134	NA	NA	NA	Transmembrane	NA	NA	NA	orf1ab_ALCTFLLNK	0.14	NA	NA	nCoV-2019_33_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Multiple Sequence Alignment (MSA) and Mutation analysis followed by RNA Secondary Structure prediction and Base Pair Probability Analysis. Potential miRNA Binding Sites and Splice sites were also analysed	One of the two recurring synonymous mutations, potentially disrupting the miR-18b binding site of Nsp4. The miR-18b miRNA was reported to be downregulated in viral infections such as HBV and Ebola while its expression in patients with cardiovascular disease is upregulated	Hosseini Rad SM, A., & McLellan, A. D. (2020). Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting. International Journal of Molecular Sciences, 21(13), 4807. https://doi.org/10.3390/ijms21134807	https://pubmed.ncbi.nlm.nih.gov/32645951/	Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting	Ali Hosseini Rad Sm , Alexander D McLellan	NA	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=606412809d714f1000207353&&LOCATION=1:9803:C:T
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	L3201P	P.3	https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of P.3 lineage 																																	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	L329I	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000				Chand, G. B., Banerjee, A., & Azad, G. K. (2020a). Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure. PeerJ, 8, e9492. https://doi.org/10.7717/peerj.9492	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337032/	Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure	Gyanendra Bahadur Chand,Atanu Banerjee,and  Gajendra Kumar Azad	NA	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
11083G>T	1	11083	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	L3606F	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage	0.01	Deleterious	-3.3	-1.32286	0.92126	NA	NA	NA	Transmembrane	NA	orf1ab polyprotein_SLFFFLYENAFLPFA	18	orf1ab_FLYENAFLPFAM	-1	NA	NA	NA	NA	NA	Homoplasic position	NA	No co - mutations reported	NA	0.5110417	Computational Analysis	Multiple sequence alignment followed by Mutation analysis, Protein structure prediction and functional implications of the mutations	The relative abundance of a mutation can be taken as a surrogate of viral viability, which would be dictated by the effect of the mutation on protein stability and its function with respect to specific biomolecular events during host-pathogen interaction. Mutants with relatively low values of differences in Grantham's index or Kyte-Doolittle index and comparable H-bonding or salt-bridge capacity showed a dramatic decrease in relative abundance. L3606F is a mutation with very low differences in Grantham's index and reversal in the difference in apparent partitioning energy showed low abundance.	Laha, S., Chakraborty, J., Das, S., Manna, S. K., Biswas, S., & Chatterjee, R. (2020). Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission. Infection, Genetics and Evolution, 85, 104445. https://doi.org/10.1016/j.meegid.2020.104445	https://reader.elsevier.com/reader/sd/pii/S1567134820302768?token=338AC50A40D839C11FE8EC0F73EE52B342F47E580D74A3997A06DB442157203A1C3059D3F88EB1104BFAB967FB300D2C	Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission	Sayantan Laha, Joyeeta Chakraborty, Shantanab Das, Soumen Kanti Manna, Sampa Biswas, RaghunathChatterjee	Africa(0.0395809),Asia(0.165097),Australia(0.157237),Europe(0.0726157),NorthAmerica(0.0398486),SouthAmerica(0.0366625)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7d230&&LOCATION=1:11083:G:T
12053C>T	1	12053	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	L3930F	P.3	https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of P.3 lineage 																																	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
17523G>T	1	17523	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	M1352I	B.1.617.1	https://outbreak.info/situation-reports?pango=B.1.617.1	Characteristic mutation of B.1.617.1 lineage 																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
8653G>C	1	8653	G	C	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	M2796I	None	-	None	0.27	Tolerated	0.646	2.26391	0.771654	NA	Lumenal	NA	Transmembrane	NA	orf1ab polyprotein_IFYLITPVHVMSKHT	17	orf1ab_YLITPVHVM	0.04	NA	NA	nCoV-2019_28_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Sequence and mutation analysis followed by secondary structure predictions.	The triple site mutation 28881-28883 that brings change in two amino acid 203-204:RG>KR, is known to play a critical role in virion assembly and structure. The mutated 203/204 region of N protein affects the SR (serine-arginine)-rich motif of the protein (a crucial region for controlling viral transcription and replication) by introducing lysin in between them that might hamper the phosphorylation at serine residue required for normal functioning of N protein. Significant reduction in pathogenicity has been observed with the deletion of SR domain, therefore it is important to target 203-204:RG>KR positions of the N protein to design the drugs for controlling the disease.  	Rehman, S., Mahmood, T., Aziz, E., & Batool, R. (2020). Identification of novel mutations in SARS-COV-2 isolates from Turkey. Archives of Virology, 165(12), 2937–2944. https://doi.org/10.1007/s00705-020-04830-0	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538173/	Identication of novel mutations in SARS-COV-2 isolates from Turkey	Shazia Rehman, Tariq Mahmood, Ejaz Aziz, Riffat Batool	NA	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7b667&&LOCATION=1:8653:G:C
8653G>T	1	8653	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	M2796I	None	-	None	0.27	Tolerated	0.646	2.26391	0.771654	NA	Lumenal	NA	Transmembrane	NA	orf1ab polyprotein_IFYLITPVHVMSKHT	17	orf1ab_YLITPVHVM	0.04	NA	NA	nCoV-2019_28_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Sequence and mutation analysis followed by secondary structure predictions.	The triple site mutation 28881-28883 that brings change in two amino acid 203-204:RG>KR, is known to play a critical role in virion assembly and structure. The mutated 203/204 region of N protein affects the SR (serine-arginine)-rich motif of the protein (a crucial region for controlling viral transcription and replication) by introducing lysin in between them that might hamper the phosphorylation at serine residue required for normal functioning of N protein. Significant reduction in pathogenicity has been observed with the deletion of SR domain, therefore it is important to target 203-204:RG>KR positions of the N protein to design the drugs for controlling the disease.  	Rehman, S., Mahmood, T., Aziz, E., & Batool, R. (2020). Identification of novel mutations in SARS-COV-2 isolates from Turkey. Archives of Virology, 165(12), 2937–2944. https://doi.org/10.1007/s00705-020-04830-0	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538173/	Identication of novel mutations in SARS-COV-2 isolates from Turkey	Shazia Rehman, Tariq Mahmood, Ejaz Aziz, Riffat Batool	NA	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7b669&&LOCATION=1:8653:G:T
4236A>G	1	4236	A	G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	N1324S	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage																																		
6729A>G	1	6729	A	G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	N2155S	None	-	None	0.52	Tolerated	0.523	1.05805	0.0472441	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_23_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0002092	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. N2155S was predicted to have DDG value of -0.60  kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Asia(0.000209249)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7b348&&LOCATION=1:8371:G:C
15324C>T	1	15324	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	N619N	None	-	None	1	Tolerated	-3.3	0.0713543	0.992646	NA	RdRp_catalytic	NA	NA	NA	orf1ab polyprotein_RAMPNMLRIMASLVL	3.6	NA	NA	NA	NA	NA	NA	NA	Homoplasic position	NA	No co - mutations reported	NA	0.1589578	Computational Analysis	Genome sequence filtering, retrieval and preprocessing followed by statistical analysis	15324C>T mutation is found to be decrease the mutation rates of M and E genes	Eskier, D. ğ., Karakülah, G., Suner, A. ı., & Oktay, Y. (2020). RdRp mutations are associated with SARS-CoV-2 genome evolution. PeerJ, 8, e9587. https://doi.org/10.7717/peerj.9587	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380272/	RdRp mutations are associated with SARS-CoV-2 genome evolution	Doğa Eskier, Gökhan Karakülah, Aslı Suner and Yavuz Oktay	Africa(0.0640279),Asia(0.0167399),Australia(0.0117561),Europe(0.0376629),NorthAmerica(0.00980771),SouthAmerica(0.0189633)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef80182&&LOCATION=1:15324:C:T
204G>T	1	204	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Upstream variant 	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	NA	None	-	None	NA	NA	1.6	4.10688	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef7538d&&LOCATION=1:204:G:T
16466C>T	1	16466	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	P1000L	B.1.617.2	https://outbreak.info/situation-reports?pango=B.1.617.2	Characteristic mutation of B.1.617.2 lineage																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	P214L	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. P214L was predicted to have DDG value of -0.83  kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	NA	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	P314F	B.1.525	https://outbreak.info/situation-reports?pango=B.1.525	Characteristic mutation of B.1.525 lineage																												Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
14408C>T	1	14408	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	P314L	B.1.1.7##B.1.351##P.1##B.1.427/B.1.429##P.3##B.1.616##B.1.617.1##B.1.617.2##B.1.617.3##B.1.620##B.1.621	https://outbreak.info/situation-reports?pango=B.1.1.7##https://outbreak.info/situation-reports?pango=B.1.351##https://outbreak.info/situation-reports?pango=P.1##https://outbreak.info/situation-reports?pango=B.1.427##https://outbreak.info/situation-reports?pango=P.3##https://outbreak.info/situation-reports?pango=B.1.616##https://outbreak.info/situation-reports?pango=B.1.617.1##https://outbreak.info/situation-reports?pango=B.1.617.2##https://outbreak.info/situation-reports?pango=B.1.617.3##https://outbreak.info/situation-reports?pango=B.1.620##https://outbreak.info/situation-reports?pango=B.1.621	Characteristic mutation of B.1.1.7##B.1.351##P.1##B.1.427/B.1.429##P.3##B.1.616##B.1.617.1##B.1.617.2##B.1.617.3##B.1.620##B.1.621 lineages 																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428##Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010##Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/##https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/##https://pubmed.ncbi.nlm.nih.gov/33961693/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant##Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil##Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group##Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6##Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
12119C>T	1	12119	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	P3952S	None	-	None	0.18	Tolerated	1.65	3.29452	1	NA	NA	NA	NA	NA	orf1ab polyprotein_SEFSSLPSYAAFATA	14	orf1ab_ASEFSSLPSY	-1	NA	NA	nCoV-2019_41_LEFT	NA	NA	NA	NA	No co - mutations reported	NA	0.0012381	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. P3952S was predicted to have DDG value of -1.21  kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Asia(0.000418498),Europe(0.000278984),NorthAmerica(0.000540582)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7ddd2&&LOCATION=1:12119:C:T
17747C>T	1	17747	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	P504L	None	-	None	0	Deleterious	1.65	3.32576	1	NA	RNA_virus_helicase_C_Terminal	NA	NA	NA	NA	NA	orf1ab_REFLTRNPAW	-1	NA	NA	nCoV-2019_58_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0150810	Computational Analysis	Topology-based machine learning prediction of protein-protein binding affinity changes and protein folding stability changes	 P504L mutation was increasingly found in the United States along with few co-occurring mutations. Once mutations 17858A>G-(Y541C) and 17747C>T-(P504L) were first found in the United States, they had a rapid increase in the first two weeks. In early March, the ratio of both mutations start to decrease and approach zero after May 19, 2020, suggesting that mutations 17858A>G-(Y541C) and 17747C>T-(P504L) may hinder the transmission of SARS-CoV-2. It is also noted that 17858A>G-(Y541C) and 17747C>T-(P504L) never show up with 23403A>G-(D614G) in more than a thousand SNP variant, which provides a side evidence that these two mutations may inhibit the contagiousness of SARS-CoV-2.##Predicted changes in the α-helix, β-sheet, and β-turn secondary structures of the protein near these sites.	Wang, R., Chen, J., Gao, K., Hozumi, Y., Yin, C., & Wei, G. (2020). Characterizing SARS-CoV-2 mutations in the United States. Research Square. https://doi.org/10.21203/rs.3.rs-49671/v1##Cao, C., He, L., Tian, Y., Qin, Y., Sun, H., Ding, W., Gui, L., & Wu, P. (2021). Molecular epidemiology analysis of early variants of SARS-CoV-2 reveals the potential impact of mutations P504L and Y541C (NSP13) in the clinical COVID-19 outcomes. Infection, Genetics and Evolution, 92, 104831. https://doi.org/10.1016/j.meegid.2021.104831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430589/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010360/	Characterizing SARS-CoV-2 mutations in the United States##Molecular epidemiology analysis of early variants of SARS-CoV-2 reveals the potential impact of mutations P504L and Y541C (NSP13) in the clinical COVID-19 outcomes	Rui Wang, Jiahui Chen, Kaifu Gao, Yuta Hozumi , Changchuan Yin, and Guo-Wei Wei##Canhui Cao,a,b Liang He,a,c Yuan Tian,a,c Yu Qin,a,c Haiyin Sun,a,c Wencheng Ding,a,c Lingli Gui,d,⁎⁎ and Peng Wua,c,⁎	Africa(0.000334);Asia(0.000658);Europe(0.000572);Oceania(0.013517)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef81cb7&&LOCATION=1:17747:C:T
16394C>T	1	16394	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	P976L	B.1.427/B.1.429	https://outbreak.info/situation-reports?pango=B.1.427	Charactersitic mutation of B.1.427/B.1.429 lineage																																	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
8371G>C	1	8371	G	C	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	Q2702H	None	-	None	0.08	Tolerated	-0.741	0.203118	0.992126	NA	NA	NA	NA	NA	NA	NA	orf1ab_VAKSHNIAL	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001943	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. Q2702H was predicted to have DDG value of -0.68  kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Europe(0.0000398549),NorthAmerica(0.000154452)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7b348&&LOCATION=1:8371:G:C
8371G>T	1	8371	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	Q2702H	None	-	None	0.08	Tolerated	-0.741	0.203118	0.992126	NA	NA	NA	NA	NA	NA	NA	orf1ab_VAKSHNIAL	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0001943	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. Q2702H was predicted to have DDG value of -0.68  kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Europe(0.0000398549),NorthAmerica(0.000154452)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7b34a&&LOCATION=1:8371:G:T
15905A>G	1	15905	A	G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	Q813R	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage																																		
17247T>C	1	17247	T	C	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	R1260R	None	-	None	0.85	Tolerated	0.412	0.929323	1	NA	NA	NA	NA	NA	NA	NA	orf1ab_IPARARVECF	0.12	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8170f&&LOCATION=1:17247:T:C
884C>T	1	884	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	R207C	None	-	None	0	Deleterious	0.737	1.79555	0.992126	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0272181	Computational Analysis	Sequence and mutation analysis followed by secondary structure predictions.	The triple site mutation 28881-28883 that brings change in two amino acid 203-204:RG>KR, is known to play a critical role in virion assembly and structure. The mutated 203/204 region of N protein affects the SR (serine-arginine)-rich motif of the protein (a crucial region for controlling viral transcription and replication) by introducing lysin in between them that might hamper the phosphorylation at serine residue required for normal functioning of N protein. Significant reduction in pathogenicity has been observed with the deletion of SR domain, therefore it is important to target 203-204:RG>KR positions of the N protein to design the drugs for controlling the disease.  	Rehman, S., Mahmood, T., Aziz, E., & Batool, R. (2020). Identification of novel mutations in SARS-COV-2 isolates from Turkey. Archives of Virology, 165(12), 2937–2944. https://doi.org/10.1007/s00705-020-04830-0	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538173/	Identication of novel mutations in SARS-COV-2 isolates from Turkey	Shazia Rehman, Tariq Mahmood, Ejaz Aziz, Riffat Batool	Africa(0.00232829),Asia(0.0140197),Australia(0.00587803),Europe(0.000996373),NorthAmerica(0.00146729),SouthAmerica(0.00252845)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef75c01&&LOCATION=1:884:C:T
3828C>T	1	3828	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	S1188L	P.1	https://outbreak.info/situation-reports?pango=P.1	Characteristic mutation of P.1. lineage 																												Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010	https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/	Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil	Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	S1498F	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA		Computational Analysis	Genome Sequencing	Associated with the epitope loss that may influence pathogenesis caused  by antibody escape variants	S;, G. (n.d.). Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants. Retrieved November 30, 2020, from https://pubmed.ncbi.nlm.nih.gov/33049387/	https://www.sciencedirect.com/science/article/pii/S1286457920301829?via%3Dihub	Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants	Aayatti Mallick Gupta, Jaydeb Chakrabarti, Sukhendu Mandal		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	S2261Y	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage																																		
8139C>T	1	8139	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	S2625F	P.3	https://outbreak.info/situation-reports?pango=P.3	Characteristic mutation of P.3 lineage 																																	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
8782C>T	1	8782	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	S2839S	None	-	None	0.67	Tolerated	-1.35	0.271811	1	NA	Lumenal	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7b7e6&&LOCATION=1:8782:C:T
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	S3158T	B.1.427/B.1.429	https://outbreak.info/situation-reports?pango=B.1.427	Charactersitic mutation of B.1.427/B.1.429 lineage																																	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
3267C>T	1	3267	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	T1001I	B.1.1.7	https://outbreak.info/situation-reports?pango=B.1.1.7	Characteristic mutation of B.1.1.7 lineage 																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
4965C>T	1	4965	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	T1567I	B.1.617.1	https://outbreak.info/situation-reports?pango=B.1.617.1	Characteristic mutation of B.1.617.1 lineage 																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
5178C>T	1	5178	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	T1638I	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage																																		
6285C>T	1	6285	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	T2007I	B.1.525	https://outbreak.info/situation-reports?pango=B.1.525	Characteristic mutation of B.1.525 lineage																												Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
21077C>T	1	21077	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	T2537I	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage																																		
8208C>T	1	8208	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	T2648I	B.1.617.3	https://outbreak.info/situation-reports?pango=B.1.617.3	Characteristic mutation of B.1.617.3 lineage																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
1059C>T	1	1059	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	T265I	B.1.351## B.1.427/B.1.429##B.1.616	https://outbreak.info/situation-reports?pango=B.1.351##https://outbreak.info/situation-reports?pango=B.1.427##https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.351,  B.1.427/B.1.429 and  B.1.616 lineages.	0.03	Deleterious	1.65	3.30383	0.992126	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Hypermutable low-fitness site	No co - mutations reported	NA	0.0003880	Computational Analysis	Multiple sequence alignment (MSA) and analysis of mutational spectra	Nonstructural protein 2 is assumed to be responsible in the modulation of the host cell survival signaling pathway by interacting with PHB and PHB2 in the host body.9, 11, 12 Change of a polar AA (threonine) to a nonpolar one (isoleucine) makes it hydrophobic and induces structural alteration in that domain	Banerjee, S., Seal, S., Dey, R., Mondal, K. K., & Bhattacharjee, P. (2020). Mutational spectra of SARS‐CoV‐2 orf1ab polyprotein and signature mutations in the United States of America. Journal of Medical Virology, 1. https://doi.org/10.1002/jmv.26417	https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26417	Mutational spectra of SARS‐CoV‐2 orf1ab polyprotein and signature mutations in the United States of America	Shuvam Banerjee , Sohan Seal , Riju Dey,  Kousik Kr. Mondal, Pritha Bhattacharjee	Africa(0.000067);Asia(0.000110);Europe(0.000100);Oceania(0.000111)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef75e00&&LOCATION=1:1059:C:T
11201A>G	1	11201	A	G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	T3646A	B.1.617.1	https://outbreak.info/situation-reports?pango=B.1.617.1	Characteristic mutation of B.1.617.1 lineage 																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			
1473C>T	1	1473	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	T403I	B.1.620	https://outbreak.info/situation-reports?pango=B.1.620	Characteristic mutation of B.1.620 lineage																																		
1917C>T	1	1917	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	T551I	None	-	None	0.2	Tolerated	1.65	3.30383	1	NA	NA	NA	NA	NA	orf1ab polyprotein_ARVVRSIFSRTLETA	14	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Computational Mutation analysis	Potential alterations in protein structure thereby causing alterations in binding ability	Weber, S., Ramirez, C., & Doerfler, W. (2020). Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world. Virus research, 289, 198170. https://doi.org/10.1016/j.virusres.2020.198170	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513834/	Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world	Stefanie Weber, Christina Ramirez and Walter Doerflera		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef7680e&&LOCATION=1:1917:C:T
627T>A	1	627	T	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	V121D	None	-	None	0.01	Deleterious	1.65	2.16835	1	NA	NA	NA	NA	NA	NA	NA	orf1ab_GEIPVAYRKVLL	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.00001200	Computational Analysis	In silico mutation analysis followed by observation of mutational effect on the protein structure using PLPro crystal structures and SWISS-MODEL protein modelling	Change of neutral to negative amino acid leading to slight destabilization of the protein##Novel non-synonymous mutations in Sanger method-based genome sequence of a viral isolate named SARS-CoV-2 NIB-1. Predicted to have a potential decrease in the protein stabilty.	Hossain, M. U., Bhattacharjee, A., Emon, M. T. H., Chowdhury, Z. M., Ahammad, I., Mosaib, M. G., Moniruzzaman, M., Rahman, M. H., Islam, M. N., Ahmed, I., Amin, M. R., Rashed, A., Das, K. C., Keya, C. A., & Salimullah, M. (2021). Novel mutations in NSP-1 and PLPro of SARS-CoV-2 NIB-1 genome mount for effective therapeutics. Journal of Genetic Engineering and Biotechnology, 19(1). https://doi.org/10.1186/s43141-021-00152-z	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017899/	Novel Mutations in NSP1 and PLPro of SARS-CoV-2 NIB-1 Genome Mount for Effective Therapeutics	Mohammad Uzzal Hossain, Arittra Bhattacharjee, Md. Tabassum Hossain Emon, Zeshan Mahmud Chowdhury, Md. Golam Mosaib, Md. Moniruzzaman, Md. Hadisur Rahman, Md. Nazrul Islam, Irfan Ahmed, Md. Ruhul Amin, Asif Rashed, Keshob Chandra Das, Chaman Ara Keya, Md. Salimullah	Asia(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef758eb&&LOCATION=1:627:T:A
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	V1883T	None	-	None	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. V1883T was predicted to have DDG value of -1.46  kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	NA	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
6236G>A	1	6236	G	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	V1991I	B.1.620	https://outbreak.info/situation-reports?pango=B.1.620	Characteristic mutation of B.1.620 lineage																																		
6446G>A	1	6446	G	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	V2061I	None	-	None	0.9	Tolerated	-0.756	0.631654	0.889764	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Computational Mutation analysis	Potential alterations in protein structure thereby causing alterations in binding ability	Weber, S., Ramirez, C., & Doerfler, W. (2020). Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world. Virus research, 289, 198170. https://doi.org/10.1016/j.virusres.2020.198170	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513834/	Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world	Stefanie Weber, Christina Ramirez and Walter Doerflera		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef79ce4&&LOCATION=1:6446:G:A
9259A>G	1	9259	A	G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	V2998V	None	-	None	0.35	Tolerated	-3.3	-0.0354961	0.826945	NA	Lumenal	NA	NA	NA	NA	NA	orf1ab_SEAGVCVSTSGRW	0.08	NA	NA	nCoV-2019_30_RIGHT	NA	NA	NA	NA	No co - mutations reported	NA	0.0004409	Computational Analysis	Multiple Sequence Alignment (MSA) and Mutation analysis followed by RNA Secondary Structure prediction and Base Pair Probability Analysis. Potential miRNA Binding Sites and Splice sites were also analysed	Mutations occurring within Nsp4  in target sequences of miR-3935 and miR-18b-5p	Hosseini Rad SM, A., & McLellan, A. D. (2020). Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting. International Journal of Molecular Sciences, 21(13), 4807. https://doi.org/10.3390/ijms21134807	https://pubmed.ncbi.nlm.nih.gov/32645951/	Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting	Ali Hosseini Rad Sm , Alexander D McLellan	Asia(0.000209249),NorthAmerica(0.000231678)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7bd4b&&LOCATION=1:9259:A:G
10979G>A	1	10979	G	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	V3572M	None	-	None	0.08	Tolerated	0.461	0.389465	0.897638	NA	NA	NA	NA	NA	NA	NA	orf1ab_VTFQSAVKR	0.09	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0006128	Computational Analysis	The structural and functional effects of the missense variants, along with the stability change, were analyzed using different prediction tools. I-mutant was employed to analyze the stability change where all the parameters were kept in default. Additionally, Mutpred2 was adopted to predict the molecular consequences and functional effect of these mutations. This was followed by homology modelling using NCBI BLASTp program and molecular docking using PyMOL.	This mutation is found to decrease the stability of the protein. Delta Delta G (DDG) is a metric for predicting how a single point mutation will affect protein stability. DDG, often referred to as 𝚫𝚫G, is the change in the change in Gibbs free energy. V3572M was predicted to have DDG value of -0.88  kcal/mol	Parvez, M. S. A., Rahman, M. M., Morshed, M. N., Rahman, D., Anwar, S., & Hosen, M. J. (2020). Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational Biology and Chemistry, 107413. https://doi.org/10.1016/j.compbiolchem.2020.107413	https://www.sciencedirect.com/science/article/pii/S1476927120314870?via%3Dihub	Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: insights into the origin, mutation spectrum, and possible pathomechanism	Md Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md Niaz Morshed, Dolilur Rahman,Saeed Anwar, Mohammad Jakir Hosen	Asia(0.000418498),Europe(0.0000398549),NorthAmerica(0.000154452)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef7d104&&LOCATION=1:10979:G:A
1397G>A	1	1397	G	A	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	V378I	None	-	None	0.62	Tolerated	-1.81	0.227575	0.133858	NA	NA	NA	NA	NA	NA	NA	orf1ab_ACHNSEVGPEHSL	0.15	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0767039	Computational Analysis	Multiple sequence alignment (MSA) and analysis of mutational spectra	Hotspot mutation in RNA-dependent-RNA polymerase domain	Pachetti, M., Marini, B., Benedetti, F., Giudici, F., Mauro, E., Storici, P., Masciovecchio, C., Angeletti, S., Ciccozzi, M., Gallo, R. C., Zella, D., & Ippodrino, R. (2020). Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant. Journal of translational medicine, 18(1), 179. https://doi.org/10.1186/s12967-020-02344-6	https://pubmed.ncbi.nlm.nih.gov/32321524/	Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant	Maria Pachetti, Bruna Marini, Francesca Benedetti, Fabiola Giudici, Elisabetta Mauro, Paola Storici , Claudio Masciovecchio, Silvia Angeletti, Massimo Ciccozzi, Robert C Gallo, Davide Zella , Rudy Ippodrino 	Africa(0.00116414),Asia(0.0259469),Australia(0.04482),Europe(0.00199275),NorthAmerica(0.00278014)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef76202&&LOCATION=1:1397:G:A
16912G>T	1	16912	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	V5550L	None	-	None	0.01	Deleterious	1.65	4.256	1	NA	NA	NA	NA	NA	orf1ab polyprotein_GDYFVLTSHTVMPLS	15	orf1ab_TYKLNVGDYFV	-1	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0045860	Computational Analysis	Multiple sequence alignment followed by Mutation analysis, Protein structure prediction and functional implications of the mutations	The relative abundance of a mutation can be taken as a surrogate of viral viability, which would be dictated by the effect of the mutation on protein stability and its function with respect to specific biomolecular events during host-pathogen interaction. V5550L mutant has relatively low values of differences in Grantham's index or Kyte-Doolittle index and comparable H-bonding or salt-bridge capacity showed a dramatic decrease in relative abundance. 	Laha, S., Chakraborty, J., Das, S., Manna, S. K., Biswas, S., & Chatterjee, R. (2020). Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission. Infection, Genetics and Evolution, 85, 104445. https://doi.org/10.1016/j.meegid.2020.104445	https://reader.elsevier.com/reader/sd/pii/S1567134820302768?token=338AC50A40D839C11FE8EC0F73EE52B342F47E580D74A3997A06DB442157203A1C3059D3F88EB1104BFAB967FB300D2C	Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission	Sayantan Laha, Joyeeta Chakraborty, Shantanab Das, Soumen Kanti Manna, Sampa Biswas, RaghunathChatterjee	Asia(0.000627746),Australia(0.000734754),Europe(0.000597824),NorthAmerica(0.00262569)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef8135c&&LOCATION=1:16912:G:T
15540C>T	1	15540	C	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	V691V	None	-	None	1	Tolerated	-3.3	-0.944394	0.945323	NA	RdRp_catalytic	NA	NA	NA	NA	NA	NA	NA	NA	NA	nCoV-2019_51_RIGHT	SARS-CoV-2_IBS_RdRP1_R	NA	NA	NA	No co - mutations reported	NA	0	Computational Analysis	Sequence analysis and mutation prediction followed by systematic variant mapping to 132 unique dignostic primer/probe sites curated from literature.	Variations spanning the diagnostic primer and probe regions with potential impact in the diagnostic outcomes	Jain, A., Rophina, M., Mahajan, S., Krishnan, B. B., Sharma, M., Mandal, S., Fernandez, T., Sultanji, S., Jolly, B., Mathew, S., Sivasubbu, S., & Scaria, V. (2020). Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(20)32290-6. Advance online publication. https://doi.org/10.1016/j.ijid.2020.10.086	https://pubmed.ncbi.nlm.nih.gov/33181329/	Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays	Abhinav Jain, Mercy Rophina, Saurabh Mahajan, Bhavya BalajiKrishnan, Manasa Sharma, Sreya Mandal, Teresa Fernandez, Sumayra Sultanji, Bani Jolly, Samatha Mathew, Sridhar Sivasubbu, Vinod Scaria		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ae6dcd0a2abef803fa&&LOCATION=1:15540:C:T
5246G>T	1	5246	G	T	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	V843F	None	-	None	0.1	Tolerated	0.746	2.72351	1	Peptidase_C16	NA	NA	NA	NA	NA	NA	orf1ab_YPQVNGLTSI	0.18	NA	NA	nCoV-2019_18_LEFT		NA	NA	NA	No co - mutations reported	NA	0.0000120	Computational Analysis	In silico mutation analysis followed by observation of mutational effect on the protein structure using PLPro crystal structures and SWISS-MODEL protein modelling	Amino acid change predicted to disturb the domain and potentially abolish the function 	Hossain, M. U., Bhattacharjee, A., Emon, M. T. H., Chowdhury, Z. M., Mosaib, M. G., Moniruzzaman, M., Rahman, M. H., Islam, M. N., Ahmed, I., Amin, M. R., Rashed, A., Das, K. C., Keya, C. A., & Salimullah, M. (n.d.). Novel Mutations in NSP1 and PLPro of SARS-CoV-2 NIB-1 Genome Mount for Effective Therapeutics. https://doi.org/10.1101/2020.12.02.408229	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017899/	Novel Mutations in NSP1 and PLPro of SARS-CoV-2 NIB-1 Genome Mount for Effective Therapeutics	Mohammad Uzzal Hossain, Arittra Bhattacharjee, Md. Tabassum Hossain Emon, Zeshan Mahmud Chowdhury, Md. Golam Mosaib, Md. Moniruzzaman, Md. Hadisur Rahman, Md. Nazrul Islam, Irfan Ahmed, Md. Ruhul Amin, Asif Rashed, Keshob Chandra Das, Chaman Ara Keya, Md. Salimullah	Asia(0.000012)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54ad6dcd0a2abef78f5a&&LOCATION=1:5246:G:T
17858A>G	1	17858	A	G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	Y1464C	None	-	None	0	Deleterious	1.65	2.24049	1	RNA_virus_helicase_C_Terminal	NA	NA	NA	NA	NA	NA	orf1ab_TVDSSQGSEY	0.02	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0000000	Computational Analysis	Computational Mutation analysis	Potential alterations in protein structure thereby causing alterations in binding ability	Weber, S., Ramirez, C., & Doerfler, W. (2020). Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world. Virus research, 289, 198170. https://doi.org/10.1016/j.virusres.2020.198170	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513834/	Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world	Stefanie Weber, Christina Ramirez and Walter Doerflera		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef81e00&&LOCATION=1:17858:A:G
9743T>C	1	9743	T	C	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	Y3160H	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage																																		
17858A<G	1	17858	A	G	ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Single Nucleotide Variation	Non Synonymous SNV	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	Y541C	None	-	None	0	Deleterious	1.65	2.24049	1	NA	RNA_virus_helicase_C_Terminal	NA	NA	NA	NA	NA	orf1ab_TVDSSQGSEY	0.02	NA	NA	NA	NA	NA	NA	NA	No co - mutations reported	NA	0.0142880	Computational Analysis	Topology-based machine learning prediction of protein-protein binding affinity changes and protein folding stability changes	Y541C mutation was increasingly found in the United States along with few co-occurring mutations. Once mutations 17858A>G-(Y541C) and 17747C>T-(P504L) were first found in the United States, they had a rapid increase in the first two weeks. In early March, the ratio of both mutations start to decrease and approach zero after May 19, 2020, suggesting that mutations 17858A>G-(Y541C) and 17747C>T-(P504L) may hinder the transmission of SARS-CoV-2. It is also noted that 17858A>G-(Y541C) and 17747C>T-(P504L) never show up with 23403A>G-(D614G) in more than a thousand SNP variant, which provides a side evidence that these two mutations may inhibit the contagiousness of SARS-CoV-2.##Predicted changes in the α-helix, β-sheet, and β-turn secondary structures of the protein near these sites	Wang, R., Chen, J., Gao, K., Hozumi, Y., Yin, C., & Wei, G. (2020). Characterizing SARS-CoV-2 mutations in the United States. Research Square. https://doi.org/10.21203/rs.3.rs-49671/v1##Cao, C., He, L., Tian, Y., Qin, Y., Sun, H., Ding, W., Gui, L., & Wu, P. (2021). Molecular epidemiology analysis of early variants of SARS-CoV-2 reveals the potential impact of mutations P504L and Y541C (NSP13) in the clinical COVID-19 outcomes. Infection, Genetics and Evolution, 92, 104831. https://doi.org/10.1016/j.meegid.2021.104831	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430589/##https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010360/	Characterizing SARS-CoV-2 mutations in the United States##Molecular epidemiology analysis of early variants of SARS-CoV-2 reveals the potential impact of mutations P504L and Y541C (NSP13) in the clinical COVID-19 outcomes	Rui Wang, Jiahui Chen, Kaifu Gao, Yuta Hozumi , Changchuan Yin, and Guo-Wei Wei##Canhui Cao,a,b Liang He,a,c Yuan Tian,a,c Yu Qin,a,c Haiyin Sun,a,c Wencheng Ding,a,c Lingli Gui,d,⁎⁎ and Peng Wua,c,⁎	Asia(0.000231);Europe(0.000095);Oceania(0.013962)	https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	http://clingen.igib.res.in/indicov/showdata.php?id=5f8d54af6dcd0a2abef81e00&&LOCATION=1:17858:A:G
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Deletion	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	Δ3675-3677	B.1.1.7##B.1.351##P.1##B.1.525	https://outbreak.info/situation-reports?pango=B.1.1.7##https://outbreak.info/situation-reports?pango=B.1.351##https://outbreak.info/situation-reports?pango=P.1##https://outbreak.info/situation-reports?pango=B.1.525	Characteristic mutation of B.1.1.7,B.1.351 and P.1,B.1.525 lineages																												Ramanathan, M., Ferguson, I. D., Miao, W., & Khavari, P. A. (2021). SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity. The Lancet. Infectious diseases, S1473-3099(21)00262-0. Advance online publication. https://doi.org/10.1016/S1473-3099(21)00262-0##Hodgson, D., Flasche, S., Jit, M., Kucharski, A. J., CMMID COVID-19 Working Group, & Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group (2021). The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26(20), 10.2807/1560-7917.ES.2021.26.20.2100428. https://doi.org/10.2807/1560-7917.ES.2021.26.20.2100428##Dejnirattisai, W., Zhou, D., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H., Tuekprakhon, A., Nutalai, R., Wang, B., López-Camacho, C., Slon-Campos, J., Walter, T. S., Skelly, D., Costa Clemens, S. A., Naveca, F. G., Nascimento, V., Nascimento, F., Fernandes da Costa, C., … Screaton, G. R. (2021). Antibody evasion by the P.1 strain of SARS-CoV-2. Cell, S0092-8674(21)00428-1. Advance online publication. https://doi.org/10.1016/j.cell.2021.03.055##Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D., Mishra, S., Crispim, M., Sales, F., Hawryluk, I., McCrone, J. T., Hulswit, R., Franco, L., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C., Manuli, E. R., Pereira, R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science (New York, N.Y.), 372(6544), 815–821. https://doi.org/10.1126/science.abh2644##Wang, P., Casner, R. G., Nair, M. S., Wang, M., Yu, J., Cerutti, G., Liu, L., Kwong, P. D., Huang, Y., Shapiro, L., & Ho, D. D. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell host & microbe, 29(5), 747–751.e4. https://doi.org/10.1016/j.chom.2021.04.007##Romano, C. M., Felix, A. C., Paula, A. V., Jesus, J. G., Andrade, P. S., Cândido, D., Oliveira, F. M., Ribeiro, A. C., Silva, F., Inemami, M., Costa, A. A., Leal, C., Figueiredo, W. M., Pannuti, C. S., Souza, W. M., Faria, N. R., & Sabino, E. C. (2021). SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 63, e36. https://doi.org/10.1590/S1678-9946202163036##de Siqueira, I. C., Camelier, A. A., Maciel, E., Nonaka, C., Neves, M., Macêdo, Y., de Sousa, K., Araujo, V. C., Paste, A. A., Souza, B., & Gräf, T. (2021). Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, S1201-9712(21)00411-2. Advance online publication. https://doi.org/10.1016/j.ijid.2021.05.010##Pereira, F., Tosta, S., Lima, M. M., Reboredo de Oliveira da Silva, L., Nardy, V. B., Gómez, M., Lima, J. G., Fonseca, V., de Oliveira, T., Lourenço, J., Alcantara, L., Giovanetti, M., & Leal, A. (2021). Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report. Journal of medical virology, 10.1002/jmv.27086. Advance online publication. https://doi.org/10.1002/jmv.27086##Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Taiwo, B. O., Hultquist, J. F., & Lorenzo-Redondo, R. (2021). High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria. medRxiv : the preprint server for health sciences, 2021.04.09.21255206. https://doi.org/10.1101/2021.04.09.21255206	https://www.sciencedirect.com/science/article/pii/S1473309921002620?via%3Dihub##https://pubmed.ncbi.nlm.nih.gov/34018481/##https://pubmed.ncbi.nlm.nih.gov/33852911/##https://pubmed.ncbi.nlm.nih.gov/33853970/##https://pubmed.ncbi.nlm.nih.gov/33887205/##https://pubmed.ncbi.nlm.nih.gov/33909850/##https://pubmed.ncbi.nlm.nih.gov/33989776/##https://pubmed.ncbi.nlm.nih.gov/33990970/##https://pubmed.ncbi.nlm.nih.gov/33880483/	SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity##The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant##Antibody evasion by the P.1 strain of SARS-CoV-2##Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil##Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization##SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil##Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil##Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report##High prevalence of SARS-CoV-2 B.1.1.7 (UK variant) and the novel B.1.5.2.5 lineage in Oyo State, Nigeria	Author links open overlay panelMuthukumarRamanathana†Ian DFergusonb†WeiliMiaob†Paul AKhavarib##David Hodgson 1, Stefan Flasche 1, Mark Jit 1, Adam J Kucharski 1, CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID) COVID-19 Working Group##Wanwisa Dejnirattisai 1, Daming Zhou 2, Piyada Supasa 3, Chang Liu 4, Alexander J Mentzer 5, Helen M Ginn 6, Yuguang Zhao 2, Helen M E Duyvesteyn 2, Aekkachai Tuekprakhon 3, Rungtiwa Nutalai 3, Beibei Wang 3, César López-Camacho 3, Jose Slon-Campos 3, Thomas S Walter 2, Donal Skelly 7, Sue Ann Costa Clemens 8, Felipe Gomes Naveca 9, Valdinete Nascimento 9, Fernanda Nascimento 9, Cristiano Fernandes da Costa 10, Paola Cristina Resende 11, Alex Pauvolid-Correa 12, Marilda M Siqueira 11, Christina Dold 13, Robert Levin 14, Tao Dong 15, Andrew J Pollard 13, Julian C Knight 16, Derrick Crook 17, Teresa Lambe 18, Elizabeth Clutterbuck 13, Sagida Bibi 13, Amy Flaxman 18, Mustapha Bittaye 18, Sandra Belij-Rammerstorfer 18, Sarah C Gilbert 18, Miles W Carroll 19, Paul Klenerman 20, Eleanor Barnes 20, Susanna J Dunachie 21, Neil G Paterson 6, Mark A Williams 6, David R Hall 6, Ruben J G Hulswit 2, Thomas A Bowden 2, Elizabeth E Fry 2, Juthathip Mongkolsapaya 22, Jingshan Ren 23, David I Stuart 24, Gavin R Screaton 25##Nuno R Faria # 1 2 3 4, Thomas A Mellan # 5 2, Charles Whittaker # 5 2, Ingra M Claro # 3 6, Darlan da S Candido # 3 4, Swapnil Mishra # 5 2, Myuki A E Crispim 7 8, Flavia C S Sales 3 6, Iwona Hawryluk 5 2, John T McCrone 9, Ruben J G Hulswit 10, Lucas A M Franco 3 6, Mariana S Ramundo 3 6, Jaqueline G de Jesus 3 6, Pamela S Andrade 11, Thais M Coletti 3 6, Giulia M Ferreira 12, Camila A M Silva 3 6, Erika R Manuli 3 6, Rafael H M Pereira 13, Pedro S Peixoto 14, Moritz U G Kraemer 4, Nelson Gaburo Jr 15, Cecilia da C Camilo 15, Henrique Hoeltgebaum 16, William M Souza 17, Esmenia C Rocha 3 6, Leandro M de Souza 3 6, Mariana C de Pinho 3 6, Leonardo J T Araujo 18, Frederico S V Malta 19, Aline B de Lima 19, Joice do P Silva 19, Danielle A G Zauli 19, Alessandro C de S Ferreira 19, Ricardo P Schnekenberg 20, Daniel J Laydon 5 2, Patrick G T Walker 5 2, Hannah M Schlüter 16, Ana L P Dos Santos 21, Maria S Vidal 21, Valentina S Del Caro 21, Rosinaldo M F Filho 21, Helem M Dos Santos 21, Renato S Aguiar 22, José L Proença-Modena 23, Bruce Nelson 24, James A Hay 25 26, Mélodie Monod 16, Xenia Miscouridou 16, Helen Coupland 5 2, Raphael Sonabend 5 2, Michaela Vollmer 5 2, Axel Gandy 16, Carlos A Prete Jr 27, Vitor H Nascimento 27, Marc A Suchard 28, Thomas A Bowden 10, Sergei L K Pond 29, Chieh-Hsi Wu 30, Oliver Ratmann 16, Neil M Ferguson 5 2, Christopher Dye 4, Nick J Loman 31, Philippe Lemey 32, Andrew Rambaut 9, Nelson A Fraiji 7 33, Maria do P S S Carvalho 7 34, Oliver G Pybus # 4 35, Seth Flaxman # 16, Samir Bhatt # 1 2 36, Ester C Sabino # 37 6##Pengfei Wang 1, Ryan G Casner 2, Manoj S Nair 3, Maple Wang 3, Jian Yu 3, Gabriele Cerutti 2, Lihong Liu 3, Peter D Kwong 4, Yaoxing Huang 3, Lawrence Shapiro 5, David D Ho 6##Camila Malta Romano 1 2, Alvina Clara Felix 2, Anderson Vicente de Paula 2, Jaqueline Góes de Jesus 2, Pamela S Andrade 2, Darlan Cândido 2 3, Franciane M de Oliveira 2, Andreia C Ribeiro 4, Francini C da Silva 4, Marta Inemami 4, Angela Aparecida Costa 4, Cibele O D Leal 2, Walter Manso Figueiredo 4, Claudio Sergio Pannuti 2, William M de Souza 5, Nuno Rodrigues Faria 6 7, Ester Cerdeira Sabino 2 6##Isadora Cristina de Siqueira 1, Aquiles Assunção Camelier 2, Elves A P Maciel 3, Carolina Kymie Vasques Nonaka 4, Margarida Celia L C Neves 5, Yasmin Santos Freitas Macêdo 6, Karoline Almeida Félix de Sousa 6, Victor Costa Araujo 7, Aurea Angelica Paste 5, Bruno Solano de Freitas Souza 8, Tiago Gräf 6##Felicidade Pereira 1, Stephane Tosta 1 2, Maricélia Maia Lima 3, Luciana Reboredo de Oliveira da Silva 1, Vanessa Brandão Nardy 1, Marcela Kelly Astete Gómez 1, Jaqueline Gomes Lima 1, Vagner Fonseca 2 4 5, Tulio de Oliveira 5, Jose Lourenço 6, Luiz Carlos Junior Alcantara 2 7, Marta Giovanetti 2 7, Arabela Leal 1##Egon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, Adeola A Fowotade, Ewean C Omoruyi, Johnson A Adeniji, Taylor J Dean, Babafemi O Taiwo, Judd F Hultquist, Ramon Lorenzo-Redondo		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Deletion	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	Δ500-532																												Genomic analysis followed by phylogenetic studies	Experimental	Δ500-532 results in an 11-amino-acid residue deletion of A79PHGHVMVELV89 in the N terminus of SARS-CoV-2 Nsp1.  In this predicted globular N-terminal domain structure, residues in the region corresponding to the Δ500-532 form a central beta-strand, removal of which would likely cause complete destruction of the barrel fold. This N-terminal deletion in Nsp1 may affect its function in mRNA and protein metabolic processes.	Lin, J. W., Tang, C., Wei, H. C., Du, B., Chen, C., Wang, M., Zhou, Y., Yu, M. X., Cheng, L., Kuivanen, S., Ogando, N. S., Levanov, L., Zhao, Y., Li, C. L., Zhou, R., Li, Z., Zhang, Y., Sun, K., Wang, C., Chen, L., … Chen, L. (2021). Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response. Cell host & microbe, 29(3), 489–502.e8. https://doi.org/10.1016/j.chom.2021.01.015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846228/#mmc9	Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response	Jing-Wen Lin , Chao Tang , Han-Cheng Wei , Baowen Du , Chuan Chen , Minjin Wang , Yongzhao Zhou , Ming-Xia Yu , Lu Cheng , Suvi Kuivanen , Natacha S Ogando , Lev Levanov , Yuancun Zhao , Chang-Ling Li , Ran Zhou , Zhidan Li , Yiming Zhang , Ke Sun , Chengdi Wang , Li Chen , Xia Xiao , Xiuran Zheng , Sha-Sha Chen , Zhen Zhou , Ruirui Yang , Dan Zhang , Mengying Xu , Junwei Song , Danrui Wang , Yupeng Li , ShiKun Lei , Wanqin Zeng , Qingxin Yang , Ping He , Yaoyao Zhang , Lifang Zhou , Ling Cao , Feng Luo , Huayi Liu , Liping Wang , Fei Ye , Ming Zhang , Mengjiao Li , Wei Fan , Xinqiong Li , Kaiju Li , Bowen Ke , Jiannan Xu , Huiping Yang , Shusen He , Ming Pan , Yichen Yan , Yi Zha , Lingyu Jiang , Changxiu Yu , Yingfen Liu , Zhiyong Xu , Qingfeng Li , Yongmei Jiang , Jiufeng Sun , Wei Hong , Hongping Wei , Guangwen Lu , Olli Vapalahti , Yunzi Luo , Yuquan Wei , Thomas Connor , Wenjie Tan , Eric J Snijder , Teemu Smura , Weimin Li , Jia Geng , Binwu Ying , Lu Chen 		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Deletion	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	Δ500-532																												Δ500-532, an in-frame deletion of Nsp1 coding region, is negatively correlated with ESR, serum IFN-β level, and CD3+CD8+ T cell counts in the blood, also showed significant enrichment with non-severe (p adjust = 0.0071) but not severe traits .	Association analysis	Potential modulations in type I interferon response	Lin, J. W., Tang, C., Wei, H. C., Du, B., Chen, C., Wang, M., Zhou, Y., Yu, M. X., Cheng, L., Kuivanen, S., Ogando, N. S., Levanov, L., Zhao, Y., Li, C. L., Zhou, R., Li, Z., Zhang, Y., Sun, K., Wang, C., Chen, L., … Chen, L. (2021). Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response. Cell host & microbe, 29(3), 489–502.e8. https://doi.org/10.1016/j.chom.2021.01.015	https://pubmed.ncbi.nlm.nih.gov/33548198/	Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response	Jing-Wen Lin , Chao Tang , Han-Cheng Wei , Baowen Du , Chuan Chen , Minjin Wang , Yongzhao Zhou , Ming-Xia Yu , Lu Cheng , Suvi Kuivanen , Natacha S Ogando , Lev Levanov , Yuancun Zhao , Chang-Ling Li , Ran Zhou , Zhidan Li , Yiming Zhang , Ke Sun , Chengdi Wang , Li Chen , Xia Xiao , Xiuran Zheng , Sha-Sha Chen , Zhen Zhou , Ruirui Yang , Dan Zhang , Mengying Xu , Junwei Song , Danrui Wang , Yupeng Li , ShiKun Lei , Wanqin Zeng , Qingxin Yang , Ping He , Yaoyao Zhang , Lifang Zhou , Ling Cao , Feng Luo , Huayi Liu , Liping Wang , Fei Ye , Ming Zhang , Mengjiao Li , Wei Fan , Xinqiong Li , Kaiju Li , Bowen Ke , Jiannan Xu , Huiping Yang , Shusen He , Ming Pan , Yichen Yan , Yi Zha , Lingyu Jiang , Changxiu Yu , Yingfen Liu , Zhiyong Xu , Qingfeng Li , Yongmei Jiang , Jiufeng Sun , Wei Hong , Hongping Wei , Guangwen Lu , Olli Vapalahti , Yunzi Luo , Yuquan Wei , Thomas Connor , Wenjie Tan , Eric J Snijder , Teemu Smura , Weimin Li , Jia Geng , Binwu Ying , Lu Chen 		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Deletion	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	Δ509-523																												Genomic analysis followed by phylogenetic studies	Experimental	This N-terminal deletion in Nsp1 may affect its function in mRNA and protein metabolic processes.	Lin, J. W., Tang, C., Wei, H. C., Du, B., Chen, C., Wang, M., Zhou, Y., Yu, M. X., Cheng, L., Kuivanen, S., Ogando, N. S., Levanov, L., Zhao, Y., Li, C. L., Zhou, R., Li, Z., Zhang, Y., Sun, K., Wang, C., Chen, L., … Chen, L. (2021). Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response. Cell host & microbe, 29(3), 489–502.e8. https://doi.org/10.1016/j.chom.2021.01.015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846228/#mmc9	Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response	Jing-Wen Lin , Chao Tang , Han-Cheng Wei , Baowen Du , Chuan Chen , Minjin Wang , Yongzhao Zhou , Ming-Xia Yu , Lu Cheng , Suvi Kuivanen , Natacha S Ogando , Lev Levanov , Yuancun Zhao , Chang-Ling Li , Ran Zhou , Zhidan Li , Yiming Zhang , Ke Sun , Chengdi Wang , Li Chen , Xia Xiao , Xiuran Zheng , Sha-Sha Chen , Zhen Zhou , Ruirui Yang , Dan Zhang , Mengying Xu , Junwei Song , Danrui Wang , Yupeng Li , ShiKun Lei , Wanqin Zeng , Qingxin Yang , Ping He , Yaoyao Zhang , Lifang Zhou , Ling Cao , Feng Luo , Huayi Liu , Liping Wang , Fei Ye , Ming Zhang , Mengjiao Li , Wei Fan , Xinqiong Li , Kaiju Li , Bowen Ke , Jiannan Xu , Huiping Yang , Shusen He , Ming Pan , Yichen Yan , Yi Zha , Lingyu Jiang , Changxiu Yu , Yingfen Liu , Zhiyong Xu , Qingfeng Li , Yongmei Jiang , Jiufeng Sun , Wei Hong , Hongping Wei , Guangwen Lu , Olli Vapalahti , Yunzi Luo , Yuquan Wei , Thomas Connor , Wenjie Tan , Eric J Snijder , Teemu Smura , Weimin Li , Jia Geng , Binwu Ying , Lu Chen 		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
	1				ORF1ab	43740578	https://www.ncbi.nlm.nih.gov/gene/43740578	NC_045512.2:266-21555	Deletion	Deletion	ORF1ab Polyprotein	7096 amino acids	QHD43415.1	https://www.ncbi.nlm.nih.gov/protein/QHD43415.1	Δ518-520																												Genomic analysis followed by phylogenetic studies	Experimental	This N-terminal deletion in Nsp1 may affect its function in mRNA and protein metabolic processes.	Lin, J. W., Tang, C., Wei, H. C., Du, B., Chen, C., Wang, M., Zhou, Y., Yu, M. X., Cheng, L., Kuivanen, S., Ogando, N. S., Levanov, L., Zhao, Y., Li, C. L., Zhou, R., Li, Z., Zhang, Y., Sun, K., Wang, C., Chen, L., … Chen, L. (2021). Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response. Cell host & microbe, 29(3), 489–502.e8. https://doi.org/10.1016/j.chom.2021.01.015	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846228/#mmc9	Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response	Jing-Wen Lin , Chao Tang , Han-Cheng Wei , Baowen Du , Chuan Chen , Minjin Wang , Yongzhao Zhou , Ming-Xia Yu , Lu Cheng , Suvi Kuivanen , Natacha S Ogando , Lev Levanov , Yuancun Zhao , Chang-Ling Li , Ran Zhou , Zhidan Li , Yiming Zhang , Ke Sun , Chengdi Wang , Li Chen , Xia Xiao , Xiuran Zheng , Sha-Sha Chen , Zhen Zhou , Ruirui Yang , Dan Zhang , Mengying Xu , Junwei Song , Danrui Wang , Yupeng Li , ShiKun Lei , Wanqin Zeng , Qingxin Yang , Ping He , Yaoyao Zhang , Lifang Zhou , Ling Cao , Feng Luo , Huayi Liu , Liping Wang , Fei Ye , Ming Zhang , Mengjiao Li , Wei Fan , Xinqiong Li , Kaiju Li , Bowen Ke , Jiannan Xu , Huiping Yang , Shusen He , Ming Pan , Yichen Yan , Yi Zha , Lingyu Jiang , Changxiu Yu , Yingfen Liu , Zhiyong Xu , Qingfeng Li , Yongmei Jiang , Jiufeng Sun , Wei Hong , Hongping Wei , Guangwen Lu , Olli Vapalahti , Yunzi Luo , Yuquan Wei , Thomas Connor , Wenjie Tan , Eric J Snijder , Teemu Smura , Weimin Li , Jia Geng , Binwu Ying , Lu Chen 		https://genome.ucsc.edu/cgi-bin/hgTracks?db=wuhCor1&lastVirtModeType=default&lastVirtModeExtraState=&virtModeType=default&virtMode=0&nonVirtPosition=&position=NC_045512v2%3A266%2D21555&hgsid=950344573_A9vhn3kpWNAevyURQKIFZD7Av59E	
29580C>T		29580	C	T	ORF10					Non Synonymous SNV					A8V	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage																																		
					ORF3b				Stoploss	Stop gain					∗23Q																												Genomic sequence analyses followed by association with clinical phenotypes of patient	Computational Prediction and association analysis	ORF3b gene was extended because of the loss of the first premature stop codon (∗23Q). Both cases were part of a family cluster in Quito, Ecuador, and presented with particularly severe COVID-19 symptoms, including quick clinical deterioration and lower levels of oxygen saturation in blood. One of the patients presented elevated levels of D-dimer, a sign of hypercoagulability and inflammation in COVID-19 patients, and ultimately succumbed to disease.	Konno, Y., Kimura, I., Uriu, K., Fukushi, M., Irie, T., Koyanagi, Y., Sauter, D., Gifford, R. J., USFQ-COVID19 Consortium, Nakagawa, S., & Sato, K. (2020). SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant. Cell reports, 32(12), 108185. https://doi.org/10.1016/j.celrep.2020.108185	https://pubmed.ncbi.nlm.nih.gov/32941788/	SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant				
					ORF7a					Stop gain					*122R	B.1.616	https://outbreak.info/situation-reports?pango=B.1.616	Characteristic mutation of B.1.616 lineage																																		
Δ27387-27756					ORF7a				Deletion	Deletion					370-nucleotide deletion																												Experimental	This major deletion was confirmed independently by long-range PCR and Sanger sequencing (with primers 5′-AACTCGTAATCGGAGCTGTGA-3′ and 5′-TGTCATTCTCCTAAGAAGCTATTAAA-3′).	The entire ORF7a and the original stop codon for ORF6 were lost. The latter resulted in an extension of the Orf6 protein by 2 amino acids. Furthermore, ORF7b was potentially extended in the 5′ direction by 27 nucleotides due to the occurrence of an in-frame start codon. The repeated reemergence of ORF7a deletion variants may suggest that the accessory protein could impose a fitness cost that exceeds the benefits of its canonical function in certain situations.	Tse, H., Wong, S. C., Ip, K. F., Cheng, V. C., To, K. K., Lung, D. C., & Choi, G. K. (2021). Genome Sequences of Three SARS-CoV-2 ORF7a Deletion Variants Obtained from Patients in Hong Kong. Microbiology resource announcements, 10(15), e00251-21. https://doi.org/10.1128/MRA.00251-21	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050975/	Genome Sequences of Three SARS-CoV-2 ORF7a Deletion Variants Obtained from Patients in Hong Kong				
					ORF7a					Non Synonymous SNV					V82A	B.1.617.1##B.1.617.3	https://outbreak.info/situation-reports?pango=B.1.617.1##https://outbreak.info/situation-reports?pango=B.1.617.3	Characteristic mutation of B.1.671.1 and B.1.617.3 lineages 																												Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ciab411. Advance online publication. https://doi.org/10.1093/cid/ciab411	https://pubmed.ncbi.nlm.nih.gov/33961693/	Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees	Pragya D Yadav 1, Gajanan N Sapkal 1, Priya Abraham 1, Raches Ella 2, Gururaj Deshpande 1, Deepak Y Patil 1, Dimpal A Nyayanit 1, Nivedita Gupta 3, Rima R Sahay 1, Anita M Shete 1, Samiran Panda 3, Balram Bhargava 3, V Krishna Mohan 2			